Personensuche

Personensuche

Bitte geben Sie den Namen der gesuchten Person ein.

Es wurde 1 Person gefunden.

Prof. Dr. med. Dirk Schadendorf

Institut für Dermatologie der Medizinischen Fakultät am Universitätsklinikum Essen

Anschrift
Hufelandstraße 55
45122 Essen
Telefon
+49 201 723 2460
Webseite
http://www.uk-essen.de/index.php?id=hautklinik

Funktionen

  • Direktor/in, Klinik für Dermatologie

Die folgenden Publikationen sind in der Online-Universitätsbibliographie der Universität Duisburg-Essen verzeichnet. Weitere Informationen finden Sie gegebenenfalls auch auf den persönlichen Webseiten der Person.

    Artikel in Zeitschriften

  • Karreman, Matthia A.; Bauer, Alexander T.; Solecki, Gergely; Berghoff, Anna S.; Mayer, Chanté D; Frey, Katharina; Hebach, Nils; Feinauer, Manuel J.; Schieber, Nicole L.; Tehranian, Cedric; Mercier, Luc; Singhal, Mahak; Venkataramani, Varun; Schubert, Marc C.; Hinze, Daniel; Hölzel, Michael; Helfrich, Iris; Schadendorf, Dirk; Schneider, Stefan W.; Westphal, Dana; Augustin, Hellmut G.; Goetz, Jacky G.; Schwab, Yannick; Wick, Wolfgang; Winkler, Frank
    Active Remodeling of Capillary Endothelium via Cancer Cell-Derived MMP9 Promotes Metastatic Brain Colonization
    In: Cancer Research Jg. 83 (2023) Nr. 8, S. 1299 - 1314
    ISSN: 1538-7445; 0008-5472
    Online Volltext: dx.doi.org/
  • Weber, Jeffrey S.; Schadendorf, Dirk; Del Vecchio, Michele; Larkin, James; Atkinson, Victoria; Schenker, Michael; Pigozzo, Jacopo; Gogas, Helen; Dalle, Stéphane; Meyer, Nicolas; Ascierto, Paolo A.; Sandhu, Shahneen; Eigentler, Thomas; Gutzmer, Ralf; Hassel, Jessica C.; Robert, Caroline; Carlino, Matteo S.; Di Giacomo, Anna Maria; Butler, Marcus O.; Muñoz-Couselo, Eva; Brown, Michael P.; Rutkowski, Piotr; Haydon, Andrew; Grob, Jean-Jacques; Schachter, Jacob; Queirolo, Paola; De La Cruz-Merino, Luis; Van Der Westhuizen, Andre; Menzies, Alexander M.; Re, Sandra; Bas, Tuba; De Pril, Veerle; Braverman, Julia; Tenney, Daniel J.; Tang, Hao; Long, Georgina V.
    Adjuvant Therapy of Nivolumab Combined with Ipilimumab Versus Nivolumab Alone in Patients with Resected Stage IIIB-D or Stage IV Melanoma (CheckMate 915)
    In: Journal of Clinical Oncology (JCO) Jg. 41 (2023) Nr. 3, S. 517 - 527
    ISSN: 0732-183X; 1527-7755
    Online Volltext: dx.doi.org/ Online Volltext (Open Access)
  • Nascentes Melo, Luiza Martins; Kumar, Suresh; Riess, Valeria; Szylo, Krystina J.; Eisenburger, Robin; Schadendorf, Dirk; Ubellacker, Jessalyn M.; Tasdogan, Alpaslan
    Advancements in melanoma cancer metastasis models
    In: Pigment Cell and Melanoma Research Jg. 36 (2023) Nr. 2, S. 206 - 223
    ISSN: 1755-1471; 1755-148X
    Online Volltext: dx.doi.org/ (Open Access)
  • van Akkooi, Alexander C.J.; Schadendorf, Dirk; Eggermont, Alexander M.M.
    Alternatives and reduced need for sentinel lymph node biopsy (SLNB) staging for melanoma
    In: European Journal of Cancer (EJC) Jg. 182 (2023) S. 163 - 169
    ISSN: 1879-0852; 0959-8049; 1879-2995
    Online Volltext: dx.doi.org/
  • Küppers, Ralf; Schadendorf, Dirk; ICGC/TCGA Pan-Cancer Analysis of Whole Genomes Consortium, et.al.
    Author Correction: Pan-cancer analysis of whole genomes
    In: Nature Jg. 614 (2023) Nr. 7948, S. E39
    ISSN: 0028-0836; 1476-4687
    Online Volltext: dx.doi.org/ (Open Access)
  • Franklin, Cindy; Mohr, Peter; Bluhm, Leonie; Meier, Friedegund; Garzarolli, Marlene; Weichenthal, Michael; Kähler, Katharina; Grimmelmann, Imke; Gutzmer, Ralf; Utikal, Jochen; Terheyden, Patrick; Herbst, Rudolf; Haferkamp, Sebastian; Pfoehler, Claudia; Forschner, Andrea; Leiter, Ulrike; Ziller, Fabian; Meiss, Frank; Ulrich, Jens; Kreuter, Alexander; Gebhardt, Christoffer; Welzel, Julia; Schilling, Bastian; Kaatz, Martin; Scharfetter-Kochanek, Karin; Dippel, Edgar; Nashan, Dorothee; Sachse, Michael; Weishaupt, Carsten; Löffler, Harald; Gambichler, Thilo; Loquai, Carmen; Heinzerling, Lucie; Grabbe, Stephan; Debus, Dirk; Schley, Gaston; Hassel, Jessica C.; Weyandt, Gerhard; Trommer, Maike; Lodde, Georg; Placke, Jan-Malte; Zimmer, Lisa; Livingstone, Elisabeth; Becker, Jürgen Christian; Horn, Susanne; Schadendorf, Dirk; Ugurel, Selma
    Brain metastasis and survival outcomes after first-line therapy in metastatic melanoma: a multicenter DeCOG study on 1704 patients from the prospective skin cancer registry ADOREG
    In: Journal for ImmunoTherapy of Cancer Jg. 11 (2023) Nr. 4,
    ISSN: 2051-1426
    Online Volltext: dx.doi.org/ (Open Access)
  • Lodde, Georg; Krefting, Frederik; Placke, Jan-Malte; Schneider, Lea; Fiedler, Melanie; Dittmer, Ulf; Becker, Jürgen; Hölsken, Stefanie; Schadendorf, Dirk; Ugurel, Selma; Sondermann, Wiebke
    COVID-19 vaccination in psoriasis patients receiving systemic treatment : A prospective single-center study
    In: Frontiers in Immunology Jg. 14 (2023) S. 1107438
    ISSN: 1664-3224
    Online Volltext: dx.doi.org/ (Open Access)
  • Mavarani, Laven; Albayrak-Rena, Sarah; Potthoff, Anja; Hower, Martin; Dolff, Sebastian; Sammet, Stefanie; Maischack, Felix; Schadendorf, Dirk; Schmidt, Börge; Esser, Stefan; HIV HEART AGING Study
    Changes in body mass index, weight, and waist-to-hip ratio over five years in HIV-positive individuals in the HIV Heart Aging Study compared to the general population
    In: Infection - A Journal of Infectious Disease (2023) in press
    ISSN: 1439-0973; 0300-8126
    Online Volltext: dx.doi.org/ (Open Access)
  • Lodde, Georg C.; Jansen, Philipp; Herbst, Rudolf; Terheyden, Patrick; Utikal, Jochen; Pföhler, Claudia; Ulrich, Jens; Kreuter, Alexander; Mohr, Peter; Gutzmer, Ralf; Meier, Friedegund; Dippel, Edgar; Weichenthal, Michael; Sucker, Antje; Placke, Jan-Malte; Zaremba, Anne; Albrecht, Lea Jessica; Kowall, Bernd; Galetzka, Wolfgang; Becker, Jürgen C.; Tasdogan, Alpaslan; Zimmer, Lisa; Livingstone, Elisabeth; Hadaschik, Eva; Schadendorf, Dirk; Ugurel, Selma; Griewank, Klaus
    Characterisation and outcome of RAC1 mutated melanoma
    In: European Journal of Cancer (EJC) Jg. 183 (2023) S. 1 - 10
    ISSN: 1879-0852; 0959-8049; 1879-2995
    Online Volltext: dx.doi.org/
  • Hench, Juergen; Mihic-Probst, Daniela; Agaimy, Abbas; Frank, Stephan; Meyer, Peter; Hultschig, Claus; Simi, Sara; Alos, Lucia; Balamurugan, Thiagarajah; Blokx, Willeke; Bosisio, Francesca; Cappellesso, Rocco; Griewank, Klaus; Hadaschik, Eva; van Kempen, Leon C.; Kempf, Werner; Lentini, Maria; Mazzucchelli, Luca; Rinaldi, Gaetana; Rutkowski, Piotr; Schadendorf, Dirk; Schilling, Bastian; Szumera-Cieckiewicz, Anna; van den Oord, Joost; Mandalà, Mario; Massi, Daniela
    Clinical, histopathological and molecular features of dedifferentiated melanomas : An EORTC Melanoma Group Retrospective Analysis
    In: European Journal of Cancer (EJC) Jg. 187 (2023) S. 7 - 14
    ISSN: 1879-0852; 0959-8049; 1879-2995
    Online Volltext: dx.doi.org/
  • Philip, Manuel; Puppel, Sven Holger; Stiller, Mathias; Paschen, Annette; Rösch, Alexander; Zaremba, Anne; Schadendorf, Dirk; Horn, Susanne
    Database for queries of melanoma cohorts with molecular and clinical data
    In: Pigment Cell and Melanoma Research Jg. 36 (2023) Nr. 2, S. 252 - 258
    ISSN: 1755-1471; 1755-148X
    Online Volltext: dx.doi.org/ (Open Access)
  • Jansen, Philipp; Baguer, Daniel Otero; Duschner, Nicole; Arrastia, Jean Le'Clerc; Schmidt, Maximilian; Landsberg, Jennifer; Wenzel, Jörg; Schadendorf, Dirk; Hadaschik, Eva; Maass, Peter; Schaller, Jörg; Griewank, Klaus
    Deep learning detection of melanoma metastases in lymph nodes
    In: European Journal of Cancer (EJC) Jg. 188 (2023) S. 161 - 170
    ISSN: 1879-0852; 0959-8049; 1879-2995
    Online Volltext: dx.doi.org/
  • Wong, Selina K.; Blum, Steven M.; Sun, Xiaopeng; Da Silva, Inês P.; Zubiri, Leyre; Ye, Fei; Bai, Kun; Zhang, Kevin; Ugurel, Selma; Zimmer, Lisa; Livingstone, Elisabeth; Schadendorf, Dirk; Serra-Bellver, Patricio; Muñoz-Couselo, Eva; Ortiz, Carolina; Lostes, Julia; Huertas, Roberto M.; Arance, Ana; Pickering, Lisa; Long, Georgina V.; Carlino, Matteo S.; Buchbinder, Elizabeth I.; Vázquez-Cortés, Leticia; Jara-Casas, Diego; Márquez-Rodas, Iván; González-Espinoza, Iván R.; Balko, Justin M.; Menzies, Alexander M.; Sullivan, Ryan J.; Johnson, Douglas B.
    Efficacy and safety of immune checkpoint inhibitors in young adults with metastatic melanoma
    In: European Journal of Cancer (EJC) Jg. 181 (2023) S. 188 - 197
    ISSN: 1879-0852; 0959-8049; 1879-2995
    Online Volltext: dx.doi.org/
  • Martins Nascentes Melo, Luiza; Herrera-Rios, Dayana; Hinze, Daniel; Löffek, Stefanie; Oezel, Irem; Turiello, Roberta; Klein, Juliane; Leonardelli, Sonia; Westedt, Isa-Vanessa; Al-Matary, Yahya; Egea-Rodriguez, Sara; Brenzel, Alexandra; Bau, Maja; Sucker, Antje; Hadaschik, Eva; Wirsdörfer, Florian; Hanenberg, Helmut; Uhlenbrock, Niklas; Rauh, Daniel; Poźniak, Joanna; Rambow, Florian; Marine, Jean-Christophe; Effern, Maike; Glodde, Nicole; Schadendorf, Dirk; Jablonska, Jadwiga; Hölzel, Michael; Helfrich, Iris
    Glucocorticoid activation by HSD11B1 limits T cell-driven interferon signaling and response to PD-1 blockade in melanoma
    In: Journal for ImmunoTherapy of Cancer Jg. 11 (2023) Nr. 4,
    ISSN: 2051-1426
    Online Volltext: dx.doi.org/ (Open Access)
  • Stupia, Simone; Heeke, Christina; Brüggemann, Alicia; Zaremba-Montenari, Anne; Thier, Beatrice; Kretz, Julia; Sucker, Antje; Philip, Manuel; Zelinskyy, Gennadiy; Ferrone, Soldano; Rösch, Alexander; Horn, Susanne; Hadaschik, Eva; Schadendorf, Dirk; Trilling, Mirko; Dittmer, Ulf; Griewank, Klaus; Zhao, Fang; Paschen, Annette
    HLA class II loss and JAK1/2 deficiency coevolve in melanoma leading to CD4 T cell and IFNγ cross-resistance
    In: Clinical Cancer Research (2023) in press
    ISSN: 1557-3265; 1078-0432
    Online Volltext: dx.doi.org/
  • Schadendorf, Dirk; Tawbi, Hussein; Lipson, Evan J.; Stephen Hodi, F.; Rutkowski, Piotr; Gogas, Helen; Lao, Christopher D.; Grob, Jean-Jacques; Moshyk, Andriy; Lord-Bessen, Jennifer; Hamilton, Melissa; Guo, Shien; Shi, Ling; Keidel, Sarah; Long, Georgina V.
    Health-related quality of life with nivolumab plus relatlimab versus nivolumab monotherapy in patients with previously untreated unresectable or metastatic melanoma : RELATIVITY-047 trial
    In: European Journal of Cancer (EJC) Jg. 187 (2023) S. 164 - 173
    ISSN: 1879-0852; 0959-8049; 1879-2995
    Online Volltext: dx.doi.org/ (Open Access)
  • Zaremba, Anne; Mohr, Peter; Gutzmer, Ralf; Meier, Friedegund; Pföhler, Claudia; Weichenthal, Michael; Terheyden, Patrick; Forschner, Andrea; Leiter, Ulrike; Ulrich, Jens; Utikal, Jochen; Welzel, Julia; Kaatz, Martin; Gebhardt, Christoffer; Herbst, Rudolf; Sindrilaru, Anca; Dippel, Edgar; Sachse, Michael; Meiss, Frank; Heinzerling, Lucie; Haferkamp, Sebastian; Weishaupt, Carsten; Löffler, Harald; Kreft, Sophia; Griewank, Klaus; Livingstone, Elisabeth; Schadendorf, Dirk; Ugurel, Selma; Zimmer, Lisa
    Immune checkpoint inhibition in patients with NRAS mutated and NRAS wild type melanoma : a multicenter Dermatologic Cooperative Oncology Group study on 637 patients from the prospective skin cancer registry ADOREG
    In: European Journal of Cancer (EJC) Jg. 188 (2023) S. 140 - 151
    ISSN: 1879-0852; 0959-8049; 1879-2995
    Online Volltext: dx.doi.org/
  • Nuñez, Nicolas Gonzalo; Berner, Fiamma; Friebel, Ekaterina; Unger, Susanne; Wyss, Nina; Martinez Gomez, Julia; Purde, Mette-Triin; Niederer, Rebekka; Porsch, Maximilian; Lichtensteiger, Christa; Kramer, Rafaela; Erdmann, Michael; Schmitt, Christina; Heinzerling, Lucie; Abdou, Marie-Therese; Karbach, Julia; Schadendorf, Dirk; Zimmer, Lisa; Ugurel, Selma; Klümper, Niklas; Hölzel, Michael; Power, Laura; Kreutmair, Stefanie; Capone, Mariaelena; Madonna, Gabriele; Cevhertas, Lacin; Heider, Anja; Amaral, Teresa; Hasan Ali, Omar; Bomze, David; Dimitriou, Florentia; Diem, Stefan; Ascierto, Paolo Antonio; Dummer, Reinhard; Jäger, Elke; Driessen, Christoph; Levesque, Mitchell Paul; van de Veen, Willem; Joerger, Markus; Früh, Martin; Becher, Burkhard; Flatz, Lukas
    Immune signatures predict development of autoimmune toxicity in patients with cancer treated with immune checkpoint inhibitors
    In: Med Jg. 4 (2023) Nr. 2, S. 113 - 129.e7
    ISSN: 2666-6340
    Online Volltext: dx.doi.org/ (Open Access)
  • de Braud, Filippo; Dooms, Christophe; Heist, Rebecca S.; Lebbe, Celeste; Wermke, Martin; Gazzah, Anas; Schadendorf, Dirk; Rutkowski, Piotr; Wolf, Jürgen; Ascierto, Paolo A.; Gil-Bazo, Ignacio; Kato, Shumei; Wolodarski, Maria; McKean, Meredith; Muñoz Couselo, Eva; Sebastian, Martin; Santoro, Armando; Cooke, Vesselina; Manganelli, Luca; Wan, Kitty; Gaur, Anil; Kim, Jaeyeon; Caponigro, Giordano; Couillebault, Xuân-Mai; Evans, Helen; Campbell, Catarina D.; Basu, Sumit; Moschetta, Michele; Daud, Adil
    Initial Evidence for the Efficacy of Naporafenib in Combination With Trametinib in NRAS-Mutant Melanoma : Results From the Expansion Arm of a Phase Ib, Open-Label Study
    In: Journal of Clinical Oncology (JCO) Jg. 41 (2023) Nr. 14, S. 2651 - 2660
    ISSN: 0732-183X; 1527-7755
    Online Volltext: dx.doi.org/
  • Lodde, Georg; Leven, Anna-Sophia; Schadendorf, Dirk; Gutzmer, Ralf
    Medikamentöse Therapie des inoperablen Melanoms
    In: Die Onkologie (2023) in press
    ISSN: 2731-7226; 2731-7234
    Online Volltext: dx.doi.org/
  • Schneider, Lucas; Wies, Christoph; Krieghoff-Henning, Eva I.; Bucher, Tabea-Clara; Utikal, Jochen S.; Schadendorf, Dirk; Brinker, Titus J.
    Multimodal integration of image, epigenetic and clinical data to predict BRAF mutation status in melanoma
    In: European Journal of Cancer (EJC) Jg. 183 (2023) S. 131 - 138
    ISSN: 1879-0852; 0959-8049; 1879-2995
    Online Volltext: dx.doi.org/ (Open Access)
  • Placke, Jan-Malte; Mertens, Delphine; Tasdogan, Alpaslan; Chorti, Eleftheria; Schadendorf, Dirk; Ugurel, Selma; Rösch, Alexander; Stoffels, Ingo; Klode, Joachim
    Multispectral optoacoustic tomography to differentiate between lymph node metastases and coronavirus-19 vaccine-associated lymphadenopathy
    In: Journal of the European Academy of Dermatology and Venereology Jg. 37 (2023) Nr. 5: Special issue on melanoma: Immune check point and BRAF‐MEK inhibitors in melanoma, S. 907 - 913
    ISSN: 0926-9959; 1468-3083
    Online Volltext: dx.doi.org/ (Open Access)
  • Garbe, Claus; Dummer, Reinhard; Amaral, Teresa; Amaria, Rodabe N.; Ascierto, Paolo A.; Burton, Elizabeth M.; Dreno, Brigitte; Eggermont, Alexander M. M.; Hauschild, Axel; Hoeller, Christoph; Kaufmann, Roland; Lebbe, Celeste; Mandala, Mario; Menzies, Alexander M.; Moreno, David; Michielin, Olivier; Nathan, Paul; Patel, Sapna P.; Robert, Caroline; Schadendorf, Dirk; Lorigan, Paul C.; Scolyer, Richard A.; Tawbi, Hussein A.; van de Wiel, Bart A.; Blank, Christian; Long, Georgina V.
    Neoadjuvant immunotherapy for melanoma is now ready for clinical practice
    In: Nature Medicine (2023) in press
    ISSN: 1546-170X; 1078-8956
    Online Volltext: dx.doi.org/
  • Fink, Madeleine; Pasche, Saskia; Schmidt, Kira; Tewes, Mitra; Schuler, Martin; Mülley, Bernhard W.; Schadendorf, Dirk; Scherbaum, Norbert; Kowalski, Axel; Skoda, Eva-Maria; Teufel, Martin
    Neurofeedback Treatment Affects Affective Symptoms, But Not Perceived Cognitive Impairment in Cancer Patients : Results of an Explorative Randomized Controlled Trial
    In: Integrative Cancer Therapies Jg. 22 (2023)
    ISSN: 1552-695X; 1534-7354
    Online Volltext: dx.doi.org/ (Open Access)
  • Ascierto, Paolo Antonio; Lipson, Evan J.; Dummer, Reinhard; Larkin, James; Long, Georgina V.; Sanborn, Rachel E.; Chiarion-Sileni, Vanna; Dréno, Brigitte; Dalle, Stéphane; Schadendorf, Dirk; Callahan, Margaret K.; Nyakas, Marta; Atkinson, Victoria; Gomez-Roca, Carlos Alberto; Yamazaki, Naoya; Tawbi, Hussein A.; Sarkis, Naomey; Warad, Deepti; Dolfi, Sonia; Mitra, Priyam; Suryawanshi, Satyendra; Grob, Jean-Jacques
    Nivolumab and Relatlimab in Patients With Advanced Melanoma That Had Progressed on Anti-Programmed Death-1/Programmed Death Ligand 1 Therapy : Results From the Phase I/IIa RELATIVITY-020 Trial
    In: Journal of Clinical Oncology (JCO) Jg. 41 (2023) Nr. 15, S. 2724 - 2735
    ISSN: 0732-183X; 1527-7755
    Online Volltext: dx.doi.org/ (Open Access)
  • Kehrmann, Jan; Koch, Fiona; Zumdick, Skrollan; Höwner, Anna; Best, Lara; Masshöfer, Lars; Scharfenberg, Sarah; Zeschnigk, Michael; Becker, Jürgen C.; Schadendorf, Dirk; Buer, Jan; Rösch, Alexander
    Reduced Staphylococcus Abundance Characterizes the Lesional Microbiome of Actinic Keratosis Patients after Field-Directed Therapies
    In: Microbiology Spectrum (2023) in press
    ISSN: 2165-0497
    Online Volltext: dx.doi.org/ (Open Access)
  • Albrecht, Lea Jessica; Livingstone, Elisabeth; Zimmer, Lisa; Schadendorf, Dirk
    The Latest Option: Nivolumab and Relatlimab in Advanced Melanoma
    In: Current Oncology Reports (2023) in press
    ISSN: 1534-6269; 1523-3790
    Online Volltext: dx.doi.org/ (Open Access)
  • Livingstone, Elisabeth; Zimmer, Lisa; Hassel, Jessica C.; Fluck, Michael; Eigentler, Thomas K.; Loquai, Carmen; Haferkamp, Sebastian; Gutzmer, Ralf; Meier, Friedegund; Mohr, Peter; Hauschild, Axel; Schilling, Bastian; Menzer, Christian; Kiecker, Felix; Dippel, Edgar; Rösch, Alexander; Ziemer, Mirjana; Conrad, Beate; Körner, Silvia; Windemuth-Kieselbach, Christine; Schwarz, Leonora; Garbe, Claus; Becker, Jürgen C.; Schadendorf, Dirk; Simon, Jan-Christoph; Herbst, Rudolf A.; Berking, Carola; Utikal, Jochen; Sell, Sabine; Martens, Uwe M.; Terheyden, Patrick; Stadler, Rudolf
    Adjuvant nivolumab plus ipilimumab or nivolumab alone versus placebo in patients with resected stage IV melanoma with no evidence of disease (IMMUNED) : Final results of a randomised, double-blind, phase 2 trial
    In: Lancet Jg. 400 (2022) Nr. 10358, S. 1117 - 1129
    ISSN: 1474-547X; 0140-6736; 0023-7507
    Online Volltext: dx.doi.org/
  • Khattak, Muhammad A.; Luke, Jason J.; Long, Georgina V.; Ascierto, Paolo A.; Rutkowski, Piotr; Schadendorf, Dirk; Robert, Caroline; Grob, Jean-Jacques; de la Cruz Merino, Luis; Del Vecchio, Michele; Spagnolo, Francesco; Mackiewicz, Jacek; Chiarion-Sileni, Vanna; Carlino, Matteo S.; Mohr, Peter; De Galitiis, Federica; Ross, Merrick I.; Eroglu, Zeynep; Chen, Ke; Jiang, Ruixuan; Fukunaga-Kalabis, Mizuho; Krepler, Clemens; Eggermont, Alexander M.M.; Kirkwood, John M.
    Adjuvant pembrolizumab versus placebo in resected high-risk stage II melanoma : Health-related quality of life from the randomized phase 3 KEYNOTE-716 study
    In: European Journal of Cancer (EJC) (2022) in press
    ISSN: 1879-0852; 0959-8049; 1879-2995
    Online Volltext: dx.doi.org/
  • Küppers, Ralf; Schadendorf, Dirk; Reimand, Jüri; PCAWG Drivers and Functional Interpretation Working Group; PCAWG Consortium
    Author Correction : Integrative pathway enrichment analysis of multivariate omics data
    In: Nature Communications Jg. 13 (2022)
    ISSN: 2041-1723
    Online Volltext: dx.doi.org/
  • Küppers, Ralf; Schadendorf, Dirk; Morris, Quaid D.; PCAWG Consortium
    Author Correction : Reconstructing evolutionary trajectories of mutation signature activities in cancer using TrackSig
    In: Nature Communications Jg. 13 (2022)
    ISSN: 2041-1723
    Online Volltext: dx.doi.org/
  • Küppers, Ralf; Schadendorf, Dirk; Stein, Lincoln D.; PCAWG Consortium
    Author Correction : A deep learning system accurately classifies primary and metastatic cancers using passenger mutation patterns
    In: Nature Communications Jg. 13 (2022)
    ISSN: 2041-1723
    Online Volltext: dx.doi.org/ (Open Access)
  • Küppers, Ralf; Schadendorf, Dirk; Reimand, Jüri; PCAWG Consortium
    Author Correction : Pathway and network analysis of more than 2500 whole cancer genomes
    In: Nature Communications Jg. 13 (2022)
    ISSN: 2041-1723
    Online Volltext: dx.doi.org/
  • Küppers, Ralf; Schadendorf, Dirk; Bristow, Robert G.; Boutros, Paul C.; PCAWG Consortium
    Author Correction : Divergent mutational processes distinguish hypoxic and normoxic tumours
    In: Nature Communications Jg. 13 (2022)
    ISSN: 2041-1723
    Online Volltext: dx.doi.org/
  • Küppers, Ralf; Schadendorf, Dirk; Macintyre, Geoff; PCAWG Consortium
    Author Correction : Inferring structural variant cancer cell fraction
    In: Nature Communications Jg. 13 (2022)
    ISSN: 2041-1723
    Online Volltext: dx.doi.org/ (Open Access)
  • Küppers, Ralf; Schadendorf, Dirk; Feuerbach, Lars; PCAWG Consortium
    Author Correction : Genomic footprints of activated telomere maintenance mechanisms in cancer
    In: Nature Communications Jg. 13 (2022)
    ISSN: 2041-1723
    Online Volltext: dx.doi.org/ (Open Access)
  • Küppers, Ralf; Schadendorf, Dirk; Shuai, Shimin; Stein, Lincoln D.; PCAWG Drivers and Functional Interpretation Working Group; PCAWG Consortium
    Author Correction : Combined burden and functional impact tests for cancer driver discovery using DriverPower
    In: Nature Communications Jg. 13 (2022)
    ISSN: 2041-1723
    Online Volltext: dx.doi.org/ (Open Access)
  • Küppers, Ralf; Schadendorf, Dirk; Creighton, Chad J.; PCAWG Consortium
    Author Correction : High-coverage whole-genome analysis of 1220 cancers reveals hundreds of genes deregulated by rearrangement-mediated cis-regulatory alterations
    In: Nature Communications Jg. 13 (2022)
    ISSN: 2041-1723
    Online Volltext: dx.doi.org/ (Open Access)
  • Wendlinger, Simone; Wohlfarth, Jonas; Kreft, Sophia; Siedel, Claudia; Kilian, Teresa; Dischinger, Ulrich; Heppt, Markus V.; Wistuba-Hamprecht, Kilian; Meier, Friedegund; Goebeler, Matthias; Schadendorf, Dirk; Gesierich, Anja; Kosnopfel, Corinna; Schilling, Bastian
    Blood Eosinophils Are Associated with Efficacy of Targeted Therapy in Patients with Advanced Melanoma
    In: Cancers Jg. 14 (2022) Nr. 9,
    ISSN: 2072-6694
    Online Volltext: dx.doi.org/ (Open Access)
  • Dummer, Reinhard; Flaherty, Keith T.; Robert, Caroline; Arance, Ana; De Groot, Jan Willem B.; Garbe, Claus; Gogas, Helen J.; Gutzmer, Ralf; Krajsová, Ivana; Liszkay, Gabriella; Loquai, Carmen; Mandalà, Mario; Schadendorf, Dirk; Yamazaki, Naoya; Di Pietro, Alessandra; Cantey-Kiser, Jean; Edwards, Michelle; Ascierto, Paolo A.
    COLUMBUS 5-Year Update : A Randomized, Open-Label, Phase III Trial of Encorafenib Plus Binimetinib Versus Vemurafenib or Encorafenib in Patients With BRAF V600-Mutant Melanoma
    In: Journal of Clinical Oncology (JCO) Jg. 40 (2022) Nr. 36, S. 4178 - 4188
    ISSN: 0732-183X; 1527-7755
    Online Volltext: dx.doi.org/ (Open Access)
  • Lodde, Georg; Fiedler, Melanie; Dittmer, Ulf; Placke, Jan-Malte; Jansen, Philipp; Becker, Jürgen; Zimmer, Lisa; Livingstone, Elisabeth; Schadendorf, Dirk; Sondermann, Wiebke; Ugurel, Selma
    COVID-19 vaccination in advanced skin cancer patients receiving systemic anticancer treatment : A prospective singlecenter study investigating seroconversion rates
    In: Frontiers in Oncology Jg. 12 (2022)
    ISSN: 2234-943X
    Online Volltext: dx.doi.org/ Online Volltext (Open Access)
  • Menzies, Alexander M.; da Silva, Ines Pires; Trojaniello, Claudia; Vieu, Elisabeth; Amaria, Rodabe N.; Zimmer, Lisa; Lo, Serigne N.; Burton, Elizabeth M.; Tawbi, Hussein A.; Schadendorf, Dirk; Grob, Jean J.; Ascierto, Paolo A.; Long, Georgina V.; Pires da Silva, Ines
    CTLA-4 Blockade Resistance after Relatlimab and Nivolumab
    In: The New England Journal of Medicine Jg. 386 (2022) Nr. 17, S. 1668 - 1669
    ISSN: 1533-4406; 0028-4793
    Online Volltext: dx.doi.org/
  • Arndt, Volker; Doege, Daniela; Fröhling, Stefan; Albers, Peter; Algül, Hana; Bargou, Ralf; Bokemeyer, Carsten; Bornhäuser, Martin; Brandts, Christian H.; Brossart, Peter; Brucker, Sara Yvonne; Brümmendorf, Tim H.; Döhner, Hartmut; Gattermann, Norbert; Hallek, Michael; Heinemann, Volker; Keilholz, Ulrich; Kindler, Thomas; von Levetzow, Cornelia; Lordick, Florian; Neumann, Ulf Peter; Peters, Christoph; Schadendorf, Dirk; Stilgenbauer, Stephan; Zander, Thomas; Zips, Daniel; Braun, Delia; Seufferlein, Thomas; Nettekoven, Gerd; Baumann, Michael
    Cancer care in German centers of excellence during the first 2 years of the COVID-19 pandemic
    In: Journal of Cancer Research and Clinical Oncology (2022) in press
    ISSN: 1432-1335; 0171-5216; 0084-5353; 0301-1585
    Online Volltext: dx.doi.org/ (Open Access)
  • Jansen, Philipp; Lodde, Georg; Wetter, Axel; Welt, Anja; Stuschke, Martin; Dührsen, U.; Stoffels, Ingo; Klode, Joachim; Livingstone, Elisabeth; Zimmer, Lisa; Rösch, Alexander; Hadaschik, Eva; Griewank, Klaus; Schadendorf, Dirk; Ugurel, Selma
    Checkpoint immunotherapy of cutaneous squamous cell carcinoma in patients suffering from chronic lymphocytic leukaemia : divergent outcomes in two men treated with PD-1 inhibitors
    In: Journal of the European Academy of Dermatology and Venereology Jg. 36 (2022) Nr. S1: Anti PD-1 Therapy of Advanced Cutaneous Squamous Cell Carcinoma, S. 41 - 44
    ISSN: 0926-9959; 1468-3083
    Online Volltext: dx.doi.org/ (Open Access)
  • Goldinger, Simone M.; Buder-Bakhaya, Kristina; Lo, Serigne N.; Forschner, Andrea; McKean, Meredith; Zimmer, Lisa; Khoo, Chloe; Dummer, Reinhard; Eroglu, Zeynep; Buchbinder, Elizabeth I.; Ascierto, Paolo A.; Gutzmer, Ralf; Rozeman, Elisa A.; Hoeller, Christoph; Johnson, Douglas B.; Gesierich, Anja; Kölblinger, Peter; Bennannoune, Naima; Cohen, Justine V.; Kähler, Katharina C.; Wilson, Melissa A.; Cebon, Jonathan; Atkinson, Victoria; Smith, Jessica L.; Michielin, Olivier; Long, Georgina V.; Hassel, Jessica C.; Weide, Benjamin; Haydu, Lauren E.; Schadendorf, Dirk; McArthur, Grant; Ott, Patrick A.; Blank, Christian; Robert, Caroline; Sullivan, Ryan; Hauschild, Axel; Carlino, Matteo S.; Garbe, Claus; Davies, Michael A.; Menzies, Alexander M.
    Chemotherapy after immune checkpoint inhibitor failure in metastatic melanoma : a retrospective multicentre analysis
    In: European Journal of Cancer (EJC) Jg. 162 (2022) S. 22 - 33
    ISSN: 1879-0852; 0959-8049; 1879-2995
    Online Volltext: dx.doi.org/
  • Albrecht, Lea Jessica; Höwner, Anna; Griewank, Klaus; Lueong, Smiths S.; von Neuhoff, Nils; Horn, Peter; Sucker, Antje; Paschen, Annette; Livingstone, Elisabeth; Ugurel, Selma; Zimmer, Lisa; Horn, Susanne; Siveke, Jens; Schadendorf, Dirk; Váraljai, Renáta; Rösch, Alexander
    Circulating cell‐free messenger RNA enables non‐invasive pan‐tumour monitoring of melanoma therapy independent of the mutational genotype
    In: Clinical and Translational Medicine Jg. 12 (2022) Nr. 11,
    ISSN: 2001-1326
    Online Volltext: dx.doi.org/ (Open Access)
  • da Silva, Ines Pires; Ahmed, Tasnia; McQuade, Jennifer L.; Nebhan, Caroline A.; Park, John J.; Versluis, Judith M.; Serra-Bellver, Patricio; Khan, Yasir; Slattery, Tim; Oberoi, Honey K.; Ugurel, Selma; Haydu, Lauren E.; Herbst, Rudolf; Utikal, Jochen; Pfohler, Claudia; Terheyden, Patrick; Weichenthal, Michael; Gutzmer, Ralf; Mohr, Peter; Rai, Rajat; Smith, Jessica L.; Scolyer, Richard A.; Arance, Ana M.; Pickering, Lisa; Larkin, James; Lorigan, Paul; Blank, Christian U.; Schadendorf, Dirk; Davies, Michael A.; Carlino, Matteo S.; Johnson, Douglas B.; Long, Georgina V.; Lo, Serigne N.; Menzies, Alexander M.
    Clinical Models to Define Response and Survival With Anti-PD-1 Antibodies Alone or Combined With Ipilimumab in Metastatic Melanoma
    In: Journal of Clinical Oncology (JCO) Jg. 40 (2022) Nr. 10, S. 1068 - 1080
    ISSN: 0732-183X; 1527-7755
    Online Volltext: dx.doi.org/ Online Volltext (Open Access)
  • Spassova, Ivelina; Ugurel, Selma; Kubat, Linda; Zimmer, Lisa; Terheyden, Patrick; Mohr, Annalena; Björn Andtback, Hannah; Villabona, Lisa; Leiter, Ulrike; Eigentler, Thomas; Loquai, Carmen; Hassel, Jessica C.; Gambichler, Thilo; Haferkamp, Sebastian; Mohr, Peter; Pfoehler, Claudia; Heinzerling, Lucie; Gutzmer, Ralf; Utikal, Jochen S.; Horny, Kai; Schildhaus, Hans-Ulrich; Habermann, Daniel; Hoffmann, Daniel; Schadendorf, Dirk; Becker, Jürgen
    Clinical and molecular characteristics associated with response to therapeutic PD-1/PD-L1 inhibition in advanced Merkel cell carcinoma
    In: Journal for ImmunoTherapy of Cancer Jg. 10 (2022) Nr. 1,
    ISSN: 2051-1426
    Online Volltext: dx.doi.org/ Online Volltext (Open Access)
  • Zaremba-Montenari, Anne; Meier, Friedegund; Schlein, Christian; Jansen, Philipp; Lodde, Georg; Song, Mingxia; Kretz, Julia; Möller, Inga; Stadtler, Nadine; Livingstone, Elisabeth; Zimmer, Lisa; Hadaschik, Eva; Sucker, Antje; Schadendorf, Dirk; Griewank, Klaus
    Clinical and pathological characteristics of familial melanoma with germline TERT promoter variants
    In: Pigment Cell and Melanoma Research Jg. 35 (2022) Nr. 6, S. 573 - 586
    ISSN: 1755-1471; 1755-148X
    Online Volltext: dx.doi.org/ (Open Access)
  • Gambichler, Thilo; Rohrmoser, E.-M.; Horny, Kai; Sucker, Antje; Schadendorf, Dirk; Skrygan, Marina; Susok, Laura; Stücker, Markus; Becker, Jürgen
    Comparison of mutation profiles in primary melanomas and corresponding nodal naevi using next-generation sequencing
    In: Clinical and Experimental Dermatology (CED) Jg. 47 (2022) Nr. 2, S. 373 - 380
    ISSN: 1365-2230; 0307-6938
    Online Volltext: dx.doi.org/ (Open Access)
  • Gogas, Helen; Dummer, Reinhard; Ascierto, Paolo A.; Arance, Ana; Mandalà, Mario; Liszkay, Gabriella; Garbe, Claus; Schadendorf, Dirk; Krajsová, Ivana; Gutzmer, Ralf; Chiarion Sileni, Vanna; Dutriaux, Caroline; Yamazaki, Naoya; Loquai, Carmen; Queirolo, Paola; de Willem, Groot J.; Sellier, Abir T.; Suissa, Jeanne; Murris, Juliette; Gollerkeri, Ashwin; Robert, Caroline; Flaherty, Keith T.
    Corrigendum to ‘Quality of life in patients with BRAF-mutant melanoma receiving the combination encorafenib plus binimetinib: Results from a multicentre, open-label, randomised, phase III study (COLUMBUS)’
    In: European Journal of Cancer (EJC) Jg. 160 (2022) S. 287 - 288
    ISSN: 1879-0852; 0959-8049; 1879-2995
    Online Volltext: dx.doi.org/ (Open Access)
  • Westphalen, C. Benedikt; Bokemeyer, Carsten; Büttner, Reinhard; Fröhling, Stefan; Gaidzik, Verena I.; Glimm, Hanno; Hacker, Ulrich T.; Heinemann, Volker; Illert, Anna L.; Keilholz, Ulrich; Kindler, Thomas; Kirschner, Martin; Schilling, Bastian; Siveke, Jens; Schroeder, Thomas; Tischler, Verena; Wagner, Sebastian; Weichert, Wilko; Zips, Daniel; Loges, Sonja; Schadendorf, Dirk; Schildhaus, Hans-Ulrich; Working Group Molecular Diagnostics and Therapy
    Corrigendum to “Conceptual framework for precision cancer medicine in Germany: Consensus statement of the Deutsche Krebshilfe working group Molecular Diagnostics and Therapy”
    In: European Journal of Cancer (EJC) Jg. 162 (2022) S. 245 - 246
    ISSN: 1879-0852; 0959-8049; 1879-2995
    Online Volltext: dx.doi.org/
  • Jansen, Philipp; Creosteanu, Adelaida; Matyas, Viktor; Dilling, Amrei; Pina, Ana; Saggini, Andrea; Schimming, Tobias; Landsberg, Jennifer; Burgdorf, Birte; Giaquinta, Sylvia; Müller, Hansgeorg; Emberger, Michael; Rose, Christian; Schmitz, Lutz; Geraud, Cyrill; Schadendorf, Dirk; Schaller, Jörg; Alber, Maximilian; Klauschen, Frederick; Griewank, Klaus G.
    Deep Learning Assisted Diagnosis of Onychomycosis on Whole-Slide Images
    In: Journal of Fungi Jg. 8 (2022) Nr. 9,
    ISSN: 2309-608X
    Online Volltext: dx.doi.org/ Online Volltext (Open Access)
  • Kaatz, Martin; Mohr, Peter; Livingstone, Elisabeth; Weichenthal, Michael; Kreuter, Alexander; Pföhler, Claudia; Leiter, Ulrike; Ulrich, Jens; Utikal, Jochen Sven; Gutzmer, Ralf; Herbst, Rudolf; Schadendorf, Dirk
    Effectiveness, Safety and Utilization of Vismodegib for Locally Advanced Basal Cell Carcinoma Under Real-world Conditions : Non-interventional Cohort Study JONAS
    In: Acta Dermato-Venereologica Jg. 102 (2022)
    ISSN: 1651-2057; 0001-5555; 0365-8341
    Online Volltext: dx.doi.org/ (Open Access)
  • Jansen, Philipp; Baguer, Daniel Otero; Duschner, Nicole; Le’Clerc Arrastia, Jean; Schmidt, Maximilian; Wiepjes, Bettina; Schadendorf, Dirk; Hadaschik, Eva; Maass, Peter; Schaller, Jörg; Griewank, Klaus Georg
    Evaluation of a Deep Learning Approach to Differentiate Bowen’s Disease and Seborrheic Keratosis
    In: Cancers Jg. 14 (2022) Nr. 14,
    ISSN: 2072-6694
    Online Volltext: dx.doi.org/ (Open Access)
  • Hauser, Katja; Kurz, Alexander; Haggenmüller, Sarah; Maron, Roman C.; von Kalle, Christof; Utikal, Jochen S.; Meier, Friedegund; Hobelsberger, Sarah; Gellrich, Frank F.; Sergon, Mildred; Hauschild, Axel; French, Lars E.; Heinzerling, Lucie; Schlager, Justin G.; Ghoreschi, Kamran; Schlaak, Max; Hilke, Franz J.; Poch, Gabriela; Kutzner, Heinz; Berking, Carola; Heppt, Markus V.; Erdmann, Michael; Haferkamp, Sebastian; Schadendorf, Dirk; Sondermann, Wiebke; Goebeler, Matthias; Schilling, Bastian; Kather, Jakob N.; Fröhling, Stefan; Lipka, Daniel B.; Hekler, Achim; Krieghoff-Henning, Eva; Brinker, Titus J.
    Explainable artificial intelligence in skin cancer recognition : A systematic review
    In: European Journal of Cancer (EJC) Jg. 167 (2022) S. 54 - 69
    ISSN: 1879-0852; 0959-8049; 1879-2995
    Online Volltext: dx.doi.org/ (Open Access)
  • Thielmann, Carl Maximilian; Matull, Johanna; Roth, Sebastian; Placke, Jan-Malte; Chorti, Eleftheria; Zaremba, Anne; Lodde, Georg; Jansen, Philipp; Krefting, Frederik; Kretz, Julia; Möller, Inga; Sucker, Antje; Paschen, Annette; Livingstone, Elisabeth; Zimmer, Lisa; Ugurel, Selma; Schadendorf, Dirk; Hadaschik, Eva; Griewank, Klaus
    Genetic and Clinical Characteristics of ARID1A Mutated Melanoma Reveal High Tumor Mutational Load without Implications on Patient Survival
    In: Cancers Jg. 14 (2022) Nr. 9,
    ISSN: 2072-6694
    Online Volltext: dx.doi.org/ Online Volltext (Open Access)
  • Zaremba, Anne; Jansen, Philipp; Murali, Rajmohan; Mayakonda, Anand; Riedel, Anna; Krahl, Dieter; Burkhardt, Hans; John, Stefan; Géraud, Cyrill; Philip, Manuel; Kretz, Julia; Möller, Inga; Stadtler, Nadine; Sucker, Antje; Paschen, Annette; Ugurel, Selma; Zimmer, Lisa; Livingstone, Elisabeth; Horn, Susanne; Plass, Christoph; Schadendorf, Dirk; Hadaschik, Eva; Lutsik, Pavlo; Griewank, Klaus
    Genetic and Methylation Analysis of CTNNB1 in Benign and Malignant Melanocytic Lesions
    In: Cancers Jg. 14 (2022) Nr. 17,
    ISSN: 2072-6694
    Online Volltext: dx.doi.org/ Online Volltext (Open Access)
  • Zaremba-Montenari, Anne; Jansen, Philipp; Murali, Rajmohan; Mayakonda, Anand; Riedel, Anna; Philip, Manuel; Rose, Christian; Schaller, Jörg; Müller, Hansgeorg; Kutzner, Heinz; Möller, Inga; Stadtler, Nadine; Kretz, Julia; Sucker, Antje; Bankfalvi, Agnes; Livingstone, Elisabeth; Zimmer, Lisa; Horn, Susanne; Paschen, Annette; Plass, Christoph; Schadendorf, Dirk; Hadaschik, Eva; Lutsik, Pavlo; Griewank, Klaus
    Genetic and methylation profiles distinguish benign, malignant and spitzoid melanocytic tumors
    In: International Journal of Cancer (2022) in press
    ISSN: 0020-7136; 1097-0215
    Online Volltext: dx.doi.org/ (Open Access)
  • Lodde, Georg; Jansen, Philipp; Möller, Inga; Sucker, Antje; Hassel, Jessica C.; Forschner, Andrea; Eckardt, Julia; Meier, Friedegund; Reinhardt, Lydia; Kähler, Katharina C.; Ziemer, Mirjana; Schlaak, Max; Rahimi, Farnaz; Schatton, Kerstin; Meiss, Frank; Gutzmer, Ralf; Pföhler, Claudia; Terheyden, Patrick; Schilling, Bastian; Sachse, Michael; Heppt, Markus V.; Sindrilaru, Anca; Leiter, Ulrike; Zaremba, Anne; Thielmann, Carl Maximilian; Ugurel, Selma; Zimmer, Lisa; Hadaschik, Eva; Bechrakis, Nikolaos E.; Schadendorf, Dirk; Westekemper, Henrike; Livingstone, Elisabeth; Griewank, Klaus G.; German Dermatologic Cooperative Oncology Group (DeCOG, committee ocular melanoma)
    Genetic characterization of advanced conjunctival melanoma and response to systemic treatment
    In: European Journal of Cancer (EJC) Jg. 166 (2022) S. 60 - 72
    ISSN: 1879-0852; 0959-8049; 1879-2995
    Online Volltext: dx.doi.org/
  • Beckmann, Catharina Lena; Lodde, Georg; Livingstone, Elisabeth; Schadendorf, Dirk; Böckmann, Britta
    Guideline-Based Context-Sensitive Decision Modeling for Melanoma Patients
    In: Studies in Health Technology and Informatics Jg. 296 (2022) S. 50 - 57
    ISSN: 1879-8365; 0926-9630
    Online Volltext: dx.doi.org/ (Open Access)
  • Koch, Elias A. T.; Petzold, Anne; Wessely, Anja; Dippel, Edgar; Gesierich, Anja; Gutzmer, Ralf; Hassel, Jessica C.; Haferkamp, Sebastian; Kähler, Katharina C.; Knorr, Harald; Kreuzberg, Nicole; Leiter, Ulrike; Loquai, Carmen; Meier, Friedegund; Meissner, Markus; Mohr, Peter; Pföhler, Claudia; Rahimi, Farnaz; Schadendorf, Dirk; Schell, Beatrice; Schlaak, Max; Terheyden, Patrick; Thoms, Kai-Martin; Schuler-Thurner, Beatrice; Ugurel, Selma; Ulrich, Jens; Utikal, Jochen; Weichenthal, Michael; Ziller, Fabian; Berking, Carola; Heppt, Markus V.
    Immune Checkpoint Blockade for Metastatic Uveal Melanoma : Re-Induction following Resistance or Toxicity
    In: Cancers Jg. 14 (2022) Nr. 3,
    ISSN: 2072-6694
    Online Volltext: dx.doi.org/ (Open Access)
  • Rünger, Alessandra; Schadendorf, Dirk; Hauschild, Axel; Gebhardt, Christoffer
    Immune checkpoint blockade for organ-transplant recipients with cancer : A review
    In: European Journal of Cancer (EJC) Jg. 175 (2022) S. 326 - 335
    ISSN: 1879-0852; 0959-8049; 1879-2995
    Online Volltext: dx.doi.org/
  • Franklin, Cindy; Mohr, Peter; Bluhm, Leonie; Grimmelmann, Imke; Gutzmer, Ralf; Meier, Friedegund; Garzarolli, Marlene; Weichenthal, Michael; Pfoehler, Claudia; Herbst, Rudolf; Terheyden, Patrick; Utikal, Jochen; Ulrich, Jens; Debus, Dirk; Haferkamp, Sebastian; Kaatz, Martin; Forschner, Andrea; Leiter, Ulrike; Nashan, Dorothee; Kreuter, Alexander; Sachse, Michael; Welzel, Julia; Heinzerling, Lucie; Meiss, Frank; Weishaupt, Carsten; Gambichler, Thilo; Weyandt, Gerhard; Dippel, Edgar; Schatton, Kerstin; Celik, Eren; Trommer, Maike; Helfrich, Iris; Rösch, Alexander; Zimmer, Lisa; Livingstone, Elisabeth; Schadendorf, Dirk; Horn, Susanne; Ugurel, Selma
    Impact of radiotherapy and sequencing of systemic therapy on survival outcomes in melanoma patients with previously untreated brain metastasis : a multicenter DeCOG study on 450 patients from the prospective skin cancer registry ADOREG
    In: Journal for ImmunoTherapy of Cancer Jg. 10 (2022) Nr. 6,
    ISSN: 2051-1426
    Online Volltext: dx.doi.org/ (Open Access)
  • Thier, Beatrice; Zhao, Fang; Stupia, Simone; Brüggemann, Alicia; Koch, Johannes; Schulze, Nina; Horn, Susanne; Coch, Christoph; Hartmann, Gunther; Sucker, Antje; Schadendorf, Dirk; Paschen, Annette
    Innate immune receptor signaling induces transient melanoma dedifferentiation while preserving immunogenicity
    In: Journal for ImmunoTherapy of Cancer Jg. 10 (2022) Nr. 6,
    ISSN: 2051-1426
    Online Volltext: dx.doi.org/ (Open Access)
  • Glutsch, Valerie; Schummer, Patrick; Kneitz, Hermann; Gesierich, Anja; Goebeler, Matthias; Klein, Detlef; Posch, Christian; Gebhardt, Christoffer; Haferkamp, Sebastian; Zimmer, Lisa; Becker, Jürgen; Leiter, Ulrike; Weichenthal, Michael; Schadendorf, Dirk; Ugurel, Selma; Schilling, Bastian
    Ipilimumab plus nivolumab in avelumab-refractory Merkel cell carcinoma : A multicenter study of the prospective skin cancer registry ADOREG
    In: Journal for ImmunoTherapy of Cancer Jg. 10 (2022) Nr. 11,
    ISSN: 2051-1426
    Online Volltext: dx.doi.org/ (Open Access)
  • Wolchok, Jedd D.; Chiarion-Sileni, Vanna; Gonzalez, Rene; Grob, Jean-Jacques; Rutkowski, Piotr; Lao, Christopher D.; Cowey, C Lance; Schadendorf, Dirk; Wagstaff, John; Dummer, Reinhard; Ferrucci, Pier Francesco; Smylie, Michael; Butler, Marcus O.; Hill, Andrew; Márquez-Rodas, Ivan; Haanen, John B A G; Guidoboni, Massimo; Maio, Michele; Schöffski, Patrick; Carlino, Matteo S.; Lebbé, Céleste; McArthur, Grant; Ascierto, Paolo A.; Daniels, Gregory A.; Long, Georgina V.; Bas, Tuba; Ritchings, Corey; Larkin, James; Hodi, F Stephen
    Long-Term Outcomes With Nivolumab Plus Ipilimumab or Nivolumab Alone Versus Ipilimumab in Patients With Advanced Melanoma
    In: Journal of Clinical Oncology (JCO) Jg. 40 (2022) Nr. 2, S. 127 - 137
    ISSN: 0732-183X; 1527-7755
    Online Volltext: dx.doi.org/ (Open Access)
  • Salzmann, Martin; Pawlowski, Johannes; Loquai, Carmen; Rafei-Shamsabadi, David A.; Meiss, Frank; Ugurel, Selma; Schadendorf, Dirk; Meier, Friedegund; Enk, Alexander H.; Hassel, Jessica C.
    MEK inhibitors for pre-treated, NRAS-mutated metastatic melanoma : A multi-centre, retrospective study
    In: European Journal of Cancer (EJC) Jg. 166 (2022) S. 24 - 32
    ISSN: 1879-0852; 0959-8049; 1879-2995
    Online Volltext: dx.doi.org/
  • Jansen, Philipp; Lodde, Georg; Griewank, Klaus; Hadaschik, Eva; Rösch, Alexander; Ugurel, Selma; Zimmer, Lisa; Livingstone, Elisabeth; Schadendorf, Dirk
    Management of partial and non-responding cutaneous squamous cell carcinoma
    In: Journal of the European Academy of Dermatology and Venereology Jg. 36 (2022) Nr. S1, S. 29 - 34
    ISSN: 0926-9959; 1468-3083
    Online Volltext: dx.doi.org/ (Open Access)
  • Ferdinandus, Justin; Zaremba-Montenari, Anne; Zimmer, Lisa; Umutlu, Lale; Seifert, Robert; Barbato, Francesco; Ugurel, Selma; Chorti, Eleftheria; Grünwald, Viktor; Herrmann, Ken; Schadendorf, Dirk; Fendler, Wolfgang; Livingstone, Elisabeth
    Metabolic imaging with FDG-PET and time to progression in patients discontinuing immune-checkpoint inhibition for metastatic melanoma
    In: Cancer Imaging Jg. 22 (2022) Nr. 1,
    ISSN: 1470-7330; 1740-5025
    Online Volltext: dx.doi.org/ (Open Access)
  • Maron, Roman C.; Hekler, Achim; Haggenmüller, Sarah; von Kalle, Christof; Utikal, Jochen S.; Müller, Verena; Gaiser, Maria; Meier, Friedegund; Hobelsberger, Sarah; Gellrich, Frank F.; Sergon, Mildred; Hauschild, Axel; French, Lars E.; Heinzerling, Lucie; Schlager, Justin G.; Ghoreschi, Kamran; Schlaak, Max; Hilke, Franz J.; Poch, Gabriela; Korsing, Sören; Berking, Carola; Heppt, Markus V.; Erdmann, Michael; Haferkamp, Sebastian; Schadendorf, Dirk; Sondermann, Wiebke; Goebeler, Matthias; Schilling, Bastian; Kather, Jakob N.; Fröhling, Stefan; Lipka, Daniel B.; Krieghoff-Henning, Eva; Brinker, Titus J.
    Model soups improve performance of dermoscopic skin cancer classifiers
    In: European Journal of Cancer (EJC) Jg. 173 (2022) S. 307 - 316
    ISSN: 1879-0852; 0959-8049; 1879-2995
    Online Volltext: dx.doi.org/ (Open Access)
  • Gross, Neil D.; Miller, David M.; Khushalani, Nikhil I.; Divi, Vasu; Ruiz, Emily S.; Lipson, Evan J.; Meier, Friedegund; Su, Yungpo B.; Swiecicki, Paul L.; Atlas, Jennifer; Geiger, Jessica L.; Hauschild, Axel; Choe, Jennifer H.; Hughes, Brett G.M.; Schadendorf, Dirk; Patel, Vishal A.; Homsi, Jade; Taube, Janis M.; Lim, Annette M.; Ferrarotto, Renata; Kaufman, Howard L.; Seebach, Frank; Lowy, Israel; Yoo, Suk-Young; Mathias, Melissa; Fenech, Keilah; Han, Hyunsil; Fury, Matthew G.; Rischin, Danny
    Neoadjuvant Cemiplimab for Stage II to IV Cutaneous Squamous-Cell Carcinoma
    In: The New England Journal of Medicine Jg. 387 (2022) Nr. 17, S. 1557 - 1568
    ISSN: 1533-4406; 0028-4793
    Online Volltext: dx.doi.org/
  • Steeb, Theresa; Brütting, Julia; Reinhardt, Lydia; Hoffmann, Julia; Weiler, Nina; Heppt, Markus V.; Erdmann, Michael; Doppler, Astrid; Weber, Christiane; Schadendorf, Dirk; Meier, Friedegund; Berking, Carola
    One Website to Gather them All : Usability Testing of the New German SKin Cancer INFOrmation (SKINFO) Website - A Mixed-methods Approach
    In: Journal of Cancer Education (2022) in press
    ISSN: 1543-0154; 0885-8195
    Online Volltext: dx.doi.org/ (Open Access)
  • Eggermont, Alexander Mm; Ascierto, Paolo A.; Khushalani, Nikhil I.; Schadendorf, Dirk; Boland, Genevieve; Weber, Jeffrey; Lewis, Karl D.; Johnson, Daniel; Rivalland, Gareth; Khattak, Adnan; Majem, Margarita; Gogas, Helen; Long, Georgina V.; Currie, Sue L.; Chien, David; Tagliaferri, Mary A.; Carlino, Matteo S.; Diab, Adi
    PIVOT-12 : A Phase III study of adjuvant bempegaldesleukin plus nivolumab in resected stage III/IV melanoma at high risk for recurrence
    In: Future Oncology Jg. 18 (2022) Nr. 8, S. 903 - 913
    ISSN: 1744-8301; 1479-6694
    Online Volltext: dx.doi.org/ (Open Access)
  • Luke, Jason J.; Rutkowski, Piotr; Queirolo, Paola; Del Vecchio, Michele; Mackiewicz, Jacek; Chiarion-Sileni, Vanna; de la Cruz Merino, Luis; Khattak, Muhammad A.; Schadendorf, Dirk; Long, Georgina V.; Ascierto, Paolo A.; Mandala, Mario; De Galitiis, Federica; Haydon, Andrew; Dummer, Reinhard; Grob, Jean-Jacques; Robert, Caroline; Carlino, Matteo S.; Mohr, Peter; Poklepovic, Andrew; Sondak, Vernon K.; Scolyer, Richard A.; Kirkwood, John M.; Chen, Ke; Diede, Scott J.; Ahsan, Sama; Ibrahim, Nageatte; Eggermont, Alexander M. M.
    Pembrolizumab versus placebo as adjuvant therapy in completely resected stage IIB or IIC melanoma (KEYNOTE-716) : a randomised, double-blind, phase 3 trial
    In: Lancet Jg. 399 (2022) Nr. 10336, S. 1718 - 1729
    ISSN: 1474-547X; 0140-6736; 0023-7507
    Online Volltext: dx.doi.org/
  • Long, Georgina V; Luke, Jason J; Khattak, Muhammad A; de la Cruz Merino, Luis; Del Vecchio, Michele; Rutkowski, Piotr; Spagnolo, Francesco; Mackiewicz, Jacek; Chiarion-Sileni, Vanna; Kirkwood, John M; Robert, Caroline; Grob, Jean-Jacques; de Galitiis, Federica; Schadendorf, Dirk; Carlino, Matteo S; Mohr, Peter; Dummer, Reinhard; Gershenwald, Jeffrey E; Yoon, Charles H; Wu, Xi Lawrence; Fukunaga-Kalabis, Mizuho; Krepler, Clemens; Eggermont, Alexander M M; Ascierto, Paolo A
    Pembrolizumab versus placebo as adjuvant therapy in resected stage IIB or IIC melanoma (KEYNOTE-716) : distant metastasis-free survival results of a multicentre, double-blind, randomised, phase 3 trial
    In: The Lancet Oncology Jg. 23 (2022) Nr. 11, S. 1378 - 1388
    ISSN: 1474-5488; 1470-2045
    Online Volltext: dx.doi.org/
  • Chauvistré, Heike; Shannan, Batool; Daignault-Mill, Sheena M.; Ju, Robert J.; Picard, Daniel; Egetemaier, Stefanie; Váraljai, Renáta; Gibhardt, Christine S.; Sechi, Antonio; Kaschani, Farnusch; Keminer, Oliver; Stehbens, Samantha J.; Liu, Qin; Yin, Xiangfan; Jeyakumar, Kirujan; Vogel, Felix C. E.; Krepler, Clemens; Rebecca, Vito W.; Kubat, Linda; Lueong, Smiths S.; Forster, Jan; Horn, Susanne; Remke, Marc; Ehrmann, Michael; Paschen, Annette; Becker, Jürgen; Helfrich, Iris; Rauh, Daniel; Kaiser, Markus; Gul, Sheraz; Herlyn, Meenhard; Bogeski, Ivan; Rodríguez-López, José Neptuno; Haass, Nikolas K.; Schadendorf, Dirk; Rösch, Alexander
    Persister state-directed transitioning and vulnerability in melanoma
    In: Nature Communications Jg. 13 (2022) Nr. 1,
    ISSN: 2041-1723
    Online Volltext: dx.doi.org/ (Open Access)
  • Garbe, Claus; Keim, Ulrike; Amaral, Teresa; Berking, Carola; Eigentler, Thomas K.; Flatz, Lukas; Gesierich, Anja; Leiter, Ulrike; Stadler, Rudolf; Sunderkötter, Cord; Tüting, Thomas; Utikal, Jochen; Wollina, Uwe; Zimmer, Lisa; Zouboulis, Christos C.; Ascierto, Paolo A.; Eggermont, Alexander M.M.; Grob, Jean-Jacques; Hauschild, Axel; Sekulovic, Lidija Kandolf; Long, Georgina V.; Luke, Jason J.; Michielin, Olivier; Peris, Ketty; Schadendorf, Dirk; Kirkwood, John M.; Lorigan, Paul C.
    Prognosis of Patients With Primary Melanoma Stage I and II According to American Joint Committee on Cancer Version 8 Validated in Two Independent Cohorts : Implications for Adjuvant Treatment
    In: Journal of Clinical Oncology (JCO) Jg. 40 (2022) Nr. 32, S. 3741 - 3749
    ISSN: 0732-183X; 1527-7755
    Online Volltext: dx.doi.org/ (Open Access)
  • Kennedy, Oliver J.; Kicinski, Michal; Valpione, Sara; Gandini, Sara; Suciu, Stefan; Blank, Christian U.; Long, Georgina V.; Atkinson, Victoria G.; Dalle, Stéphane; Haydon, Andrew M.; Meshcheryakov, Andrey; Khattak, Adnan; Carlino, Matteo S.; Sandhu, Shahneen; Larkin, James; Puig, Susana; Ascierto, Paolo A.; Rutkowski, Piotr; Schadendorf, Dirk; Koornstra, Rutger; Hernandez-Aya, Leonel; Di Giacomo, Anna M.; van den Eertwegh, Alfonsus J.M.; Grob, Jean-Jacques; Gutzmer, Ralf; Jamal, Rahima; van Akkooi, Alexander C.J.; Robert, Caroline; Eggermont, Alexander M.M.; Lorigan, Paul; Mandala, Mario
    Prognostic and predictive value of β-blockers in the EORTC 1325/KEYNOTE-054 phase III trial of pembrolizumab versus placebo in resected high-risk stage III melanoma
    In: European Journal of Cancer (EJC) Jg. 165 (2022) S. 97 - 112
    ISSN: 1879-0852; 0959-8049; 1879-2995
    Online Volltext: dx.doi.org/ (Open Access)
  • Dummer, Reinhard; Long, Georgina V.; Robert, Caroline; Tawbi, Hussein A.; Flaherty, Keith T.; Ascierto, Paolo A.; Nathan, Paul D.; Rutkowski, Piotr; Leonov, Oleg; Dutriaux, Caroline; Mandalà, Mario; Lorigan, Paul; Ferrucci, Pier Francesco; Grob, Jean Jacques; Meyer, Nicolas; Gogas, Helen; Stroyakovskiy, Daniil; Arance, Ana; Brase, Jan C.; Green, Steven; Haas, Tomas; Masood, Aisha; Gasal, Eduard; Ribas, Antoni; Schadendorf, Dirk
    Randomized Phase III Trial Evaluating Spartalizumab Plus Dabrafenib and Trametinib for BRAF V600-Mutant Unresectable or Metastatic Melanoma
    In: Journal of Clinical Oncology (JCO) Jg. 40 (2022) Nr. 13, S. 1428 - 1438
    ISSN: 0732-183X; 1527-7755
    Online Volltext: dx.doi.org/ (Open Access)
  • Mohr, Peter; Scherrer, Emilie; Assaf, Chalid; Bender, Marc; Berking, Carola; Chandwani, Sheenu; Eigentler, Thomas; Grimmelmann, Imke; Gutzmer, Ralf; Haferkamp, Sebastian; Hassel, Jessica C.; Hauschild, Axel; Herbst, Rudolf; Jiang, Ruixuan; Kähler, Katharina C.; Krepler, Clemens; Kreuter, Alexander; Leiter, Ulrike; Loquai, Carmen; Meier, Friedegund; Pföhler, Claudia; Rudolph, Anja; Schadendorf, Dirk; Schiavone, Maximo; Schley, Gaston; Terheyden, Patrick; Ugurel, Selma; Ulrich, Jens; Utikal, Jochen; Weishaupt, Carsten; Welzel, Julia; Weichenthal, Michael
    Real-World Therapy with Pembrolizumab : Outcomes and Surrogate Endpoints for Predicting Survival in Advanced Melanoma Patients in Germany
    In: Cancers Jg. 14 (2022) Nr. 7,
    ISSN: 2072-6694
    Online Volltext: dx.doi.org/ (Open Access)
  • Tawbi, Hussein A.; Schadendorf, Dirk; Lipson, Evan J.; Ascierto, Paolo A.; Matamala, Luis; Castillo Gutiérrez, Erika; Rutkowski, Piotr; Gogas, Helen J.; Lao, Christopher D.; De Menezes, Juliana Janoski; Dalle, Stéphane; Arance, Ana; Grob, Jean-Jacques; Srivastava, Shivani; Abaskharoun, Mena; Hamilton, Melissa; Keidel, Sarah; Simonsen, Katy L.; Sobiesk, Anne Marie; Li, Bin; Hodi, F. Stephen; Long, Georgina V.
    Relatlimab and Nivolumab versus Nivolumab in Untreated Advanced Melanoma
    In: The New England Journal of Medicine Jg. 386 (2022) Nr. 1, S. 24 - 34
    ISSN: 1533-4406; 0028-4793
    Online Volltext: dx.doi.org/
  • Schadendorf, Dirk
    Reply to: Letter comments on: Pyrexia in patients treated with dabrafenib plus trametinib across clinical trials in BRAF-mutant cancers
    In: European Journal of Cancer (EJC) Jg. 162 (2022) S. 243 - 244
    ISSN: 1879-0852; 0959-8049; 1879-2995
    Online Volltext: dx.doi.org/
  • Ferdinandus, Justin; Fendler, Wolfgang; Lückerath, Katharina; Berliner, Christoph; Kurzidem, Sabine; Hadaschik, Eva; Klode, Joachim; Zimmer, Lisa; Livingstone, Elisabeth; Schadendorf, Dirk; Herrmann, Ken; Becker, Jürgen; Ugurel, Selma
    Response to Combined Peptide Receptor Radionuclide Therapy and Checkpoint Immunotherapy with Ipilimumab Plus Nivolumab in Metastatic Merkel Cell Carcinoma
    In: Journal of Nuclear Medicine (JNM) / Society of Nuclear Medicine and Molecular Imaging (SNMMI) (Hrsg.) Jg. 63 (2022) Nr. 3, S. 396 - 398
    ISSN: 1535-5667; 0161-5505; 2159-662X; 0022-3123; 0097-9058
    Online Volltext: dx.doi.org/ (Open Access)
  • Haist, Maximilian; Stege, Henner; Lang, Berenice Mareen; Tsochataridou, Aikaterini; Salzmann, Martin; Mohr, Peter; Schadendorf, Dirk; Ugurel, Selma; Placke, Jan-Malte; Weichenthal, Michael; Gutzmer, Ralf; Leiter, Ulrike; Kaatz, Martin; Haferkamp, Sebastian; Berking, Carola; Heppt, Markus; Tschechne, Barbara; Schummer, Patrick; Gebhardt, Christoffer; Grabbe, Stephan; Loquai, Carmen
    Response to First-Line Treatment with Immune-Checkpoint Inhibitors in Patients with Advanced Cutaneous Squamous Cell Carcinoma : A Multicenter, Retrospective Analysis from the German ADOReg Registry
    In: Cancers Jg. 14 (2022) Nr. 22,
    ISSN: 2072-6694
    Online Volltext: dx.doi.org/ (Open Access)
  • Bordbari, Sharareh; Mörchen, Britta; Pylaeva, Ekaterina; Siakaeva, Elena; Spyra, Ilona; Domnich, Maksim; Droege, Freya; Kanaan, Oliver; Lang, Karl S.; Schadendorf, Dirk; Lang, Stephan; Helfrich, Iris; Jablonska, Jadwiga
    SIRT1‐mediated deacetylation of FOXO3a transcription factor supports pro‐angiogenic activity of interferon‐deficient tumor‐associated neutrophils
    In: International Journal of Cancer Jg. 150 (2022) Nr. 7, S. 1198 - 1211
    ISSN: 0020-7136; 1097-0215
    Online Volltext: dx.doi.org/ (Open Access)
  • Schadendorf, Dirk; Dummer, Reinhard; Robert, Caroline; Ribas, Antoni; Sullivan, Ryan J.; Panella, Timothy; McKean, Meredith; Santos, Edgardo S.; Brill, Kimberli; Polli, Anna; Pietro, Alessandra di; Ascierto, Paolo A.
    STARBOARD : encorafenib + binimetinib + pembrolizumab for first-line metastatic/unresectable BRAF V600-mutant melanoma
    In: Future Oncology Jg. 18 (2022) Nr. 17, S. 2041 - 2051
    ISSN: 1744-8301; 1479-6694
    Online Volltext: dx.doi.org/ (Open Access)
  • Tawbi, Hussein A; Robert, Caroline; Brase, Jan C; Gusenleitner, Daniel; Gasal, Eduard; Garrett, James; Savchenko, Alexander; Görgün, Güllü; Flaherty, Keith T; Ribas, Antoni; Dummer, Reinhard; Schadendorf, Dirk; Long, Georgina V; Nathan, Paul D; Ascierto, Paolo A
    Spartalizumab or placebo in combination with dabrafenib and trametinib in patients with BRAF V600-mutant melanoma : exploratory biomarker analyses from a randomized phase 3 trial (COMBI-i)
    In: Journal for ImmunoTherapy of Cancer Jg. 10 (2022) Nr. 6,
    ISSN: 2051-1426
    Online Volltext: dx.doi.org/ (Open Access)
  • Thielmann, Carl Maximilian; Matull, Johanna; Zaremba, Anne; Murali, Rajmohan; Chorti, Eleftheria; Lodde, Georg; Jansen, Philipp; Herbst, Rudolf; Terheyden, Patrick; Utikal, Jochen; Pföhler, Claudia; Ulrich, Jens; Kreuter, Alexander; Mohr, Peter; Gutzmer, Ralf; Meier, Friedegund; Dippel, Edgar; Weichenthal, Michael; Kretz, Julia; Möller, Inga; Sucker, Antje; Paschen, Annette; Livingstone, Elisabeth; Zimmer, Lisa; Hadaschik, Eva; Ugurel, Selma; Schadendorf, Dirk; Griewank, Klaus G.
    TERT promoter mutations are associated with longer progression-free and overall survival in patients with BRAF-mutant melanoma receiving BRAF and MEK inhibitor therapy
    In: European Journal of Cancer (EJC) Jg. 161 (2022) S. 99 - 107
    ISSN: 1879-0852; 0959-8049; 1879-2995
    Online Volltext: dx.doi.org/
  • Michel, Lars; Helfrich, Iris; Hendgen-Cotta, Ulrike Barbara; Mincu, Raluca-Ileana; Korste, Sebastian; Mrotzek, Simone Maria; Spomer, Armin; Odersky, Andrea; Rischpler, Christoph; Herrmann, Ken; Umutlu, Lale; Coman, Cristina; Ahrends, Robert; Sickmann, Albert; Löffek, Stefanie; Livingstone, Elisabeth; Ugurel, Selma; Zimmer, Lisa; Gunzer, Matthias; Schadendorf, Dirk; Totzeck, Matthias; Rassaf, Tienush
    Targeting early stages of cardiotoxicity from anti-PD1 immune checkpoint inhibitor therapy
    In: European Heart Journal Jg. 43 (2022) Nr. 4, S. 316 - 329
    ISSN: 0195-668X; 1522-9645
    Online Volltext: dx.doi.org/
  • Hegedüs, Luca; Livingstone, Elisabeth; Bankfalvi, Agnes; Viehof, Jan; Enyedi, Ágnes; Bilecz, Ágnes; Győrffy, Balázs; Baranyi, Marcell; Tőkés, Anna-Mária; Gil, Jeovanis; Marko-Varga, György; Griewank, Klaus; Zimmer, Lisa; Váraljai, Renáta; Sucker, Antje; Zaremba, Anne; Schadendorf, Dirk; Aigner, Clemens; Hegedüs, Balázs
    The Prognostic Relevance of PMCA4 Expression in Melanoma : Gender Specificity and Implications for Immune Checkpoint Inhibition
    In: International Journal of Molecular Sciences (IJMS) Jg. 23 (2022) Nr. 6,
    ISSN: 1422-0067; 1661-6596
    Online Volltext: dx.doi.org/ Online Volltext (Open Access)
  • Ascierto, Paolo A.; Schadendorf, Dirk
    Update in the treatment of non-melanoma skin cancers : the use of PD-1 inhibitors in basal cell carcinoma and cutaneous squamous-cell carcinoma
    In: Journal for ImmunoTherapy of Cancer Jg. 10 (2022) Nr. 12,
    ISSN: 2051-1426
    Online Volltext: dx.doi.org/ (Open Access)
  • Sauter, Daniel; Lodde, Georg; Nensa, Felix; Schadendorf, Dirk; Livingstone, Elisabeth; Kukuk, Markus
    Validating Automatic Concept-Based Explanations for AI-Based Digital Histopathology
    In: Sensors Jg. 22 (2022) Nr. 14,
    ISSN: 1424-8220
    Online Volltext: dx.doi.org/ Online Volltext (Open Access)
  • Bäuerle, Alexander; Martus, Peter; Erim, Yesim; Schug, Caterina; Heinen, Jana; Krakowczyk, Julia Barbara; Steinbach, Jasmin; Damerau, Mirjam; Bethge, Wolfgang; Dinkel, Andreas; Dries, Sebastian; Mehnert-Theuerkauf, Anja; Neumann, Anja; Schadendorf, Dirk; Tewes, Mitra; Wiltink, Jörg; Wünsch, Alexander; Zipfel, Stephan; Graf, Johanna; Teufel, Martin
    Web-based mindfulness and skills-based distress reduction for patients with cancer : study protocol of the multicentre, randomised, controlled confirmatory intervention trial Reduct
    In: BMJ Open Jg. 12 (2022) Nr. 6,
    ISSN: 2044-6055
    Online Volltext: dx.doi.org/ (Open Access)
  • Maron, Roman C.; Schlager, Justin G.; Haggenmüller, Sarah; von Kalle, Christof; Utikal, Jochen S.; Meier, Friedegund; Gellrich, Frank F.; Hobelsberger, Sarah; Hauschild, Axel; French, Lars; Heinzerling, Lucie; Schlaak, Max; Ghoreschi, Kamran; Hilke, Franz J.; Poch, Gabriela; Heppt, Markus V.; Berking, Carola; Haferkamp, Sebastian; Sondermann, Wiebke; Schadendorf, Dirk; Schilling, Bastian; Goebeler, Matthias; Krieghoff-Henning, Eva; Hekler, Achim; Fröhling, Stefan; Lipka, Daniel B.; Kather, Jakob N.; Brinker, Titus J.
    A benchmark for neural network robustness in skin cancer classification
    In: European Journal of Cancer Jg. 155 (2021) S. 191 - 199
    ISSN: 0959-8049; 1879-0852
    Online Volltext: dx.doi.org/ (Open Access)
  • Bottomley, Andrew; Coens, Corneel; Mierzynska, Justyna; Blank, Christian U; Mandalà, Mario; Long, Georgina V; Atkinson, Victoria G; Dalle, Stéphane; Haydon, Andrew M; Meshcheryakov, Andrey; Khattak, Adnan; Carlino, Matteo S; Sandhu, Shahneen; Puig, Susana; Ascierto, Paolo A; Larkin, James; Lorigan, Paul C; Rutkowski, Piotr; Schadendorf, Dirk; Koornstra, Rutger; Hernandez-Aya, Leonel; Di Giacomo, Anna Maria; van den Eertwegh, Alfonsus J M; Grob, Jean-Jacques; Gutzmer, Ralf; Jamal, Rahima; van Akkooi, Alexander C J; Krepler, Clemens; Ibrahim, Nageatte; Marreaud, Sandrine; Kicinski, Michal; Suciu, Stefan; Robert, Caroline; Eggermont, Alexander M M; Lesimple, Thierry; Maio, Michele; Linette, Gerald; Mortier, Laurent; Svane, Inge Marie; Schachter, Jacob; Brown, Michael; Hersey, Peter; Barrow, Catherine; Kudchadkar, Ragini; Dutriaux, Caroline; Song, Xinni; Quaglino, Pietro; Queirolo, Paola; Meier, Friedegund; Stroyakovskiy, Daniil; Guillot, Bernard; Romero, Pablo Luis Ortiz; Bastholt, Lars; Garbe, Claus; Grange, Florent; Mohr, Peter; Algazi, Alain; Bechter, Oliver; Hernberg, Micaela; Loquai, Carmen; Meiss, Frank; Chiarion Sileni, Vanna; Bar-Sela, Gil; Fitzharris, Bernard; Saiag, Philippe; Arnault, Jean-Philippe; Simon, Jan-Christoph; Stephens, Rosalie; Baurain, Jean-Francois; Lebbe, Célèste; Combemale, Patrick; Dummer, Reinhard; Hauschild, Axel; Parente, Phillip; Yamazaki, Naoya; Milhem, Mohammed; Leccia, Marie-Thérèse; Geoffrois, Lionel; Kretschmer, Lutz; Dunwoodie, Elaine; Walker, John; Lotem, Michal; Hendler, Daniel; Mackiewicz, Andrzej; Sekulovic, Lidija; Dzienis, Marcin; Hospers, Geke A.P.; Siano, Marco; Hassel, Jessica; Corrie, Philippa; Passos, Maria-Jose; Levin, Max; Hoeller, Christoph; Machet, Laurent; Hallmeyer, Sigrun; Waterston, Ashita; Descamps, Vincent; Kiecker, Felix; Aarts, Maureen; Schmidt, Henrik; Raimundo, Ana; Nyakas, Marta; Lacour, Jean-Philippe; Berking, Carola; Ferrucci, Pier Francesco; Jameson, Michael; Kim, Kevin; Yokota, Kenji; Kerger, Joseph; Aubin, François; Groenewegen, Gerard; Kapiteijn, Helena; Boehncke, Wolf-Henning; Utikal, Jochen; Casasola, Richard; Marshall, Ernest; Ferraresi, Virginia; Richtig, Erika; Matkovic, Suzana; Inozume, Takashi; Crook, Timothy; McNeil, Catriona; Kiyohara, Yoshio; Avril, Marie-Francoise; Hein, Rüdiger; Terheyden, Patrick; Nathan, Paul; Aoi, Jun; Skytta, Tanja; Jouary, Thomas; Takenouchi, Tatsuya; Straume, Oddbjorn; Martins, César; Mukhametshina, Guzel
    Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054) : health-related quality-of-life results from a double-blind, randomised, controlled, phase 3 trial
    In: The Lancet Oncology Jg. 22 (2021) Nr. 5, S. 655 - 664
    ISSN: 1474-5488; 1470-2045
    Online Volltext: dx.doi.org/
  • Eggermont, Alexander M M; Blank, Christian U; Mandalà, Mario; Long, Georgina V; Atkinson, Victoria G; Dalle, Stéphane; Haydon, Andrew M; Meshcheryakov, Andrey; Khattak, Adnan; Carlino, Matteo S; Sandhu, Shahneen; Larkin, James; Puig, Susana; Ascierto, Paolo A; Rutkowski, Piotr; Schadendorf, Dirk; Koornstra, Rutger; Hernandez-Aya, Leonel; Di Giacomo, Anna Maria; van den Eertwegh, Alfonsus J M; Grob, Jean-Jacques; Gutzmer, Ralf; Jamal, Rahima; Lorigan, Paul C; van Akkooi, Alexander C J; Krepler, Clemens; Ibrahim, Nageatte; Marreaud, Sandrine; Kicinski, Michal; Suciu, Stefan; Robert, Caroline; Menzies, Alex; Lesimple, Thierry; Maio, Michele; Linette, Gerald; Brown, Michael; Hersey, Peter; Svane, Inge Marie; Mortier, Laurent; Schachter, Jacob; Barrow, Catherine; Kudchadkar, Ragini; Song, Xinni; Dutriaux, Caroline; Quaglino, Pietro; Meier, Friedegund; Queirolo, Paola; Stroyakovskiy, Daniil; Bastholt, Lars; Guillot, Bernard; Garbe, Claus; Ortiz Romero, Pablo Luis; Grange, Florent; Mohr, Peter; Algazi, Alain; Bechter, Oliver; Hernberg, Micaela; Arnault, Jean-Philippe; Saiag, Philippe; Loquai, Carmen; Meiss, Frank; Simon, Jan-Christoph; Bar-Sela, Gil; Chiarion Sileni, Vanna; Fitzharris, Bernard; McCrystal, Mike; Parente, Phillip; Baurain, Jean-Francois; Combemale, Patrick; Lebbe, Célèste; Hauschild, Axel; Yamazaki, Naoya; Dummer, Reinhard; Milhem, Mohammed; Dzienis, Marcin; Walker, John; Geoffrois, Lionel; Leccia, Marie-Thérèse; Kretschmer, Lutz; Hendler, Daniel; Lotem, Michal; Mackiewicz, Andrzej; Sekulovic, Lidija; Dunwoodie, Elaine; Hoeller, Christoph; Machet, Laurent; Hassel, Jessica; Hospers, Geke A.P.; Passos, Maria-Jose; Levin, Max; Fehr, Martin; Corrie, Philippa; Waterston, Ashita; Hallmeyer, Sigrun; Schmidt, Henrik; Descamps, Vincent; Lacour, Jean-Philippe; Berking, Carola; Kiecker, Felix; Ferrucci, Pier Francesco; Yokota, Kenji; Aarts, Maureen; Jameson, Michael; Winge-Main, Anna Katharina; Ferreira, Paula; Kim, Kevin; McNeil, Catriona; Hofmann-Wellenhof, Reiner; Kerger, Joseph; Aubin, François; Utikal, Jochen; Ferraresi, Virginia; Inozume, Takashi; Kiyohara, Yoshio; Groenewegen, Gerard; Kapiteijn, Helena; Matkovic, Suzana; Boehncke, Wolf-Henning; Casasola, Richard; Crook, Timothy; Marshall, Ernest; Skytta, Tanja; Avril, Marie-Francoise; Jouary, Thomas; Hein, Rüdiger; Terheyden, Patrick; Aoi, Jun; Takenouchi, Tatsuya; Straume, Oddbjorn; Martins, César; Mukhametshina, Guzel; Nathan, Paul
    Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054) : distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trial
    In: The Lancet Oncology Jg. 22 (2021) Nr. 5, S. 643 - 654
    ISSN: 1474-5488; 1470-2045
    Online Volltext: dx.doi.org/
  • Hegedüs, Luca; Okumus, Özlem; Livingstone, Elisabeth; Baranyi, Marcell; Kovács, Ildikó; Döme, Balázs; Tóvári, József; Bankfalvi, Agnes; Schadendorf, Dirk; Aigner, Clemens; Hegedüs, Balázs
    Allosteric and ATP-competitive MEK-inhibition in a novel spitzoid melanoma model with a raf-and phosphorylation-independent mutation
    In: Cancers Jg. 13 (2021) Nr. 4, S. 829
    ISSN: 2072-6694
    Online Volltext: dx.doi.org/ Online Volltext (Open Access)
  • De Santis, Francesca; Fucà, Giovanni; Schadendorf, Dirk; Mantovani, Alberto; Magnani, Luca; Lisanti, Michael; Pettitt, Stephen; Bellone, Matteo; Del Sal, Giannino; Minucci, Saverio; Eggermont, Alexander; Bruzzi, Paolo; Bicciato, Silvio; Conte, Pierfranco; Noberini, Roberta; Hiscott, John; De Braud, Filippo; Del Vecchio, Michele; Di Nicola, Massimo
    Anticancer innovative therapy congress : Highlights from the 10th anniversary edition
    In: Cytokine & Growth Factor Reviews Jg. 59 (2021) S. 1 - 8
    ISSN: 1879-0305; 1359-6101
    Online Volltext: dx.doi.org/ Online Volltext (Open Access)
  • Placke, Jan-Malte; Rawitzer, Josefine; Reis, Henning; Rashidi-Alavijeh, Jassin; Livingstone, Elisabeth; Ugurel, Selma; Hadaschik, Eva; Griewank, Klaus; Schmid, Kurt Werner; Schadendorf, Dirk; Rösch, Alexander; Zimmer, Lisa
    Apoptotic Gastritis in Melanoma Patients Treated With PD-1-Based Immune Checkpoint Inhibition : Clinical and Histopathological Findings Including the Diagnostic Value of Anti-Caspase-3 Immunohistochemistry
    In: Frontiers in Oncology Jg. 11 (2021)
    ISSN: 2234-943X
    Online Volltext: dx.doi.org/ Online Volltext (Open Access)
  • Gutzmer, Ralf; Robert, Caroline; Loquai, Carmen; Schadendorf, Dirk; Squittieri, Nicholas; Arntz, Ramon; Martelli, Serena; Dummer, Reinhard
    Assessment of various efficacy outcomes using ERIVANCE-like criteria in patients with locally advanced basal cell carcinoma receiving sonidegib : results from a preplanned sensitivity analysis
    In: BMC Cancer Jg. 21 (2021) Nr. 1,
    ISSN: 1471-2407
    Online Volltext: dx.doi.org/ (Open Access)
  • Pfeiffer, Lukas; Farahpour, Farnoush; Sriram, Ashwin; Spassova, Ivelina; Hoffmann, Daniel; Kubat, Linda; Stoitzner, Patrizia; Gambichler, Thilo; Sucker, Antje; Ugurel, Selma; Schadendorf, Dirk; Becker, Jürgen C.
    BRAF and MEK inhibition in melanoma patients enables reprogramming of tumor infiltrating lymphocytes
    In: Cancer Immunology, Immunotherapy Jg. 70 (2021) Nr. 6, S. 1635 - 1647
    ISSN: 1432-0851; 0340-7004
    Online Volltext: dx.doi.org/ (Open Access)
  • Syeda, Mahrukh M.; Wiggins, Jennifer M.; Corless, Broderick C; Long, Georgina V.; Flaherty, Keith T.; Schadendorf, Dirk; Nathan, Paul D.; Robert, Caroline; Ribas, Antoni; Davies, Michael A.; Grob, Jean Jacques; Gasal, Eduard; Squires, Matthew; Marker, Mahtab; Garrett, James; Brase, Jan C.; Polsky, David
    Circulating tumour DNA in patients with advanced melanoma treated with dabrafenib or dabrafenib plus trametinib : A clinical validation study
    In: The Lancet Oncology Jg. 22 (2021) Nr. 3, S. 370 - 380
    ISSN: 1470-2045; 1474-5488
    Online Volltext: dx.doi.org/ Online Volltext (Open Access)
  • Gravemeyer, Jan; Lange, Anja; Ritter, Cathrin; Spassova, Ivelina; Song, Lina; Picard, Daniel; Remke, Marc; Horny, Kai; Sriram, Ashwin; Gambichler, Thilo; Schadendorf, Dirk; Hoffmann, Daniel; Becker, Jürgen
    Classical and Variant Merkel Cell Carcinoma Cell Lines Display Different Degrees of Neuroendocrine Differentiation and Epithelial-Mesenchymal Transition
    In: Journal of Investigative Dermatology Jg. 141 (2021) Nr. 7, S. 1675 - 1686.e4
    ISSN: 1523-1747; 0022-202X
    Online Volltext: dx.doi.org/ (Open Access)
  • Zaremba, Anne; Philip, Manuel; Hassel, Jessica C.; Glutsch, Valerie; Fiocco, Zeno; Loquai, Carmen; Rafei-Shamsabadi, David; Gutzmer, Ralf; Utikal, Jochen; Haferkamp, Sebastian; Reinhardt, Lydia; Kähler, Katharina C.; Weishaupt, Carsten; Moreira, Alvaro; Thoms, Kai-Martin; Wilhelm, Tabea; Pföhler, Claudia; Rösch, Alexander; Ugurel, Selma; Zimmer, Lisa; Stadtler, Nadine; Sucker, Antje; Kiecker, Felix; Heinzerling, Lucie; Meier, Friedegund; Meiss, Frank; Schlaak, Max; Schilling, Bastian; Horn, Susanne; Schadendorf, Dirk; Livingstone, Elisabeth
    Clinical characteristics and therapy response in unresectable melanoma patients stage IIIB-IIID with in-transit and satellite metastases
    In: European Journal of Cancer (EJC) Jg. 152 (2021) S. 139 - 154
    ISSN: 1879-0852; 0959-8049; 1879-2995
    Online Volltext: dx.doi.org/
  • Rogiers, Aljosja; Da Silva, Ines Pires; Tentori, Chiara; Tondini, Carlo Alberto; Grimes, Joseph M.; Trager, Megan H.; Nahm, Sharon; Zubiri, Leyre; Manos, Michael; Bowling, Peter; Elkrief, Arielle; Papneja, Neha; Vitale, Maria Grazia; Rose, April A.N.; Borgers, Jessica S.W.; Roy, Severine; Mangana, Joanna; Pimentel Muniz, Thiago; Cooksley, Tim; Lupu, Jeremy; Vaisman, Alon; Saibil, Samuel D.; Butler, Marcus O.; Menzies, Alexander M.; Carlino, Matteo S.; Erdmann, Michael; Berking, Carola; Zimmer, Lisa; Schadendorf, Dirk; Pala, Laura; Queirolo, Paola; Posch, Christian; Hauschild, Axel; Dummer, Reinhard; Haanen, John; Blank, Christian U.; Robert, Caroline; Sullivan, Ryan J.; Ascierto, Paolo Antonio; Miller, Wilson H; Stephen Hodi, F.; Suijkerbuijk, Karijn P.M.; Reynolds, Kerry L.; Rahma, Osama E.; Lorigan, Paul C.; Carvajal, Richard D.; Lo, Serigne; Mandala, Mario; Long, Georgina V.
    Clinical impact of COVID-19 on patients with cancer treated with immune checkpoint inhibition
    In: Journal for ImmunoTherapy of Cancer Jg. 9 (2021) Nr. 1, S. e001931
    ISSN: 2051-1426
    Online Volltext: dx.doi.org/ (Open Access)
  • Höhn, Julia; Krieghoff-Henning, Eva; Jutzi, Tanja B.; von Kalle, Christof; Utikal, Jochen S.; Meier, Friedegund; Gellrich, Frank F.; Hobelsberger, Sarah; Hauschild, Axel; Schlager, Justin G.; French, Lars; Heinzerling, Lucie; Schlaak, Max; Ghoreschi, Kamran; Hilke, Franz J.; Poch, Gabriela; Kutzner, Heinz; Heppt, Markus V.; Haferkamp, Sebastian; Sondermann, Wiebke; Schadendorf, Dirk; Schilling, Bastian; Goebeler, Matthias; Hekler, Achim; Fröhling, Stefan; Lipka, Daniel B.; Kather, Jakob N.; Krahl, Dieter; Ferrara, Gerardo; Haggenmüller, Sarah; Brinker, Titus J.
    Combining CNN-based histologic whole slide image analysis and patient data to improve skin cancer classification
    In: European Journal of Cancer Jg. 149 (2021) S. 94 - 101
    ISSN: 1879-0852; 0959-8049
    Online Volltext: dx.doi.org/ (Open Access)
  • Franklin, Cindy; Wetter, Axel; Baba, Hideo Andreas; Theysohn, Jens; Haubold, Johannes; Cosgarea, Ioana; Hadaschik, Eva; Livingstone, Elisabeth; Zimmer, Lisa; Stoffels, Ingo; Klode, Joachim; Lodde, Georg; Placke, Jan-Malte; Schadendorf, Dirk; Ugurel, Selma
    Computed tomography-guided biopsy of radiologically unclear lesions in advanced skin cancer : A retrospective analysis of 47 cases
    In: European Journal of Cancer (EJC) Jg. 150 (2021) S. 119 - 129
    ISSN: 1879-0852; 0959-8049
    Online Volltext: dx.doi.org/
  • Placke, Jan-Malte; Reis, Henning; Hadaschik, Eva; Rösch, Alexander; Schadendorf, Dirk; Stoffels, Ingo; Klode, Joachim
    Coronavirus disease 2019 vaccine mimics lymph node metastases in patients undergoing skin cancer follow-up : A monocentre study
    In: European Journal of Cancer Jg. 154 (2021) S. 167 - 174
    ISSN: 1879-0852; 0959-8049
    Online Volltext: dx.doi.org/ (Open Access)
  • Brinker, Titus J.; Kiehl, Lennard; Schmitt, Max; Jutzi, Tanja B.; Krieghoff-Henning, Eva I.; Krahl, Dieter; Kutzner, Heinz; Gholam, Patrick; Haferkamp, Sebastian; Klode, Joachim; Schadendorf, Dirk; Hekler, Achim; Fröhling, Stefan; Kather, Jakob N.; Haggenmüller, Sarah; von Kalle, Christof; Heppt, Markus; Hilke, Franz; Ghoreschi, Kamran; Tiemann, Markus; Wehkamp, Ulrike; Hauschild, Axel; Weichenthal, Michael; Utikal, Jochen S.
    Deep learning approach to predict sentinel lymph node status directly from routine histology of primary melanoma tumours
    In: European Journal of Cancer Jg. 154 (2021) S. 227 - 234
    ISSN: 1879-0852; 0959-8049
    Online Volltext: dx.doi.org/ (Open Access)
  • Gangaev, Anastasia; Rozeman, Elisa A.; Rohaan, Maartje W.; Isaeva, Olga I.; Philips, Daisy; Patiwael, Sanne; van den Berg, Joost H.; Ribas, Antoni; Schadendorf, Dirk; Schilling, Bastian; Schumacher, Ton N.; Blank, Christian U.; Haanen, John B. A. G.; Kvistborg, Pia
    Differential effects of PD-1 and CTLA-4 blockade on the melanoma-reactive CD8 T cell response
    In: Proceedings of the National Academy of Sciences of the United States of America (PNAS) Jg. 118 (2021) Nr. 43,
    ISSN: 1091-6490; 0027-8424
    Online Volltext: dx.doi.org/ Online Volltext (Open Access)
  • Placke, Jan-Malte; Soun, Camille; Bottek, Jenny; Herbst, Rudolf; Terheyden, Patrick; Utikal, Jochen; Pföhler, Claudia; Ulrich, Jens; Kreuter, Alexander; Pfeiffer, Christiane; Mohr, Peter; Gutzmer, Ralf; Meier, Friedegund; Dippel, Edgar; Weichenthal, Michael; Zimmer, Lisa; Livingstone, Elisabeth; Becker, Jürgen; Lodde, Georg; Sucker, Antje; Griewank, Klaus; Horn, Susanne; Hadaschik, Eva; Rösch, Alexander; Schadendorf, Dirk; Engel, Daniel Robert; Ugurel, Selma
    Digital Quantification of Tumor PD-L1 Predicts Outcome of PD-1-Based Immune Checkpoint Therapy in Metastatic Melanoma
    In: Frontiers in Oncology Jg. 11 (2021)
    ISSN: 2234-943X
    Online Volltext: dx.doi.org/ Online Volltext (Open Access)
  • Stege, Henner; Haist, Maximilian; Schultheis, Michael; Fleischer, Maria Isabel; Mohr, Peter; Meier, Friedegund; Schadendorf, Dirk; Ugurel, Selma; Livingstone, Elisabeth; Zimmer, Lisa; Herbst, Rudolf; Pföhler, Claudia; Kähler, Katharina; Weichenthal, Michael; Terheyden, Patrick; Nashan, Dorothée; Debus, Dirk; Kaatz, Martin; Ziller, Fabian; Haferkamp, Sebastian; Forschner, Andrea; Leiter, Ulrike; Kreuter, Alexander; Ulrich, Jens; Kleemann, Johannes; Bradfisch, Fabienne; Grabbe, Stephan; Loquai, Carmen
    Discontinuation of braf/mek-directed targeted therapy after complete remission of metastatic melanoma : a retrospective multicenter adoreg study
    In: Cancers Jg. 13 (2021) Nr. 10, S. 2312
    ISSN: 2072-6694
    Online Volltext: dx.doi.org/ (Open Access)
  • Le Rhun, E.; Guckenberger, M.; Smits, M.; Dummer, R.; Bachelot, T.; Sahm, F.; Galldiks, N.; de Azambuja, E.; Berghoff, A.S.; Metellus, P.; Peters, S.; Hong, Y.-K.; Winkler, F.; Schadendorf, Dirk; van den Bent, M.; Seoane, J.; Stahel, R.; Minniti, G.; Wesseling, P.; Weller, M.; Preusser, M.
    EANO–ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up of patients with brain metastasis from solid tumours
    In: Annals of Oncology Jg. 32 (2021) Nr. 11, S. 1332 - 1347
    ISSN: 1569-8041; 0923-7534
    Online Volltext: dx.doi.org/ (Open Access)
  • Kähler, Katharina C.; Gutzmer, Ralf; Meier, Friedegrund; Zimmer, Lisa; Heppt, Markus; Gesierich, Anja; Thoms, Kai-Martin; Utikal, Jochen; Hassel, Jessica C.; Loquai, Carmen; Pföhler, Claudia; Heinzerling, Lucie; Kaatz, Martin; Göppner, Daniela; Pflugfelder, Annette; Bohne, Ann-Sophie; Satzger, Imke; Reinhardt, Lydia; Placke, Jan-Malte; Schadendorf, Dirk; Ugurel, Selma
    Early Exanthema Upon Vemurafenib Plus Cobimetinib Is Associated With a Favorable Treatment Outcome in Metastatic Melanoma : A Retrospective Multicenter DeCOG Study
    In: Frontiers in Oncology Jg. 11 (2021)
    ISSN: 2234-943X
    Online Volltext: dx.doi.org/ (Open Access)
  • Gutzmer, Ralf; Schulze, Hans Joachim; Hauschild, Axel; Leiter, Ulrike; Meier, Friedegund E.; Haferkamp, Sebastian; Ulrich, Claas; Wahl, Renate Ursula; Berking, Carola; Herbst, Rudolf A.; Häckl, Manuel; Schadendorf, Dirk
    Effectiveness, safety and utilization of vismodegib in locally advanced basal cell carcinoma under real-world conditions in Germany : The non-interventional study NIELS
    In: Journal of the European Academy of Dermatology and Venereology Jg. 35 (2021) Nr. 8, S. 1678 - 1685
    ISSN: 0926-9959; 1468-3083
    Online Volltext: dx.doi.org/ (Open Access)
  • Zimmer, Lisa; Livingstone, Elisabeth; Krackhardt, Angela; Schultz, Erwin S.; Göppner, Daniela; Assaf, Chalid; Trebing, Dietrich; Stelter, Kai; Windemuth-Kieselbach, Christine; Ugurel, Selma; Schadendorf, Dirk
    Encorafenib, binimetinib plus pembrolizumab triplet therapy in patients with advanced BRAFV⁶⁰⁰ mutant melanoma : safety and tolerability results from the phase I IMMU-TARGET trial
    In: The European Journal of Cancer Jg. 158 (2021) S. 72 - 84
    ISSN: 1879-0852; 0959-8049
    Online Volltext: dx.doi.org/
  • Yang, Yongjie; Ma, Yanfang; Lu, Jingli; Zhang, Qiwen; Guan, Kelei; Liu, Kefeng; Kang, Jian; Du, Shuzhang; Tang, Shu; Liu, Xuehui; Zhang, Ailing; Schadendorf, Dirk; Agarwala, Sanjiv S.; Zhang, Xiaojian
    Evaluation of the reporting quality of clinical practice guidelines on melanoma using the RIGHT checklist
    In: Annals of Translational Medicine Jg. 9 (2021) Nr. 14,
    ISSN: 2305-5839; 2305-5847
    Online Volltext: dx.doi.org/ (Open Access)
  • Lodde, Georg; Forschner, Andrea; Hassel, Jessica; Wulfken, Lena M.; Meier, Friedegund; Mohr, Peter; Kähler, Katharina; Schilling, Bastian; Loquai, Carmen; Berking, Carola; Hüning, Svea; Schatton, Kerstin; Gebhardt, Christoffer; Eckardt, Julia; Gutzmer, Ralf; Reinhardt, Lydia; Glutsch, Valerie; Nikfarjam, Ulrike; Erdmann, Michael; Stang, Andreas; Kowall, Bernd; Rösch, Alexander; Ugurel, Selma; Zimmer, Lisa; Schadendorf, Dirk; Livingstone, Elisabeth
    Factors influencing the adjuvant therapy decision : Results of a real-world multicenter data analysis of 904 melanoma patients
    In: Cancers Jg. 13 (2021) Nr. 10, S. 2319
    ISSN: 2072-6694
    Online Volltext: dx.doi.org/ Online Volltext (Open Access)
  • Jansen, Philipp; Müller, Hansgeorg; Lodde, Georg C.; Zaremba, Anne; Möller, Inga; Sucker, Antje; Paschen, Annette; Esser, Stefan; Schaller, Jörg; Gunzer, Matthias; Standl, Fabian; Bauer, Sebastian; Schadendorf, Dirk; Mentzel, Thomas; Hadaschik, Eva; Griewank, Klaus G.
    GNA14, GNA11, and GNAQ Mutations Are Frequent in Benign but Not Malignant Cutaneous Vascular Tumors
    In: Frontiers in Genetics Jg. 12 (2021)
    ISSN: 1664-8021
    Online Volltext: dx.doi.org/ Online Volltext (Open Access)
  • Merz, Simon F.; Jansen, Philipp; Ulankiewicz, Ricarda; Bornemann, Lea; Schimming, Tobias; Griewank, Klaus; Cibir, Zülal; Kraus, Andreas; Stoffels, Ingo; Aspelmeier, Timo; Brandau, Sven; Schadendorf, Dirk; Hadaschik, Eva; Ebel, Gernot; Gunzer, Matthias; Klode, Joachim
    High-resolution three-dimensional imaging for precise staging in melanoma
    In: European Journal of Cancer (EJC) Jg. 159 (2021) S. 182 - 193
    ISSN: 1879-0852; 0959-8049; 1879-2995
    Online Volltext: dx.doi.org/ (Open Access)
  • Koch, Elias A. T.; Petzold, Anne; Wessely, Anja; Dippel, Edgar; Gesierich, Anja; Gutzmer, Ralf; Hassel, Jessica C.; Haferkamp, Sebastian; Hohberger, Bettina; Kähler, Katharina C.; Knorr, Harald; Kreuzberg, Nicole; Leiter, Ulrike; Loquai, Carmen; Meier, Friedegund; Meissner, Markus; Mohr, Peter; Pföhler, Claudia; Rahimi, Farnaz; Schadendorf, Dirk; Schell, Beatrice; Schlaak, Max; Terheyden, Patrick; Thoms, Kai-Martin; Schuler-Thurner, Beatrice; Ugurel, Selma; Ulrich, Jens; Utikal, Jochen; Weichenthal, Michael; Ziller, Fabian; Berking, Carola; Heppt, Markus V.
    Immune checkpoint blockade for metastatic uveal melanoma : Patterns of response and survival according to the presence of hepatic and extrahepatic metastasis
    In: Cancers Jg. 13 (2021) Nr. 13,
    ISSN: 2072-6694
    Online Volltext: dx.doi.org/ (Open Access)
  • Weber, Jeffrey S.; Ascierto, Paolo A.; Middleton, Mark R.; Hennicken, Delphine; Zoffoli, Roberto; Pieters, Anne; Amadi, Adenike; Kupas, Katrin; Kotapati, Srividya; Moshyk, Andriy; Schadendorf, Dirk
    Indirect treatment comparison of nivolumab versus placebo as adjuvant treatment for resected melanoma
    In: European Journal of Cancer (EJC) Jg. 158 (2021) S. 225 - 233
    ISSN: 1879-0852; 0959-8049; 1879-2995
    Online Volltext: dx.doi.org/ (Open Access)
  • Rischin, Danny; Khushalani, Nikhil I; Schmults, Chrysalyne D; Guminski, Alexander; Chang, Anne Lynn S; Lewis, Karl D; Lim, Annette M; Hernandez-Aya, Leonel; Hughes, Brett G M; Schadendorf, Dirk; Hauschild, Axel; Thai, Alesha A; Stankevich, Elizabeth; Booth, Jocelyn; Yoo, Suk-Young; Li, Siyu; Chen, Zhen; Okoye, Emmanuel; Chen, Chieh-I; Mastey, Vera; Sasane, Medha; Lowy, Israel; Fury, Matthew G; Migden, Michael R
    Integrated analysis of a phase 2 study of cemiplimab in advanced cutaneous squamous cell carcinoma : Extended follow-up of outcomes and quality of life analysis
    In: Journal for ImmunoTherapy of Cancer Jg. 9 (2021) Nr. 8,
    ISSN: 2051-1426
    Online Volltext: dx.doi.org/ (Open Access)
  • Höhn, Julia; Hekler, Achim; Krieghoff-Henning, Eva; Kather, Jakob Nikolas; Utikal, Jochen Sven; Meier, Friedegund; Gellrich, Frank Friedrich; Hauschild, Axel; French, Lars; Schlager, Justin Gabriel; Ghoreschi, Kamran; Wilhelm, Tabea; Kutzner, Heinz; Heppt, Markus; Haferkamp, Sebastian; Sondermann, Wiebke; Schadendorf, Dirk; Schilling, Bastian; Maron, Roman C.; Schmitt, Max; Jutzi, Tanja; Fröhling, Stefan; Lipka, Daniel B.; Brinker, Titus Josef
    Integrating patient data into skin cancer classification using convolutional neural networks : Systematic review
    In: Journal of Medical Internet Research Jg. 23 (2021) Nr. 7,
    ISSN: 1438-8871; 1439-4456
    Online Volltext: dx.doi.org/ (Open Access)
  • Váraljai, Renáta; Horn, Susanne; Sucker, Antje; Pierscianek, Daniela; Schmitt, Verena; Carpinteiro, Alexander; Becker, Katrin; Reifenberger, Julia; Rösch, Alexander; Felsberg, Joerg; Reifenberger, Guido; Sure, Ulrich; Schadendorf, Dirk; Helfrich, Iris
    Integrative genomic analyses of patient-matched intracranial and extracranial metastases reveal a novel brain-specific landscape of genetic variants in driver genes of malignant melanoma
    In: Cancers Jg. 13 (2021) Nr. 4, S. 731
    ISSN: 2072-6694
    Online Volltext: dx.doi.org/ Online Volltext (Open Access)
  • Albrecht, Margarete; Hadaschik, Eva; Zimmer, Lisa; Livingstone, Elisabeth; Hamacher, Rainer; Bauer, Sebastian; Schadendorf, Dirk; Ugurel, Selma
    Kutanes Angiosarkom mit klinischem Bild eines Quincke-Ödems
    In: Der Hautarzt Jg. 72 (2021) Nr. 9, S. 801 - 804
    ISSN: 1432-1173; 0017-8470
    Online Volltext: dx.doi.org/ (Open Access)
  • Chorti, Eleftheria; Kebir, Sied; Ahmed, Misbah S.; Keyvani, Kathy; Umutlu, Lale; Kanaki, Theodora; Zaremba, Anne; Reinboldt-Jockenhöfer, Finja; Knispel, Sarah; Gratsias, Emmanouil; Rösch, Alexander; Ugurel, Selma; Scheffler, Björn; Schadendorf, Dirk; Livingstone, Elisabeth; Meier, Friedegund; Glas, Martin; Zimmer, Lisa
    Leptomeningeal disease from melanoma : Poor prognosis despite new therapeutic modalities
    In: European Journal of Cancer (EJC) Jg. 148 (2021) S. 395 - 404
    ISSN: 1879-0852; 0959-8049; 1879-2995
    Online Volltext: dx.doi.org/
  • Salzmann, Martin; Tosev, Georgi; Heck, Melanie; Schadendorf, Dirk; Maatouk, Imad; Enk, Alexander H.; Hartmann, Martin; Hassel, Jessica C.
    Male fertility during and after immune checkpoint inhibitor therapy : A cross-sectional pilot study
    In: European Journal of Cancer (EJC) Jg. 152 (2021) S. 41 - 48
    ISSN: 1879-0852; 0959-8049; 1879-2995
    Online Volltext: dx.doi.org/
  • Harbers, Franziska Noelle; Thier, Beatrice; Stupia, Simone; Zhu, Si; Schwamborn, Marion; Peller, Vicky; Chauvistré, Heike; Crivello, Pietro; Fleischhauer, Katharina; Rösch, Alexander; Sucker, Antje; Schadendorf, Dirk; Chen, Yong; Paschen, Annette; Zhao, Fang
    Melanoma Differentiation Trajectories Determine Sensitivity Toward Pre-Existing CD8⁺ Tumor-Infiltrating Lymphocytes
    In: Journal of Investigative Dermatology Jg. 141 (2021) Nr. 10, S. 2480 - 2489
    ISSN: 1523-1747; 0022-202X
    Online Volltext: dx.doi.org/ (Open Access)
  • Bhave, Prachi; Pallan, Lalit; Long, Georgina V.; Menzies, Alexander M.; Atkinson, Victoria; Cohen, Justine V.; Sullivan, Ryan J.; Chiarion-Sileni, Vanna; Nyakas, Marta; Kähler, Katharina; Hauschild, Axel; Plummer, Ruth; Trojaniello, Claudia; Ascierto, Paolo A.; Zimmer, Lisa; Schadendorf, Dirk; Allayous, Clara; Lebbe, Celeste; Maurichi, Andrea; Santinami, Mario; Roy, Severine; Robert, Caroline; Lesimple, Thierry; Patel, Sapna; Versluis, Judith M.; Blank, Christian U.; Khattak, Adnan; Van der Westhuizen, Andre; Carlino, Matteo S.; Shackleton, Mark; Haydon, Andrew
    Melanoma recurrence patterns and management after adjuvant targeted therapy : A multicentre analysis
    In: British Journal of Cancer (BJC) Jg. 124 (2021) Nr. 3, S. 574 - 580
    ISSN: 1532-1827; 0007-0920
    Online Volltext: dx.doi.org/ (Open Access)
  • Bäuerle, Alexander; Musche, Venja; Schmidt, Kira; Schweda, Adam; Fink, Madeleine; Weismüller, Benjamin; Kohler, Hannah; Herrmann, Ken; Tewes, Mitra; Schadendorf, Dirk; Skoda, Eva-Maria; Teufel, Martin
    Mental health burden of german cancer patients before and after the outbreak of covid-19 : Predictors of mental health impairment
    In: International Journal of Environmental Research and Public Health = IJERPH Jg. 18 (2021) Nr. 5,
    ISSN: 1660-4601; 1661-7827
    Online Volltext: dx.doi.org/ Online Volltext (Open Access)
  • Fan, Kaiji; Spassova, Ivelina; Gravemeyer, Jan; Ritter, Cathrin; Horny, Kai; Lange, Anja; Gambichler, Thilo; Ødum, Niels; Schrama, David; Schadendorf, Dirk; Ugurel, Selma; Becker, Jürgen
    Merkel cell carcinoma-derived exosome-shuttle miR-375 induces fibroblast polarization by inhibition of RBPJ and p53
    In: Oncogene Jg. 40 (2021) Nr. 5, S. 980 - 996
    ISSN: 1476-5594; 0950-9232
    Online Volltext: dx.doi.org/ (Open Access)
  • Gutzmer, Ralf; Drusio, Christina; Becker, Jürgen; Schadendorf, Dirk; Ugurel, Selma
    Merkel-Zell-Karzinom
    In: Der Onkologe Jg. 27 (2021) Nr. 6, S. 569 - 578
    ISSN: 1433-0415; 0947-8965
    Online Volltext: dx.doi.org/
  • Thielmann, Carl Maximilian; Ugurel, Selma; Livingstone, Elisabeth; Zimmer, Lisa; Paredes, Bruno E.; Brinkmeier, Thomas; Griewank, Klaus; Schadendorf, Dirk; Klode, Joachim; Stoffels, Ingo; Hadaschik, Eva
    Metastatic pigmented epithelioid melanocytoma in a 7-year-old female
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Jg. 19 (2021) Nr. 8, S. 1217 - 1219
    ISSN: 1610-0387; 1563-2571; 1610-0379; 0301-0481
    Online Volltext: dx.doi.org/ (Open Access)
  • Zaremba, Anne; Lodde, Georg; Murali, Rajmohan; Philip, Manuel; Cosgarea, Ioana; Jansen, Philipp; Chorti, Eleftheria; Rose, Christian; Hemmerlein, Bernhard; Matull, Johanna; Thielmann, Carl Maximilian; Kretz, Julia; Möller, Inga; Sucker, Antje; Paschen, Annette; Livingstone, Elisabeth; Zimmer, Lisa; Horn, Susanne; Schadendorf, Dirk; Hadaschik, Eva; Griewank, Klaus
    Molecular pathology as a diagnostic aid in difficult-to-classify melanocytic tumours with spitzoid morphology
    In: European Journal of Cancer Jg. 148 (2021) S. 340 - 347
    ISSN: 1879-0852; 0959-8049
    Online Volltext: dx.doi.org/ Online Volltext (Open Access)
  • Frangieh, Chris J.; Melms, Johannes C.; Thakore, Pratiksha I.; Geiger-Schuller, Kathryn R.; Ho, Patricia; Luoma, Adrienne M.; Cleary, Brian; Jerby-Arnon, Livnat; Malu, Shruti; Cuoco, Michael S.; Zhao, Maryann; Ager, Casey R.; Rogava, Meri; Hovey, Lila; Rotem, Asaf; Bernatchez, Chantale; Wucherpfennig, Kai W.; Johnson, Bruce E.; Rozenblatt-Rosen, Orit; Schadendorf, Dirk; Regev, Aviv; Izar, Benjamin
    Multimodal pooled Perturb-CITE-seq screens in patient models define mechanisms of cancer immune evasion
    In: Nature Genetics Jg. 53 (2021) Nr. 3, S. 332 - 341
    ISSN: 1061-4036; 1546-1718
    Online Volltext: dx.doi.org/; Online Volltext: dx.doi.org/ (Open Access)
  • Nguyen, Tan-Trieu; Ramsay, Lee Ann; Ahanfeshar-Adams, Mozhdeh; Lajoie, Mathieu; Schadendorf, Dirk; Alain, Tommy; Watson, Ian R.
    Mutations in the IFNγ-JAK-STAT pathway causing resistance to immune checkpoint inhibitors in melanoma increase sensitivity to oncolytic virus treatment
    In: Clinical Cancer Research Jg. 27 (2021) Nr. 12, S. 3432 - 3442
    ISSN: 1557-3265; 1078-0432
    Online Volltext: dx.doi.org/ (Open Access)
  • Thielmann, Carl Maximilian; Chorti, Eleftheria; Matull, Johanna; Murali, Rajmohan; Zaremba-Montenari, Anne; Lodde, Georg; Jansen, Philipp; Richter, Luisa; Kretz, Julia; Möller, Inga; Sucker, Antje; Herbst, Rudolf; Terheyden, Patrick; Utikal, Jochen; Pföhler, Claudia; Ulrich, Jens; Kreuter, Alexander; Mohr, Peter; Gutzmer, Ralf; Meier, Friedegund; Dippel, Edgar; Weichenthal, Michael; Paschen, Annette; Livingstone, Elisabeth; Zimmer, Lisa; Schadendorf, Dirk; Hadaschik, Eva; Ugurel, Selma; Griewank, Klaus
    NF1-mutated melanomas reveal distinct clinical characteristics depending on tumour origin and respond favourably to immune checkpoint inhibitors
    In: European Journal of Cancer (EJC) Jg. 159 (2021) S. 113 - 124
    ISSN: 1879-0852; 0959-8049; 1879-2995
    Online Volltext: dx.doi.org/
  • de Semir, David; Bezrookove, Vladimir; Nosrati, Mehdi; Dar, Altaf A.; Miller, James R.; Leong, Stanley P.; Kim, Kevin B.; Liao, Wilson; Soroceanu, Liliana; McAllister, Sean; Debs, Robert J.; Schadendorf, Dirk; Leachman, Sancy A.; Cleaver, James E.; Kashani-Sabet, Mohammed
    Nuclear receptor coactivator NCOA3 regulates UV radiation⇓induced DNA damage and melanoma susceptibility
    In: Cancer Research Jg. 81 (2021) Nr. 11, S. 2956 - 2969
    ISSN: 1538-7445; 0008-5472
    Online Volltext: dx.doi.org/ Online Volltext (Open Access)
  • Knispel, Sarah; Gassenmaier, Maximilian; Menzies, Alexander M.; Loquai, Carmen; Johnson, Douglas B.; Franklin, Cindy; Gutzmer, Ralf; Hassel, Jessica C.; Weishaupt, Carsten; Eigentler, Thomas; Schilling, Bastian; Schummer, Patrick; Sirokay, Judith; Kiecker, Felix; Owen, Carina N.; Fleischer, Maria I.; Cann, Christopher; Kähler, Katharina C.; Mohr, Peter; Bluhm, Leonie; Niebel, Dennis; Thoms, Kai-Martin; Goldinger, Simone M.; Reinhardt, Lydia; Meier, Friedegund; Berking, Carola; Reinhard, Raphael; Susok, Laura; Ascierto, Paolo A.; Drexler, Konstantin; Pföhler, Claudia; Tietze, Julia; Heinzerling, Lucie; Livingstone, Elisabeth; Ugurel, Selma; Long, Georgina V.; Stang, Andreas; Schadendorf, Dirk; Zimmer, Lisa
    Outcome of melanoma patients with elevated LDH treated with first-line targeted therapy or PD-1-based immune checkpoint inhibition
    In: European Journal of Cancer (EJC) Jg. 148 (2021) S. 61 - 75
    ISSN: 1879-0852; 0959-8049; 1879-2995
    Online Volltext: dx.doi.org/
  • Steeb, Theresa; Wessely, Anja; Alter, Mareike; Bayerl, Christiane; Bender, Armin; Bruning, Guido; Dabrowski, Evelyn; Debus, Dirk; Devereux, Nina; Dippel, Edgar; Drexler, Konstantin; Dücker, Pia; Dummer, Reinhard; Emmert, Steffen; Elsner, Peter; Enk, Alexander; Gebhardt, Christoffer; Gesierich, Anja; Goebeler, Matthias; Goerdt, Sergij; Goetze, Steven; Gutzmer, Ralf; Haferkamp, Sebastian; Hansel, Gesina; Hassel, Jessica C.; Heinzerling, Lucie; Kähler, Katharina C.; Kaume, Kjell M.; Krapf, Wolfgang; Kreuzberg, Nicole; Lehmann, Percy; Livingstone, Elisabeth; Löffler, Harald; Loquai, Carmen; Mauch, Cornelia; Mangana, Johanna; Meier, Friedegund; Meissner, Markus; Moritz, Rose K. C.; Maul, Lara Valeska; Müller, Verena; Mohr, Peter; Navarini, Alexander; Van Nguyen, Ahn; Pfeiffer, Christiane; Pföhler, Claudia; Posch, Christian; Richtig, Erika; Rompel, Rainer; Sachse, Michael M.; Sauder, Stefanie; Schadendorf, Dirk; Schatton, Kerstin; Schulze, Hans-Joachim; Schultz, Erwin; Schilling, Bastian; Schmuth, Matthias; Simon, Jan. C.; Streit, Markus; Terheyden, Patrick; Thiem, Alexander; Tüting, Thomas; Welzel, Julia; Weyandt, Gerhard; Wesselmann, Ulrich; Wollina, Uwe; Ziemer, Mirjana; Zimmer, Lisa; Zutt, Markus; Berking, Carola; Schlaak, Max; Heppt, Markus V.
    Patterns of care and follow-up care of patients with uveal melanoma in German-speaking countries : A multinational survey of the German Dermatologic Cooperative Oncology Group (DeCOG)
    In: Journal of Cancer Research and Clinical Oncology Jg. 147 (2021) Nr. 6, S. 1763 - 1771
    ISSN: 1432-1335; 0171-5216; 0084-5353; 0301-1585
    Online Volltext: dx.doi.org/ (Open Access)
  • Rischin, Danny; Khushalani, Nikhil I.; Schmults, Chrysalyne D.; Guminski, Alexander; Chang, Anne Lynn S.; Lewis, Karl D.; Lim, Annette M.; Hernandez-Aya, Leonel; Hughes, Brett G. M.; Schadendorf, Dirk; Hauschild, Axel; Stankevich, Elizabeth; Booth, Jocelyn; Yoo, Suk-Young; Okoye, Emmanuel; Lowy, Israel; Fury, Matthew G.; Migden, Michael R.;
    Phase 2 study of cemiplimab in patients with advanced cutaneous squamous cell carcinoma (CSCC) : follow-up at 43 months
    48th Annual Scientific Meeting Cancer care and research: Learning from the past and improving the future, 16-18 November 2021,
    In: Asia-Pacific Journal of Clinical Oncology Jg. 17 (2021) Nr. 9, SI, S. 166
    ISSN: 1743-7555; 1743-7563
    Online Volltext: dx.doi.org/ (Open Access)
  • Schadendorf, Dirk; Robert, Caroline; Dummer, Reinhard; Flaherty, Keith T.; Tawbi, Hussein A.; Menzies, Alexander M.; Banerjee, Hiya; Lau, Mike; Long, Georgina V.
    Pyrexia in patients treated with dabrafenib plus trametinib across clinical trials in BRAF-mutant cancers
    In: European Journal of Cancer (EJC) Jg. 153 (2021) S. 234 - 241
    ISSN: 1879-0852; 0959-8049; 1879-2995
    Online Volltext: dx.doi.org/ (Open Access)
  • Gogas, Helen; Dummer, Reinhard; Ascierto, Paolo A.; Arance, Ana; Mandalà, Mario; Liszkay, Gabriella; Garbe, Claus; Schadendorf, Dirk; Krajsová, Ivana; Gutzmer, Ralf; Sileni, Vanna Chiarion; Dutriaux, Caroline; Yamazaki, Naoya; Loquai, Carmen; Queirolo, Paola; Jan de Willem, Groot; Sellier, Abir Tadmouri; Suissa, Jeanne; Murris, Juliette; Gollerkeri, Ashwin; Robert, Caroline; Flaherty, Keith T.
    Quality of life in patients with BRAF-mutant melanoma receiving the combination encorafenib plus binimetinib : Results from a multicentre, open-label, randomised, phase III study (COLUMBUS)
    In: European Journal of Cancer (EJC) Jg. 152 (2021) S. 116 - 128
    ISSN: 1879-0852; 0959-8049; 1879-2995
    Online Volltext: dx.doi.org/
  • Jansen, Philipp; Lodde, Georg; Zaremba, Anne; Thielmann, Carl Maximilian; Matull, Johanna; Müller, Hansgeorg; Möller, Inga; Sucker, Antje; Esser, Stefan; Schaller, Jörg; Schadendorf, Dirk; Mentzel, Thomas; Hadaschik, Eva; Griewank, Klaus
    Rare TERT Promoter Mutations Present in Benign and Malignant Cutaneous Vascular Tumors
    In: Dermato Jg. 1 (2021) Nr. 1, S. 18 - 25
    ISSN: 2673-6179
    Online Volltext: dx.doi.org/ (Open Access)
  • Eggermont, Alexander M M; Blank, Christian U.; Mandala, Mario; Long, Georgina V.; Atkinson, Victoria G.; Dalle, Stéphane; Haydon, Andrew M.; Meshcheryakov, Andrey; Khattak, Adnan; Carlino, Matteo S.; Sandhu, Shahneen; Larkin, James; Puig, Susana; Ascierto, Paolo A.; Rutkowski, Piotr; Schadendorf, Dirk; Koornstra, Rutger; Hernandez-Aya, Leonel; Di Giacomo, Anna Maria; van den Eertwegh, Alfonsus J M; Grob, Jean-Jacques; Gutzmer, Ralf; Jamal, Rahima; Lorigan, Paul C.; van Akkooi, Alexander C J; Krepler, Clemens; Ibrahim, Nageatte; Marreaud, Sandrine; Kicinski, Michal; Suciu, Stefan; Robert, Caroline
    Reply to E. Hindié
    In: Journal of Clinical Oncology (JCO) Jg. 39 (2021) Nr. 8, S. 944 - 946
    ISSN: 0732-183X; 1527-7755
    Online Volltext: dx.doi.org/ (Open Access)
  • Zaremba, Anne; Hadaschik, Eva; Schadendorf, Dirk; Griewank, Klaus
    Response to comment : Molecular pathology as a diagnostic aid in difficult to classify melanocytic tumours with spitzoid morphology
    In: European Journal of Cancer (EJC) Jg. 157 (2021) S. 514 - 515
    ISSN: 1879-0852; 0959-8049; 1879-2995
    Online Volltext: dx.doi.org/
  • Maron, Roman C.; Haggenmüller, Sarah; von Kalle, Christof; Utikal, Jochen S.; Meier, Friedegund; Gellrich, Frank F.; Hauschild, Axel; French, Lars E.; Schlaak, Max; Ghoreschi, Kamran; Kutzner, Heinz; Heppt, Markus V.; Haferkamp, Sebastian; Sondermann, Wiebke; Schadendorf, Dirk; Schilling, Bastian; Hekler, Achim; Krieghoff-Henning, Eva; Kather, Jakob N.; Fröhling, Stefan; Lipka, Daniel B.; Brinker, Titus J.
    Robustness of convolutional neural networks in recognition of pigmented skin lesions
    In: European Journal of Cancer (EJC) Jg. 145 (2021) S. 81 - 91
    ISSN: 1879-0852; 0959-8049
    Online Volltext: dx.doi.org/ (Open Access)
  • Brase, Jan C.; Walter, Robert F.H.; Savchenko, Alexander; Gusenleitner, Daniel; Garrett, James; Schimming, Tobias; Varaljai, Renata; Castelletti, Deborah; Kim, Ju; Dakappagari, Naveen; Schultz, Ken; Robert, Caroline; Long, Georgina V.; Nathan, Paul D.; Ribas, Antoni; Flaherty, Keith T.; Karaszewska, Boguslawa; Schachter, Jacob; Sucker, Antje; Schmid, Kurt Werner; Zimmer, Lisa; Livingstone, Elisabeth; Gasal, Eduard; Schadendorf, Dirk; Rösch, Alexander
    Role of Tumor-Infiltrating B Cells in Clinical Outcome of Patients with Melanoma Treated With Dabrafenib Plus Trametinib
    In: Clinical Cancer Research Jg. 27 (2021) Nr. 16, S. 4500 - 4510
    ISSN: 1557-3265; 1078-0432
    Online Volltext: dx.doi.org/ (Open Access)
  • Haggenmüller, Sarah; Maron, Roman C.; Hekler, Achim; Utikal, Jochen S.; Barata, Catarina; Barnhill, Raymond L.; Beltraminelli, Helmut; Berking, Carola; Betz-Stablein, Brigid; Blum, Andreas; Braun, Stephan A.; Carr, Richard; Combalia, Marc; Fernandez-Figueras, Maria-Teresa; Ferrara, Gerardo; Fraitag, Sylvie; French, Lars E.; Gellrich, Frank F.; Ghoreschi, Kamran; Goebeler, Matthias; Guitera, Pascale; Haenssle, Holger A.; Haferkamp, Sebastian; Heinzerling, Lucie; Heppt, Markus V.; Hilke, Franz J.; Hobelsberger, Sarah; Krahl, Dieter; Kutzner, Heinz; Lallas, Aimilios; Liopyris, Konstantinos; Llamas-Velasco, Mar; Malvehy, Josep; Meier, Friedegund; Müller, Cornelia S.L.; Navarini, Alexander A.; Navarrete-Dechent, Cristián; Perasole, Antonio; Poch, Gabriela; Podlipnik, Sebastian; Requena, Luis; Rotemberg, Veronica M.; Saggini, Andrea; Sangueza, Omar P.; Santonja, Carlos; Schadendorf, Dirk; Schilling, Bastian; Schlaak, Max; Schlager, Justin G.; Sergon, Mildred; Sondermann, Wiebke; Soyer, H. Peter; Starz, Hans; Stolz, Wilhelm; Vale, Esmeralda; Weyers, Wolfgang; Zink, Alexander; Krieghoff-Henning, Eva; Kather, Jakob N.; von Kalle, Christof; Lipka, Daniel B.; Fröhling, Stefan; Hauschild, Axel; Kittler, Harald; Brinker, Titus J.
    Skin cancer classification via convolutional neural networks : Systematic review of studies involving human experts
    In: European Journal of Cancer (EJC) Jg. 156 (2021) S. 202 - 216
    ISSN: 1879-0852; 0959-8049; 1879-2995
    Online Volltext: dx.doi.org/ (Open Access)
  • Wessely, Anja; Steeb, Theresa; Berking, Carola; Schlaak, Max; Heppt, Markus V.; Alter, Mareike; Bayerl, Christiane; Bender, Armin; Bruning, Guido; Dabrowski, Evelyn; Debus, Dirk; Devereux, Nina; Dippel, Edgar; Drexler, Konstantin; Dücker, Pia; Dummer, Reinhard; Emmert, Steffen; Elsner, Peter; Enk, Alexander; Gebhardt, Christoffer; Gesierich, Anja; Goebeler, Matthias; Goerdt, Sergij; Goetze, Steven; Gutzmer, Ralf; Haferkamp, Sebastian; Hansel, Gesina; Hassel, Jessica C.; Heinzerling, Lucie; Kähler, Katharina C.; Kaume, Kjell M.; Krapf, Wolfgang; Kreuzberg, Nicole; Lehmann, Percy; Livingstone, Elisabeth; Löffler, Harald; Loquai, Carmen; Mauch, Cornelia; Mangana, Johanna; Meier, Friedegund; Meissner, Markus; Moritz, Rose K.C.; Maul, Lara Valeska; Müller, Verena; Mohr, Peter; Navarini, Alexander; Van Nguyen, Ahn; Pfeiffer, Christiane; Pföhler, Claudia; Posch, Christian; Richtig, Erika; Rompel, Rainer; Sachse, Michael M.; Sauder, Stefanie; Schadendorf, Dirk; Schatton, Kerstin; Schulze, Hans-Joachim; Schultz, Erwin; Schilling, Bastian; Schmuth, Matthias; Simon, Jan C.; Streit, Markus; Terheyden, Patrick; Thiem, Alexander; Tüting, Thomas; Welzel, Julia; Weyandt, Gerhard; Wesselmann, Ulrich; Wollina, Uwe; Ziemer, Mirjana; Zimmer, Lisa; Zutt, Markus
    Surveillance of patients with conjunctival melanoma in German-speaking countries : A multinational survey of the German dermatologic cooperative oncology group
    In: European Journal of Cancer (EJC) Jg. 143 (2021) S. 43 - 45
    ISSN: 1879-0852; 0959-8049
    Online Volltext: dx.doi.org/
  • Hodi, F Stephen; Wolchok, Jedd D.; Schadendorf, Dirk; Larkin, James; Long, Georgina V.; Qian, Xiaozhong; Saci, Abdel; Young, Tina C.; Srinivasan, Sujaya; Chang, Han; Tang, Hao; Wind-Rotolo, Megan; Rizzo, Jasmine I.; Jackson, Donald G.; Ascierto, Paolo A.
    TMB and Inflammatory Gene Expression Associated with Clinical Outcomes following Immunotherapy in Advanced Melanoma
    In: Cancer Immunology Research Jg. 9 (2021) Nr. 10, S. 1202 - 1213
    ISSN: 2326-6074; 2326-6066
    Online Volltext: dx.doi.org/ (Open Access)
  • Malvehy, Josep; Samoylenko, Igor; Schadendorf, Dirk; Gutzmer, Ralf; Grob, Jean-Jacques; Sacco, Joseph J.; Gorski, Kevin S.; Anderson, Abraham; Pickett, Cheryl A.; Liu, Kate; Gogas, Helen
    Talimogene laherparepvec upregulates immune-cell populations in non-injected lesions : Findings from a phase II, multicenter, open-label study in patients with stage IIIB-IVM1c melanoma
    In: Journal for ImmunoTherapy of Cancer Jg. 9 (2021) Nr. 3, S. e001621
    ISSN: 2051-1426
    Online Volltext: dx.doi.org/ (Open Access)
  • Hu, Hai; Khodadadi-Jamayran, Alireza; Dolgalev, Igor; Cho, Hyunwoo; Badri, Sana; Chiriboga, Luis A.; Zeck, Briana; de Rodas Gregorio, MiguelLopez; Dowling, Catríona M.; Labbe, Kristen; Deng, Jiehui; Chen, Ting; Zhang, Hua; Zappile, Paul; Chen, Ze; Ueberheide, Beatrix; Karatza, Angeliki; Han, Han; Ranieri, Michela; Tang, Sittinon; Jour, George; Osman, Iman; Sucker, Antje; Schadendorf, Dirk; Tsirigos, Aristotelis; Schalper, Kurt A.; Velcheti, Vamsidhar; Huang, Hsin-Yi; Jin, Yujuan; Ji, Hongbin; Poirier, John T.; Li, Fei; Wong, Kwok-Kin
    Targeting the Atf7ip–Setdb1 complex augments antitumor immunity by boosting tumor immunogenicity
    In: Cancer Immunology Research Jg. 9 (2021) Nr. 11, S. 1298 - 1315
    ISSN: 2326-6074; 2326-6066
    Online Volltext: dx.doi.org/ (Open Access)
  • Zaremba, Anne; Eggermont, Alexander M.M.; Robert, Caroline; Dummer, Reinhardt; Ugurel, Selma; Livingstone, Elisabeth; Ascierto, Paolo A.; Long, Georgina V.; Schadendorf, Dirk; Zimmer, Lisa
    The concepts of rechallenge and retreatment with immune checkpoint blockade in melanoma patients
    In: European Journal of Cancer (EJC) Jg. 155 (2021) S. 268 - 280
    ISSN: 1879-0852; 0959-8049; 1879-2995
    Online Volltext: dx.doi.org/
  • Váraljai, Renáta; Elouali, S.; Lueong, Smiths S.; Wistuba-Hamprecht, Kilian; Seremet, Teofila C.; Siveke, Jens; Becker, Jürgen; Sucker, Antje; Paschen, Annette; Horn, Peter; Neyns, Bart; Weide, Benjamin M.; Schadendorf, Dirk; Rösch, Alexander
    The predictive and prognostic significance of cell-free DNA concentration in melanoma
    In: Journal of the European Academy of Dermatology and Venereology Jg. 35 (2021) Nr. 2, S. 387 - 395
    ISSN: 0926-9959; 1468-3083
    Online Volltext: dx.doi.org/ (Open Access)
  • Küppers, Ralf; Schadendorf, Dirk; Stein, Lincoln D.; PCAWG Consortium
    A deep learning system accurately classifies primary and metastatic cancers using passenger mutation patterns
    In: Nature Communications Jg. 11 (2020)
    ISSN: 2041-1723
    Online Volltext: dx.doi.org/ (Open Access)
  • Dummer, Reinhard; Brase, Jan C.; Garrett, James; Campbell, Catarina D.; Gasal, Eduard; Squires, Matthew; Gusenleitner, Daniel; Santinami, Mario; Atkinson, Victoria; Mandalà, Mario; Chiarion-Sileni, Vanna; Flaherty, Keith; Larkin, James; Robert, Caroline; Kefford, Richard; Kirkwood, John M.; Hauschild, Axel; Schadendorf, Dirk; Long, Georgina V.
    Adjuvant dabrafenib plus trametinib versus placebo in patients with resected, BRAFV⁶⁰⁰-mutant, stage III melanoma (COMBI-AD) : Exploratory biomarker analyses from a randomised, phase 3 trial
    In: The Lancet Oncology Jg. 21 (2020) Nr. 3, S. 358 - 372
    ISSN: 1474-5488; 1470-2045
    Online Volltext: dx.doi.org/ Online Volltext (Open Access)
  • Zimmer, Lisa; Livingstone, Elisabeth; Hassel, Jessica C.; Fluck, Michael; Eigentler, Thomas; Loquai, Carmen; Haferkamp, Sebastian; Gutzmer, Ralf; Meier, Friedegund; Mohr, Peter; Hauschild, Axel; Schilling, Bastian; Menzer, Christian; Kieker, Felix; Dippel, Edgar; Rösch, Alexander; Simon, Jan-Christoph; Conrad, Beate; Körner, Silvia; Windemuth-Kieselbach, Christine; Schwarz, Leonora; Garbe, Claus; Becker, Jürgen C.; Schadendorf, Dirk; Berking, Carola; Herbst, Rudolf A.; Martens, Uwe M; Sell, Sabine; Stadler, Rudolf; Terheyden, Patrick; Utikal, Jochen
    Adjuvant nivolumab plus ipilimumab or nivolumab monotherapy versus placebo in patients with resected stage IV melanoma with no evidence of disease (IMMUNED) : a randomised, double-blind, placebo-controlled, phase 2 trial
    In: The Lancet Jg. 395 (2020) Nr. 10236, S. 1558 - 1568
    ISSN: 1474-547X; 0140-6736
    Online Volltext: dx.doi.org/
  • Eggermont, Alexander M.M.; Rutkowski, Piotr; Dutriaux, Caroline; Hofman-Wellenhof, Rainer; Dziewulski, Peter; Marples, Maria; Grange, Floren; Lok, Catherine; Pennachioli, Elisabetta; Robert, Caroline; van Akkooi, Alexander C.J.; Bastholt, Lars; Minisini, Alessandro; Marshall, Ernest; Salès, François; Grob, Jean-Jacques; Bechter, Oliver; Schadendorf, Dirk; Marreaud, Sandrine; Kicinski, Michal; Suciu, Stefan; Testori, Alessandro A.E.
    Adjuvant therapy with pegylated interferon-alfa2b vs observation in stage II B/C patients with ulcerated primary : Results of the European Organisation for Research and Treatment of Cancer 18081 randomised trial
    In: European Journal of Cancer Jg. 133 (2020) S. 94 - 103
    ISSN: 1879-0852; 0959-8049
    Online Volltext: dx.doi.org/
  • Bhat, Hilal; Zaun, Gregor; Hamdan, Thamer A.; Lang, Judith; Adomati, Tom; Schmitz, Rosa; Friedrich, Sarah-Kim; Bergerhausen, Michael; Cham, Lamin B.; Li, Fanghui; Ali, Murtaza; Zhou, Fan; Khairnar, Vishal; Duhan, Vikas; Brandenburg, Tim; Machlah, Yara Maria; Schiller, Maximilian; Berry, Arshia; Xu, Haifeng; Vollmer, Jörg; Häussinger, Dieter; Thier, Beatrice; Pandyra, Aleksandra A.; Schadendorf, Dirk; Paschen, Annette; Schuler, Martin; Lang, Philipp A.; Lang, Karl S.
    Arenavirus Induced CCL5 Expression Causes NK Cell-Mediated Melanoma Regression
    In: Frontiers in Immunology Jg. 11 (2020) S. 1849
    ISSN: 1664-3224
    Online Volltext: dx.doi.org/ Online Volltext (Open Access)
  • Jutzi, Tanja B.; Krieghoff-Henning, Eva I.; Holland-Letz, Tim; Utikal, Jochen Sven; Hauschild, Axel; Schadendorf, Dirk; Sondermann, Wiebke; Fröhling, Stefan; Hekler, Achim; Schmitt, Max; Maron, Roman C.; Brinker, Titus J.
    Artificial Intelligence in Skin Cancer Diagnostics : The Patients' Perspective
    In: Frontiers in Medicine Jg. 7 (2020) S. 233
    ISSN: 2296-858X
    Online Volltext: dx.doi.org/ (Open Access)
  • Eggermont, Alexander M. M.; Kicinski, Michal; Blank, Christian U.; Mandala, Mario; Long, Georgina V.; Atkinson, Victoria; Dalle, Stéphane; Haydon, Andrew; Khattak, Adnan; Carlino, Matteo S.; Sandhu, Shahneen; Larkin, James; Puig, Susana; Ascierto, Paolo A.; Rutkowski, Piotr; Schadendorf, Dirk; Koornstra, Rutger; Hernandez-Aya, Leonel; Di Giacomo, Anna Maria; Van Den Eertwegh, Alfonsus J. M.; Grob, Jean-Jacques; Gutzmer, Ralf; Jamal, Rahima; Lorigan, Paul C.; Krepler, Clemens; Ibrahim, Nageatte; Marreaud, Sandrine; Van Akkooi, Alexander; Robert, Caroline; Suciu, Stefan
    Association between Immune-Related Adverse Events and Recurrence-Free Survival among Patients with Stage III Melanoma Randomized to Receive Pembrolizumab or Placebo : A Secondary Analysis of a Randomized Clinical Trial
    In: JAMA Oncology Jg. 6 (2020) Nr. 4, S. 519 - 527
    ISSN: 2374-2445; 2374-2437
    Online Volltext: dx.doi.org/ (Open Access)
  • Puzanov, Igor; Ribas, Antoni; Robert, Caroline; Schachter, Jacob; Nyakas, Marta; Daud, Adil; Arance, Ana; Carlino, Matteo S.; O'Day, Steven J.; Long, Georgina V.; Margolin, Kim A.; Dummer, Reinhard; Schadendorf, Dirk; Lutzky, Jose; Ascierto, Paolo A.; Tarhini, Ahmad; Lin, Jianxin; Mogg, Robin; Homet Moreno, Blanca; Ibrahim, Nageatte; Hamid, Omid
    Association of BRAF V600E/K Mutation Status and Prior BRAF/MEK Inhibition with Pembrolizumab Outcomes in Advanced Melanoma : Pooled Analysis of 3 Clinical Trials
    In: JAMA Oncology Jg. 6 (2020) Nr. 8, S. 1256 - 1264
    ISSN: 2374-2445; 2374-2437
    Online Volltext: dx.doi.org/ (Open Access)
  • Liu, David; Schilling, Bastian; Liu, Derek; Sucker, Antje; Livingstone, Elisabeth; Jerby-Arnon, Livnat; Zimmer, Lisa; Gutzmer, Ralf; Satzger, Imke; Loquai, Carmen; Grabbe, Stephan; Vokes, Natalie; Margolis, Claire A.; Conway, Jake; He, Meng Xiao; Elmarakeby, Haitham; Dietlein, Felix; Miao, Diana; Tracy, Adam; Gogas, Helen; Goldinger, Simone M.; Utikal, Jochen; Blank, Christian U.; Rauschenberg, Ricarda; von Bubnoff, Dagmar; Krackhardt, Angela; Weide, Benjamin; Haferkamp, Sebastian; Kiecker, Felix; Izar, Ben; Garraway, Levi; Regev, Aviv; Flaherty, Keith; Paschen, Annette; Van Allen, Eliezer M.; Schadendorf, Dirk
    Author Correction: Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma
    In: Nature Medicine Jg. 26 (2020) Nr. 7, S. 1147
    ISSN: 1546-170X; 1078-8956
    Online Volltext: dx.doi.org/ (Open Access)
  • Küppers, Ralf; Schadendorf, Dirk
    Author Correction: Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples
    In: Nature Communications Jg. 11 (2020) Nr. 1, S. 6232
    ISSN: 2041-1723
    Online Volltext: dx.doi.org/ (Open Access)
  • Cabrita, Rita; Lauss, Martin; Sanna, Adriana; Donia, Marco; Skaarup Larsen, Mathilde; Mitra, Shamik; Johansson, Iva; Phung, Bengt; Harbst, Katja; Vallon-Christersson, Johan; van Schoiack, Alison; Lövgren, Kristina; Warren, Sarah; Jirström, Karin; Olsson, Håkan; Pietras, Kristian; Ingvar, Christian; Isaksson, Karolin; Schadendorf, Dirk; Schmidt, Henrik; Bastholt, Lars; Carneiro, Ana; Wargo, Jennifer A.; Svane, Inge Marie; Jönsson, Göran
    Author Correction: Tertiary lymphoid structures improve immunotherapy and survival in melanoma
    In: Nature Jg. 580 (2020) Nr. 7801, S. E1
    ISSN: 0028-0836; 1476-4687
    Online Volltext: dx.doi.org/ (Open Access)
  • Musche, Venja; Bäuerle, Alexander; Steinbach, Jasmin; Schweda, Adam; Hetkamp, Madeleine; Weismüller, Benjamin; Kohler, Hannah; Beckmann, Mingo; Herrmann, Ken; Tewes, Mitra; Schadendorf, Dirk; Skoda, Eva-Maria; Teufel, Martin
    COVID-19-Related Fear and Health-Related Safety Behavior in Oncological Patients
    In: Frontiers in Psychology Jg. 11 (2020) S. 1984
    ISSN: 1664-1078
    Online Volltext: dx.doi.org/ (Open Access)
  • Brenner, Ellen; Schörg, Barbara F.; Ahmetlić, Fatima; Wieder, Thomas; Hilke, Franz Joachim; Simon, Nadine; Schroeder, Christopher; Demidov, German; Riedel, Tanja; Fehrenbacher, Birgit; Schaller, Martin; Forschner, Andrea; Eigentler, Thomas; Niessner, Heike; Sinnberg, Tobias; Böhm, Katharina S.; Hömberg, Nadine; Braumüller, Heidi; Dauch, Daniel; Zwirner, Stefan; Zender, Lars; Sonanini, Dominik; Geishauser, Albert; Bauer, Jürgen; Eichner, Martin; Jarick, Katja J.; Beilhack, Andreas; Biskup, Saskia; Döcker, Dennis; Schadendorf, Dirk; Quintanilla-Martinez, Leticia; Pichler, Bernd J.; Kneilling, Manfred; Mocikat, Ralph; Röcken, Martin
    Cancer immune control needs senescence induction by interferon-dependent cell cycle regulator pathways in tumours
    In: Nature Communications Jg. 11 (2020) Nr. 1, S. 1335
    ISSN: 2041-1723
    Online Volltext: dx.doi.org/ (Open Access)
  • Migden, Michael R.; Khushalani, Nikhil I.; Chang, Anne Lynn S.; Lewis, Karl D.; Schmults, Chrysalyne D.; Hernandez-Aya, Leonel; Meier, Friedegund; Schadendorf, Dirk; Guminski, Alexander; Hauschild, Axel; Wong, Deborah J.; Daniels, Gregory A.; Berking, Carola; Jankovic, Vladimir; Stankevich, Elizabeth; Booth, Jocelyn; Li, Siyu; Weinreich, David M.; Yancopoulos, George D.; Lowy, Israel; Fury, Matthew G.; Rischin, Danny
    Cemiplimab in locally advanced cutaneous squamous cell carcinoma : results from an open-label, phase 2, single-arm trial
    In: The Lancet Oncology Jg. 21 (2020) Nr. 2, S. 294 - 305
    ISSN: 1474-5488; 1470-2045
    Online Volltext: dx.doi.org/ Online Volltext (Open Access)
  • Sun, Wei; Zhao, Fang; Xu, Yu; Huang, Kai; Guo, Xianling; Zheng, Biqiang; Liu, Xin; Luo, Zhiguo; Kong, Yunyi; Xu, Midie; Schadendorf, Dirk; Chen, Yong
    Chondroitin polymerizing factor (CHPF) promotes development of malignant melanoma through regulation of CDK1
    In: Cell Death and Disease Jg. 11 (2020) Nr. 7,
    ISSN: 2041-4889
    Online Volltext: dx.doi.org/ (Open Access)
  • David, Paul; Drabczyk-Pluta, Malgorzata; Pastille, Eva; Knuschke, Torben; Werner, Tanja; Honke, Nadine; Megger, Dominik A.; Akhmetzyanova, Ilseyar; Shaabani, Namir; Eyking-Singer, Annette; Cario, Elke; Kershaw, Olivia; Gruber, Achim D.; Tenbusch, Matthias; Dietze, Kirsten; Trilling, Mirko; Liu, Jia; Schadendorf, Dirk; Streeck, Hendrik; Lang, Karl S.; Xie, Youhua; Zimmer, Lisa; Sitek, Barbara; Paschen, Annette; Westendorf, Astrid; Dittmer, Ulf; Zelinskyy, Gennadiy
    Combination immunotherapy with anti-PD-L1 antibody and depletion of regulatory T cells during acute viral infections results in improved virus control but lethal immunopathology
    In: PLoS Pathogens Jg. 16 (2020) Nr. 3,
    ISSN: 1553-7374; 1553-7366
    Online Volltext: dx.doi.org/ (Open Access)
  • Dummer, Reinhard; Lebbé, Celeste; Atkinson, Victoria; Mandalà, Mario; Nathan, Paul D.; Arance, Ana; Richtig, Erika; Yamazaki, Naoya; Robert, Caroline; Schadendorf, Dirk; Tawbi, Hussein A.; Ascierto, Paolo A.; Ribas, Antoni; Flaherty, Keith T.; Pakhle, Neha; Campbell, Catarina D.; Gusenleitner, Daniel; Masood, Aisha; Brase, Jan C.; Gasal, Eduard; Long, Georgina V.
    Combined PD-1, BRAF and MEK inhibition in advanced BRAF-mutant melanoma : safety run-in and biomarker cohorts of COMBI-i
    In: Nature Medicine Jg. 26 (2020) Nr. 10, S. 1557 - 1563
    ISSN: 1546-170X; 1078-8956
    Online Volltext: dx.doi.org/
  • Küppers, Ralf; Schadendorf, Dirk; Shuai, Shimin; Stein, Lincoln D.
    Combined burden and functional impact tests for cancer driver discovery using DriverPower
    In: Nature Communications Jg. 11 (2020)
    ISSN: 2041-1723
    Online Volltext: dx.doi.org/ (Open Access)
  • Massi, Daniela; Mihic-Probst, Daniela; Schadendorf, Dirk; Dummer, Reinhard; Mandalà, Mario
    Dedifferentiated melanomas : Morpho-phenotypic profile, genetic reprogramming and clinical implications
    In: Cancer Treatment Reviews Jg. 88 (2020) S. 102060
    ISSN: 1532-1967; 0305-7372
    Online Volltext: dx.doi.org/
  • Küppers, Ralf; Schadendorf, Dirk; Bristow, Robert G.; Boutros, Paul C.; PCAWG Consortium
    Divergent mutational processes distinguish hypoxic and normoxic tumours
    In: Nature Communications Jg. 11 (2020)
    ISSN: 2041-1723
    Online Volltext: dx.doi.org/ (Open Access)
  • Chorti, Eleftheria; Kanaki, Theodora; Zimmer, Lisa; Hadaschik, Eva; Ugurel, Selma; Gratsias, Emmanouil; Rösch, Alexander; Bonella, Francesco; Wessendorf, Thomas; Wälscher, Julia; Theegarten, Dirk; Schadendorf, Dirk; Livingstone, Elisabeth
    Drug-induced sarcoidosis-like reaction in adjuvant immunotherapy : Increased rate and mimicker of metastasis
    In: European Journal of Cancer Jg. 131 (2020) S. 18 - 26
    ISSN: 1879-0852; 0959-8049
    Online Volltext: dx.doi.org/
  • Matull, Johanna; Livingstone, Elisabeth; Wetter, Axel; Zimmer, Lisa; Zaremba, Anne; Lahner, Harald; Schadendorf, Dirk; Ugurel, Selma
    Durable Complete Response in a Melanoma Patient With Unknown Primary, Associated With Sequential and Severe Multi-Organ Toxicity After a Single Dose of CTLA-4 Plus PD-1 Blockade : A Case Report
    In: Frontiers in Oncology Jg. 10 (2020) S. 592609
    ISSN: 2234-943X
    Online Volltext: dx.doi.org/ Online Volltext (Open Access)
  • Pohl, Julia; Mincu, Raluca-Ileana; Mrotzek, Simone Maria; Hinrichs, Lena; Michel, Lars; Livingstone, Elisabeth; Zimmer, Lisa; Wakili, Reza; Schadendorf, Dirk; Rassaf, Tienush; Totzeck, Matthias
    ECG Changes in Melanoma Patients Undergoing Cancer Therapy : Data from the ECoR Registry
    In: Journal of Clinical Medicine (JCM) Jg. 9 (2020) Nr. 7,
    ISSN: 2077-0383
    Online Volltext: dx.doi.org/ Online Volltext (Open Access)
  • Textoris-Taube, Kathrin; Cammann, Clemens; Henklein, Petra; Topfstedt, Eylin; Ebstein, Frédéric; Henze, Sarah; Liepe, Juliane; Zhao, Fang; Schadendorf, Dirk; Dahlmann, Burkhardt; Uckert, Wolfgang; Paschen, Annette; Mishto, Michele; Seifert, Ulrike
    ER-aminopeptidase 1 determines the processing and presentation of an immunotherapy-relevant melanoma epitope
    In: European Journal of Immunology Jg. 50 (2020) Nr. 2, S. 270 - 283
    ISSN: 1521-4141; 0014-2980
    Online Volltext: dx.doi.org/ (Open Access)
  • Brinker, Titus J.; Faria, Bianca Lisa; De Faria, Olber Moreira; Klode, Joachim; Schadendorf, Dirk; Utikal, Jochen S.; Mons, Ute; Krieghoff-Henning, Eva; Lisboa, Oscar Campos; Oliveira, Ana Carla Cruz; Lino, Henrique Augusto; Bernardes-Souza, Breno
    Effect of a Face-Aging Mobile App-Based Intervention on Skin Cancer Protection Behavior in Secondary Schools in Brazil : A Cluster-Randomized Clinical Trial
    In: JAMA Dermatology Jg. 156 (2020) Nr. 7, S. 737 - 745
    ISSN: 2168-6084; 2168-6068
    Online Volltext: dx.doi.org/ (Open Access)
  • Hekler, Achim; Kather, Jakob N.; Krieghoff-Henning, Eva; Utikal, Jochen S.; Meier, Friedegund; Gellrich, Frank F.; Upmeier zu Belzen, Julius; French, Lars; Schlager, Justin G.; Ghoreschi, Kamran; Wilhelm, Tabea; Kutzner, Heinz; Berking, Carola; Heppt, Markus V.; Haferkamp, Sebastian; Sondermann, Wiebke; Schadendorf, Dirk; Schilling, Bastian; Izar, Benjamin; Maron, Roman; Schmitt, Max; Fröhling, Stefan; Lipka, Daniel B.; Brinker, Titus J.
    Effects of Label Noise on Deep Learning-Based Skin Cancer Classification
    In: Frontiers in Medicine Jg. 7 (2020) S. 177
    ISSN: 2296-858X
    Online Volltext: dx.doi.org/ (Open Access)
  • Koch, F.; Salva, Katrin Agnes; Wirtz, M.; Hadaschik, Eva; Varaljai, Renáta; Schadendorf, Dirk; Rösch, Alexander
    Efficacy of cold atmospheric plasma vs. diclofenac 3% gel in patients with actinic keratoses : A prospective, randomized and rater-blinded study (ACTICAP)
    In: Journal of the European Academy of Dermatology and Venereology Jg. 34 (2020) Nr. 12, S. E844 - E846
    ISSN: 1468-3083; 0926-9959
    Online Volltext: dx.doi.org/
  • Ugurel, Selma; Schadendorf, Dirk; Horny, K.; Sucker, Antje; Schramm, Sabine; Utikal, Jochen; Pföhler, Claudia; Herbst, Rudolf A.; Schilling, B.; Blank, Christian U.; Becker, Jürgen; Paschen, Annette; Zimmer, Lisa; Livingstone, Elisabeth; Horn, Peter; Rebmann, Vera
    Elevated baseline serum PD-1 or PD-L1 predicts poor outcome of PD-1 inhibition therapy in metastatic melanoma
    In: Annals of Oncology Jg. 31 (2020) Nr. 1, S. 144 - 152
    ISSN: 1569-8041; 0923-7534
    Online Volltext: dx.doi.org/ (Open Access)
  • Sondermann, Wiebke; von Kalle, Christof; Utikal, Jochen S.; Schadendorf, Dirk; Esser, Stefan; Durani, Benjamin; Durani, Hendrike; Jansen, Martin; Brinker, Titus J.
    Externe wissenschaftliche Evaluation der ersten Teledermatologie-App ohne direkten Patientenkontakt in Deutschland („Online Hautarzt – AppDoc“)
    In: Der Hautarzt Jg. 71 (2020) Nr. 11, S. 887 - 897
    ISSN: 1432-1173; 0017-8470
    Online Volltext: dx.doi.org/ (Open Access)
  • Zaremba, Anne; Zimmer, Lisa; Chorti, Eleftheria; Reissig, Timm M.; Bauer, Sebastian; Podleska, Lars; Schulz, Andrea; Hadaschik, Eva; Griewank, Klaus; Rösch, Alexander; Schadendorf, Dirk; Livingstone, Elisabeth
    Fatal swelling of the groin – Clear cell sarcoma : A rare but important differential diagnosis to malignant melanoma
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Jg. 18 (2020) Nr. 10, S. 1165 - 1168
    ISSN: 1610-0387; 1563-2571; 1610-0379; 0301-0481
    Online Volltext: dx.doi.org/ (Open Access)
  • Dummer, R.; Hauschild, A.; Santinami, M.; Atkinson, V.; MandalÃ, M.; Kirkwood, J.M.; Sileni, V. Chiarion; Larkin, J.; Nyakas, M.; Dutriaux, C.; Haydon, A.; Robert, C.; Mortier, L.; Schachter, J.; Lesimple, T.; Plummer, R.; Dasgupta, K.; Gasal, E.; Tan, M.; Long, G.V.; Schadendorf, Dirk
    Five-Year Analysis of Adjuvant Dabrafenib plus Trametinib in Stage III Melanoma
    In: The New England Journal of Medicine Jg. 383 (2020) Nr. 12, S. 1139 - 1148
    ISSN: 1533-4406; 0028-4793
    Online Volltext: dx.doi.org/ Online Volltext (Open Access)
  • Robert, Caroline; Long, Georgina V.; Brady, Benjamin; Dutriaux, Caroline; Di Giacomo, Anna Maria; Mortier, Laurent; Rutkowski, Piotr; Hassel, Jessica C.; McNeil, Catriona M.; Kalinka, Ewa Anna; Lebbé, Céleste; Charles, Julie; Hernberg, Micaela M.; Savage, Kerry J.; Chiarion-Sileni, Vanna; Mihalcioiu, Catalin; Mauch, Cornelia; Arance, Ana; Cognetti, Francesco; Ny, Lars; Schmidt, Henrik; Schadendorf, Dirk; Gogas, Helen; Zoco, Jesús; Re, Sandra; Ascierto, Paolo A.; Atkinson, Victoria
    Five-Year Outcomes With Nivolumab in Patients With Wild-Type BRAF Advanced Melanoma
    In: Journal of Clinical Oncology (JCO) Jg. 38 (2020) Nr. 33, S. 3937 - 3946
    ISSN: 0732-183X; 1527-7755
    Online Volltext: dx.doi.org/ (Open Access)
  • Livingstone, Elisabeth; Zaremba, Anne; Horn, Susanne; Ugurel, Selma; Casalini, Belén; Schlaak, Max; Hassel, Jessica Cecile; Herbst, Rudolf A.; Utikal, Jochen; Weide, Benjamin M.; Gutzmer, Ralf; Meier, Friedegund E.; Koelsche, Christian; Hadaschik, Eva; Sucker, Antje; Reis, Henning; Merkelbach-Bruse, Sabine; Siewert, Martina M.; Sahm, Felix; von Deimling, Andreas; Cosgarea, Ioana; Zimmer, Lisa; Schadendorf, Dirk; Schilling, Bastian; Griewank, Klaus
    GNAQ and GNA11 mutant nonuveal melanoma : A subtype distinct from both cutaneous and uveal melanoma
    In: British Journal of Dermatology: BJD Jg. 183 (2020) Nr. 5, S. 928 - 939
    ISSN: 1365-2133; 0007-0963; 0366-2845
    Online Volltext: dx.doi.org/ (Open Access)
  • Landi, Maria Teresa; Bishop, D. Timothy; MacGregor, Stuart; Machiela, Mitchell J.; Stratigos, Alexander J.; Ghiorzo, Paola; Brossard, Myriam; Calista, Donato; Choi, Jiyeon; Fargnoli, Maria Concetta; Zhang, Tongwu; Rodolfo, Monica; Trower, Adam J.; Menin, Chiara; Martinez, Jacobo; Hadjisavvas, Andreas; Song, Lei; Stefanaki, Irene; Scolyer, Richard; Yang, Rose; Goldstein, Alisa M.; Potrony, Miriam; Kypreou, Katerina P.; Pastorino, Lorenza; Queirolo, Paola; Pellegrini, Cristina; Cattaneo, Laura; Zawistowski, Matthew; Gimenez-Xavier, Pol; Rodriguez, Arantxa; Elefanti, Lisa; Manoukian, Siranoush; Rivoltini, Licia; Smith, Blair H.; Loizidou, Maria A.; Del Regno, Laura; Massi, Daniela; Mandala, Mario; Khosrotehrani, Kiarash; Akslen, Lars A.; Amos, Christopher I.; Andresen, Per A.; Avril, Marie-Françoise; Azizi, Esther; Soyer, H. Peter; Bataille, Veronique; Dalmasso, Bruna; Bowdler, Lisa M.; Burdon, Kathryn P.; Chen, Wei V.; Codd, Veryan; Craig, Jamie E.; Dębniak, Tadeusz; Falchi, Mario; Fang, Shenying; Friedman, Eitan; Simi, Sarah; Galan, Pilar; Garcia-Casado, Zaida; Gillanders, Elizabeth M.; Gordon, Scott; Green, Adele; Gruis, Nelleke A.; Hansson, Johan; Harland, Mark; Harris, Jessica; Helsing, Per; Henders, Anjali; Hočevar, Marko; Höiom, Veronica; Hunter, David; Ingvar, Christian; Kumar, Rajiv; Lang, Julie; Lathrop, G. Mark; Lee, Jeffrey E.; Li, Xin; Lubiński, Jan; Mackie, Rona M.; Malt, Maryrose; Malvehy, Josep; McAloney, Kerrie; Mohamdi, Hamida; Molven, Anders; Moses, Eric K.; Neale, Rachel E.; Novaković, Srdjan; Nyholt, Dale R.; Olsson, Håkan; Orr, Nicholas; Fritsche, Lars G.; Puig-Butille, Joan Anton; Qureshi, Abrar A.; Radford-Smith, Graham L.; Randerson-Moor, Juliette; Requena, Celia; Rowe, Casey; Samani, Nilesh J.; Sanna, Marianna; Schadendorf, Dirk; Schulze, Hans-Joachim; Simms, Lisa A.; Smithers, Mark; Song, Fengju; Swerdlow, Anthony J.; van der Stoep, Nienke; Kukutsch, Nicole A.; Visconti, Alessia; Wallace, Leanne; Ward, Sarah V.; Wheeler, Lawrie; Sturm, Richard A.; Hutchinson, Amy; Jones, Kristine; Malasky, Michael; Vogt, Aurelie; Zhou, Weiyin; Pooley, Karen A.; Elder, David E.; Han, Jiali; Hicks, Belynda; Hayward, Nicholas K.; Kanetsky, Peter A.; Brummett, Chad; Montgomery, Grant W.; Olsen, Catherine M.; Hayward, Caroline; Dunning, Alison M.; Martin, Nicholas G.; Evangelou, Evangelos; Mann, Graham J.; Long, Georgina; Pharoah, Paul D. P.; Easton, Douglas F.; Barrett, Jennifer H.; Cust, Anne E.; Abecasis, Goncalo; Duffy, David L.; Whiteman, David C.; Gogas, Helen; De Nicolo, Arcangela; Tucker, Margaret A.; Newton-Bishop, Julia A.; Peris, Ketty; Chanock, Stephen J.; Demenais, Florence; Brown, Kevin M.; Puig, Susana; Nagore, Eduardo; Shi, Jianxin; Iles, Mark M.; Law, Matthew H.
    Genome-wide association meta-analyses combining multiple risk phenotypes provide insights into the genetic architecture of cutaneous melanoma susceptibility
    In: Nature Genetics Jg. 52 (2020) Nr. 5, S. 494 - 504
    ISSN: 1061-4036; 1546-1718
    Online Volltext: dx.doi.org/ Online Volltext (Open Access)
  • Küppers, Ralf; Schadendorf, Dirk; Feuerbach, Lars; PCAWG Consortium
    Genomic footprints of activated telomere maintenance mechanisms in cancer
    In: Nature Communications Jg. 11 (2020)
    ISSN: 2041-1723
    Online Volltext: dx.doi.org/ (Open Access)
  • Mandala, M.; Arance, A.; Dummer, R.; Ascierto, P.A.; Gogas, H.; Liszkay, G.; Garbe, C.; Schadendorf, Dirk; Krajsová, I.; Gutzmer, R.; Chiarion Sileni, V.; Dutriaux, C.; Loquai, C.; Tadmouri, A.; Pickard, M.D.; Gollerkeri, A.; Robert, C.; Flaherty, K.T.
    Healthcare Resource Utilization in Patients Treated with Encorafenib PLUS Binimetinib for BRAF-Mutant Metastatic Melanoma : DATA from Columbus, a Phase 3 Trial in BRAF-Mutant Melanoma
    In: Value in Health Jg. 23 (2020) Nr. Suppl. 2, S. 428
    ISSN: 1524-4733; 1098-3015
    Online Volltext: dx.doi.org/ (Open Access)
  • Küppers, Ralf; Schadendorf, Dirk; Creighton, Chad J.; PCAWG Consortium
    High-coverage whole-genome analysis of 1220 cancers reveals hundreds of genes deregulated by rearrangement-mediated cis-regulatory alterations
    In: Nature Communications Jg. 11 (2020)
    ISSN: 2041-1723
    Online Volltext: dx.doi.org/ (Open Access)
  • Leiter, Ulrike; Loquai, Carmen; Reinhardt, Lydia; Rafei-Shamsabadi, David; Gutzmer, Ralf; Kaehler, Katharina; Heinzerling, Lucie; Hassel, Jessica C.; Glutsch, Valerie; Sirokay, Judith; Schlecht, Nora; Rübben, Albert; Gambichler, Thilo; Schatton, Kerstin; Pfoehler, Claudia; Franklin, Cindy; Terheyden, Patrick; Haferkamp, Sebastian; Mohr, Peter; Bischof, Lena; Livingstone, Elisabeth; Zimmer, Lisa; Weichenthal, Michael; Schadendorf, Dirk; Meiwes, Andreas; Keim, Ulrike; Garbe, Claus; Becker, Jürgen; Ugurel, Selma
    Immune checkpoint inhibition therapy for advanced skin cancer in patients with concomitant hematological malignancy : A retrospective multicenter DeCOG study of 84 patients
    In: Journal for ImmunoTherapy of Cancer Jg. 8 (2020) Nr. 2, S. e000897
    ISSN: 2051-1426
    Online Volltext: dx.doi.org/ (Open Access)
  • Zaremba, Anne; Zimmer, Lisa; Griewank, Klaus; Ugurel, Selma; Rösch, Alexander; Schadendorf, Dirk; Livingstone, Elisabeth
    Immuntherapie beim malignen Melanom
    In: Der Internist Jg. 61 (2020) Nr. 7, S. 669 - 675
    ISSN: 1432-1289; 0020-9554
    Online Volltext: dx.doi.org/ (Open Access)
  • Knispel, Sarah; Stang, Andreas; Zimmer, Lisa; Lax, Hildegard; Gutzmer, Ralf; Heinzerling, Lucie; Weishaupt, Carsten; Pföhler, Claudia; Gesierich, Anja; Herbst, Rudolf; Kaehler, Katharina C.; Weide, Benjamin; Berking, Carola; Loquai, Carmen; Utikal, Jochen; Terheyden, Patrick; Kaatz, Martin; Schlaak, Max; Kreuter, Alexander; Ulrich, Jens; Mohr, Peter; Dippel, Edgar; Livingstone, Elisabeth; Becker, Jürgen; Weichenthal, Michael; Chorti, Eleftheria; Gronewold, Janine; Schadendorf, Dirk; Ugurel, Selma
    Impact of a preceding radiotherapy on the outcome of immune checkpoint inhibition in metastatic melanoma : A multicenter retrospective cohort study of the DeCOG
    In: Journal for ImmunoTherapy of Cancer Jg. 8 (2020) Nr. 1, S. e000395
    ISSN: 2051-1426
    Online Volltext: dx.doi.org/ (Open Access)
  • Hemstock, Matthew; Amadi, Adenike; Kupas, Katrin; Roskell, Neil; Kotapati, Srividya; Gooden, Kyna; Middleton, Mark R.; Schadendorf, Dirk
    Indirect treatment comparison of nivolumab versus placebo for the adjuvant treatment of melanoma
    In: The European Journal of Cancer Jg. 132 (2020) S. 176 - 186
    ISSN: 0959-8049; 1879-0852
    Online Volltext: dx.doi.org/ (Open Access)
  • Küppers, Ralf; Schadendorf, Dirk; Cmero, Marek; Macintyre, Geoff; PCAWG Consortium
    Inferring structural variant cancer cell fraction
    In: Nature Communications Jg. 11 (2020)
    ISSN: 2041-1723
    Online Volltext: dx.doi.org/ (Open Access)
  • Melms, Johannes C.; Vallabhaneni, Sreeram; Mills, Caitlin E.; Yapp, Clarence; Chen, Jia-Yun; Morelli, Eugenio; Waszyk, Patricia; Kumar, Sushil; Deming, Derrick; Moret, Nienke; Rodriguez, Steven; Subramanian, Kartik; Rogava, Meri; Cartwright, Adam N.R.; Luoma, Adrienne; Mei, Shaolin; Brinker, Titus J.; Miller, David M.; Spektor, Alexander; Schadendorf, Dirk; Riggi, Nicolo; Wucherpfennig, Kai W.; Sorger, Peter K.; Izar, Benjamin
    Inhibition of haspin kinase promotes cell-intrinsic and extrinsic antitumor activity
    In: Cancer Research Jg. 80 (2020) Nr. 4, S. 798 - 810
    ISSN: 1538-7445; 0008-5472
    Online Volltext: dx.doi.org/ Online Volltext (Open Access)
  • Conway, Jake R.; Dietlein, Felix; Taylor-Weiner, Amaro; AlDubayan, Saud; Vokes, Natalie; Keenan, Tanya; Reardon, Brendan; He, Meng Xiao; Margolis, Claire A.; Weirather, Jason L.; Haq, Rizwan; Schilling, Bastian; Stephen Hodi, F.; Schadendorf, Dirk; Liu, David; Van Allen, Eliezer M.
    Integrated molecular drivers coordinate biological and clinical states in melanoma
    In: Nature Genetics Jg. 52 (2020) Nr. 12, S. 1373 - 1383
    ISSN: 1061-4036; 1546-1718
    Online Volltext: dx.doi.org/ Online Volltext (Open Access)
  • Küppers, Ralf; Schadendorf, Dirk; Reimand, Jüri; PCAWG Drivers and Functional Interpretation Working Group; PCAWG Consortium
    Integrative pathway enrichment analysis of multivariate omics data
    In: Nature Communications Jg. 11 (2020)
    ISSN: 2041-1723
    Online Volltext: dx.doi.org/ (Open Access)
  • Hauschild, Axel; Ascierto, Paolo A.; Schadendorf, Dirk; Grob, Jean Jacques; Ribas, Antoni; Kiecker, Felix; Dutriaux, Caroline; Demidov, Lev V.; Lebbé, Céleste; Rutkowski, Piotr; Blank, Christian U.; Gutzmer, Ralf; Millward, Michael; Kefford, Richard; Haas, Tomas; D'Amelio, Anthony; Gasal, Eduard; Mookerjee, Bijoyesh; Chapman, Paul B.
    Long-term outcomes in patients with BRAF V600-mutant metastatic melanoma receiving dabrafenib monotherapy : Analysis from phase 2 and 3 clinical trials
    In: European Journal of Cancer Jg. 125 (2020) S. 114 - 120
    ISSN: 1879-0852; 0959-8049
    Online Volltext: dx.doi.org/ Online Volltext (Open Access)
  • Eggermont, Alexander M.M.; Blank, Christian U.; Mandala, Mario; Long, Georgina V.; Atkinson, Victoria G.; Dalle, Stéphane; Haydon, Andrew M.; Meshcheryakov, Andrey; Khattak, Adnan; Carlino, Matteo S.; Sandhu, Shahneen; Larkin, James; Puig, Susana; Ascierto, Paolo A.; Rutkowski, Piotr; Schadendorf, Dirk; Koornstra, Rutger; Hernandez-Aya, Leonel; Di Giacomo, Anna Maria; van den Eertwegh, Alfonsus J.M.; Grob, Jean-Jacques; Gutzmer, Ralf; Jamal, Rahima; Lorigan, Paul C.; van Akkooi, Alexander C.J.; Krepler, Clemens; Ibrahim, Nageatte; Marreaud, Sandrine; Kicinski, Michal; Suciu, Stefan; Robert, Caroline
    Longer follow-up confirms recurrence-free survival benefit of adjuvant pembrolizumab in high-risk stage III melanoma : Updated results from the EORTC 1325-MG/KEYNOTE-054 trial
    In: Journal of Clinical Oncology (JCO) Jg. 38 (2020) Nr. 33, S. 3925 - 3936
    ISSN: 0732-183X; 1527-7755
    Online Volltext: dx.doi.org/ (Open Access)
  • Herrera-Rios, Dayana; Mughal, Sadaf S.; Teuber-Hanselmann, Sarah; Pierscianek, Daniela; Sucker, Antje; Jansen, Philipp; Schimming, Tobias; Klode, Joachim; Reifenberger, Julia; Felsberg, Jörg; Keyvani, Kathy; Brors, Benedikt; Sure, Ulrich; Reifenberger, Guido; Schadendorf, Dirk; Helfrich, Iris
    Macrophages/microglia represent the major source of indolamine 2,3-dioxygenase expression in melanoma metastases of the brain
    In: Frontiers in Immunology Jg. 11 (2020) Article-No: 120
    ISSN: 1664-3224
    Online Volltext: dx.doi.org/ Online Volltext (Open Access)
  • Lodde, Georg; Zimmer, Lisa; Livingstone, Elisabeth; Schadendorf, Dirk; Ugurel, Selma
    Malignes Melanom
    In: Der Hautarzt Jg. 71 (2020) S. 63 - 77
    ISSN: 1432-1173; 0017-8470
    Online Volltext: dx.doi.org/
  • Lodde, Georg; Zimmer, Lisa; Livingstone, Elisabeth; Schadendorf, Dirk; Ugurel, Selma
    Malignes Melanom
    In: Der Onkologe Jg. 26 (2020) Nr. 1, S. 75 - 87
    ISSN: 0947-8965; 1433-0415
    Online Volltext: dx.doi.org/
  • Lodde, Georg; Zimmer, Lisa; Livingstone, Elisabeth; Schadendorf, Dirk; Ugurel, Selma
    Malignes Melanom
    In: Der Pathologe Jg. 41 (2020) Nr. 3, S. 281 - 292
    ISSN: 0172-8113
    Online Volltext: dx.doi.org/
  • Zaremba, Anne; Zimmer, Lisa; Griewank, Klaus; Ugurel, Selma; Rösch, Alexander; Schadendorf, Dirk; Livingstone, Elisabeth
    Malignes Melanom : Stellenwert der BRAF-Inhibition beim malignen Melanom
    In: Der Onkologe Jg. 26 (2020) Nr. 8, S. 713 - 720
    ISSN: 1433-0415; 0947-8965
    Online Volltext: dx.doi.org/
  • Gutzmer, Ralf; Vordermark, Dirk; Hassel, Jessica C.; Krex, Dietmar; Wendl, Christina; Schadendorf, Dirk; Sickmann, Thomas; Rieken, Stefan; Pukrop, Tobias; Höller, Christoph; Eigentler, Thomas K.; Meier, Friedegund
    Melanoma brain metastases – Interdisciplinary management recommendations 2020
    In: Cancer Treatment Reviews Jg. 89 (2020) S. 102083
    ISSN: 1532-1967; 0305-7372
    Online Volltext: dx.doi.org/
  • Tasdogan, Alpaslan; Faubert, Brandon; Ramesh, Vijayashree; Ubellacker, Jessalyn M.; Shen, Bo; Solmonson, Ashley; Murphy, Malea M.; Gu, Zhimin; Gu, Wen; Martin, Misty; Kasitinon, Stacy Y.; Vandergriff, Travis; Mathews, Thomas P.; Zhao, Zhiyu; Schadendorf, Dirk; DeBerardinis, Ralph J.; Morrison, Sean J.
    Metabolic heterogeneity confers differences in melanoma metastatic potential
    In: Nature Jg. 577 (2020) Nr. 7788, S. 115 - 120
    ISSN: 0028-0836; 1476-4687
    Online Volltext: dx.doi.org/ Online Volltext (Open Access)
  • Michel, Lars; Schadendorf, Dirk; Rassaf, Tienush
    Onkokardiologie : Neue Herausforderungen, neue Möglichkeiten
    In: Herz: Cardiovascular Diseases Jg. 45 (2020) S. 619 - 625
    ISSN: 1615-6692; 0340-9937
    Online Volltext: dx.doi.org/ Online Volltext (Open Access)
  • Ascierto, Paolo Antonio; Del Vecchio, Michelle; Mackiewicz, Andrzej; Robert, Caroline; Chiarion-Sileni, Vanna; Arance, Ana; Lebbé, Céleste; Svane, Inge Marie; Mcneil, Catriona; Rutkowski, Piotr; Loquai, Carmen; Mortier, Laurent; Hamid, Omid; Bastholt, Lars; Dreno, Brigitte; Schadendorf, Dirk; Garbe, Claus; Nyakas, Marta; Grob, Jean-Jacques; Thomas, Luc; Liszkay, Gabriella; Smylie, Michael; Hoeller, Christoph; Ferraresi, Virginia; Grange, Florent; Gutzmer, Ralf; Pikiel, Joanna; Hosein, Fareeda; Simsek, Burcin; Maio, Michele
    Overall survival at 5 years of follow-up in a phase III trial comparing ipilimumab 10 mg/kg with 3 mg/kg in patients with advanced melanoma
    In: Journal for ImmunoTherapy of Cancer Jg. 8 (2020) Nr. 1,
    ISSN: 2051-1426
    Online Volltext: dx.doi.org/ (Open Access)
  • Küppers, Ralf; Schadendorf, Dirk; ICGC/TCGA Pan-Cancer Analysis of Whole Genomes Consortium; et al.
    Pan-cancer analysis of whole genomes
    In: Nature Jg. 578 (2020) Nr. 7793, S. 82 - 93
    ISSN: 0028-0836; 1476-4687
    Online Volltext: dx.doi.org/ (Open Access)
  • Küppers, Ralf; Schadendorf, Dirk
    Pathway and network analysis of more than 2500 whole cancer genomes
    In: Nature Communications Jg. 11 (2020)
    ISSN: 2041-1723
    Online Volltext: dx.doi.org/
  • Rischin, Danny; Migden, Michael R.; Lim, Annette M.; Schmults, Chrysalyne D.; Khushalani, Nikhil I.; Hughes, Brett G.M.; Schadendorf, Dirk; Dunn, Lara A.; Hernandez-Aya, Leonel; Chang, Anne Lynn S.; Modi, Badri; Hauschild, Axel; Ulrich, Claas; Eigentler, Thomas; Stein, Brian; Pavlick, Anna C.; Geiger, Jessica L.; Gutzmer, Ralf; Alam, Murad; Okoye, Emmanuel; Mathias, Melissa; Jankovic, Vladimir; Stankevich, Elizabeth; Booth, Jocelyn; Li, Siyu; Lowy, Israel; Fury, Matthew G.; Guminski, Alexander
    Phase 2 study of cemiplimab in patients with metastatic cutaneous squamous cell carcinoma : Primary analysis of fixed-dosing, long-term outcome of weight-based dosing
    In: Journal for ImmunoTherapy of Cancer Jg. 8 (2020) Nr. 1, S. e000775
    ISSN: 2051-1426
    Online Volltext: dx.doi.org/ (Open Access)
  • Spassova, Ivelina; Ugurel, Selma; Terheyden, Patrick; Sucker, Antje; Hassel, Jessica C.; Ritter, Cathrin; Kubat, Linda; Habermann, Daniel; Farahpour, Farnoush; Saeedghalati, Mohammadkarim; Peiffer, Lukas; Kumar, Rajiv; Schrama, David; Hoffmann, Daniel; Schadendorf, Dirk; Becker, Jürgen
    Predominance of Central Memory T Cells with High T-Cell Receptor Repertoire Diversity is Associated with Response to PD-1/PD-L1 Inhibition in Merkel Cell Carcinoma
    In: Clinical Cancer Research Jg. 26 (2020) Nr. 9, S. 2257 - 2267
    ISSN: 1078-0432; 1557-3265
    Online Volltext: dx.doi.org/
  • Garbe, Claus; Keim, Ulrike; Suciu, Stefan; Amaral, Teresa; Eigentler, Thomas K.; Gesierich, Anja; Hauschild, Axel; Heinzerling, Lucie; Kiecker, Felix; Schadendorf, Dirk; Stadler, Rudolf; Sunderkötter, Cord; Tüting, Thomas; Utikal, Jochen; Wollina, Uwe; Zouboulis, Christos C.; Keilholz, Ulrich; Testori, Alessandro; Martus, Peter; Leiter, Ulrike; Eggermont, Alexander M.M.
    Prognosis of patients with stage III melanoma according to American joint committee on cancer version 8 : A reassessment on the basis of 3 independent stage III melanoma cohorts
    In: Journal of Clinical Oncology (JCO) Jg. 38 (2020) Nr. 22, S. 2543 - 2551
    ISSN: 0732-183X; 1527-7755
    Online Volltext: dx.doi.org/ (Open Access)
  • Ascierto, P.A.; Lewis, K.D.; Di Giacomo, A.M.; Demidov, L.; Mandalà, M.; Bondarenko, I.; Herbert, C.; Mackiewicz, A.; Rutkowski, P.; Guminski, A.; Simmons, B.; Ye, C.; Hooper, G.; Wongchenko, M.J.; Goodman, G.R.; Yan, Y.; Schadendorf, Dirk
    Prognostic impact of baseline tumour immune infiltrate on disease-free survival in patients with completely resected, BRAFv⁶⁰⁰ mutation–positive melanoma receiving adjuvant vemurafenib
    In: Annals of Oncology Jg. 31 (2020) Nr. 1, S. 153 - 159
    ISSN: 1569-8041; 0923-7534
    Online Volltext: dx.doi.org/ (Open Access)
  • Schadendorf, Dirk; Hauschild, Axel; Fosko, Scott W.; Zloty, David M.; Labeille, Bruno; Grob, Jean Jacques; Puig, Susana; Makrutzki, Martina; Gilberg, Frank; Hong, A.; Dréno, Brigitte; Rogers, Gary S.; Kunstfeld, Rainer
    Quality‐of‐life analysis with intermittent vismodegib regimens in patients with multiple basal cell carcinomas : Patient‐reported outcomes from the MIKIE study
    In: Journal of the European Academy of Dermatology and Venereology Jg. 34 (2020) Nr. 9, S. e526 - e529
    ISSN: 1468-3083; 0926-9959
    Online Volltext: dx.doi.org/
  • Dummer, Reinhard; Ascierto, Paolo A.; Nathan, Paul; Robert, Caroline; Schadendorf, Dirk
    Rationale for Immune Checkpoint Inhibitors plus Targeted Therapy in Metastatic Melanoma : A Review
    In: JAMA Oncology Jg. 6 (2020) Nr. 12, S. 1957 - 1966
    ISSN: 2374-2445; 2374-2437
    Online Volltext: dx.doi.org/
  • Küppers, Ralf; Schadendorf, Dirk; Morris, Quaid D.; PCAWG Consortium
    Reconstructing evolutionary trajectories of mutation signature activities in cancer using TrackSig
    In: Nature Communications Jg. 11 (2020)
    ISSN: 2041-1723
    Online Volltext: dx.doi.org/
  • Hekler, Achim; Utikal, Jochen S.; Solass, Wiebke; Schmitt, Max; Klode, Joachim; Schadendorf, Dirk; Sondermann, Wiebke; Franklin, Cindy; Bestvater, Felix; Krahl, Dieter; von Kalle, Christof; Fröhling, Stefan; Brinker, Titus J.
    Reply to the letter to the editor: ‘Deep learning outperformed 11 pathologists in the classification of histopathological melanoma images’
    In: European Journal of Cancer Jg. 130 (2020) S. 262 - 264
    ISSN: 1879-0852; 1879-2995; 0959-8049; 0014-2964
    Online Volltext: dx.doi.org/ (Open Access)
  • Bazhin, Alexandr V.; Tambor, Vojtech; Dikov, Boyan; Philippov, Pavel P.; Schadendorf, Dirk; Eichmüller, Stefan B.
    Retraction Note to : cGMP-phosphodiesterase 6, transducin and Wnt5a/Frizzled-2-signaling control cGMP and Ca2+ homeostasis in melanoma cells
    In: Cellular and Molecular Life Sciences - CMLS Jg. 77 (2020) Nr. 5,
    ISSN: 1420-682X; 1420-9071
    Online Volltext: dx.doi.org/ (Open Access)
  • Küppers, Ralf; Schadendorf, Dirk
    Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples
    In: Nature Communications Jg. 11 (2020) Nr. 1, S. 4748
    ISSN: 2041-1723
    Online Volltext: dx.doi.org/ (Open Access)
  • Jansen, Philipp; Stoffels, Ingo; Müseler, Anne-Christine; Petri, Maximilian; Brinker, Titus J.; Schedlowski, Manfred; Schadendorf, Dirk; Engler, Harald; Klode, Joachim
    Salivary cortisol levels and anxiety in melanoma patients undergoing sentinel lymph node excision under local anesthesia versus general anesthesia : A prospective study
    In: World Journal of Surgical Oncology Jg. 18 (2020) Nr. 1, S. 53
    ISSN: 1477-7819
    Online Volltext: dx.doi.org/ Online Volltext (Open Access)
  • Turiello, Roberta; Capone, Mariaelena; Giannarelli, Diana; Morretta, Elva; Monti, Maria Chiara; Madonna, Gabriele; Mallardo, Domenico; Festino, Lucia; Azzaro, Rosa; Levesque, Mitchell P.; Imhof, Laurence; Weide, Benjamin; Amaral, Teresa; Chevrier, Marc; Sucker, Antje; Rutkowski, Piotr; Schadendorf, Dirk; Lebbe, Celeste; Luke, Jason John; Wistuba-Hamprecht, Kilian; Dummer, Reinhard; Pinto, Aldo; Morello, Silvana; Ascierto, Paolo A.
    Serum CD73 is a prognostic factor in patients with metastatic melanoma and is associated with response to anti-PD-1 therapy
    In: Journal for ImmunoTherapy of Cancer Jg. 8 (2020) Nr. 2, S. e001689
    ISSN: 2051-1426
    Online Volltext: dx.doi.org/ (Open Access)
  • Küppers, Ralf; Schadendorf, Dirk; PCAWG Tumour Subtypes and Clinical Translation; PCAWG Consortium
    Sex differences in oncogenic mutational processes
    In: Nature Communications Jg. 11 (2020) Nr. 1, S. 4330
    ISSN: 2041-1723
    Online Volltext: dx.doi.org/ (Open Access)
  • Dummer, Reinhard G.; Ascierto, Paolo A.; Basset-Seguin, Nicole; Dréno, Brigitte; Garbe, Claus; Gutzmer, Ralf; Hauschild, Axel; Krattinger, Regina; Lear, John T.; Malvehy, Josep; Schadendorf, Dirk; Grob, Jean Jacques
    Sonidegib and vismodegib in the treatment of patients with locally advanced basal cell carcinoma : A joint expert opinion
    In: Journal of the European Academy of Dermatology and Venereology Jg. 34 (2020) Nr. 9, S. 1944 - 1956
    ISSN: 1468-3083; 0926-9959
    Online Volltext: dx.doi.org/ Online Volltext (Open Access)
  • Ugurel, Selma; Röhmel, Joachim; Ascierto, Paolo A.; Becker, Jürgen C.; Flaherty, Keith T.; Grob, Jean J.; Hauschild, Axel; Larkin, James; Livingstone, Elisabeth; Long, Georgina V.; Lorigan, Paul; McArthur, Grant A.; Ribas, Antoni; Robert, Caroline; Zimmer, Lisa; Schadendorf, Dirk; Garbe, Claus
    Survival of patients with advanced metastatic melanoma : The impact of MAP kinase pathway inhibition and immune checkpoint inhibition - Update 2019
    In: European Journal of Cancer Jg. 130 (2020) S. 126 - 138
    ISSN: 1879-0852; 0959-8049
    Online Volltext: dx.doi.org/
  • Farah, Maya; Reuben, Alexandre; Spassova, Ivelina; Yang, Richard K.; Kubat, Linda; Nagarajan, Priyadharsini; Ning, Jing; Li, Wen; Aung, Phyu P.; Curry, Jonathan L.; Torres-Cabala, Carlos A.; Hudgens, Courtney W.; Ugurel, Selma; Schadendorf, Dirk; Gumbs, Curtis; Little, Latasha D.; Futreal, Andrew; Wistuba, Ignacio I.; Prieto, Victor G.; Wang, Linghua; Wong, Michael K.; Wargo, Jennifer A.; Becker, Jürgen; Tetzlaff, Michael T.
    T-Cell Repertoire in Combination with T-Cell Density Predicts Clinical Outcomes in Patients with Merkel Cell Carcinoma
    In: The Journal of Investigative Dermatology Jg. 140 (2020) Nr. 11, S. 2146 - 2156.e4
    ISSN: 1523-1747; 0022-202X
    Online Volltext: dx.doi.org/ (Open Access)
  • Such, Lina; Zhao, Fang; Liu, Derek; Thier, Beatrice; Le-Trilling, Vu Thuy Khanh; Sucker, Antje; Coch, Christoph; Pieper, Natalia; Howe, Sebastian; Bhat, Hilal; Kalkavan, Halime; Ritter, Cathrin; Brinkhaus, Robin; Ugurel, Selma; Köster, Johannes; Seifert, Ulrike; Dittmer, Ulf; Schuler, Martin; Lang, Karl S.; Kufer, Thomas A.; Hartmann, Gunther; Becker, Jürgen; Horn, Susanne; Ferrone, Soldano; Liu, David; Van Allen, Eliezer M.; Schadendorf, Dirk; Griewank, Klaus; Trilling, Mirko; Paschen, Annette
    Targeting the innate immunoreceptor RIG-I overcomes melanoma-intrinsic resistance to T cell immunotherapy
    In: The Journal of Clinical Investigation (JCI) Jg. 130 (2020) Nr. 8, S. 4266 - 4281
    ISSN: 1558-8238; 0021-9738
    Online Volltext: dx.doi.org/ Online Volltext (Open Access)
  • Cabrita, Rita; Lauss, Martin; Sanna, Adriana; Donia, Marco; Larsen, Mathilde; Schadendorf, Dirk
    Tertiary lymphoid structures improve immunotherapy and survival in melanoma
    In: Nature Jg. 577 (2020) Nr. 7791, S. 561 - 565
    ISSN: 0028-0836; 1476-4687
    Online Volltext: dx.doi.org/
  • Gebhardt, Christoffer; Ascierto, Paolo; Atkinson, Victoria; Corrie, Pippa; Dummer, Reinhard; Schadendorf, Dirk
    The concepts of rechallenge and retreatment in melanoma: A proposal for consensus definitions
    In: European Journal of Cancer Jg. 138 (2020) S. 68 - 76
    ISSN: 1879-0852; 0959-8049
    Online Volltext: dx.doi.org/
  • Ascierto, Paolo A.; Dummer, Reinhard; Gogas, Helen J.; Flaherty, Keith T.; Arance, Ana; Mandala, Mario; Liszkay, Gabriella; Garbe, Claus; Schadendorf, Dirk; Krajsova, Ivana; Gutzmer, Ralf; de Groot, Jan Willem B.; Loquai, Carmen; Gollerkeri, Ashwin; Pickard, Michael D.; Robert, Caroline
    Update on tolerability and overall survival in COLUMBUS : landmark analysis of a randomised phase 3 trial of encorafenib plus binimetinib vs vemurafenib or encorafenib in patients with BRAF V600–mutant melanoma
    In: European Journal of Cancer Jg. 126 (2020) S. 33 - 44
    ISSN: 1879-0852; 0959-8049
    Online Volltext: dx.doi.org/ (Open Access)
  • Matsuya, Taisuke; Nakamura, Yasuhiro; Matsushita, Shigeto; Tanaka, Ryota; Teramoto, Yukiko; Asami, Yuri; Uehara, Jiro; Aoki, Megumi; Yamamura, Kentaro; Nakamura, Yoshiyuki; Fujisawa, Yasuhiro; Livingstone, Elisabeth; Zimmer, Lisa; Schadendorf, Dirk; Kagamu, Hiroshi; Fujimoto, Manabu; Honma, Masaru; Ishida-Yamamoto, Akemi; Araki, Ryuichiro; Yamamoto, Akifumi
    Vitiligo expansion and extent correlate with durable response in anti-programmed death 1 antibody treatment for advanced melanoma : A multi-institutional retrospective study
    In: The Journal of Dermatology Jg. 47 (2020) Nr. 6, S. 629 - 635
    ISSN: 1346-8138; 0385-2407
    Online Volltext: dx.doi.org/
  • Brinker, Titus J.; Hekler, Achim; Enk, Alexander H.; Klode, Joachim; Hauschild, Axel; Berking, Carola; Schilling, Bastian; Haferkamp, Sebastian; Schadendorf, Dirk; Fröhling, Stefan; von Kalle, Christof; Ludwig-Peitsch, Wiebke; Sirokay, Judith; Heinzerling, Lucie; Albrecht, Magarete; Baratella, Katharina; Bischof, Lena; Chorti, Eleftheria; Dith, Anna; Drusio, Christina; Giese, Nina; Gratsias, Emmanouil; Griewank, Klaus; Hallasch, Sandra; Hanhart, Zdenka; Herz, Saskia; Hohaus, Katja; Jansen, Philipp; Jockenhöfer, Finja; Kanaki, Theodora; Knispel, Sarah; Leonhard, Katja; Martaki, Anna; Matei, Liliana; Matull, Johanna; Olischewski, Alexandra; Petri, Maximilian; Placke, Jan-Malte; Raub, Simon; Salva, Katrin; Schlott, Swantje; Sody, Elsa; Steingrube, Nadine; Stoffels, Ingo; Ugurel, Selma; Sondermann, Wiebke; Zaremba, Anne; Gebhardt, Christoffer; Booken, Nina; Christolouka, Maria; Buder-Bakhaya, Kristina; Bokor-Billmann, Therezia; Gholam, Patrick; Hänßle, Holger; Salzmann, Martin; Schäfer, Sarah; Schäkel, Knut; Schank, Timo; Bohne, Ann-Sophie; Deffaa, Sophia; Drerup, Katharina; Egberts, Friederike; Erkens, Anna-Sophie; Ewald, Benjamin; Falkvoll, Sandra; Gerdes, Sascha; Harde, Viola; Jost, Marion; Kosova, Katja; Messinger, Laetitia; Metzner, Malte; Morrison, Kirsten; Motamedi, Rogina; Pinczker, Anja; Rosenthal, Anne; Scheller, Natalie; Schwarz, Thomas; Stölzl, Dora; Thielking, Federieke; Tomaschewski, Elena; Wehkamp, Ulrike; Weichenthal, Michael; Wiedow, Oliver; Bär, Claudia Maria; Bender-Säbelkampf, Sophia; Horbrügger, Marc; Karoglan, Ante; Kraas, Luise; Faulhaber, Jörg; Geraud, Cyrill; Guo, Ze; Koch, Philipp; Linke, Miriam; Maurier, Nolwenn; Müller, Verena; Thomas, Benjamin; Utikal, Jochen Sven; Alamri, Ali Saeed M.; Baczako, Andrea; Betke, Matthias; Haas, Carolin; Hartmann, Daniela; Heppt, Markus V.; Kilian, Katharina; Krammer, Sebastian; Lapczynski, Natalie Lidia; Mastnik, Sebastian; Nasifoglu, Suzan; Ruini, Cristel; Sattler, Elke; Schlaak, Max; Wolff, Hans; Achatz, Birgit; Bergbreiter, Astrid; Drexler, Konstantin; Ettinger, Monika; Halupczok, Anna; Hegemann, Marie; Dinauer, Verena; Maagk, Maria; Mickler, Marion; Philipp, Biance; Wilm, Anna; Wittmann, Constanze; Gesierich, Anja; Glutsch, Valerie; Kahlert, Katrin; Kerstan, Andreas; Schrüfer, Philipp
    A convolutional neural network trained with dermoscopic images performed on par with 145 dermatologists in a clinical melanoma image classification task
    In: European Journal of Cancer Jg. 111 (2019) S. 148 - 154
    ISSN: 0959-8049
    Online Volltext: dx.doi.org/ (Open Access)
  • Heinzerling, Lucie; Ascierto, Paolo Antonio; Dummer, Reinhard; Gogas, Helen; Lebbé, Celeste; Long, Georgina V.; McArthur, Grant A .; Moslehi, Javad; Neilan, Tomas G.; Ribas, Antoni; Robert, Caroline; Schadendorf, Dirk; Wolchok, Jedd D.; Hauschild, Axel
    Adverse events 2.0—Let us get SERIOs : New reporting for adverse event outcomes needed in the era of immunooncology
    In: European Journal of Cancer Jg. 112 (2019) S. 29 - 31
    ISSN: 0959-8049; 1879-0852
    Online Volltext: dx.doi.org/
  • Gogas, Helen J.; Flaherty, Keith T.; Dummer, Reinhard; Ascierto, Paolo A.; Arance, Ana; Mandala, Mario; Liszkay, Gabriella; Garbe, Claus; Schadendorf, Dirk; Krajsova, Ivana; Gutzmer, Ralf; Sileni, Vanna Chiarion; Dutriaux, Caroline; de Groot, Jan Willem B.; Yamazaki, Naoya; Loquai, Carmen; Gollerkeri, Ashwin; Pickard, Michael D.; Robert, Caroline
    Adverse events associated with encorafenib plus binimetinib in the COLUMBUS study : incidence, course and management
    In: European Journal of Cancer Jg. 119 (2019) S. 97 - 106
    ISSN: 0959-8049
    Online Volltext: dx.doi.org/ (Open Access)
  • Cosgarea, Ioana; Koelsch, Bernd; Fischer, Christine; Griewank, Klaus; van den Berg, Linda; Kutritz, Anja; Schadendorf, Dirk; Kindler-Röhrborn, Andrea
    An Animal Model of Cutaneous Cyst Development Enables the Identification of Three Quantitative Trait Loci, Including the Homologue of a Human Locus (TRICY1)
    In: The Journal of Investigative Dermatology Jg. 139 (2019) Nr. 10, S. 2235 - 2238.e5
    ISSN: 0022-202X
    Online Volltext: dx.doi.org/ (Open Access)
  • Storim, Julian; Verheyen, Jens; Wolff, Eva; Wohlschläger, Jeremias; Heintschel von Heinegg, Evelyn; Schadendorf, Dirk; Esser, Stefan
    Antiretroviral therapy suppresses rectal HIV-RNA shedding despite inflammation in MSM with rectal C. trachomatis and N. gonorrhoeae infections - A cross-sectional, single-center study
    In: Sexually Transmitted Infections Jg. 95 (2019) Nr. 2, S. 95 - 98
    ISSN: 1472-3263; 1368-4973
    Online Volltext: dx.doi.org/ (Open Access)
  • Váraljai, Renáta; Wistuba-Hamprecht, Kilian; Seremet, Teofila; Diaz, Joey Mark S.; Nsengimana, Jérémie; Sucker, Antje; Griewank, Klaus; Placke, Jan-Malte; Horn, Peter A.; Neuhoff, Nils von; Shannan, Batool; Chauvistré, Heike; Vogel, Felix C.E.; Horn, Susanne; Becker, Jürgen; Newton-Bishop, Julia; Stang, Andreas; Neyns, Bart; Weide, Benjamin; Schadendorf, Dirk; Rösch, Alexander
    Application of circulating cell-free tumor DNA profiles for therapeutic monitoring and outcome prediction in genetically heterogeneous metastatic melanoma
    In: JCO Precision Oncology Jg. 3 (2019)
    ISSN: 2473-4284
    Online Volltext: dx.doi.org/ Online Volltext (Open Access)
  • Stoffels, Ingo; Jansen, Philipp; Petri, Maximilian; Goerdt, Lukas; Brinker, Titus J.; Griewank, Klaus; Pöppel, Thorsten; Schadendorf, Dirk; Klode, Joachim
    Assessment of Nonradioactive Multispectral Optoacoustic Tomographic Imaging With Conventional Lymphoscintigraphic Imaging for Sentinel Lymph Node Biopsy in Melanoma
    In: JAMA Network Open Jg. 2 (2019) Nr. 8, S. e199020
    ISSN: 2574-3805
    Online Volltext: dx.doi.org/ (Open Access)
  • Reinsch, Nico; Streeck, Hendrik; Holzendorf, Volker; Schulze, Christina; Neumann, Till; Brockmeyer, Norbert H.; Kehrmann, Jan; Schadendorf, Dirk; Esser, Stefan
    B-type natriuretic peptides for the prediction of cardiovascular events and mortality in patients living with HIV : Results from the HIV-HEART study
    In: International Journal of Cardiology Jg. 281 (2019) S. 127 - 132
    ISSN: 1874-1754; 0167-5273
    Online Volltext: dx.doi.org/
  • van Herpen, Carla M.L.; Agarwala, Sanjiv S.; Hauschild, Axel; Berking, Carola; Beck, J. Thaddeus; Schadendorf, Dirk; Jansen, Rob; Queirolo, Paola; Ascierto, Paolo A.; Blank, Christian U.; Heinrich, Michael C.; Pal, Rupam R.; Derti, Adnan; Antona, Victor; Nauwelaerts, Heidi; Zubel, Angela; Dummer, Reinhard
    Biomarker results from a phase II study of MEK1/2 inhibitor binimetinib (MEK162) in patients with advanced NRAS- or BRAF-mutated melanoma
    In: OncoTarget Jg. 10 (2019) Nr. 19, S. 1850 - 1859
    ISSN: 1949-2553
    Online Volltext: dx.doi.org/ (Open Access)
  • Mincu, Raluca I.; Mahabadi, Amir Abbas; Michel, Lars; Mrotzek, Simone; Schadendorf, Dirk; Rassaf, Tienush; Totzeck, Matthias
    Cardiovascular Adverse Events Associated with BRAF and MEK Inhibitors : A Systematic Review and Meta-analysis
    In: JAMA Network Open Jg. 2 (2019) Nr. 8, S. e198890
    ISSN: 2574-3805
    Online Volltext: dx.doi.org/ (Open Access)
  • Syeda, Mahrukh M; WIGGINS, JENNIFER M; Corless, Broderick; Long, Georgina V.; Flaherty, Keith; Schadendorf, Dirk; Nathan, Paul D.; Robert, Caroline; Ribas, Antoni; Davies, Michael A.; Grob, Jean Jacques; Gasal, Eduard; Squires, Matthew; Marker, Mahtab; Brase, Jan C.; Polsky, David
    Circulating tumor DNA (ctDNA) kinetics to predict survival in patients (pts) with unresectable or metastatic melanoma treated with dabrafenib (D) or D + trametinib (T)
    In: Journal of Clinical Oncology Jg. 37 (2019) Nr. 15_suppl, S. 9510
    ISSN: 0732-183X; 1527-7755
    Online Volltext: dx.doi.org/
  • Zaremba, Anne; Murali, Rajmohan; Jansen, Philipp; Möller, Inga; Sucker, Antje; Paschen, Annette; Zimmer, Lisa; Livingstone, Elisabeth; Brinker, Titus J.; Hadaschik, Eva; Franklin, Cindy; Rösch, Alexander; Ugurel, Selma; Schadendorf, Dirk; Griewank, Klaus; Cosgarea, Ioana
    Clinical and genetic analysis of melanomas arising in acral sites
    In: European Journal of Cancer Jg. 119 (2019) S. 66 - 76
    ISSN: 1879-0852; 0959-8049
    Online Volltext: dx.doi.org/ (Open Access)
  • Brinker, Titus J.; Hekler, Achim; Hauschild, Axel; Berking, Carola; Schilling, Bastian; Enk, Alexander H.; Haferkamp, Sebastian; Karoglan, Ante; von Kalle, Christof; Weichenthal, Michael; Sattler, Elke; Schadendorf, Dirk; Gaiser, Maria R.; Klode, Joachim; Utikal, Jochen S.
    Comparing artificial intelligence algorithms to 157 German dermatologists : the melanoma classification benchmark
    In: European Journal of Cancer Jg. 111 (2019) S. 30 - 37
    ISSN: 1879-0852; 0959-8049
    Online Volltext: dx.doi.org/ (Open Access)
  • Kappelmann-Fenzl, Melanie; Kuphal, Silke; Krupar, Rosemarie; Schadendorf, Dirk; Umansky, Viktor; Vardimon, Lily; Hellerbrand, Claus; Bosserhoff, Anja-Katrin
    Complex formation with monomeric α-tubulin and importin 13 fosters c-jun protein stability and is required for c-jun’s nuclear translocation and activity
    In: Cancers Jg. 11 (2019) Nr. 11, S. 1806
    ISSN: 2072-6694
    Online Volltext: dx.doi.org/ (Open Access)
  • Sekulic, Aleksandar; Migden, Michael R.; Basset-Seguin, Nicole; Garbe, Claus; Gesierich, Anja; Lao, Christopher D.; Miller, Chris; Mortier, Laurent; Murrell, Dédée F.; Hamid, Omid; Quevedo, Jorge F.; Hou, Jeannie; Mckenna, Edward; Dimier, Natalie; Williams, Sarah; Schadendorf, Dirk; Hauschild, Axel
    Correction to: Long-term safety and efficacy of vismodegib in patients with advanced basal cell carcinoma : final update of the pivotal ERIVANCE BCC study
    In: BMC Cancer Jg. 19 (2019) S. 366
    ISSN: 1471-2407
    Online Volltext: dx.doi.org/ (Open Access)
  • Sondermann, Wiebke; Utikal, Jochen Sven; Enk, Alexander H.; Schadendorf, Dirk; Klode, Joachim; Hauschild, Axel; Weichenthal, Michael; French, Lars E.; Berking, Carola; Schilling, Bastian; Haferkamp, Sebastian; Fröhling, Stefan; Kalle, Christof von; Brinker, Titus J.
    Corrigendum to ‘Prediction of melanoma evolution in melanocytic nevi via artificial intelligence : A call for prospective data’ (European Journal of Cancer (2019) 119 (30–34), (S0959804919304095), (10.1016/j.ejca.2019.07.009))
    In: European Journal of Cancer Jg. 123 (2019) S. 171
    ISSN: 0959-8049; 1879-0852; 1879-2995
    Online Volltext: dx.doi.org/ (Open Access)
  • Hekler, Achim; Utikal, Jochen S.; Enk, Alexander H.; Solass, Wiebke; Schmitt, Max; Klode, Joachim; Schadendorf, Dirk; Sondermann, Wiebke; Franklin, Cindy; Bestvater, Felix; Flaig, Michael J.; Krahl, Dieter; Kalle, Christof von; Fröhling, Stefan; Brinker, Titus J.
    Deep learning outperformed 11 pathologists in the classification of histopathological melanoma images
    In: European Journal of Cancer Jg. 118 (2019) S. 91 - 96
    ISSN: 0959-8049; 0277-5379; 0964-1947; 1879-0852
    Online Volltext: dx.doi.org/ (Open Access)
  • Brinker, Titus J.; Hekler, Achim; Enk, Alexander H.; Klode, Joachim; Hauschild, Axel; Berking, Carola; Schilling, Bastian; Haferkamp, Sebastian; Schadendorf, Dirk; Holland-Letz, Tim; von Kalle, Christof; Ludwig-Peitsch, Wiebke; Sirokay, Judith; Heinzerling, Lucie; Albrecht, Magarete; Baratella, Katharina; Bischof, Lena; Chorti, Eleftheria; Dith, Anna; Drusio, Christina; Giese, Nina; Gratsias, Emmanouil; Griewank, Klaus; Hallasch, Sandra; Hanhart, Zdenka; Herz, Saskia; Hohaus, Katja; Jansen, Philipp; Jockenhöfer, Finja; Kanaki, Theodora; Knispel, Sarah; Leonhard, Katja; Martaki, Anna; Matei, Liliana; Matull, Johanna; Olischewski, Alexandra; Petri, Maximilian; Placke, Jan-Malte; Raub, Simon; Salva, Katrin; Schlott, Swantje; Sody, Elsa; Steingrube, Nadine; Stoffels, Ingo; Ugurel, Selma; Zaremba, Anne; Gebhardt, Christoffer; Booken, Nina; Christolouka, Maria; Buder-Bakhaya, Kristina; Bokor-Billmann, Therezia; Gholam, Patrick; Hänßle, Holger; Salzmann, Martin; Schäfer, Sarah; Schäkel, Knut; Schank, Timo; Bohne, Ann-Sophie; Deffaa, Sophia; Drerup, Katharina; Egberts, Friederike; Erkens, Anna-Sophie; Ewald, Benjamin; Falkvoll, Sandra; Gerdes, Sascha; Harde, Viola; Jost, Marion; Kosova, Katja; Messinger, Laetitia; Metzner, Malte; Morrison, Kirsten; Motamedi, Rogina; Pinczker, Anja; Rosenthal, Anne; Scheller, Natalie; Schwarz, Thomas; Stölzl, Dora; Thielking, Federieke; Tomaschewski, Elena; Wehkamp, Ulrike; Weichenthal, Michael; Wiedow, Oliver; Bär, Claudia Maria; Bender-Säbelkampf, Sophia; Horbrügger, Marc; Karoglan, Ante; Kraas, Luise; Faulhaber, Jörg; Geraud, Cyrill; Guo, Ze; Koch, Philipp; Linke, Miriam; Maurier, Nolwenn; Müller, Verena; Thomas, Benjamin; Utikal, Jochen Sven; Alamri, Ali Saeed M.; Baczako, Andrea; Betke, Matthias; Haas, Carolin; Hartmann, Daniela; Heppt, Markus V.; Kilian, Katharina; Krammer, Sebastian; Lapczynski, Natalie Lidia; Mastnik, Sebastian; Nasifoglu, Suzan; Ruini, Cristel; Sattler, Elke; Schlaak, Max; Wolff, Hans; Achatz, Birgit; Bergbreiter, Astrid; Drexler, Konstantin; Ettinger, Monika; Halupczok, Anna; Hegemann, Marie; Dinauer, Verena; Maagk, Maria; Mickler, Marion; Philipp, Biance; Wilm, Anna; Wittmann, Constanze; Gesierich, Anja; Glutsch, Valerie; Kahlert, Katrin; Kerstan, Andreas; Schrüfer, Philipp
    Deep learning outperformed 136 of 157 dermatologists in a head-to-head dermoscopic melanoma image classification task
    In: European Journal of Cancer Jg. 113 (2019) S. 47 - 54
    ISSN: 0959-8049
    Online Volltext: dx.doi.org/ (Open Access)
  • Brinker, Titus J.; Hekler, Achim; Enk, Alexander H.; Berking, Carola; Haferkamp, Sebastian; Hauschild, Axel; Weichenthal, Michael; Klode, Joachim; Schadendorf, Dirk; Holland-Letz, Tim; Kalle, Christof von; Fröhling, Stefan; Schilling, Bastian; Utikal, Jochen S.
    Deep neural networks are superior to dermatologists in melanoma image classification
    In: European Journal of Cancer Jg. 119 (2019) S. 11 - 17
    ISSN: 0959-8049; 1879-0852; 0964-1947; 0277-5379
    Online Volltext: dx.doi.org/ (Open Access)
  • Vokes, Natalie; Margolis, Claire; Liu, David; Schilling, Bastian; Schadendorf, Dirk; Van Allen, Eliezer Mendel
    Distinct immunogenomic properties of melanomas with stable disease as best response to immune checkpoint blockade (ICB)
    In: Journal of Clinical Oncology Jg. 37 (2019) Nr. 15_Suppl, S. 2515 - 2515
    ISSN: 0732-183X; 1527-7755
    Online Volltext: dx.doi.org/
  • Kreft, Sophia; Gesierich, Anja; Eigentler, Thomas; Franklin, Cindy; Valpione, Sara; Ugurel, Selma; Utikal, Jochen; Haferkamp, Sebastian; Blank, Christian; Larkin, James; Garbe, Claus; Schadendorf, Dirk; Lorigan, Paul; Schilling, Bastian
    Efficacy of PD-1–based immunotherapy after radiologic progression on targeted therapy in stage IV melanoma
    In: European Journal of Cancer Jg. 116 (2019) S. 207 - 215
    ISSN: 1879-0852; 0959-8049
    Online Volltext: dx.doi.org/
  • Lebbé, Celeste; Meyer, Nicolas; Mortier, Laurent; Marquez-Rodas, Ivan; Robert, Caroline; Rutkowski, Piotr; Menzies, Alexander M.; Eigentler, Thomas; Ascierto, Paolo A.; Smylie, Michael; Schadendorf, Dirk; Ajaz, Mazhar; Svane, Inge Marie; Gonzalez, Rene; Rollin, Linda; Lord-Bessen, Jennifer; Saci, Abdel; Grigoryeva, Elena; Pigozzo, Jacopo
    Evaluation of Two Dosing Regimens for Nivolumab in Combination With Ipilimumab in Patients With Advanced Melanoma : Results From the Phase IIIb/IV CheckMate 511 Trial
    In: Journal of Clinical Oncology (JCO) Jg. 37 (2019) Nr. 11, S. 867 - 875
    ISSN: 0732-183X; 1527-7755
    Online Volltext: dx.doi.org/ (Open Access)
  • Schilling, Bastian; Martens, Alexander; Geukes Foppen, Marnix H.; Gebhardt, Christoffer; Hassel, Jessica C.; Rozeman, Elisa A.; Gesierich, Anja; Gutzmer, Ralf; Kähler, Katharina C.; Livingstone, Elisabeth; Diamantopoulos, Panagiotis T.; Gogas, Helen; Madonna, Gabriele; Ascierto, Paolo A.; Goldinger, Simone M.; Mangana, Johanna; Garbe, Claus; Schadendorf, Dirk; Blank, Christian; Weide, Benjamin
    First-line therapy-stratified survival in BRAF-mutant melanoma: a retrospective multicenter analysis
    In: Cancer Immunology, Immunotherapy Jg. 68 (2019) Nr. 5, S. 765 - 772
    ISSN: 1432-0851; 0340-7004
    Online Volltext: dx.doi.org/
  • Larkin, James; Chiarion-Sileni, Vanna; Gonzalez, Rene; Grob, Jean-Jacques; Rutkowski, Piotr; Lao, Christopher D.; Cowey, C Lance; Schadendorf, Dirk; Wagstaff, John; Dummer, Reinhard; Ferrucci, Pier F.; Smylie, Michael; Hogg, David; Hill, Andrew; Márquez-Rodas, Ivan; Haanen, John; Guidoboni, Massimo; Maio, Michele; Schöffski, Patrick; Carlino, Matteo S.; Lebbé, Céleste; McArthur, Grant; Ascierto, Paolo A.; Daniels, Gregory A.; Long, Georgina V.; Bastholt, Lars; Rizzo, Jasmine I.; Balogh, Agnes; Moshyk, Andriy; Hodi, F Stephen; Wolchok, Jedd D.
    Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
    In: The New England Journal of Medicine Jg. 381 (2019) Nr. 16, S. 1535 - 1546
    ISSN: 1533-4406; 0028-4793
    Online Volltext: dx.doi.org/ (Open Access)
  • Robert, Caroline; Flaherty, Keith; Nathan, Paul; Hersey, Peter; Garbe, Claus; Milhem, Mohammed; Demidov, Lev; Mohr, Peter; Hassel, Jessica C.; Rutkowski, Piotr; Dummer, Reinhard; Utikal, Jochen; Kiecker, Felix; Larkin, James; D'Amelio, Anthony; Mookerjee, Bijoyesh; Schadendorf, Dirk
    Five-year outcomes from a phase 3 METRIC study in patients with BRAF V600 E/K–mutant advanced or metastatic melanoma
    In: European Journal of Cancer Jg. 109 (2019) S. 61 - 69
    ISSN: 0959-8049
    Online Volltext: dx.doi.org/ Online Volltext (Open Access)
  • Robert, C.; Grob, J.J.; Stroyakovskiy, D.; Karaszewska, B.; Hauschild, A.; Levchenko, E.; Chiarion Sileni, V.; Schachter, J.; Garbe, C.; Bondarenko, I.; Gogas, H.; Mandalá, M.; Haanen, J.B.A.G.; Lebbé, C.; MacKiewicz, A.; Rutkowski, P.; Nathan, P.D.; Ribas, A.; Davies, M.A.; Flaherty, K.T.; Burgess, P.; Tan, M.; Gasal, E.; Voi, M.; Schadendorf, Dirk; Long, G.V.; Grob, Jean J.; Haanen, John B.A.G.; Nathan, Paul D.; Davies, Michael A.; Flaherty, Keith T.; Long, Georgina V.
    Five-year outcomes with dabrafenib plus trametinib in metastatic melanoma
    In: The New England Journal of Medicine Jg. 381 (2019) Nr. 7, S. 626 - 636
    ISSN: 1533-4406; 0028-4793
    Online Volltext: dx.doi.org/ (Open Access)
  • Jansen, Philipp; Cosgarea, Ioana; Murali, Rajmohan; Möller, Inga; Sucker, Antje; Franklin, Cindy; Paschen, Annette; Zaremba, Anne; Brinker, Titus Josef; Stoffels, Ingo; Schadendorf, Dirk; Klode, Joachim; Hadaschik, Eva; Griewank, Klaus
    Frequent Occurrence of NRAS and BRAF Mutations in Human Acral Naevi
    In: Cancers Jg. 11 (2019) Nr. 4, S. 546
    ISSN: 2072-6694
    Online Volltext: dx.doi.org/ Online Volltext (Open Access)
  • Emmons, Michael F.; Faião-Flores, Fernanda; Sharma, Ritin; Thapa, Ram; Messina, Jane L.; Becker, Jürgen; Schadendorf, Dirk; Seto, Edward; Sondak, Vernon K.; Koomen, John M.; Chen, Yian A.; Lau, Eric K.; Wan, Lixin; Licht, Jonathan D.; Smalley, Keiran S. M.
    HDAC8 regulates a stress response pathway in melanoma to mediate escape from BRAF inhibitor therapy
    In: Cancer Research Jg. 79 (2019) Nr. 11, S. 2947 - 2961
    ISSN: 1538-7445; 0008-5472
    Online Volltext: dx.doi.org/ Online Volltext (Open Access)
  • Schadendorf, Dirk; Di Giacomo, Anna Maria; Demidov, Lev; Merelli, Barbara; Bondarenko, Igor; Ascierto, Paolo A.; Herbert, Christopher; Mackiewicz, Andrzej; Rutkowski, Piotr; Guminski, Alexander; Goodman, Grant R.; Simmons, Brian; Ye, Chenglin; Hong, Agnes; Lewis, Karl
    Health-related quality of life in patients with fully resected BRAFV⁶⁰⁰ mutation–positive melanoma receiving adjuvant vemurafenib
    In: European Journal of Cancer Jg. 123 (2019) S. 155 - 161
    ISSN: 0959-8049; 0014-2964
    Online Volltext: dx.doi.org/ (Open Access)
  • Ugurel, Selma; Schadendorf, Dirk; Sucker, A.; Schramm, Sara; Utikal, J.; Pfohler, C.; Herbst, R.; Schilling, Bastian; Blank, C.; Becker, J. C.; Paschen, Annette; Zimmer, Lisa; Livingstone, Elisabeth; Horn, Peter; Rebmann, Vera
    High PD-1 or PD-L1 Concentrations in the Serum of Melanoma Patients are predictive for reduced Therapeutic Success of PD-1 Inhibition
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Jg. 17 (2019) Nr. Suppl. 5, S. 7 - 7
    ISSN: 1610-0387; 1563-2571; 1610-0379; 0301-0481
  • Ascierto, Paolo Antonio; Schadendorf, Dirk
    Immunotherapy in non-melanoma skin cancer : Updates and new perspectives
    In: Drugs in Context Jg. 8 (2019) S. 212583
    ISSN: 1740-4398; 1745-1981
    Online Volltext: dx.doi.org/ (Open Access)
  • Kanaki, Theodora; Stang, Andreas; Gutzmer, Ralf; Zimmer, Lisa; Chorti, Eleftheria; Sucker, Antje; Ugurel, Selma; Hadaschik, Eva; Gräger, Nikolai S.; Satzger, Imke; Schadendorf, Dirk; Livingstone, Elisabeth
    Impact of American Joint Committee on Cancer 8th edition classification on staging and survival of patients with melanoma
    In: European Journal of Cancer Jg. 119 (2019) S. 18 - 29
    ISSN: 0959-8049; 1879-0852; 1879-2995; 0964-1947; 0277-5379
    Online Volltext: dx.doi.org/
  • Brütting, Julia; Bergmann, Maike; Schadendorf, Dirk; Weber, Christiane; Tilgen, Wolfgang G.; Berking, Carola; Meier, Friedegund E.; im Auftrag der NVKH
    Informations- und Hilfsangebote für Melanompatienten : Präferenzielle Unterschiede zwischen Patienten und Ärzten
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Jg. 17 (2019) Nr. 6, S. 652 - 654
    ISSN: 1610-0387; 1563-2571; 1610-0379; 0301-0481
    Online Volltext: dx.doi.org/
  • Liu, David; Schilling, Bastian; Liu, Derek; Sucker, Antje; Livingstone, Elisabeth; Jerby-Amon, Livnat; Zimmer, Lisa; Gutzmer, Ralf; Satzger, Imke; Loquai, Carmen; Grabbe, Stephan; Vokes, Natalie; Margolis, Claire A.; Conway, Jake; He, Meng Xiao; Elmarakeby, Haitham; Dietlein, Felix; Miao, Diana; Tracy, Adam; Gogas, Helen; Goldinger, Simone M.; Utikal, Jochen; Blank, Christian U.; Rauschenberg, Ricarda; Bubnoff, Dagmar von; Krackhardt, Angela; Weide, Benjamin; Haferkamp, Sebastian; Kiecker, Felix; Izar, Ben; Garraway, Levi; Regev, Aviv; Flaherty, Keith; Paschen, Annette; Allen, Eliezer M. van; Schadendorf, Dirk
    Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma
    In: Nature Medicine Jg. 25 (2019) Nr. 12, S. 1916 - 1927
    ISSN: 1546-170X; 1078-8956
    Online Volltext: dx.doi.org/ (Open Access)
  • Ugurel, Selma; Spassova, Ivelina; Wohlfarth, Jonas; Drusio, Christina; Cherouny, Angela; Melior, Anita; Sucker, Antje; Zimmer, Lisa; Ritter, Cathrin; Schadendorf, Dirk; Becker, Jürgen
    MHC class-I downregulation in PD-1/PD-L1 inhibitor refractory Merkel cell carcinoma and its potential reversal by histone deacetylase inhibition : a case series
    In: Cancer Immunology, Immunotherapy Jg. 68 (2019) Nr. 6, S. 983 - 990
    ISSN: 0340-7004; 1432-0851
    Online Volltext: dx.doi.org/
  • Drusio, Christina; Becker, Jürgen; Schadendorf, Dirk; Ugurel, Selma
    Merkelzellkarzinom
    In: Best Practice Onkologie Jg. 14 (2019) Nr. 7/8, S. 312 - 323
    ISSN: 1862-8559; 0946-4565
    Online Volltext: dx.doi.org/
  • Drusio, Christina; Becker, Jürgen; Schadendorf, Dirk; Ugurel, Selma
    Merkelzellkarzinom
    In: Der Hautarzt Jg. 70 (2019) Nr. 3, S. 215 - 227
    ISSN: 1432-1173; 0017-8470
    Online Volltext: dx.doi.org/
  • Zaremba, Anne; Chorti, Eleftheria; Jockenhöfer, Finja; Bolz, Saskia; Sirin, Selma; Glas, Martin; Becker, Jürgen C.; Ugurel, Selma; Rösch, Alexander; Schadendorf, Dirk; Livingstone, Elisabeth; Hagenacker, Tim; Zimmer, Lisa
    Metastatic Merkel cell carcinoma and myasthenia gravis : contraindication for therapy with immune checkpoint inhibitors?
    In: Journal for ImmunoTherapy of Cancer Jg. 7 (2019) Nr. 1, S. 141
    ISSN: 2051-1426
    Online Volltext: dx.doi.org/ Online Volltext (Open Access)
  • Pylaeva, Ekaterina; Harati, Mozhgan Dehghan; Spyra, Ilona; Bordbari, Sharareh; Strachan, Sarah; Thakur, Basant Kumar; Höing, Benedikt; Franklin, Cindy; Skokowa, Julia; Welte, Karl; Schadendorf, Dirk; Bankfalvi, Agnes; Brandau, Sven; Lang, Stephan; Jablonska, Jadwiga
    NAMPT signaling is critical for the proangiogenic activity of tumor-associated neutrophils
    In: International Journal of Cancer Jg. 144 (2019) Nr. 1, S. 136 - 149
    ISSN: 0020-7136; 1097-0215
    Online Volltext: dx.doi.org/ (Open Access)
  • Urbonas, Vincas; Schadendorf, Dirk; Zimmer, Lisa; Danson, Sarah J.; Marshall, Ernest; Corrie, Pippa G.; Wheater, Matthew J.; Plummer, E.; Mauch, Cornelia; Scudder, Claire; Goff, Matthew; Love, Sharon B.; Mohammed, S.B.; Middleton, Mark R.
    Paclitaxel with or without trametinib or pazopanib in advanced wild-type BRAF melanoma (PACMEL) : a multicentre, open-label, randomised, controlled phase II trial
    In: Annals of Oncology Jg. 30 (2019) Nr. 2, S. 317 - 324
    ISSN: 1569-8041; 0923-7534
    Online Volltext: dx.doi.org/ (Open Access)
  • Hekler, Achim; Utikal, Jochen Sven; Enk, Alexander H.; Berking, Carola; Klode, Joachim; Schadendorf, Dirk; Jansen, Philipp; Franklin, Cindy; Holland-Letz, Tim; Krahl, Dieter; von Kalle, Christof; Fröhling, Stefan; Brinker, Titus Josef
    Pathologist-level classification of histopathological melanoma images with deep neural networks
    In: European Journal of Cancer Jg. 115 (2019) S. 79 - 83
    ISSN: 0959-8049
    Online Volltext: dx.doi.org/ (Open Access)
  • Schadendorf, Dirk; Hauschild, Axel; Santinami, Mario; Atkinson, Victoria; Mandalà, Mario; Chiarion-Sileni, Vanna; Larkin, James; Nyakas, Marta; Dutriaux, Caroline; Haydon, Andrew; Robert, Caroline; Mortier, Laurent; Lesimple, Thierry; Plummer, Ruth; Schachter, Jacob; Dasgupta, Kohinoor; Manson, Stephanie; Koruth, Roy; Mookerjee, Bijoyesh; Kefford, Richard; Dummer, Reinhard; Kirkwood, John M.; Long, Georgina V.
    Patient-reported outcomes in patients with resected, high-risk melanoma with BRAFV600E or BRAFV600K mutations treated with adjuvant dabrafenib plus trametinib (COMBI-AD) : a randomised, placebo-controlled, phase 3 trial
    In: The Lancet Oncology Jg. 20 (2019) Nr. 5, S. 701 - 710
    ISSN: 1474-5488
    Online Volltext: dx.doi.org/
  • Sondermann, Wiebke; Utikal, Jochen Sven; Enk, Alexander H.; Schadendorf, Dirk; Klode, Joachim; Hauschild, Axel; Weichenthal, Michael; French, Lars E.; Berking, Carola; Schilling, Bastian; Haferkamp, Sebastian; Fröhling, Stefan; Kalle, Christof von; Brinker, Titus J.
    Prediction of melanoma evolution in melanocytic nevi via artificial intelligence : A call for prospective data
    In: European Journal of Cancer Jg. 119 (2019) S. 30 - 34
    ISSN: 0964-1947; 0959-8049; 0277-5379; 1879-0852
    Online Volltext: dx.doi.org/ (Open Access)
  • Eggermont, Alexander M.M.; Blank, Christian U.; Mandala, Mario; Long, Georgina V.; Atkinson, Victoria G.; Dalle, Stéphane; Haydon, Andrew; Lichinitser, Mikhail; Khattak, Adnan; Carlino, Matteo S.; Sandhu, Shahneen; Larkin, James; Puig, Susana; Ascierto, Paolo A.; Rutkowski, Piotr; Schadendorf, Dirk; Koornstra, Rutger; Hernandez-Aya, Leonel; Di Giacomo, Anna Maria; van den Eertwegh, Alfonsus JM.; Grob, Jean-Jacques; Gutzmer, Ralf; Jamal, Rahima; Lorigan, Paul C.; Lupinacci, Robert; Krepler, Clemens; Ibrahim, Nageatte; Kicinski, Michal; Marreaud, Sandrine; van Akkooi, Alexander C.; Suciu, Stefan; Robert, Caroline
    Prognostic and predictive value of AJCC-8 staging in the phase III EORTC1325/KEYNOTE-054 trial of pembrolizumab vs placebo in resected high-risk stage III melanoma
    In: European Journal of Cancer Jg. 116 (2019) S. 148 - 157
    ISSN: 1879-0852; 0959-8049
    Online Volltext: dx.doi.org/
  • Viehof, Jan; Livingstone, Elisabeth; Loscha, Elena; Stockhammer, Paul; Bankfalvi, Agnes; Plönes, Till; Mardanzai, Khaled; Zimmer, Lisa; Sucker, Antje; Schadendorf, Dirk; Hegedüs, Balazs; Aigner, Clemens
    Prognostic factors for pulmonary metastasectomy in malignant melanoma : Size matters
    In: European Journal of Cardio-Thoracic Surgery Jg. 56 (2019) Nr. 6, S. 1104 - 1109
    ISSN: 1873-734X; 1010-7940; 1567-4258; 1878-3309
    Online Volltext: dx.doi.org/ (Open Access)
  • Schadendorf, Dirk; Melanoma GWAS Consortium
    Publisher Correction : Novel pleiotropic risk loci for melanoma and nevus density implicate multiple biological pathways
    In: Nature Communications Jg. 10 (2019) Nr. 1, S. 299
    ISSN: 2041-1723
    Online Volltext: dx.doi.org/ (Open Access)
  • Duffy, David L.; Zhu, Gu; Li, Xin; Sanna, Marianna; Jacobs, Leonie C.; Evans, David M.; Yazar, Seyhan; Beesley, Jonathan; Lawrence, Matthew H.; Kraft, Peter; Visconti, Alessia; Taylor, John C.; Lui, Fan; Wright, Margaret J.; Henders, Anjali K.; Bowdler, Lisa; Glass, Dan; Ikram, Arfan M.; Uitterlinden, André G.; Madden, Pamela A.; Heath, Andrew C.; Nelson, Elliot C.; Green, Adele C.; Chanock, Stephen; Barrett, Jennifer H.; Brown, Matthew A.; Hayward, Nicholas K.; MacGregor, Stuart; Sturm, Richard A.; Hewitt, Alex W.; Leenhardt, Jeffrey E.; Brossard, Myriam; Moses, Eric K.; Song, Fengju; Kumar, Rajiv; Easton, Douglas F.; Pharoah, Paul D. P.; Swerdlow, Anthony J.; Kypreou, Katerina P.; Harland, Mark; Randerson-Moor, Juliette; Akslen, Lars A.; Andresen, Per A.; Avril, Marie-Françoise; Azizi, Esther; Scarrà, Giovanna Bianchi; Brown, Kevin M.; Dębniak, Tadeusz; Elder, David E.; Fang, Shenying; Friedman, Eitan; Galan, Pilar; Ghiorzo, Paola; Gillanders, Elizabeth M.; Goldstein, Alisa M.; Gruis, Nelleke A.; Hansson, Johan; Helsing, Per; Hočevar, Marko; Höiom, Veronica; Ingvar, Christian; Kanetsky, Peter A.; Chen, Wei V.; Landi, Maria Teresa; Lang, Julie; Lathrop, G. Mark; Lubiński, Jan; Mackie, Rona M.; Mann, Graham J.; Molven, Anders; Novaković, Srdjan; Olsson, Håkan; Puig, Susana; Puig-Butille, Joan Anton; Radford-Smith, Graham L.; van Doorn, Remco; Whiteman, David C.; Craig, Jamie E.; Schadendorf, Dirk; Simms, Lisa A.; Burdon, Kathryn P.; Nyholt, Dale R.; Pooley, Karen A.; Orr, Nicholas; Stratigos, Alexander J.; Cust, Anne E.; Ward, Sarah V.; Schulze, Hans-Joachim; Dunning, Alison M.; Demenais, Florence; Amos, Christopher I.; Kayser, Manfred; Hunter, David J.; Newton Bishop, Julia A.; Spector, Timothy D.; Montgomery, Grant W.; Mackey, David A.; Smith, George Davey; Nijsten, Tamar E.; Bishop, D. Timothy; Bataille, Veronique; Falchi, Mario; Han, Jiali; Martin, Nicholas G.
    Publisher Correction: Novel pleiotropic risk loci for melanoma and nevus density implicate multiple biological pathways
    In: Nature Communications Jg. 10 (2019) Nr. 1, S. 299
    ISSN: 2041-1723
    Online Volltext: dx.doi.org/ (Open Access)
  • Taylor, Fiona; Regan, Meredith M.; Schadendorf, Dirk; Atkins, Michael B.; Lawrance, Rachael; Moreno-Koehler, Alejandro; Moshyk, Andriy; Rao, Sumati; Ritchings, Corey; KOTAPATI, SRIVIDYA; Lord-Bessen, Jennifer; Rizzo, Jasmine I.; McDermott, David F.; Middleton, Mark R.
    Quality of life (QoL) and symptom burden in patients (pts) with advanced melanoma during the treatment-free interval (TFI) after discontinuation of nivolumab (NIVO) or NIVO plus ipilimumab (IPI)
    In: Journal of Clinical Oncology Jg. 37 (2019) Nr. 15_Suppl, S. 9568
    ISSN: 0732-183X; 1527-7755
    Online Volltext: dx.doi.org/
  • Brütting, Julia; Reinhardt, Lydia; Bergmann, Maike; Schadendorf, Dirk; Weber, Christiane; Tilgen, Wolfgang; Berking, Carola; Meier, Friedegund
    Quality, Readability, and Understandability of German Booklets Addressing Melanoma Patients
    In: Journal of Cancer Education Jg. 34 (2019) Nr. 4, S. 760 - 767
    ISSN: 1543-0154; 0885-8195
    Online Volltext: dx.doi.org/
  • Long, Georgina V.; Dummer, Reinhard; Schadendorf, Dirk; Santinami, Mario; Atkinson, Victoria; Mandalà, Mario; Chiarion-Sileni, Vanna; Larkin, James; Nyakas, Marta; Dutriaux, Caroline; Haydon, Andrew; Robert, Caroline; Mortier, Laurent; Schachter, Jacob; Lesimple, Thierry; Plummer, Ruth; Dasgupta, Kohinoor; Haas, Tomas; Shilkrut, Mark; Gasal, Eduard; Kefford, Richard; Kirkwood, John M.; Hauschild, Axel
    Reply to E. Hindié and K.R. Hess
    In: Journal of Clinical Oncology (JCO) Jg. 37 (2019) Nr. 15, S. 1356 - 1358
    ISSN: 0732-183X; 1527-7755
    Online Volltext: dx.doi.org/ Online Volltext (Open Access)
  • Schadendorf, Dirk; Ascierto, Paolo A.; Haanen, John; Espinosa, Enrique; Demidov, Lev; Garbe, Claus; Guida, Michele; Lorigan, Paul; Chiarion-Sileni, Vanna; Gogas, Helen; Maio, Michele; Fierro, Maria Teresa; Hoeller, Christoph; Terheyden, Patrick; Gutzmer, Ralf; Guren, Tormod K.; Bafaloukos, Dimitrios; Rutkowski, Piotr; Plummer, Ruth; Waterston, Ashita; Kaatz, Martin; Mandala, Mario; Marquez-Rodas, Ivan; Muñoz-Couselo, Eva; Dummer, Reinhard; Grigoryeva, Elena; Young, Tina C.; Nathan, Paul
    Safety and efficacy of nivolumab in challenging subgroups with advanced melanoma who progressed on or after ipilimumab treatment : A single-arm, open-label, phase II study (CheckMate 172)
    In: European Journal of Cancer Jg. 121 (2019) S. 144 - 153
    ISSN: 0959-8049
    Online Volltext: dx.doi.org/
  • Nathan, Paul; Ascierto, Paolo A.; Haanen, John; Espinosa, Enrique; Demidov, Lev; Garbe, Claus; Guida, Michele; Lorigan, Paul; Chiarion-Sileni, Vanna; Gogas, Helen; Maio, Michele; Fierro, Maria Teresa; Hoeller, Christoph; Terheyden, Patrick; Gutzmer, Ralf; Guren, Tormod K.; Bafaloukos, Dimitrios; Rutkowski, Piotr; Plummer, Ruth; Waterston, Ashita; Kaatz, Martin; Mandala, Mario; Marquez-Rodas, Ivan; Muñoz-Couselo, Eva; Dummer, Reinhard; Grigoryeva, Elena; Young, Tina C.; Schadendorf, Dirk
    Safety and efficacy of nivolumab in patients with rare melanoma subtypes who progressed on or after ipilimumab treatment : a single-arm, open-label, phase II study (CheckMate 172)
    In: European Journal of Cancer Jg. 119 (2019) S. 168 - 178
    ISSN: 0959-8049
    Online Volltext: dx.doi.org/ (Open Access)
  • Weichenthal, Michael; Ugurel, Selma; Leiter, Ulrike M.; Satzger, Imke; Kähler, Katharina C.; Welzel, Julia; Pföhler, Claudia; Feldmann-Böddeker, Ingrid; Meier, Friedegund Elke; Terheyden, Patrick; Haferkamp, Sebastian; Herbst, Rudolf; Ulrich, Jens; Utikal, Jochen; Kreuter, Alexander; Gutzmer, Ralf; Schadendorf, Dirk; Mohr, Peter
    Salvage therapy after failure from anti-PD-1 single agent treatment : A Study by the German ADOReg melanoma registry
    In: Journal of Clinical Oncology Jg. 37 (2019) Nr. 15_Suppl, S. 9505
    ISSN: 0732-183X; 1527-7755
    Online Volltext: dx.doi.org/
  • Stoffels, Ingo; Herrmann, Ken; Rekowski, Jan; Jansen, Philipp; Schadendorf, Dirk; Stang, Andreas; Klode, Joachim
    Sentinel lymph node excision with or without preoperative hybrid single-photon emission computed tomography/computed tomography (SPECT/CT) in melanoma : Study protocol for a multicentric randomized controlled trial
    In: Trials Jg. 20 (2019) Nr. 1, S. 99
    ISSN: 1745-6215; 1468-6694; 1468-6708
    Online Volltext: dx.doi.org/ Online Volltext (Open Access)
  • Shannan, B.; Matschke, Johann; Chauvistré, Heike; Vogel, F.; Klein, Diana; Meier, Friedegund; Westphal, Dana; Bruns, Johannes; Rauschenberg, Ricarda; Utikal, Jochen; Forschner, Andrea; Berking, Carola; Terheyden, Patrick; Dabrowski, Evelyn; Gutzmer, Ralf; Rafei-Shamsabadi, David Ali; Meiss, Frank; Heinzerling, Lucie M.; Zimmer, Lisa; Livingstone, Elisabeth; Váraljai, Renáta; Hoewner, A.; Horn, Susanne; Klode, Joachim; Stuschke, Martin; Scheffler, Björn; Marchetto, Aruna; Sannino, Giuseppina; Grünewald, Thomas Georg Philipp; Schadendorf, Dirk; Jendrossek, Verena; Rösch, Alexander
    Sequence-dependent cross-resistance of combined radiotherapy plus BRAFV⁶⁰⁰E inhibition in melanoma
    In: European Journal of Cancer Jg. 109 (2019) S. 137 - 153
    ISSN: 1879-0852; 0959-8049
    Online Volltext: dx.doi.org/
  • Brütting, Julia; Bergmann, Maike; Schadendorf, Dirk; Weber, Christiane; Tilgen, Wolfgang; Berking, Carola; Meier, Friedegund; on behalf of the NVKH
    Sources of information and support for melanoma patients : differences between patients' and clinicians' preferences, Clinical letter
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Jg. 17 (2019) Nr. 6, S. 652 - 654
    ISSN: 1610-0387; 1563-2571; 1610-0379; 0301-0481
    Online Volltext: dx.doi.org/
  • Hekler, Achim; Utikal, Jochen S.; Enk, Alexander H.; Hauschild, Axel; Weichenthal, Michael; Maron, Roman C.; Berking, Carola; Haferkamp, Sebastian; Klode, Joachim; Schadendorf, Dirk; Schilling, Bastian; Holland-Letz, Tim; Izar, Benjamin; von Kalle, Christof; Fröhling, Stefan; Brinker, Titus J.; Schmitt, Laurenz; Peitsch, Wiebke K.; Hoffmann, Friederike; Becker, Jürgen; Drusio, Christina; Jansen, Philipp; Lodde, Georg; Sammet, Stefanie; Sondermann, Wiebke; Ugurel, Selma; Zader, Jeannine; Salzmann, Martin; Schäfer, Sarah; Schäkel, Knut; Winkler, Julia; Wölbing, Priscilla; Asper, Hiba; Bohne, Ann-Sophie; Brown, Victoria; Burba, Bianca; Deffaa, Sophia; Dietrich, Cecilia; Dietrich, Matthias; Drerup, Katharina Antonia; Egberts, Friederike; Erkens, Anna-Sophie; Greven, Salim; Harde, Viola; Jost, Marion; Kaeding, Merit; Kosova, Katharina; Lischner, Stephan; Maagk, Maria; Messinger, Anna Laetitia; Metzner, Malte; Motamedi, Rogina; Rosenthal, Ann-Christine; Seidl, Ulrich; Stemmermann, Jana; Torz, Kaspar; Velez, Juliana Giraldo; Haiduk, Jennifer; Alter, Mareike; Bär, Claudia; Bergenthal, Paul; Gerlach, Anne; Holtorf, Christian; Karoglan, Ante; Kindermann, Sophie; Kraas, Luise; Felcht, Moritz; Gaiser, Maria R.; Klemke, Claus-Detlev; Kurzen, Hjalmar; Leibing, Thomas; Müller, Verena; Reinhard, Raphael R.; Winter, Franziska; Eicher, Laurie; Hartmann, Daniela; Heppt, Markus; Kilian, Katharina; Krammer, Sebastian; Lill, Diana; Niesert, Anne-Charlotte; Oppel, Eva; Sattler, Elke; Senner, Sonja; Wallmichrath, Jens; Wolff, Hans; Gesierich, Anja; Giner, Tina; Glutsch, Valerie; Kerstan, Andreas; Presser, Dagmar; Schrüfer, Philipp; Schummer, Patrick; Stolze, Ina; Weber, Judith; Drexler, Konstantin; Mickler, Marion; Stauner, Camila Toledo; Thiem, Alexander
    Superior skin cancer classification by the combination of human and artificial intelligence
    In: European Journal of Cancer Jg. 120 (2019) S. 114 - 121
    ISSN: 0959-8049
    Online Volltext: dx.doi.org/ (Open Access)
  • Ascierto, Paolo A.; Long, Georgina V.; Robert, Caroline; Brady, Benjamin; Dutriaux, Caroline; Di Giacomo, Anna Maria; Mortier, Laurent; Hassel, Jessica C.; Rutkowski, Piotr; McNeil, Catriona; Kalinka-Warzocha, Ewa; Savage, Kerry J.; Hernberg, Micaela M.; Lebbé, Celeste; Charles, Julie; Mihalcioiu, Catalin; Chiarion-Sileni, Vanna; Mauch, Cornelia; Cognetti, Francesco; Ny, Lars; Arance, Ana; Svane, Inge Marie; Schadendorf, Dirk; Gogas, Helen; Saci, Abdel; Jiang, Joel; Rizzo, Jasmine; Atkinson, Victoria
    Survival Outcomes in Patients with Previously Untreated BRAF Wild-Type Advanced Melanoma Treated with Nivolumab Therapy : Three-Year Follow-up of a Randomized Phase 3 Trial
    In: JAMA Oncology Jg. 5 (2019) Nr. 2, S. 187 - 194
    ISSN: 2374-2445; 2374-2437
    Online Volltext: dx.doi.org/ (Open Access)
  • Jacquelot, Nicolas; Yamazaki, Takahiro; Roberti, Maria P.; Duong, Connie P. M.; Andrews, Miles C.; Verlingue, Loic; Ferrere, Gladys; Becharef, Sonia; Vétizou, Marie; Daillère, Romain; Messaoudene, Meriem; Enot, David P.; Stoll, Gautier; Ugel, Stefano; Marigo, Ilaria; Foong Ngiow, Shin; Marabelle, Aurélien; Prevost-Blondel, Armelle; Gaudreau, Pierre-Olivier; Gopalakrishnan, Vancheswaran; Eggermont, Alexander M.; Opolon, Paule; Klein, Christophe; Madonna, Gabriele; Ascierto, Paolo A.; Sucker, Antje; Schadendorf, Dirk; Smyth, Mark J.; Soria, Jean-Charles; Kroemer, Guido; Bronte, Vincenzo; Wargo, Jennifer; Zitvogel, Laurence
    Sustained Type I interferon signaling as a mechanism of resistance to PD-1 blockade
    In: Cell Research Jg. 29 (2019) Nr. 10, S. 846 - 861
    ISSN: 1748-7838; 1001-0602
    Online Volltext: dx.doi.org/ (Open Access)
  • Maron, Roman C.; Weichenthal, Michael; Utikal, Jochen S.; Hekler, A.; Berking, Carola; Hauschild, Axel; Enk, Alexander H.; Haferkamp, Sebastian; Klode, Joachim; Schadendorf, Dirk; Jansen, Philipp; Holland-Letz, Tim; Schilling, Bastian; von Kalle, Christof; Fröhling, Stefan; Gaiser, Maria R.; Hartmann, Daniela; Gesierich, Anja; Kähler, Katharina C.; Wehkamp, Ulrike; Karoglan, Ante; Bär, Claudia; Brinker, Titus J.; Schmitt, Laurenz; Peitsch, Wiebke K.; Hoffmann, Friederike; Becker, Jürgen; Drusio, Christina; Lodde, G.; Sammet, Stefanie; Sondermann, Wiebke; Ugurel, Selma; Zader, Jeannine; Salzmann, Martin; Schäfer, S.; Schäkel, Knut; Winkler, J.; Wölbing, Priscilla; Asper, Hiba; Bohne, Ann-Sophie; Brown, Victoria; Burba, Bianca; Deffaa, Sophia; Dietrich, Cecilia; Dietrich, Matthias; Drerup, Katharina Antonia; Egberts, Friederike; Erkens, Anna-Sophie; Greven, S.; Harde, V.; Jost, Marion; Kaeding, M.; Kosova, Katharina; Lischner, Stephan; Maagk, M.; Messinger, Anna Laetitia; Metzner, M.; Motamedi, Rogina; Rosenthal, Ann-Christine; Seidl, Ulrich; Stemmermann, Jana; Torz, Kaspar; Velez, Juliana Giraldo; Haiduk, Jennifer; Alter, Mareike; Bergenthal, Paul; Gerlach, Anne; Holtorf, Christian; Kindermann, Sophie; Kraas, L.; Felcht, Moritz; Klemke, Claus-Detlev; Kurzen, Hjalmar; Leibing, Thomas; Müller, Verena; Reinhard, Raphael R.; Winter, Franziska; Eicher, Laurie; Heppt, Markus; Kilian, Katharina; Krammer, Sebastian; Lill, D.; Niesert, Anne-Charlotte; Oppel, Eva; Sattler, Elke; Senner, S.; Wallmichrath, Jens; Wolff, Hans; Giner, Tina; Glutsch, Valerie; Kerstan, Andreas; Presser, Dagmar; Schrüfer, Philipp; Schummer, Patrick; Stolze, Ina; Weber, Judith; Drexler, Konstantin; Mickler, Marion; Stauner, Camila Toledo; Thiem, Alexander
    Systematic outperformance of 112 dermatologists in multiclass skin cancer image classification by convolutional neural networks
    In: European Journal of Cancer Jg. 119 (2019) S. 57 - 65
    ISSN: 0959-8049
    Online Volltext: dx.doi.org/ (Open Access)
  • Vogel, Felix C. E.; Bordag, Natalie; Zügner, E.; Trajkovic-Arsic, Marija; Chauvistré, Heike; Shannan, Batool; Váraljai, Renáta; Horn, Susanne; Magnes, Christoph; Siveke, Jens; Schadendorf, Dirk; Rösch, Alexander
    Targeting the H3K4 Demethylase KDM5B Reprograms the Metabolome and Phenotype of Melanoma Cells
    In: The Journal of Investigative Dermatology Jg. 139 (2019) Nr. 12, S. 2506 - 2516.e10
    ISSN: 1523-1747; 0022-202X
    Online Volltext: dx.doi.org/ (Open Access)
  • Phung, Bengt; Cieśla, Maciej; Sanna, Adriana; Guzzi, Nicola; Beneventi, Giulia; Cao Thi Ngoc, Phuong; Lauss, Martin; Cabrita, Rita; Cordero, Eugenia; Bosch, Ana; Rosengren, Frida; Häkkinen, Jari; Griewank, Klaus; Paschen, Annette; Harbst, Katja; Olsson, Håkan; Ingvar, Christian; Carneiro, Ana; Tsao, Hensin; Schadendorf, Dirk; Pietras, Kristian; Bellodi, Cristian; Jönsson, Göran
    The X-Linked DDX3X RNA Helicase Dictates Translation Reprogramming and Metastasis in Melanoma
    In: Cell Reports Jg. 27 (2019) Nr. 12, S. 3573 - 3586.e7
    ISSN: 2211-1247
    Online Volltext: dx.doi.org/ (Open Access)
  • Jansen, Philipp; Petri, Maximilian; Merz, Simon F.; Brinker, Titus J.; Schadendorf, Dirk; Stang, Andreas; Stoffels, Ingo; Klode, Joachim
    The prognostic value of sentinel lymph nodes on distant metastasis–free survival in patients with high-risk squamous cell carcinoma
    In: European Journal of Cancer Jg. 111 (2019) S. 107 - 115
    ISSN: 1879-0852; 0959-8049
    Online Volltext: dx.doi.org/
  • Schadendorf, Dirk; Livingstone, Elisabeth; Zimmer, Lisa
    Treatment in metastatic melanoma : Time to re-think
    In: Annals of Oncology Jg. 30 (2019) Nr. 4, S. 501 - 503
    ISSN: 0923-7534; 1569-8041
    Online Volltext: dx.doi.org/ (Open Access)
  • Wagner, Nikolaus B.; Weide, Benjamin; Gries, Mirko; Reith, Maike; Tarnanidis, Kathrin; Schuermans, Valerie; Kemper, Charlotte; Kehrel, Coretta; Funder, Anne; Lichtenberger, Ramtin; Sucker, Antje; Herpel, Esther; Holland-Letz, Tim; Schadendorf, Dirk; Garbe, Claus; Umansky, Viktor; Utikal, Jochen; Gebhardt, Christoffer
    Tumor microenvironment-derived S100A8/A9 is a novel prognostic biomarker for advanced melanoma patients and during immunotherapy with anti-PD-1 antibodies
    In: Journal for ImmunoTherapy of Cancer Jg. 7 (2019) Nr. 1, S. 343
    ISSN: 2051-1426
    Online Volltext: dx.doi.org/ (Open Access)
  • Brütting, Julia; Bergmann, Maike; Garzarolli, Marlene; Rauschenberg, Ricarda; Weber, Christiane; Berking, Carola; Tilgen, Wolfgang; Schadendorf, Dirk; Meier, Friedegund
    Unmet information needs of patients with melanoma in Germany
    In: Melanoma Research Jg. 29 (2019) Nr. 2, S. 196 - 204
    ISSN: 0960-8931; 1473-5636
    Online Volltext: dx.doi.org/
  • Varaljai, R.; Wistuba-Hamprecht, K.; Seremet, T.; Diaz, JMS; Nsengimana, J.; Sucker, A.; Griewank, Klaus; Horn, Peter; von Neuhoff, N.; Shannan, B.; Chauvistre, H.; Vogel, FCE; Horn, S.; Becker, J. C.; Newton-Bishop, J.; Stang, Andreas; Neyns, B.; Weide, B.; Schadendorf, Dirk; Rösch, Alexander
    ctDNA as a noninvasive monitoring tool in metastatic melanoma
    In: Journal of Clinical Oncology Jg. 37 (2019) Nr. Suppl. 15, S. 9548
    ISSN: 0732-183X; 1527-7755
    Online Volltext: dx.doi.org/
  • Jerby-Arnon, Livnat; Shah, Parin; Cuoco, Michael S.; Rodman, Christopher; Su, Mei-Ju; Melms, Johannes C.; Leeson, Rachel; Kanodia, Abhay; Mei, Shaolin; Lin, Jia-Ren; Wang, Shu; Rabasha, Bokang; Liu, David; Zhang, Gao; Margolais, Claire; Ashenberg, Orr; Ott, Patrick A.; Buchbinder, Elizabeth I.; Haq, Rizwan; Hodi, F. Stephen; Boland, Genevieve M.; Sullivan, Ryan J.; Frederick, Dennie T.; Miao, Benchun; Moll, Tabea; Flaherty, Keith T.; Herlyn, Meenhard; Jenkins, Russell W.; Thummalapalli, Rohit; Kowalczyk, Monika S.; Cañadas, Israel; Schilling, Bastian; Cartwright, Adam N.R.; Luoma, Adrienne M.; Malu, Shruti; Hwu, Patrick; Bernatchez, Chantale; Forget, Marie-Andrée; Barbie, David A.; Shalek, Alex K.; Tirosh, Itay; Sorger, Peter K.; Wucherpfennig, Kai; Van Allen, Eliezer M.; Schadendorf, Dirk; Johnson, Bruce E.; Rotem, Asaf; Rozenblatt-Rosen, Orit; Garraway, Levi A.; Yoon, Charles H.; Izar, Benjamin; Regev, Aviv
    A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade
    In: Cell Jg. 175 (2018) Nr. 4, S. 984 - 997.e24
    ISSN: 1097-4172; 0092-8674
    Online Volltext: dx.doi.org/ (Open Access)
  • Brinker, Titus Josef; Brieske, Christian Martin; Esser, Stefan; Klode, Joachim; Mons, Ute; Batra, Anil; Rüther, Tobias; Seeger, Werner; Enk, Alexander H.; von Kalle, Christof; Berking, Carola; Heppt, Markus V.; Gatzka, Martina V.; Bernardes-Souza, Breno; Schlenk, Richard F.; Schadendorf, Dirk
    A Face-Aging App for Smoking Cessation in a Waiting Room Setting : Pilot Study in an HIV Outpatient Clinic
    In: Journal of Medical Internet Research Jg. 20 (2018) Nr. 8, S. e10976
    ISSN: 1439-4456; 1438-8871
    Online Volltext: dx.doi.org/ (Open Access)
  • D’Angelo, Sandra P.; Hamid, Omid A.; Tarhini, Ahmad; Schadendorf, Dirk; Chmielowski, Bartosz; Collichio, Frances A.; Pavlick, Anna C.; Lewis, Karl D.; Weil, Susan C.; Heyburn, John; Schweizer, Charles; O’Shannessy, Daniel J.; Carvajal, Richard D.
    A phase 2 study of ontuxizumab, a monoclonal antibody targeting endosialin, in metastatic melanoma
    In: Investigational New Drugs: The Journal of New Anticancer Agents Jg. 36 (2018) Nr. 1, S. 103 - 113
    ISSN: 1573-0646; 0167-6997
    Online Volltext: dx.doi.org/ Online Volltext (Open Access)
  • Brinker, Titus Josef; Heckl, Marlene; Gatzka, Martina; Heppt, Markus V.; Rodrigues, Henrique Resende; Schneider, Sven; Sondermann, Wiebke; E Silva, Carolina de Almeida; Kirchberger, Michael C.; Klode, Joachim; Enk, Alexander H.; Knispel, Sarah; von Kalle, Christof; Stoffels, Ingo; Schadendorf, Dirk; Nakamura, Yasuhiro; Esser, Stefan; Assis, Aisllan; Bernardes-Souza, Breno
    A skin cancer prevention facial-aging mobile app for secondary schools in Brazil : Appearance-focused interventional study
    In: JMIR mhealth and uhealth Jg. 6 (2018) Nr. 3,
    ISSN: 2291-5222
    Online Volltext: dx.doi.org/ (Open Access)
  • Brinker, Titus Josef; Faria, Bianca Lisa; Gatzka, Martina; de Faria, Olber Moreira; Heppt, Markus V.; Kirchberger, Michael C.; Schadendorf, Dirk; Nakamura, Yasuhiro; Buslaff, Fabian; Lisboa, Oscar Campos; Oliveira, Ana Carla Cruz; Lino, Henrique Augusto; Bernardes-Souza, Breno
    A skin cancer prevention photoageing intervention for secondary schools in Brazil delivered by medical students : protocol for a randomised controlled trial
    In: BMJ Open Jg. 8 (2018) Nr. 3, S. e018299
    ISSN: 2053-3624; 2044-6055
    Online Volltext: dx.doi.org/ (Open Access)
  • Wirtz, M.; Stoffels, Ingo; Dissemond, Joachim; Schadendorf, Dirk; Rösch, Alexander
    Actinic keratoses treated with cold atmospheric plasma
    In: Journal of the European Academy of Dermatology and Venereology Jg. 32 (2018) Nr. 1, S. e37 - e39
    ISSN: 0926-9959; 1468-3083
    Online Volltext: dx.doi.org/
  • Grob, Jean Jacques; Garbe, Claus; Ascierto, Paolo; Larkin, James; Dummer, Reinhard; Schadendorf, Dirk
    Adjuvant melanoma therapy with new drugs : should physicians continue to focus on metastatic disease or use it earlier in primary melanoma?
    In: The Lancet Oncology Jg. 19 (2018) Nr. 12, S. e720 - e725
    ISSN: 1470-2045; 1474-5488
    Online Volltext: dx.doi.org/
  • Eggermont, Alexander M.M.; Blank, Christian U.; Mandala, Mario; Long, Georgina V.; Atkinson, Victoria; Dalle, Stéphane; Haydon, Andrew; Lichinitser, Mikhail; Khattak, Adnan; Carlino, Matteo S.; Sandhu, Shahneen; Larkin, James; Puig, Susana; Ascierto, Paolo A.; Rutkowski, Piotr; Schadendorf, Dirk; Koornstra, Rutger; Hernandez-Aya, Leonel; Maio, Michele; Van Den Eertwegh, Alfonsus J. M.; Grob, Jean-Jacques; Gutzmer, Ralf; Jamal, Rahima; Lorigan, Paul; Ibrahim, Nageatte; Marreaud, Sandrine; Van Akkooi, Alexander C. J.; Suciu, Stefan; Robert, Caroline
    Adjuvant pembrolizumab versus placebo in resected stage III melanoma
    In: The New England Journal of Medicine Jg. 378 (2018) Nr. 19, S. 1789 - 1801
    ISSN: 1533-4406; 0028-4793
    Online Volltext: dx.doi.org/ Online Volltext (Open Access)
  • Maio, Michele; Lewis, Karl; Demidov, Lev; Mandalà, Mario; Bondarenko, Igor; Ascierto, Paolo A; Herbert, Christopher; Mackiewicz, Andrzej; Rutkowski, Piotr; Guminski, Alexander; Goodman, Grant R; Simmons, Brian; Ye, Chenglin; Yan, Yibing; Schadendorf, Dirk; BRIM8 Investigators
    Adjuvant vemurafenib in resected, BRAF mutation-positive melanoma (BRIM8) : a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial
    In: The Lancet Oncology Jg. 19 (2018) Nr. 4, S. 510 - 520
    ISSN: 1470-2045; 1474-5488
    Online Volltext: dx.doi.org/
  • Hillen, Uwe; Leiter, Ulrike; Haase, Sylvie; Kaufmann, Roland; Becker, Jürgen; Gutzmer, Ralf; Terheyden, Patrick; Krause-Bergmann, Albrecht; Schulze, Hans-Joachim; Hassel, Jessica; Lahner, Nina; Wollina, Uwe; Ziller, Fabian; Utikal, Jochen; Hafner, Christine; Ulrich, Jens; Machens, Hans-Günther; Weishaupt, Carsten; Hauschild, Axel; Mohr, Peter; Pföhler, Claudia; Maurer, Jan; Wolff, Patrick; Windemuth-Kieselbach, Christine; Schadendorf, Dirk; Livingstone, Elisabeth; Dermatologic Cooperative Oncology Group (DeCOG)
    Advanced cutaneous squamous cell carcinoma : A retrospective analysis of patient profiles and treatment patterns-Results of a non-interventional study of the DeCOG
    In: European Journal of Cancer Jg. 96 (2018) S. 34 - 43
    ISSN: 1879-2995; 0959-8049
    Online Volltext: dx.doi.org/
  • Atkinson, Victoria G.; Hauschild, Axel; Santinami, Mario; Mandala, Mario; Chiarion Sileni, Vanna; Larkin, James M. G.; Nyakas, Marta S.; Dutriaux, Caroline; Haydon, Andrew M. M.; Mortier, Laurent; Robert, Caroline; Schachter, Jacob M.; Schadendorf, Dirk; Feng, X.; Jong, Egbert de; Mookerjee, Bijoyesh P.; Kefford, Rick F.; Dummer, Reinhard G.; Kirkwood, John M.; Long, Georgina V.
    Adverse events (AEs) over time in patients (pts) treated with adjuvant dabrafenib plus trametinib (D + T) or placebo (Pbo) in the COMBI-AD trial
    In: Annals of Oncology Jg. 29 (2018) Nr. Suppl. 8, S. viii446
    ISSN: 0923-7534; 1569-8041
    Online Volltext: dx.doi.org/ (Open Access)
  • Gogas, Helen; Dummer, Reinhard; Ascierto, Paolo Antonio; Arance, Ana M.; Mandalà, Mario; Liszkay, Gabriella; Garbe, Claus; Schadendorf, Dirk; Krajsova, Ivana; Gutzmer, Ralf; Chiarion-Sileni, Vanna; Dutriaux, Caroline; de Groot, Jan Willem; Yamazaki, Naoya; Loquai, Carmen; de Parseval, Laure A.; Pickard, Michael D.; Gollerkeri, Ashwin; Robert, Caroline; Flaherty, Keith
    Adverse events of special interest in the phase 3 COLUMBUS study
    In: Journal of Clinical Oncology (JCO) Jg. 36 (2018) Nr. Suppl. 15, S. 9567 - 9567
    ISSN: 0732-183X; 1527-7755
    Online Volltext: dx.doi.org/
  • Kugel, Curtis H.; Douglass, Stephen M.; Webster, Marie R.; Kaur, Amanpreet; Liu, Qin; Yin, Xiangfan; Weiss, Sarah A.; Darvishian, Farbod; Al-Rohil, Rami N.; Ndoye, Abibatou; Behera, Reeti; Alicea, Gretchen M.; Ecker, Brett L.; Fane, Mitchell; Allegrezza, Michael J.; Svoronos, Nikolaos; Kumar, Vinit; Wang, Daniel Y.; Somasundaram, Rajasekharan; Hu-Lieskovan, Siwen; Ozgun, Alpaslan; Herlyn, Meenhard; Conejo-Garcia, Jose R.; Gabrilovich, Dmitry; Stone, Erica L.; Nowicki, Theodore S.; Sosman, Jeffrey; Rai, Rajat; Carlino, Matteo S.; Long, Georgina V.; Marais, Richard; Ribas, Antoni; Eroglu, Zeynep; Davies, Michael A.; Schilling, Bastian; Schadendorf, Dirk; Xu, Wei; Amaravadi, Ravi K.; Menzies, Alexander M.; McQuade, Jennifer L.; Johnson, Douglas B.; Osman, Iman; Weeraratna, Ashani T.
    Age correlates with response to anti-PD1, reflecting age-related differences in intratumoral effector and regulatory T-Cell populations
    In: Clinical Cancer Research Jg. 24 (2018) Nr. 21, S. 5347 - 5356
    ISSN: 1078-0432; 1557-3265
    Online Volltext: dx.doi.org/ Online Volltext (Open Access)
  • McQuade, Jennifer L; Daniel, Carrie R; Hess, Kenneth R; Mak, Carmen; Wang, Daniel Y; Rai, Rajat R; Park, John J; Haydu, Lauren E; Spencer, Christine; Wongchenko, Matthew; Lane, Stephen; Lee, Dung-Yang; Kaper, Mathilde; McKean, Meredith; Beckermann, Kathryn E; Rubinstein, Samuel M; Rooney, Isabelle; Musib, Luna; Budha, Nageshwar; Hsu, Jessie; Nowicki, Theodore S; Avila, Alexandre; Haas, Tomas; Puligandla, Maneka; Lee, Sandra; Fang, Shenying; Wargo, Jennifer A; Gershenwald, Jeffrey E; Lee, Jeffrey E; Hwu, Patrick; Chapman, Paul B; Sosman, Jeffrey A; Schadendorf, Dirk; Grob, Jean-Jacques; Flaherty, Keith T; Walker, Dana; Yan, Yibing; McKenna, Edward; Legos, Jeffrey J; Carlino, Matteo S; Ribas, Antoni; Kirkwood, John M; Long, Georgina V; Johnson, Douglas B; Menzies, Alexander M; Davies, Michael A
    Association of body-mass index and outcomes in patients with metastatic melanoma treated with targeted therapy, immunotherapy, or chemotherapy : a retrospective, multicohort analysis
    In: The Lancet Oncology Jg. 19 (2018) Nr. 3, S. 310 - 322
    ISSN: 1470-2045
    Online Volltext: dx.doi.org/ Online Volltext (Open Access)
  • Griewank, Klaus; Wiesner, Thomas; Murali, Rajmohan; Pischler, Carina; Müller, Hansgeorg; Koelsche, Christian; Möller, Inga; Franklin, Cindy; Cosgarea, Ioana; Sucker, Antje; Schadendorf, Dirk; Schaller, Jörg; Horn, Susanne; Brenn, Thomas; Mentzel, Thomas
    Atypical fibroxanthoma and pleomorphic dermal sarcoma harbor frequent NOTCH1/2 and FAT1 mutations and similar DNA copy number alteration profiles
    In: Modern Pathology Jg. 31 (2018) Nr. 3, S. 418 - 428
    ISSN: 1530-0285; 0893-3952
    Online Volltext: dx.doi.org/ Online Volltext (Open Access)
  • Schaarschmidt, Benedikt Michael; Grueneisen, Johannes; Stebner, Vanessa; Klode, Joachim; Stoffels, Ingo; Umutlu, Lale; Schadendorf, Dirk; Heusch, Philipp; Antoch, Gerald; Pöppel, Thorsten
    Can integrated 18F-FDG PET/MR replace sentinel lymph node resection in malignant melanoma?
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 45 (2018) Nr. 12, S. 2093 - 2102
    ISSN: 1619-7089; 1619-7070
    Online Volltext: dx.doi.org/
  • Shukla, Sachet A.; Bachireddy, Pavan; Schilling, Bastian; Galonska, Christina; Zhan, Qian; Bango, Clyde; Langer, Rupert; Lee, Patrick C.; Gusenleitner, Daniel; Keskin, Derin B.; Babadi, Mehrtash; Mohammad, Arman; Gnirke, Andreas; Clement, Kendell; Cartun, Zachary J.; Van Allen, Eliezer M.; Miao, Diana; Huang, Ying; Snyder, Alexandra; Merghoub, Taha; Wolchok, Jedd D.; Garraway, Levi A.; Meissner, Alexander; Weber, Jeffrey S.; Hacohen, Nir; Neuberg, Donna; Potts, Patrick R.; Murphy, George F.; Lian, Christine G.; Schadendorf, Dirk; Hodi, F. Stephen; Wu, Catherine J.
    Cancer-Germline Antigen Expression Discriminates Clinical Outcome to CTLA-4 Blockade
    In: Cell Jg. 173 (2018) Nr. 3, S. 624 - 633.e8
    ISSN: 1097-4172; 0092-8674
    Online Volltext: dx.doi.org/ Online Volltext (Open Access)
  • Totzeck, Matthias; Mincu, Raluca-Ileana; Mrotzek, Simone; Schadendorf, Dirk; Rassaf, Tienush
    Cardiovascular diseases in patients receiving small molecules with anti-vascular endothelial growth factor activity : A meta-analysis of approximately 29,000 cancer patients
    In: European Journal of Preventive Cardiology Jg. 25 (2018) Nr. 5, S. 482 - 494
    ISSN: 2047-4881; 2047-4873
    Online Volltext: dx.doi.org/
  • Fan, Kaiji; Ritter, Cathrin; Nghiem, Paul; Blom, Astrid; Verhaegen, Monique E.; Dlugosz, Andrzej; Ødum, Niels; Woetmann, Anders; Tothill, Richard W.; Hicks, Rodney J.; Sand, Michael; Schrama, David; Schadendorf, Dirk; Ugurel, Selma; Becker, Jürgen C.
    Circulating cell-free miR-375 as surrogate marker of tumor burden in Merkel cell carcinoma
    In: Clinical Cancer Research Jg. 24 (2018) Nr. 23, S. 5873 - 5882
    ISSN: 1078-0432; 1557-3265
    Online Volltext: dx.doi.org/ Online Volltext (Open Access)
  • Hecht, Markus; Meier, Friedegund; Zimmer, Lisa; Polat, Bülent; Loquai, Carmen; Weishaupt, Carsten; Forschner, Andrea; Gutzmer, Ralf; Utikal, Jochen S.; Goldinger, Simone M.; Geier, Michael; Hassel, Jessica C.; Balermpas, Panagiotis; Kiecker, Felix; Rauschenberg, Ricarda; Dietrich, Ursula; Clemens, Patrick; Berking, Carola; Grabenbauer, Gerhard; Schadendorf, Dirk; Grabbe, Stephan; Schuler, Gerold; Fietkau, Rainer; Distel, Luitpold V.; Heinzerling, Lucie
    Clinical outcome of concomitant vs interrupted BRAF inhibitor therapy during radiotherapy in melanoma patients
    In: British Journal of Cancer (BJC) Jg. 118 (2018) Nr. 6, S. 785 - 792
    ISSN: 1532-1827; 0007-0920
    Online Volltext: dx.doi.org/ (Open Access)
  • Valpione, Sara; Carlino, Matteo S.; Mangana, Johanna; Mooradian, Meghan J.; McArthur, Grant; Schadendorf, Dirk; Hauschild, Axel; Menzies, Alexander M.; Arance, Ana; Ascierto, Paolo A.; Giacomo, AnnaMaria Di; de Rosa, Francesco; Larkin, James; Park, John J.; Goldinger, Simone M.; Sullivan, Ryan J.; Xu, Wen; Livingstone, Elisabeth; Weichenthal, Michael; Rai, Rajat; Gaba, Lydia; Long, Georgina V.; Lorigan, Paul
    Corrigendum to “Rechallenge with BRAF-directed treatment in metastatic melanoma : A multi-institutional retrospective study*” [Eur J Cancer 91 (2018) 116–124]
    In: European Journal of Cancer Jg. 93 (2018) S. 158
    ISSN: 1879-2995; 0959-8049
    Online Volltext: dx.doi.org/ (Open Access)
  • Olischewsky, Alexandra; De Schrijver, Sofie; Bankfalvi, Agnes; Wetter, Axel; Zimmer, Lisa; Livingstone, Elisabeth; Schadendorf, Dirk; Ugurel, Selma
    Dose-dependent toxicity of ipilimumab in metastatic melanoma
    In: European Journal of Cancer Jg. 95 (2018) S. 104 - 108
    ISSN: 1879-2995; 0959-8049
    Online Volltext: dx.doi.org/
  • Schadendorf, Dirk; Hauschild, Axel; Santinami, Mario; Atkinson, Victoria; Mandalà, Mario; Chiarion-Sileni, Vanna; Larkin, James M. G.; Nyakas, Marta; Dutriaux, Caroline; Haydon, Andrew; Mortier, Laurent; Robert, Caroline; Schachter, Jacob; Ji, Ran; Aimone, Paola; Manson, Stephanie; Kefford, Richard; Dummer, Reinhard; Kirkwood, John M.; Long, Georgina V.
    Effect on health-related quality of life (HRQOL) of adjuvant treatment (tx) with dabrafenib plus trametinib (D + T) in patients (pts) with resected stage III BRAF-mutant melanoma.
    In: Journal of Clinical Oncology (JCO) Jg. 36 (2018) Nr. Suppl. 15, S. 9590 - 9590
    ISSN: 0732-183X; 1527-7755
    Online Volltext: dx.doi.org/
  • Grob, Jean Jacques; Schadendorf, Dirk; Lorigan, Paul; Ascierto, Paolo; Larkin, James; Nathan, Paul; Robert, Caroline; Hauschild, Axel; Weber, Jeffrey; Daud, Adil; Hamid, Omid; Dummer, Reinhard; Hansson, Johan; Hoeller, Christoph; Schachter, Jacob; Van Akkooi, Alexander C. J.; Garbe, Claus
    Eighth American Joint Committee on Cancer (AJCC) melanoma classification : Let us reconsider stage III
    In: European Journal of Cancer Jg. 91 (2018) S. 168 - 170
    ISSN: 0959-8049; 1879-0852
    Online Volltext: dx.doi.org/
  • Dummer, Reinhard; Ascierto, Paolo A; Gogas, Helen J; Arance, Ana; Mandala, Mario; Liszkay, Gabriella; Garbe, Claus; Schadendorf, Dirk; Krajsova, Ivana; Gutzmer, Ralf; Chiarion-Sileni, Vanna; Dutriaux, Caroline; de Groot, Jan Willem B; Yamazaki, Naoya; Loquai, Carmen; Moutouh-de Parseval, Laure A; Pickard, Michael D; Sandor, Victor; Robert, Caroline; Flaherty, Keith T
    Encorafenib plus binimetinib versus vemurafenib or encorafenib in patients with BRAF-mutant melanoma (COLUMBUS) : a multicentre, open-label, randomised phase 3 trial
    In: The Lancet Oncology Jg. 19 (2018) Nr. 5, S. 603 - 615
    ISSN: 1470-2045; 1474-5488
    Online Volltext: dx.doi.org/; Online Volltext: dx.doi.org/ (Open Access)
  • Dummer, Reinhard G.; Schadendorf, Dirk; Hauschild, Axel; Santinami, Mario; Atkinson, Victoria G.; Mandala, Mario; Chiarion Sileni, Vanna; Larkin, James M. G.; Nyakas, Marta S.; Dutriaux, Caroline; Haydon, Andrew M. M.; Mortier, Laurent; Robert, Caroline; Schachter, Jacob M.; Feng, X.; Jong, Egbert de; Mookerjee, Bijoyesh P.; Kefford, Rick F.; Kirkwood, John M.; Long, Georgina V.
    Estimate of long-term relapse-free survival (RFS) and analysis of baseline factors associated with RFS in the COMBI-AD trial
    In: Annals of Oncology Jg. 29 (2018) Nr. Suppl. 8, S. viii445
    ISSN: 0923-7534; 1569-8041
    Online Volltext: dx.doi.org/ (Open Access)
  • Pieper, Natalia; Zaremba, Anne; Leonardelli, Sonia; Harbers, Franziska Noelle; Schwamborn, Marion; Lübcke, Silke; Schrörs, Barbara; Baingo, Jolanthe; Schramm, Alexander; Haferkamp, Sebastian; Seifert, Ulrike; Sucker, Antje; Lennerz, Volker; Wölfel, Thomas; Schadendorf, Dirk; Schilling, Bastian; Paschen, Annette; Zhao, Fang
    Evolution of melanoma cross-resistance to CD8⁺ T cells and MAPK inhibition in the course of BRAFi treatment
    In: OncoImmunology Jg. 7 (2018) Nr. 8,
    ISSN: 2162-402X; 2162-4011
    Online Volltext: dx.doi.org/ Online Volltext (Open Access)
  • Schaarschmidt, B. M.; Grueneisen, J.; Stebner, Vanessa; Klode, Joachim; Stoffels, Ingo; Umutlu, Lale; Schadendorf, Dirk; Heusch, P.; Antoch, G.; Pöppel, Thorsten
    F-18-FDG PET/MR including DWI in initial N-Staging in patients with malignant melanoma : Is it a possible replacement for sentinel lymph node biopsy?
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 45 (2018) Nr. Suppl. 1, S. 38
    ISSN: 1619-7070; 1619-7089
  • Brinker, Titus J.; Klode, Joachim; Esser, Stefan; Schadendorf, Dirk
    Facial-aging app availability in waiting rooms as a potential opportunity for skin cancer prevention
    In: JAMA Dermatology Jg. 154 (2018) Nr. 9, S. 1085 - 1086
    ISSN: 2168-6068; 2168-6084
    Online Volltext: dx.doi.org/ (Open Access)
  • Wagner, Tobias; Augustin, Matthias; Blome, Christine; Forschner, Andrea; Garbe, Claus; Gutzmer, Ralf; Hauschild, Axel; Heinzerling, Lucie; Livingstone, Elisabeth; Loquai, Carmen; Schadendorf, Dirk; Terheyden, Patrick; Mueller-Brenne, Tina; Kähler, Katharina C.
    Fear of cancer progression in patients with stage IA malignant melanoma
    In: European Journal of Cancer Care Jg. 27 (2018) Nr. 5,
    ISSN: 1365-2354; 0961-5423
    Online Volltext: dx.doi.org/
  • Miao, Diana; Margolis, Claire A.; Vokes, Natalie I.; Liu, David; Taylor-Weiner, Amaro; Wankowicz, Stephanie M.; Adeegbe, Dennis; Keliher, Daniel; Schilling, Bastian; Tracy, Adam; Manos, Michael; Chau, Nicole G.; Hanna, Glenn J.; Polak, Paz; Rodig, Scott J.; Signoretti, Sabina; Sholl, Lynette M.; Engelman, Jeffrey A.; Getz, Gad; Jänne, Pasi A.; Haddad, Robert I.; Choueiri, Toni K.; Barbie, David A.; Haq, Rizwan; Awad, Mark M.; Schadendorf, Dirk; Hodi, F. Stephen; Bellmunt, Joaquim; Wong, Kwok-Kin; Hammerman, Peter; Van Allen, Eliezer M.
    Genomic correlates of response to immune checkpoint blockade in microsatellite-stable solid tumors
    In: Nature Genetics Jg. 50 (2018) Nr. 9, S. 1271 - 1281
    ISSN: 1061-4036; 1546-1718
    Online Volltext: dx.doi.org/ Online Volltext (Open Access)
  • Brütting, Julia; Bergmann, Maike; Garzarolli, Marlene; Rauschenberg, Ricarda; Weber, Christiane; Berking, Carola; Tilgen, Wolfgang; Schadendorf, Dirk; Meier, Friedegund; NVKH Supporting Group
    Information-seeking and use of information resources among melanoma patients of German skin cancer centers
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Jg. 16 (2018) Nr. 9, S. 1093 - 1101
    ISSN: 1610-0387; 1563-2571; 1610-0379; 0301-0481
    Online Volltext: dx.doi.org/
  • Brütting, Julia; Bergmann, M.; Weber, C.; Berking, C.; Tilgen, W.; Schadendorf, Dirk; Meier, F.
    Informationsangebote für Melanompatienten und ihre Bekanntheit unter Betroffenen
    In: Der Hautarzt Jg. 69 (2018) Nr. 4, S. 335 - 339
    ISSN: 1432-1173; 0017-8470
    Online Volltext: dx.doi.org/
  • Griewank, Klaus G.; Koelsche, Christian; van de Nes, Johannes A. P.; Schrimpf, Daniel; Gessi, Marco; Möller, Inga; Sucker, Antje; Scolyer, Richard A.; Buckland, Michael E.; Murali, Rajmohan; Pietsch, Torsten; Deimling, Andreas von; Schadendorf, Dirk
    Integrated genomic classification of melanocytic tumors of the central nervous system using mutation analysis, copy number alterations, and DNA methylation profiling
    In: Clinical Cancer Research Jg. 24 (2018) Nr. 18, S. 4494 - 4504
    ISSN: 1078-0432; 1557-3265
    Online Volltext: dx.doi.org/
  • Teramoto, Yukiko; Nakamura, Yasuhiro; Asami, Yuri; Matsuya, Taisuke; Brinker, Titus J.; Jansen, Philipp; Schulz, Andrea; Stoffels, Ingo; Klode, Joachim; Schadendorf, Dirk; Yamamoto, Akifumi
    Intraoperative use of LIGHTVISION : a novel fluorescence navigation system using indocyanine green for sentinel lymph node biopsy in skin cancer patients
    In: European Journal of Dermatology, EJD Jg. 28 (2018) Nr. 4, S. 532 - 534
    ISSN: 1952-4013; 1167-1122
    Online Volltext: dx.doi.org/
  • Knappe, Ulrich J.; Tischoff, Iris; Tannapfel, Andrea; Reinbold, Wolf-Dieter; Möller, Inga; Sucker, Antje; Schadendorf, Dirk; Griewank, Klaus; van de Nes, Johannes
    Intraventricular melanocytoma diagnosis confirmed by gene mutation profile
    In: Neuropathology Jg. 38 (2018) Nr. 3, S. 288 - 292
    ISSN: 1440-1789; 0919-6544
    Online Volltext: dx.doi.org/
  • Haselmann, Verena; Gebhardt, Christoffer; Brechtel, Ingrid; Duda, Angelika; Czerwinski, Claudia; Sucker, Antje; Holland-Letz, Tim; Utikal, Jochen; Schadendorf, Dirk; Neumaier, Michael
    Liquid profiling of circulating tumor DNA in plasma of melanoma patients for companion diagnostics and monitoring of BRAF inhibitor therapy
    In: Clinical Chemistry Jg. 64 (2018) Nr. 5, S. 830 - 842
    ISSN: 1530-8561; 0009-9147
    Online Volltext: dx.doi.org/ (Open Access)
  • Hauschild, Axel; Dummer, Reinhard; Schadendorf, Dirk; Santinami, Mario; Atkinson, Victoria; Mandalà, Mario; Chiarion-Sileni, Vanna; Larkin, James; Nyakas, Marta; Dutriaux, Caroline; Haydon, Andrew; Robert, Caroline; Mortier, Laurent; Schachter, Jacob; Lesimple, Thierry; Plummer, Ruth; Dasgupta, Kohinoor; Haas, Tomas; Shilkrut, Mark; Gasal, Eduard; Kefford, Richard; Kirkwood, John M.; Long, Georgina V.
    Longer Follow-Up Confirms Relapse-Free Survival Benefit With Adjuvant Dabrafenib Plus Trametinib in Patients With Resected BRAF V600–Mutant Stage III Melanoma
    In: Journal of Clinical Oncology (JCO) Jg. 36 (2018) Nr. 35, S. 3441 - 3449
    ISSN: 0732-183X; 1527-7755
    Online Volltext: dx.doi.org/ (Open Access)
  • Kirchberger, Michael Constantin; Ugurel, Selma; Mangana, Johanna; Heppt, Markus Valentin; Eigentler, Thomas Kurt; Berking, Carola; Schadendorf, Dirk; Schuler, Gerold; Dummer, Reinhard; Heinzerling, Lucie
    MEK inhibition may increase survival of NRAS-mutated melanoma patients treated with checkpoint blockade : Results of a retrospective multicentre analysis of 364 patients
    In: European Journal of Cancer Jg. 98 (2018) S. 10 - 16
    ISSN: 0959-8049; 1879-0852
    Online Volltext: dx.doi.org/
  • Schadendorf, Dirk; Van Akkooi, Alexander; Berking, Carola; Griewank, Klaus; Gutzmer, Ralf; Hauschild, Axel; Stang, Andreas; Rösch, Alexander; Ugurel, Selma
    Melanoma
    In: The Lancet Jg. 392 (2018) Nr. 10151, S. 971 - 984
    ISSN: 0140-6736; 1474-547X
    Online Volltext: dx.doi.org/
  • Drusio, Christina; Becker, Jürgen C.; Schadendorf, Dirk; Ugurel, Selma
    Merkelzellkarzinom
    In: Der Onkologe Jg. 24 (2018) Nr. 12, S. 1037 - 1049
    ISSN: 0947-8965; 1433-0415
    Online Volltext: dx.doi.org/
  • Drusio, Christina; Schadendorf, Dirk; Ugurel, Selma
    Mit Nivolumab und Pembrolizumab gegen das Melanom : Wirkprinzip und Umgang mit immunvermittelten Nebenwirkungen der Anti-PD1-Therapie
    In: Deutsche Apotheker Zeitung: DAZ Jg. 158 (2018) Nr. 30,
    ISSN: 0011-9857
  • Dummer, Reinhard; Hauschild, Axel; Santinami, Mario; Atkinson, Victoria; Mandalà, Mario; Chiarion-Sileni, Vanna; Larkin, James M. G.; Nyakas, Marta; Dutriaux, Caroline; Haydon, Andrew Mark; Robert, Caroline; Schadendorf, Dirk; Aimone, Paola; Mookerjee, Bijoyesh; Campbell, Catarina D.; Garrett, James; Brase, Jan C.; Kefford, Richard; Kirkwood, John M.; Long, Georgina V.
    Mutational and immune gene expression profiling at relapse in patients (pts) treated with adjuvant dabrafenib plus trametinib (D + T) or placebo (pbo) in the COMBI-AD trial
    In: Journal of Clinical Oncology (JCO) Jg. 36 (2018) Nr. Suppl. 15, S. 9574 - 9574
    ISSN: 0732-183X; 1527-7755
    Online Volltext: dx.doi.org/
  • Scholz, S.L.; Cosgarea, I.; Süßkind, D.; Murali, R.; Möller, I.; Reis, Henning; Leonardelli, S.; Schilling, Bastian; Schimming, T.; Hadaschik, Eva; Franklin, Cindy; Paschen, Annette; Sucker, A.; Steuhl, Klaus-Peter; Schadendorf, Dirk; Westekemper, Henrike; Griewank, Klaus
    NF1 mutations in conjunctival melanoma
    In: British Journal of Cancer (BJC) Jg. 118 (2018) Nr. 9, S. 1243 - 1247
    ISSN: 1532-1827; 0007-0920
    Online Volltext: dx.doi.org/ (Open Access)
  • Hodi, Frank Stephen; Chiarion-Sileni, Vanna; Gonzalez, Rene; Grob, Jean-Jacques; Rutkowski, Piotr; Cowey, Charles Lance; Lao, Christopher D; Schadendorf, Dirk; Wagstaff, John; Dummer, Reinhard; Ferrucci, Pier Francesco; Smylie, Michael; Hill, Andrew; Hogg, David; Marquez-Rodas, Ivan; Jiang, Joel; Rizzo, Jasmine; Larkin, James; Wolchok, Jedd D
    Nivolumab plus ipilimumab or nivolumab alone versus ipilimumab alone in advanced melanoma (CheckMate 067) : 4-year outcomes of a multicentre, randomised, phase 3 trial
    In: The Lancet Oncology Jg. 19 (2018) Nr. 11, S. 1480 - 1492
    ISSN: 1474-5488; 1470-2045
    Online Volltext: dx.doi.org/
  • Duffy, David L.; Zhu, Gu; Li, Xin; Sanna, Marianna; Iles, Mark M.; Jacobs, Leonie C.; Evans, David M.; Yazar, Seyhan; Beesley, Jonathan; Law, Matthew H.; Kraft, Peter; Visconti, Alessia; Taylor, John C.; Lui, Fan; Wright, Margaret J.; Henders, Anjali K.; Bowdler, Lisa; Glass, Dan; Ikram, Arfan M.; Uitterlinden, André G.; Madden, Pamela A.; Heath, Andrew C.; Nelson, Elliot C.; Green, Adele C.; Chanock, Stephen; Barrett, Jennifer H.; Brown, Matthew A.; Hayward, Nicholas K.; MacGregor, Stuart; Sturm, Richard A.; Hewitt, Alex W.; Lee, Jeffrey E.; Brossard, Myriam; Moses, Eric K.; Song, Fengju; Kumar, Rajiv; Easton, Douglas F.; Pharoah, Paul D. P.; Swerdlow, Anthony J.; Kypreou, Katerina P.; Harland, Mark; Randerson-Moor, Juliette; Akslen, Lars A.; Andresen, Per A.; Avril, Marie-Françoise; Azizi, Esther; Scarrà, Giovanna Bianchi; Brown, Kevin M.; Dębniak, Tadeusz; Elder, David E.; Fang, Shenying; Friedman, Eitan; Galan, Pilar; Ghiorzo, Paola; Gillanders, Elizabeth M.; Goldstein, Alisa M.; Gruis, Nelleke A.; Hansson, Johan; Helsing, Per; Hočevar, Marko; Höiom, Veronica; Ingvar, Christian; Kanetsky, Peter A.; Chen, Wei V.; Landi, Maria Teresa; Lang, Julie; Lathrop, G. Mark; Lubiński, Jan; Mackie, Rona M.; Mann, Graham J.; Molven, Anders; Novaković, Srdjan; Olsson, Håkan; Puig, Susana; Puig-Butille, Joan Anton; Radford-Smith, Graham L.; van der Stoep, Nienke; van Doorn, Remco; Whiteman, David C.; Craig, Jamie E.; Schadendorf, Dirk; Simms, Lisa A.; Burdon, Kathryn P.; Nyholt, Dale R.; Pooley, Karen A.; Orr, Nicholas; Stratigos, Alexander J.; Cust, Anne E.; Ward, Sarah V.; Schulze, Hans-Joachim; Dunning, Alison M.; Demenais, Florence; Amos, Christopher I.; Kayser, Manfred; Hunter, David J.; Newton Bishop, Julia A.; Spector, Timothy D.; Montgomery, Grant W.; Mackey, David A.; Smith, George Davey; Nijsten, Tamar E.; Bishop, D. Timothy; Bataille, Veronique; Falchi, Mario; Han, Jiali; Martin, Nicholas G.
    Novel pleiotropic risk loci for melanoma and nevus density implicate multiple biological pathways
    In: Nature Communications Jg. 9 (2018) Nr. 1, S. 4774
    ISSN: 2041-1723
    Online Volltext: dx.doi.org/ (Open Access)
  • Carlino, Matteo S.; Long, Georgina V.; Schadendorf, Dirk; Robert, Caroline; Ribas, Antoni; Richtig, Erika; Nyakas, Marta; Caglevic, Christian; Tarhini, Ahmed; Blank, Christian; Hoeller, Christoph; Bar-Sela, Gil; Barrow, Catherine; Wolter, Pascal; Zhou, Honghong; Emancipator, Kenneth; Jensen, Erin H.; Ebbinghaus, Scot; Ibrahim, Nageatte; Daud, Adil
    Outcomes by line of therapy and programmed death ligand 1 expression in patients with advanced melanoma treated with pembrolizumab or ipilimumab in KEYNOTE-006 : A randomised clinical trial
    In: European Journal of Cancer Jg. 101 (2018) S. 236 - 243
    ISSN: 0959-8049; 1879-0852
    Online Volltext: dx.doi.org/ (Open Access)
  • Hodi, Frank S.; Chiarion-Sileni, Vanna; Gonzalez, René C.; Grob, Jean J.; Rutkowski, Piotr; Cowey, Charles L.; Lao, Christopher D.; Schadendorf, Dirk; Wagstaff, John; Dummer, Reinhard G.; Ferrucci, Pier F.; Smylie, Michael; Hill, A. G.; Hogg, David; Márquez-Rodas, Iván; Jiang, Joel; Rizzo, Jasmine I.; Larkin, James M. G.; Wolchok, J.
    Overall survival at 4 years of follow-up in a phase III trial of nivolumab plus ipilimumab combination therapy in advanced melanoma (CheckMate 067)
    In: Annals of Oncology Jg. 29 (2018) Nr. Suppl. 8, S. viii735
    ISSN: 0923-7534; 1569-8041
    Online Volltext: dx.doi.org/ (Open Access)
  • Dummer, Reinhard; Ascierto, Paolo A.; Gogas, Helen J.; Arance, Ana; Mandala, Mario; Liszkay, Gabriella; Garbe, Claus; Schadendorf, Dirk; Krajsova, Ivana; Gutzmer, Ralf; Chiarion Sileni, Vanna; Dutriaux, Caroline; de Groot, Jan Willem B.; Yamazaki, Naoya; Loquai, Carmen; Moutouh-de Parseval, Laure A.; Pickard, Michael D.; Sandor, Victor; Robert, Caroline; Flaherty, Keith T.
    Overall survival in patients with BRAF-mutant melanoma receiving encorafenib plus binimetinib versus vemurafenib or encorafenib (COLUMBUS) : a multicentre, open-label, randomised, phase 3 trial
    In: The Lancet Oncology Jg. 19 (2018) Nr. 10, S. 1315 - 1327
    ISSN: 1470-2045; 1474-5488
    Online Volltext: dx.doi.org/
  • Larkin, James; Minor, David; D'Angelo, Sandra; Neyns, Bart; Smylie, Michael; Miller, Wilson H.; Gutzmer, Ralf; Linette, Gerald; Chmielowski, Bartosz; Lao, Christopher D.; Lorigan, Paul; Grossmann, Kenneth; Hassel, Jessica C.; Sznol, Mario; Daud, Adil; Sosman, Jeffrey; Khushalani, Nikhil; Schadendorf, Dirk; Hoeller, Christoph; Walker, Dana; Kong, George; Horak, Christine; Weber, Jeffrey
    Overall survival in patients with advanced melanoma who received nivolumab versus investigator's choice chemotherapy in CheckMate 037 : A Randomized, Controlled, Open-Label Phase III Trial
    In: Journal of Clinical Oncology (JCO) Jg. 36 (2018) Nr. 4, S. 383 - 390
    ISSN: 0732-183X; 1527-7755
    Online Volltext: dx.doi.org/ Online Volltext (Open Access)
  • Petri, Maximilian; Stoffels, Ingo; Griewank, Klaus; Jose, Jithin; Engels, Peter; Schulz, Andrea; Pötzschke, Harald; Jansen, Philipp; Schadendorf, Dirk; Dissemond, Joachim; Klode, Joachim
    Oxygenation Status in Chronic Leg Ulcer After Topical Hemoglobin Application May Act as a Surrogate Marker to Find the Best Treatment Strategy and to Avoid Ineffective Conservative Long-term Therapy
    In: Molecular Imaging and Biology Jg. 20 (2018) Nr. 1, S. 124 - 130
    ISSN: 1860-2002; 1536-1632
    Online Volltext: dx.doi.org/
  • Migden, Michael R.; Rischin, Danny; Schmults, Chrysalyne D.; Guminski, Alexander; Hauschild, Axel; Lewis, Karl D.; Chung, Christine H.; Hernandez-Aya, Leonel; Lim, Annette M.; Chang, Anne Lynn S.; Rabinowits, Guilherme; Thai, Alesha A.; Dunn, Lara A.; Hughes, Brett G.M.; Khushalani, Nikhil I.; Modi, Badri; Schadendorf, Dirk; Gao, Bo; Seebach, Frank; Li, Siyu; Li, Jingjin; Mathias, Melissa; Booth, Jocelyn; Mohan, Kosalai; Stankevich, Elizabeth; Babiker, Hani M.; Brana, Irene; Gil-Martin, Marta; Homsi, Jade; Johnson, Melissa L.; Moreno, Victor; Niu, Jiaxin; Owonikoko, Taofeek K.; Papadopoulos, Kyriakos P.; Yancopoulos, George D.; Lowy, Israel; Fury, Matthew G.
    PD-1 blockade with cemiplimab in advanced cutaneous squamous-cell carcinoma
    In: The New England Journal of Medicine Jg. 379 (2018) Nr. 4, S. 341 - 351
    ISSN: 1533-4406; 0028-4793
    Online Volltext: dx.doi.org/ Online Volltext (Open Access)
  • Ribas, Antoni; Robert, Caroline; Squires, Matthew; Schadendorf, Dirk; Davies, Michael A.; Nathan, Paul D.; Tan, Puay; Powell, William; Jaeger, Savina; Grob, Jean Jacques; Flaherty, Keith; Long, Georgina V.
    PD-L1 and CD8 expression and association with outcomes in patients (pts) with BRAF V600E/K–mutant metastatic melanoma (MM) who received dabrafenib + trametinib (D+T) in the randomized phase 3 COMBI-v study.
    In: Journal of Clinical Oncology (JCO) Jg. 36 (2018) Nr. 5 Suppl., S. 183
    ISSN: 0732-183X; 1527-7755
    Online Volltext: dx.doi.org/
  • Schaper-Gerhardt, Katrin; Okoye, Steven; Herbst, Rudolf; Ulrich, Jens; Terheyden, Patrick; Pföhler, Claudia; Utikal, Jochen S.; Kreuter, Alexander; Mohr, Peter; Dippel, Edgar; Satzger, Imke; Sucker, Antje; Schadendorf, Dirk; Ugurel, Selma; Gutzmer, Ralf
    PD-L1 status does not predict the outcome of BRAF inhibitor therapy in metastatic melanoma
    In: European Journal of Cancer Jg. 88 (2018) S. 67 - 76
    ISSN: 1879-2995; 0959-8049
    Online Volltext: dx.doi.org/
  • De Semir, David; Bezrookove, Vladimir; Nosrati, Mehdi; Dar, Altaf A.; Wu, Clayton; Shen, Julia; Rieken, Christopher; Venkatasubramanian, Meenakshi; Miller, James R.; Desprez, Pierre-Yves; McAllister, Sean; Soroceanu, Liliana; Debs, Robert J.; Salomonis, Nathan; Schadendorf, Dirk; Cleaver, James E.; Kashani-Sabet, Mohammed
    PHIP as a therapeutic target for driver-negative subtypes of melanoma, breast, and lung cancer
    In: Proceedings of the National Academy of Sciences of the United States of America (PNAS) Jg. 115 (2018) Nr. 25, S. E5766 - E5775
    ISSN: 1091-6490; 0027-8424
    Online Volltext: dx.doi.org/ (Open Access)
  • Tykodi, Scott S.; Schadendorf, Dirk; Cella, David; Reck, Martin; Harrington, Kevin; Wagner, Samuel; Shaw, James W.
    Patient-reported outcomes with nivolumab in advanced solid cancers
    In: Cancer Treatment Reviews Jg. 70 (2018) S. 75 - 87
    ISSN: 1532-1967; 0305-7372
    Online Volltext: dx.doi.org/ (Open Access)
  • Milsch, Laura; Gesierich, Anja; Kreft, Sophia; Livingstone, Elisabeth; Zimmer, Lisa; Goebeler, Matthias; Schadendorf, Dirk; Schilling, Bastian
    Patterns of disease control and survival in patients with melanoma brain metastases undergoing immune-checkpoint blockade
    In: European Journal of Cancer Jg. 99 (2018) S. 58 - 65
    ISSN: 0959-8049; 1879-0852
    Online Volltext: dx.doi.org/
  • Dummer, Reinhard; Michielin, Olivier; Nägeli, Mirjam Chantal; Goldinger, Simone M.; Campigotto, Federico; Kriemler-Krahn, Ulrike; Schmid, Herbert; Pedroncelli, Alberto; Micaletto, Sara; Schadendorf, Dirk
    Phase I, open-label study of pasireotide in patients with BRAF-wild type and NRAS-wild type, unresectable and/or metastatic melanoma
    In: ESMO Open Jg. 3 (2018) Nr. 5, S. e000388
    ISSN: 2059-7029
    Online Volltext: dx.doi.org/ (Open Access)
  • Jansen, Philipp; Stoffels, Ingo; Klode, Joachim; Jockenhöfer, Finja; Augustin, Matthias; Schadendorf, Dirk; Dissemond, Joachim
    Postsurgical treatment of split skin graft donor sites in dermatological departments
    In: The International Journal of Lower Extremity Wounds Jg. 17 (2018) Nr. 1, S. 22 - 29
    ISSN: 1552-6941; 1534-7346
    Online Volltext: dx.doi.org/
  • Krajewski, Christin; Benson, Sven; Elsenbruch-Harnish, Sigrid; Schadendorf, Dirk; Livingstone, Elisabeth
    Predictors of quality of life in melanoma patients 4 years after diagnosis : Results of a nationwide cohort study in Germany
    In: Journal of Psychosocial Oncology Jg. 36 (2018) Nr. 6, S. 734 - 753
    ISSN: 1540-7586; 0734-7332
    Online Volltext: dx.doi.org/
  • Scholz, Simone L.; Murali, Rajmohan; Westekemper, Henrike; Schadendorf, Dirk; Griewank, Klaus G.
    Re: van Poppelen et al.: Genetic background of iris melanomas and iris melanocytic tumors of uncertain malignant potential (Ophthalmology. 2018;125:904-912)
    In: Ophthalmology Jg. 125 (2018) Nr. 11, S. e78 - e79
    ISSN: 1549-4713; 0161-6420
    Online Volltext: dx.doi.org/ (Open Access)
  • Valpione, Sara; Carlino, Matteo S.; Mangana, Johanna; Mooradian, Meghan J.; McArthur, Grant; Schadendorf, Dirk; Hauschild, Axel; Menzies, Alexander M.; Arance, Ana; Ascierto, Paolo A.; Di Giacomo, AnnaMaria; de Rosa, Francesco; Larkin, James; Park, John J.; Goldinger, Simone M.; Sullivan, Ryan J.; Xu, Wen; Livingstone, Elisabeth; Weichenthal, Michael; Rai, Rajat; Gaba, Lydia; Long, Georgina V.; Lorigan, Paul
    Rechallenge with BRAF-directed treatment in metastatic melanoma: A multi-institutional retrospective study
    In: European Journal of Cancer Jg. 91 (2018) S. 116 - 124
    ISSN: 1879-2995; 0959-8049
    Online Volltext: dx.doi.org/ (Open Access)
  • Schadendorf, Dirk; Jiang, Joel; Kelleher, Thomas; Postow, Michael A.
    Reply to M. Horiguchi et al [Patients With Advanced Melanoma Who Discontinued Treatment With Nivolumab and Ipilimumab as a Result of Adverse Events Lived Significantly Longer Than Patients Who Continued Treatment]
    In: Journal of Clinical Oncology (JCO) Jg. 36 (2018) Nr. 7, S. 721
    ISSN: 0732-183X; 1527-7755
    Online Volltext: dx.doi.org/ (Open Access)
  • Bezrookove, Vladimir; Nosrati, Mehdi; Miller, James R.; De Semir, David; Dar, Altaf A.; Vosoughi, Elham; Vaquero, Edith; Sucker, Antje; Lazar, Alexander J.; Gershenwald, Jeffrey E.; Davies, Michael A.; Schadendorf, Dirk; Kashani-Sabet, Mohammed
    Role of elevated PHIP copy number as a prognostic and progression marker for cutaneous melanoma
    In: Clinical Cancer Research Jg. 24 (2018) Nr. 17, S. 4119 - 4125
    ISSN: 1557-3265; 1078-0432
    Online Volltext: dx.doi.org/ Online Volltext (Open Access)
  • Machiraju, Devayani; Moll, Iris; Gebhardt, Christoffer; Sucker, Antje; Buder-Bakhaya, Kristina; Schadendorf, Dirk; Hassel, Jessica C.
    STAT5 expression correlates with recurrence and survival in melanoma patients treated with interferon-α
    In: Melanoma Research Jg. 28 (2018) Nr. 3, S. 204 - 210
    ISSN: 0960-8931; 1473-5636
    Online Volltext: dx.doi.org/
  • Jockenhöfer, Finja; Schimming, Tobias T.; Schaller, Jörg; Moege, Jürgen; Livingstone, Elisabeth; Salva, Katrin A.; Zimmer, Lisa; Schadendorf, Dirk; Rösch, Alexander
    Sebaceous tumours: more than skin deep
    In: Gut Jg. 67 (2018) Nr. 11, S. 2045 - 2053
    ISSN: 0017-5749; 1468-3288
    Online Volltext: dx.doi.org/
  • Brinker, Titus Josef; Hekler, Achim; Utikal, Jochen Sven; Grabe, Niels; Schadendorf, Dirk; Klode, Joachim; Berking, Carola; Steeb, Theresa; Enk, Alexander H.; von Kalle, Christof
    Skin Cancer Classification using Convolutional Neural Networks : Systematic Review
    In: Journal of Medical Internet Research Jg. 20 (2018) Nr. 10, S. e11936
    ISSN: 1439-4456; 1438-8871
    Online Volltext: dx.doi.org/ (Open Access)
  • Brinker, Titus Josef; Hekler, Achim; von Kalle, Christof; Schadendorf, Dirk; Esser, Stefan; Berking, Carola; Zacher, Martina T.; Sondermann, Wiebke; Grabe, Niels; Steeb, Theresa; Utikal, Jochen Sven; French, Lars E.; Enk, Alexander H.
    Teledermatology : Comparison of Store-and-Forward Versus Live Interactive Video Conferencing
    In: Journal of Medical Internet Research Jg. 20 (2018) Nr. 10, S. e11871
    ISSN: 1438-8871; 1439-4456
    Online Volltext: dx.doi.org/ (Open Access)
  • Rachakonda, Sivaramakrishna; Kong, Haiying; Srinivas, Nalini; Garcia-Casado, Zaida; Requena, Celia; Fallah, Mahdi; Heidenreich, Barbara; Planelles, Dolores; Traves, Victor; Schadendorf, Dirk; Nagore, Eduardo; Kumar, Rajiv
    Telomere length, telomerase reverse transcriptase promoter mutations, and melanoma risk
    In: Genes, Chromosomes and Cancer Jg. 57 (2018) Nr. 11, S. 564 - 572
    ISSN: 1098-2264; 1045-2257
    Online Volltext: dx.doi.org/
  • Kähler, Katharina C.; Blome, Christine; Forschner, Andrea; Gutzmer, Ralf; Hauschild, Axel; Heinzerling, Lucie; Livingstone, Elisabeth; Loquai, Carmen; Müller-Brenne, Tina; Schadendorf, Dirk; Utikal, Jochen; Wagner, Tobias; Augustin, Matthias
    The outweigh of toxicity versus risk of recurrence for adjuvant interferon therapy : A survey in German melanoma patients and their treating physicians
    In: OncoTarget Jg. 9 (2018) Nr. 40, S. 26217 - 26225
    ISSN: 1949-2553
    Online Volltext: dx.doi.org/ (Open Access)
  • Knispel, Sarah; Zimmer, Lisa; Kanaki, Theodora; Ugurel, Selma; Schadendorf, Dirk; Livingstone, Elisabeth
    The safety and efficacy of dabrafenib and trametinib for the treatment of melanoma
    In: Expert Opinion on Drug Safety Jg. 17 (2018) Nr. 1, S. 73 - 87
    ISSN: 1744-764X; 1474-0338
    Online Volltext: dx.doi.org/
  • Horn, Susanne; Leonardelli, Sonia; Sucker, Antje; Schadendorf, Dirk; Griewank, Klaus; Paschen, Annette
    Tumor CDKN2A-Associated JAK2 Loss and Susceptibility to Immunotherapy Resistance
    In: Journal of the National Cancer Institute Jg. 110 (2018) Nr. 6, S. 677 - 681
    ISSN: 0198-0157; 0027-8874
    Online Volltext: dx.doi.org/ (Open Access)
  • Long, Georgina V.; Hauschild, Axel; Santinami, Mario; Atkinson, Victoria G.; Mandala, Mario; Chiarion-Sileni, Vanna; Larkin, James M. G.; Robert, Caroline; Schadendorf, Dirk; Dasgupta, Kohinoor; Shilkrut, Mark; Garrett, James; Brase, Jan C.; Kefford, Rick F.; Kirkwood, John M.; Dummer, Reinhard G.
    Updated relapse-free survival (RFS) and biomarker analysis in the COMBI-AD trial of adjuvant dabrafenib + trametinib (D + T) in patients (pts) with resected BRAF V600-mutant stage III melanoma
    In: Annals of Oncology Jg. 29 (2018) Nr. Suppl. 8, S. viii734 - viii735
    ISSN: 0923-7534; 1569-8041
    Online Volltext: dx.doi.org/ (Open Access)
  • Schadendorf, Dirk; et.al.
    Updated relapse-free survival (RFS) and biomarker analysis in the COMBI-AD trial of adjuvant dabrafenib plus trametinib (D plus T) in patients (pts) with resected BRAF V600-mutant stage III melanoma
    In: Annals of Oncology Jg. 29 (2018) Nr. Suppl. 8,
    ISSN: 1569-8041; 0923-7534
  • Augustin, Matthias; Blome, Christine; Forschner, Andrea; Gutzmer, Ralf; Hauschild, Axel; Heinzerling, Lucie; Livingstone, Elisabeth; Loquai, Carmen; Schadendorf, Dirk; Utikal, Jochen; Wagner, Tobias; Wilden, Sophia; Kähler, Katharina C.
    Willingness to pay for a cure of low-risk melanoma patients in Germany
    In: PLoS ONE Jg. 13 (2018) Nr. 5, S. e0197780
    ISSN: 1932-6203
    Online Volltext: dx.doi.org/ (Open Access)
  • Brinker, Titus Josef; Enk, Alexander; Gatzka, Martina; Nakamura, Yasuhiro; Sondermann, Wiebke; Omlor, Albert Joachim; Petri, Maximilian Philip; Karoglan, Ante; Seeger, Werner; Klode, Joachim; Kalle, Christof von; Schadendorf, Dirk
    A Dermatologist's ammunition in the war against smoking : a photoaging app
    In: Journal of Medical Internet Research Jg. 19 (2017) Nr. 9, S. e326
    ISSN: 1439-4456
    Online Volltext: dx.doi.org/ Online Volltext (Open Access)
  • Brinker, Titus Josef; Owczarek, Andreas Dawid; Seeger, Werner; Groneberg, David Alexander; Brieske, Christian Martin; Jansen, Philipp; Klode, Joachim; Stoffels, Ingo; Schadendorf, Dirk; Izar, Benjamin; Fries, Fabian Norbert; Hofmann, Felix Johannes
    A medical student-delivered smoking prevention program, education against tobacco, for secondary schools in Germany : Randomized controlled trial
    In: Journal of Medical Internet Research Jg. 19 (2017) Nr. 6, S. e199
    ISSN: 1439-4456
    Online Volltext: dx.doi.org/ (Open Access)
  • Faria, Bianca Lisa; Brieske, Christian M; Cosgarea, Ioana; Omlor, Albert J; Fries, Fabian N; Moreira de Faria, Christian Olber; Lino, Henrique Augusto; Oliveira, Ana Carla Cruz; Lisboa, Oscar Campos; Klode, Joachim; Schadendorf, Dirk; Bernardes-Souza, Breno; Brinker, Titus J
    A smoking prevention photoageing intervention for secondary schools in Brazil delivered by medical students: protocol for a randomised trial.
    In: BMJ Open Jg. 7 (2017) S. e018589
    ISSN: 2053-3624; 2044-6055
    Online Volltext: dx.doi.org/ Online Volltext (Open Access)
  • Sucker, Antje; Zhao, Fang; Pieper, Natalia; Heeke, Christina; Maltaner, Raffaela; Stadtler, Nadine; Real, Birgit; Bielefeld, Nicola; Howe, Sebastian; Weide, Benjamin; Gutzmer, Ralf; Utikal, Jochen; Loquai, Carmen; Gogas, Helen; Klein-Hitpaß, Ludger; Zeschnigk, Michael; Westendorf, Astrid; Trilling, Mirko; Horn, Susanne; Schilling, Bastian; Schadendorf, Dirk; Griewank, Klaus; Paschen, Annette
    Acquired IFNγ 3 resistance impairs anti-Tumor immunity and gives rise to T-cell-resistant melanoma lesions
    In: Nature Communications Jg. 8 (2017)
    ISSN: 2041-1723
    Online Volltext: dx.doi.org/ (Open Access)
  • van de Nes, Johannes; Koelsche, Christian; Gessi, Marco; Möller, Inga; Sucker, Antje; Scolyer, Richard A.; Buckland, Michael E.; Pietsch, Torsten; Murali, Rajmohan; Schadendorf, Dirk; Griewank, Klaus
    Activating CYSLTR2 and PLCB4 Mutations in Primary Leptomeningeal Melanocytic Tumors
    In: The Journal of Investigative Dermatology Jg. 137 (2017) Nr. 9, S. 2033 - 2035
    ISSN: 1523-1747; 0022-202X
    Online Volltext: dx.doi.org/
  • Möller, Inga; Murali, Rajmohan; Müller, Hansgeorg; Wiesner, Thomas; Jackett, Louise A.; Scholz, Simone L.; Cosgarea, Ioana; van de Nes, Johannes; Sucker, Antje; Hillen, Uwe; Schilling, Bastian; Paschen, Annette; Kutzner, Heinz; Rütten, Arno; Böckers, Martin; Scolyer, Richard A.; Schadendorf, Dirk; Griewank, Klaus
    Activating cysteinyl leukotriene receptor 2 (CYSLTR2) mutations in blue nevi
    In: Modern Pathology Jg. 30 (2017) Nr. 3, S. 350 - 356
    ISSN: 1530-0285; 0893-3952
    Online Volltext: dx.doi.org/ Online Volltext (Open Access)
  • Long, G.V.; Hauschild, A.; Santinami, M.; Atkinson, V.; Mandal, M.; Chiarion-Sileni, V.; Larkin, J.; Nyakas, M.; Dutriaux, C.; Haydon, A.; Robert, C.; Mortier, L.; Schachter, J.; Schadendorf, Dirk; Lesimple, T.; Plummer, R.; Ji, R.; Zhang, P.; Mookerjee, B.; Legos, J.; Kefford, R.; Dummer, R.; Kirkwood, J.M.
    Adjuvant dabrafenib plus trametinib in stage III BRAF-mutated melanoma
    In: The New England Journal of Medicine Jg. 377 (2017) Nr. 19, S. 1813 - 1823
    ISSN: 1533-4406; 0028-4793
    Online Volltext: dx.doi.org/ Online Volltext (Open Access)
  • Dummer, Reinhard; Schadendorf, Dirk; Ascierto, Paolo A; Arance, Ana; Dutriaux, Caroline; Di Giacomo, Anna Maria; Rutkowski, Piotr; Del Vecchio, Michele; Gutzmer, Ralf; Mandala, Mario; Thomas, Luc; Demidov, Lev; Garbe, Claus; Hogg, David; Liszkay, Gabriella; Queirolo, Paola; Wasserman, Ernesto; Ford, James; Weill, Marine; Sirulnik, L Andres; Jehl, Valentine; Bozón, Viviana; Long, Georgina V; Flaherty, Keith
    Binimetinib versus dacarbazine in patients with advanced NRAS-mutant melanoma (NEMO) : a multicentre, open-label, randomised, phase 3 trial
    In: The Lancet Oncology Jg. 18 (2017) Nr. 4, S. 435 - 445
    ISSN: 1470-2045
    Online Volltext: dx.doi.org/
  • Schadendorf, Dirk; Schuler, Martin
    Checkpointinhibitoren
    In: Der Onkologe Jg. 23 (2017) Nr. 8, S. 619 - 625
    ISSN: 1433-0415; 0947-8965
    Online Volltext: dx.doi.org/
  • Ugurel, Selma; Loquai, Carmen; Terheyden, Patrick; Schadendorf, Dirk; Richtig, Erika; Utikal, Jochen; Gutzmer, Ralf; Rass, Knuth; Sunderkötter, Cord; Stein, Annette; Fluck, Michael; Kaatz, Martin; Trefzer, Uwe; Kähler, Katharina; Stadler, Rudolf; Berking, Carola; Höller, Christoph; Kerschke, Laura; Edler, Lutz; Kopp-Schneider, Annette; Becker, Jürgen
    Chemosensitivity-directed therapy compared to dacarbazine in chemo-naive advanced metastatic melanoma : a multicenter randomized phase-3 DeCOG trial
    In: OncoTarget Jg. 8 (2017) Nr. 44, S. 76029 - 76043
    ISSN: 1949-2553
    Online Volltext: dx.doi.org/ (Open Access)
  • Franklin, Cindy; Rooms, Isabelle; Fiedler, Melanie; Reis, Henning; Milsch, Laura; Herz, Saskia; Livingstone, Elisabeth; Zimmer, Lisa; Schmid, Kurt Werner; Dittmer, Ulf; Schadendorf, Dirk; Schilling, Bastian
    Cytomegalovirus reactivation in patients with refractory checkpoint inhibitor-induced colitis
    In: European Journal of Cancer Jg. 86 (2017) S. 248 - 256
    ISSN: 1879-2995; 0959-8049; 1879-0852; 0014-2964
    Online Volltext: dx.doi.org/
  • Long, G.V.; Flaherty, K.T.; Stroyakovskiy, D.; Gogas, H.; Levchenko, E.; de Braud, F.; Larkin, J.; Garbe, C.; Jouary, T.; Hauschild, A.; Chiarion-Sileni, V.; Lebbe, C.; Mandalà, M.; Millward, M.; Arance, A.; Bondarenko, I.; Haanen, J.B.A.G.; Hansson, J.; Utikal, J.; Ferraresi, V.; Mohr, P.; Probachai, V.; Schadendorf, Dirk; Nathan, P.; Robert, C.; Ribas, A.; Davies, M.A.; Lane, S.R.; Legos, J.J.; Mookerjee, B.; Grob, J-J
    Dabrafenib plus trametinib versus dabrafenib monotherapy in patients with metastatic BRAF V600E/K-mutant melanoma : long-term survival and safety analysis of a phase 3 study
    In: Annals of Oncology Jg. 28 (2017) Nr. 7, S. 1631 - 1639
    ISSN: 1569-8041
    Online Volltext: dx.doi.org/ (Open Access)
  • Guo, Jun; Carvajal, Richard D.; Dummer, Reinhard G.; Hauschild, Axel; Daud, Adil I.; Bastian, Boris C.; Markovic, Svetomir N.; Queirolo, Paola; Arance, Ana Maria; Berking, Carola; Camargo, Veridiana P.; Herchenhorn, Daniel; Petrella, Teresa M.; Schadendorf, Dirk; Sharfman, William H.; Testori, Alessandro; Novick, Steven C.; Hertle, Sabine; Nourry, C.; Chen, Q.; Hodi, Frank Stephen
    Efficacy and safety of nilotinib in patients with kit-mutated metastatic or inoperable melanoma : Final results from the global, single-arm, phase ii team trial
    In: Annals of Oncology Jg. 28 (2017) Nr. 6, S. 1380 - 1387
    ISSN: 1569-8041; 0923-7534
    Online Volltext: dx.doi.org/ (Open Access)
  • Schadendorf, Dirk; Wolchok, Jedd D.; Stephen Hodi, F.; Chiarion-Sileni, Vanna; Gonzalez, Rene; Rutkowski, Piotr; Grob, Jean-Jacques; Lance Cowey, C.; Lao, Christopher D.; Chesney, Jason; Robert, Caroline; Grossmann, Kenneth; McDermott, David; Walker, Dana; Bhore, Rafia; Larkin, James; Postow, Michael A.
    Efficacy and safety outcomes in patients with advanced melanoma who discontinued treatment with nivolumab and ipilimumab because of adverse events : a pooled analysis of randomized phase II and III trials
    In: Journal of Clinical Oncology (JCO) Jg. 35 (2017) Nr. 34, S. 3807 - 3814
    ISSN: 0732-183X; 1527-7755
    Online Volltext: dx.doi.org/ Online Volltext (Open Access)
  • Becker, Jürgen; Lorenz, Eva; Ugurel, Selma; Eigentler, Thomas K.; Kiecker, Felix; Pföhler, Claudia; Kellner, Ivonne; Meier, Friedegund; Kähler, Katharina; Mohr, Peter; Berking, Carola; Haas, Gabriele; Helwig, Christoph; Oksen, Dina; Schadendorf, Dirk; Mahnke, Lisa; Bharmal, Murtuza
    Evaluation of real-world treatment outcomes in patients with distant metastatic Merkel cell carcinoma following second-line chemotherapy in Europe
    In: OncoTarget Jg. 8 (2017) Nr. 45, S. 79731 - 79741
    ISSN: 1949-2553
    Online Volltext: dx.doi.org/ (Open Access)
  • Hamid, Omid; Puzanov, Igor; Dummer, Reinhard; Schachter, Jacob; Daud, Adil; Schadendorf, Dirk; Blank, Christian; Cranmer, Lee D.; Robert, Caroline; Pavlick, Anna C.; Gonzalez, Rene; Hodi, F. Stephen; Ascierto, Paolo A.; Salama, April K. S.; Margolin, Kim A.; Gangadhar, Tara C.; Wei, Ziwen; Ebbinghaus, Scot; Ibrahim, Nageatte; Ribas, Antoni
    Final analysis of a randomised trial comparing pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory advanced melanoma
    In: European Journal of Cancer Jg. 86 (2017) S. 37 - 45
    ISSN: 1879-2995; 0959-8049; 1879-0852; 0014-2964
    Online Volltext: dx.doi.org/
  • Scholz, Simone L.; Möller, Inga; Reis, Henning; Süßkind, Daniela; van de Nes, Johannes; Leonardelli, Sonia; Schilling, Bastian; Livingstone, Elisabeth; Schimming, Tobias; Paschen, Annette; Sucker, Antje; Murali, Rajmohan; Steuhl, Klaus-Peter; Schadendorf, Dirk; Westekemper, Henrike; Griewank, Klaus
    Frequent GNAQ, GNA11, and EIF1AX Mutations in Iris Melanoma
    In: Investigative Ophthalmology & Visual Science, IOVS Jg. 58 (2017) Nr. 9, S. 3464 - 3470
    ISSN: 1552-5783; 0146-0404
    Online Volltext: dx.doi.org/ (Open Access)
  • Ugurel, Selma; Kiecker, Felix; Fröhling, Stefan; Wetter, Axel; Bankfalvi, Agnes; Sucker, Antje; Zimmer, Lisa; Livingstone, Elisabeth; Rösch, Alexander; Becker, Jürgen; Schadendorf, Dirk
    Fulminant response to combined checkpoint inhibition with ipilimumab plus nivolumab after failure of nivolumab monotherapy in metastatic melanoma
    In: European Journal of Cancer Jg. 83 (2017) S. 142 - 145
    ISSN: 0959-8049; 1879-2995
    Online Volltext: dx.doi.org/
  • Schrörs, Barbara; Lübcke, Silke; Lennerz, Volker; Fatho, Martina; Bicker, Anne; Wölfel, Catherine; Derigs, Patrick; Hankeln, Thomas; Schadendorf, Dirk; Paschen, Annette; Wölfel, Thomas
    HLA class I loss in metachronous metastases prevents continuous T cell recognition of mutated neoantigens in a human melanoma model
    In: OncoTarget Jg. 8 (2017) Nr. 17, S. 28312 - 28327
    ISSN: 1949-2553
    Online Volltext: dx.doi.org/ (Open Access)
  • Schadendorf, Dirk; Larkin, James; Wolchok, Jedd; Hodi, F. Stephen; Chiarion-Sileni, Vanna; Gonzalez, Rene; Rutkowski, Piotr; Grob, Jean-Jacques; Cowey, C. Lance; Lao, Christopher; Wagstaff, John; Callahan, Margaret K.; Postow, Michael A.; Smylie, Michael; Ferrucci, Pier Francesco; Dummer, Reinhard; Hill, Andrew; Taylor, Fiona; Sabater, Javier; Walker, Dana; Kotapati, Srividya; Abernethy, Amy; Long, Georgina V.
    Health-related quality of life results from the phase III CheckMate 067 study
    In: European Journal of Cancer Jg. 82 (2017) S. 80 - 91
    ISSN: 1879-2995; 0959-8049; 1879-0852; 0014-2964
    Online Volltext: dx.doi.org/ (Open Access)
  • Potrony, Miriam; Rebollo-Morell, Aida; Giménez-Xavier, Pol; Zimmer, Lisa; Puig-Butille, Joan Anton; Tell-Marti, Gemma; Sucker, Antje; Badenas, Celia; Carrera, Cristina; Malvehy, Josep; Schadendorf, Dirk; Puig, Susana
    IRF4 rs12203592 functional variant and melanoma survival
    In: International Journal of Cancer Jg. 140 (2017) Nr. 8, S. 1845 - 1849
    ISSN: 0020-7136; 1097-0215
    Online Volltext: dx.doi.org/
  • Schadendorf, Dirk; Nghiem, Paul; Bhatia, Shailender; Hauschild, Axel; Saiag, Philippe; Mahnke, Lisa; Hariharan, Subramanian; Kaufman, Howard L.
    Immune evasion mechanisms and immune checkpoint inhibition in advanced merkel cell carcinoma
    In: OncoImmunology Jg. 6 (2017) Nr. 10,
    ISSN: 2162-402X; 2162-4011
    Online Volltext: dx.doi.org/ (Open Access)
  • Franklin, Cindy; Livingstone, Elisabeth; Rösch, Alexander; Schilling, Bastian; Schadendorf, Dirk
    Immunotherapy in melanoma : Recent advances and future directions
    In: European Journal of Surgical Oncology Jg. 43 (2017) Nr. 3, S. 604 - 611
    ISSN: 1532-2157; 0748-7983
    Online Volltext: dx.doi.org/
  • Robertson, A. Gordon; Shih, Juliann; Yau, Christina; Gibb, Ewan A.; Oba, Junna; Mungall, Karen L.; Hess, Julian M.; Uzunangelov, Vladislav; Walter, Vonn; Danilova, Ludmila; Lichtenberg, Tara M.; Kucherlapati, Melanie; Kimes, Patrick K.; Tang, Ming; Penson, Alexander; Babur, Ozgun; Akbani, Rehan; Bristow, Christopher A.; Hoadley, Katherine A.; Iype, Lisa; Chang, Matthew T.; Abdel-Rahman, Mohamed H.; Ally, Adrian; Auman, J. Todd; Balasundaram, Miruna; Balu, Saianand; Benz, Christopher; Beroukhim, Rameen; Birol, Inanc; Bodenheimer, Tom; Bowen, Jay; Bowlby, Reanne; Brooks, Denise; Carlsen, Rebecca; Cebulla, Colleen M.; Cherniack, Andrew D.; Chin, Lynda; Cho, Juok; Chuah, Eric; Chudamani, Sudha; Cibulskis, Carrie; Cibulskis, Kristian; Cope, Leslie; Coupland, Sarah E.; Defreitas, Timothy; Demchok, John A.; Desjardins, Laurence; Dhalla, Noreen; Esmaeli, Bita; Felau, Ina; Ferguson, Martin L.; Frazer, Scott; Gabriel, Stacey B.; Gastier-Foster, Julie M.; Gehlenborg, Nils; Gerken, Mark; Gershenwald, Jeffrey E.; Getz, Gad; Griewank, Klaus; Grimm, Elizabeth A.; Hayes, D. Neil; Hegde, Apurva M.; Heiman, David I.; Helsel, Carmen; Hobensack, Shital; Holt, Robert A.; Hoyle, Alan P.; Hu, Xin; Hutter, Carolyn M.; Jager, Martine J.; Jefferys, Stuart R.; Jones, Corbin D.; Jones, Steven J.M.; Kandoth, Cyriac; Kasaian, Katayoon; Kim, Jaegil; Kucherlapati, Raju; Lander, Eric; Lawrence, Michael S.; Lazar, Alexander J.; Lee, Semin; Leraas, Kristen M.; Lin, Pei; Liu, Jia; Liu, Wenbin; Lolla, Laxmi; Lu, Yiling; Ma, Yussanne; Mahadeshwar, Harshad S.; Mariani, Odette; Marra, Marco A.; Mayo, Michael; Meier, Sam; Meng, Shaowu; Meyerson, Matthew; Mieczkowski, Piotr A.; Mills, Gordon B.; Moore, Richard A.; Mose, Lisle E.; Mungall, Andrew J.; Murray, Bradley A.; Naresh, Rashi; Noble, Michael S.; Pantazi, Angeliki; Parfenov, Michael; Park, Peter J.; Parker, Joel S.; Perou, Charles M.; Pihl, Todd; Pilarski, Robert; Protopopov, Alexei; Radenbaugh, Amie; Rai, Karan; Ramirez, Nilsa C.; Ren, Xiaojia; Reynolds, Sheila M.; Roach, Jeffrey; Roman-Roman, Sergio; Roszik, Jason; Sadeghi, Sara; Saksena, Gordon; Sastre, Xavier; Schadendorf, Dirk; Schein, Jacqueline E.; Schoenfield, Lynn; Schumacher, Steven E.; Seidman, Jonathan; Seth, Sahil; Sethi, Geetika; Sheth, Margi; Shi, Yan; Shields, Carol; Shmulevich, Ilya; Simons, Janae V.; Singh, Arun D.; Sipahimalani, Payal; Skelly, Tara; Sofia, Heidi; Soloway, Matthew G.; Song, Xingzhi; Stern, Marc-Henri; Stuart, Joshua; Sun, Qiang; Sun, Huandong; Tam, Angela; Tan, Donghui; Tang, Jiabin; Tarnuzzer, Roy; Taylor, Barry S.; Thiessen, Nina; Thorsson, Vesteinn; Tse, Kane; Veluvolu, Umadevi; Verhaak, Roel G.W.; Voet, Doug; Wan, Yunhu; Wang, Zhining; Weinstein, John N.; Wilkerson, Matthew D.; Williams, Michelle D.; Wise, Lisa; Woodman, Scott E.; Wong, Tina; Wu, Ye; Yang, Liming; Yang, Lixing; Zenklusen, Jean C.; Zhang, Jiashan; Zhang, Hailei; Zmuda, Erik
    Integrative analysis identifies four molecular and clinical subsets in uveal melanoma
    In: Cancer Cell Jg. 32 (2017) Nr. 2, S. 204 - 220.e15
    ISSN: 1535-6108; 1878-3686
    Online Volltext: dx.doi.org/ (Open Access)
  • Ascierto, Paolo A; Del Vecchio, Michele; Robert, Caroline; Mackiewicz, Andrzej; Chiarion-Sileni, Vanna; Arance, Ana; Lebbé, Céleste; Bastholt, Lars; Hamid, Omid; Rutkowski, Piotr; McNeil, Catriona; Garbe, Claus; Loquai, Carmen; Dreno, Brigitte; Thomas, Luc; Grob, Jean-Jacques; Liszkay, Gabriella; Nyakas, Marta; Gutzmer, Ralf; Pikiel, Joanna; Grange, Florent; Hoeller, Christoph; Ferraresi, Virginia; Smylie, Michael; Schadendorf, Dirk; Mortier, Laurent; Svane, Inge Marie; Hennicken, Delphine; Qureshi, Anila; Maio, Michele
    Ipilimumab 10 mg/kg versus ipilimumab 3 mg/kg in patients with unresectable or metastatic melanoma : a randomised, double-blind, multicentre, phase 3 trial
    In: The Lancet Oncology Jg. 18 (2017) Nr. 5, S. 611 - 622
    ISSN: 1470-2045
    Online Volltext: dx.doi.org/
  • Zimmer, Lisa; Apuri, Susmitha; Eroglu, Zeynep; Kottschade, Lisa A.; Forschner, Andrea; Gutzmer, Ralf; Schlaak, Max; Heinzerling, Lucie; Krackhardt, Angela M.; Loquai, Carmen; Markovic, Svetomir N.; Joseph, Richard W.; Markey, Kelly; Utikal, Jochen S.; Weishaupt, Carsten; Goldinger, Simone M.; Sondak, Vernon K.; Zager, Jonathan S.; Schadendorf, Dirk; Khushalani, Nikhil I.
    Ipilimumab alone or in combination with nivolumab after progression on anti-PD-1 therapy in advanced melanoma
    In: European Journal of Cancer Jg. 75 (2017) S. 47 - 55
    ISSN: 1879-2995; 0959-8049; 1879-0852; 0014-2964
    Online Volltext: dx.doi.org/
  • Sekulic, Aleksandar; Migden, Michael R.; Basset-Seguin, Nicole; Garbe, Claus; Gesierich, Anja; Lao, Christopher D.; Miller, Chris; Mortier, Laurent; Murrell, Dedee F.; Hamid, Omid; Quevedo, Jorge F.; Hou, Jeannie; McKenna, Edward; Dimier, Natalie; Williams, Sarah; Schadendorf, Dirk; Hauschild, Axel
    Long-term safety and efficacy of vismodegib in patients with advanced basal cell carcinoma : final update of the pivotal ERIVANCE BCC study
    In: BMC Cancer Jg. 17 (2017) S. 332
    ISSN: 1471-2407
    Online Volltext: dx.doi.org/ (Open Access)
  • Reinhardt, Julia; Landsberg, Jennifer; Schmid-Burgk, Jonathan L.; Ramis, Bartomeu Bibiloni; Bald, Tobias; Glodde, Nicole; Lopez-Ramos, Dorys; Young, Arabella; Ngiow, Shin Foong; Nettersheim, Daniel; Schorle, Hubert; Quast, Thomas; Kolanus, Waldemar; Schadendorf, Dirk; Long, Georgina V.; Madore, Jason; Scolyer, Richard A.; Ribas, Antoni; Smyth, Mark J.; Tumeh, Paul C.; Tuting, Thomas; Holzel, Michael
    MAPK signaling and inflammation link melanoma phenotype switching to induction of CD73 during immunotherapy
    In: Cancer Research Jg. 77 (2017) Nr. 17, S. 4697 - 4709
    ISSN: 1538-7445; 0008-5472
    Online Volltext: dx.doi.org/
  • Gerber, Tobias; Willscher, Edith; Loeffler-Wirth, Henry; Hopp, Lydia; Schadendorf, Dirk; Schartl, Manfred; Anderegg, Ulf; Camp, Gray; Treutlein, Barbara; Binder, Hans; Kunz, Manfred
    Mapping heterogeneity in patient-derived melanoma cultures by single-cell RNA-seq
    In: OncoTarget Jg. 8 (2017) Nr. 1, S. 846 - 862
    ISSN: 1949-2553
    Online Volltext: dx.doi.org/ (Open Access)
  • Delker, Sarah; Livingstone, Elisabeth; Schimming, Tobias; Schadendorf, Dirk; Griewank, Klaus
    Melanoma diagnosed in lesions previously treated by laser therapy
    In: The Journal of Dermatology Jg. 44 (2017) Nr. 1, S. 23 - 28
    ISSN: 1346-8138; 0385-2407
    Online Volltext: dx.doi.org/
  • Schadendorf, Dirk; Lebbé, Céleste; zur Hausen, Axel; Avril, Marie-Françoise; Hariharan, Subramanian; Bharmal, Murtuza; Becker, Jürgen
    Merkel cell carcinoma : Epidemiology, prognosis, therapy and unmet medical needs
    In: European Journal of Cancer Jg. 71 (2017) S. 53 - 69
    ISSN: 1879-2995; 0959-8049
    Online Volltext: dx.doi.org/ (Open Access)
  • Cosgarea, I.; Körber, Andreas; Dill, D.; Schadendorf, Dirk; Ugurel, Selma
    Metastatic recurrence of 17-year relapse-free melanoma during anti-TNFa therapy
    In: Journal of the European Academy of Dermatology and Venereology Jg. 31 (2017) Nr. 8, S. e368 - e369
    ISSN: 0926-9959; 1468-3083
    Online Volltext: dx.doi.org/
  • Long, Georgina V.; Weber, Jeffrey S.; Larkin, James; Atkinson, Victoria; Grob, Jean-Jacques; Schadendorf, Dirk; Dummer, Reinhard; Robert, Caroline; Márquez-Rodas, Ivan; McNeil, Catriona; Schmidt, Henrik; Briscoe, Karen; Baurain, Jean-François; Hodi, F Stephen; Wolchok, Jedd D.
    Nivolumab for Patients With Advanced Melanoma Treated Beyond Progression : Analysis of 2 Phase 3 Clinical Trials
    In: JAMA Oncology Jg. 3 (2017) Nr. 11, S. 1511 - 1519
    ISSN: 2374-2445; 2374-2437
    Online Volltext: dx.doi.org/ Online Volltext (Open Access)
  • Wolchok, J.D.; Chiarion-Sileni, V.; Gonzalez, R.; Rutkowski, P.; Grob, J.-J.; Cowey, C.L.; Lao, C.D.; Wagstaff, J.; Schadendorf, Dirk; Ferrucci, P.F.; Smylie, M.; Dummer, R.; Hill, A.; Hogg, D.; Haanen, J.; Carlino, M.S.; Bechter, O.; Maio, M.; Marquez-Rodas, I.; Guidoboni, M.; McArthur, G.; Lebbé, C.; Ascierto, P.A.; Long, G.V.; Cebon, J.; Sosman, J.; Postow, M.A.; Callahan, M.K.; Walker, D.; Rollin, L.; Bhore, R.; Hodi, F.S.; Larkin, J.
    Overall survival with combined nivolumab and ipilimumab in advanced melanoma
    In: The New England Journal of Medicine Jg. 377 (2017) Nr. 14, S. 1345 - 1356
    ISSN: 1533-4406; 0028-4793
    Online Volltext: dx.doi.org/ Online Volltext (Open Access)
  • Wistuba-Hamprecht, Kilian; Martens, Alexander; Heubach, Florian; Romano, Emanuela; Geukes Foppen, Marnix; Yuan, Jianda; Postow, Michael; Wong, Phillip; Mallardo, Domenico; Schilling, Bastian; Di Giacomo, Anna Maria; Khammari, Amir; Dreno, Brigitte; Maio, Michele; Schadendorf, Dirk; Ascierto, Paolo A.; Wolchok, Jedd D.; Blank, Christian U.; Garbe, Claus; Pawelec, Graham; Weide, Benjamin
    Peripheral CD8 effector-memory type 1 T-cells correlate with outcome in ipilimumab-treated stage IV melanoma patients
    In: European Journal of Cancer Jg. 73 (2017) S. 61 - 70
    ISSN: 1879-2995; 0959-8049; 0014-2964; 1879-0852
    Online Volltext: dx.doi.org/ Online Volltext (Open Access)
  • Brinker, Titus Josef; Schadendorf, Dirk; Klode, Joachim; Cosgarea, Ioana; Rösch, Alexander; Jansen, Philipp; Stoffels, Ingo; Izar, Benjamin
    Photoaging Mobile Apps as a Novel Opportunity for Melanoma Prevention: Pilot Study.
    In: JMIR mhealth and uhealth Jg. 5 (2017) Nr. 7,
    ISSN: 2291-5222
    Online Volltext: dx.doi.org/ Online Volltext; Online Volltext (Open Access)
  • Brinker, Titus Josef; Brieske, Christian Martin; Schaefer, Christoph Matthias; Buslaff, Fabian; Gatzka, Martina; Petri, Maximilian Philip; Sondermann, Wiebke; Schadendorf, Dirk; Stoffels, Ingo; Klode, Joachim
    Photoaging mobile apps in school-based melanoma prevention: pilot study
    In: Journal of Medical Internet Research Jg. 19 (2017) Nr. 9, S. e319
    ISSN: 1439-4456
    Online Volltext: dx.doi.org/ (Open Access)
  • Brüggemann, C.; Kirchberger, Michael Constantin; Goldinger, Simone Maria; Weide, Benjamin M.; Konrad, Andreas; Erdmann, Michael K.; Schadendorf, Dirk; Croner, Roland Siegfried; Krähenbühl, Lukas; Kähler, Katharina Charlotte; Hafner, C.; Leisgang, Waltraud; Kiesewetter, Franklin F.; Dummer, Reinhard G.; Schuler, Gerold; Stürzl, Michael; Heinzerling, Lucie M.
    Predictive value of PD-L1 based on mRNA level in the treatment of stage IV melanoma with ipilimumab
    In: Journal of Cancer Research and Clinical Oncology Jg. 143 (2017) Nr. 10, S. 1977 - 1984
    ISSN: 0171-5216
    Online Volltext: dx.doi.org/
  • Jacquelot, N; Roberti, M P; Enot, D P; Rusakiewicz, S; Ternès, N; Jegou, S; Woods, D M; Sodré, A L; Hansen, M; Meirow, Y; Sade-Feldman, M; Burra, A; Kwek, S S; Flament, C; Messaoudene, M; Duong, C P M; Chen, L; Kwon, B S; Anderson, A C; Kuchroo, V K; Weide, B; Aubin, F; Borg, C; Dalle, S; Beatrix, O; Ayyoub, M; Balme, B; Tomasic, G; Di Giacomo, A M; Maio, M; Schadendorf, Dirk; Melero, I; Dréno, B; Khammari, A; Dummer, R; Levesque, M; Koguchi, Y; Fong, L; Lotem, M; Baniyash, M; Schmidt, H; Svane, I M; Kroemer, G; Marabelle, A; Michiels, S; Cavalcanti, A; Smyth, M J; Weber, J S; Eggermont, A M; Zitvogel, L
    Predictors of responses to immune checkpoint blockade in advanced melanoma
    In: Nature Communications Jg. 8 (2017) S. 592
    ISSN: 2041-1723
    Online Volltext: dx.doi.org/ (Open Access)
  • Reinsch, Nico; Arendt, Marina; Geisel, Henrike; Schulze, Christina; Holzendorf, Volker; Warnke, Anna; Neumann, Till; Brockmeyer, Norbert H.; Schadendorf, Dirk; Eisele, Lewin; Erbel, Raimund; Moebus, Susanne; Jöckel, Karl-Heinz; Esser, Stefan
    Prolongation of the QTc interval in HIV-infected individuals compared to the general population
    In: Infection - A Journal of Infectious Disease Jg. 45 (2017) Nr. 5, S. 659 - 667
    ISSN: 1439-0973; 0300-8126
    Online Volltext: dx.doi.org/
  • Eigentler, Thomas K.; Mühlenbein, Corinna; Follmann, Markus; Schadendorf, Dirk; Garbe, Claus
    S3-Leitlinie Diagnostik, Therapie und Nachsorge des Melanoms – Update 2015/2016, Kurzversion 2.0
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Jg. 15 (2017) Nr. 6, S. e1 - e41
    ISSN: 1610-0387; 1563-2571; 1610-0379; 0301-0481
    Online Volltext: dx.doi.org/
  • Griewank, Klaus; Müller, Hansgeorg; Jackett, Louise A.; Emberger, Michael; Möller, Inga; van de Nes, Johannes; Zimmer, Lisa; Livingstone, Elisabeth; Wiesner, Thomas; Scholz, Simone L.; Cosgarea, Ioana; Sucker, Antje; Schimming, Tobias; Hillen, Uwe; Schilling, Bastian; Paschen, Annette; Reis, Henning; Mentzel, Thomas; Kutzner, Heinz; Rütten, Arno; Murali, Rajmohan; Scolyer, Richard A.; Schadendorf, Dirk
    SF3B1 and BAP1 mutations in blue nevus-like melanoma
    In: Modern Pathology Jg. 30 (2017) Nr. 7, S. 928 - 939
    ISSN: 1530-0285; 0893-3952
    Online Volltext: dx.doi.org/ Online Volltext (Open Access)
  • Weber, Jeffrey S.; Hodi, F. Stephen; Wolchok, Jedd D.; Topalian, Suzanne L.; Schadendorf, Dirk; Larkin, James; Sznol, Mario; Long, Georgina V.; Li, Hewei; Waxman, Ian M.; Jiang, Joel; Robert, Caroline
    Safety profile of nivolumab monotherapy : a pooled analysis of patients with advanced melanoma
    In: Journal of Clinical Oncology (JCO) Jg. 35 (2017) Nr. 7, S. 785 - 792
    ISSN: 0732-183X; 1527-7755
    Online Volltext: dx.doi.org/
  • Esser, Stefan; Krotzek, Judith; Dirks, Henrike; Scherbaum, Norbert; Schadendorf, Dirk
    Sexual risk behavior, sexually transmitted infections, and HIV transmission risks in HIV-positive men who have sex with men (MSM) – approaches for medical prevention
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Jg. 15 (2017) Nr. 4, S. 421 - 428
    ISSN: 1610-0387; 1563-2571; 1610-0379; 0301-0481
    Online Volltext: dx.doi.org/
  • Kalkavan, Halime; Sharma, Piyush; Kasper, Stefan; Helfrich, Iris; Pandyra, Aleksandra A.; Gassa, Asmae; Virchow, Isabel; Flatz, Lukas; Brandenburg, Tim; Namineni, Sukumar; Heikenwalder, Mathias; Höchst, Bastian; Knolle, Percy A.; Wollmann, Guido; Von Laer, Dorothee; Drexler, Ingo; Rathbun, Jessica; Cannon, Paula M.; Scheu, Stefanie; Bauer, Jens; Chauhan, Jagat; Häussinger, Dieter; Willimsky, Gerald; Löhning, Max; Schadendorf, Dirk; Brandau, Sven; Schuler, Martin; Lang, Philipp A.; Lang, Karl S.
    Spatiotemporally restricted arenavirus replication induces immune surveillance and type i interferon-dependent tumour regression
    In: Nature Communications Jg. 8 (2017) S. 14447
    ISSN: 2041-1723
    Online Volltext: dx.doi.org/ (Open Access)
  • Ugurel, Selma; Röhmel, Joachim; Ascierto, Paolo A.; Flaherty, Keith T.; Grob, Jean Jacques; Hauschild, Axel; Larkin, James; Long, Georgina V.; Lorigan, Paul; McArthur, Grant A.; Ribas, Antoni; Robert, Caroline; Schadendorf, Dirk; Garbe, Claus
    Survival of patients with advanced metastatic melanoma : the impact of novel therapies–update 2017
    In: European Journal of Cancer Jg. 83 (2017) S. 247 - 257
    ISSN: 1879-2995; 0959-8049
    Online Volltext: dx.doi.org/
  • Wittig-Blaich, Stephanie; Wittig, Rainer; Schmidt, Steffen; Lyer, Stefan; Bewerunge-Hudler, Melanie; Gronert-Sum, Sabine; Strobel-Freidekind, Olga; Müller, Carolin; List, Markus; Jaskot, Aleksandra; Christiansen, Helle; Hafner, Mathias; Schadendorf, Dirk; Block, Ines; Mollenhauer, Jan
    Systematic screening of isogenic cancer cells identifies DUSP6 as context-specific synthetic lethal target in melanoma
    In: OncoTarget Jg. 8 (2017) Nr. 14, S. 23760 - 23774
    ISSN: 1949-2553
    Online Volltext: dx.doi.org/ (Open Access)
  • Cosgarea, Ioana; Ugurel, Selma; Sucker, Antje; Livingstone, Elisabeth; Zimmer, Lisa; Ziemer, Mirjana; Utikal, Jochen; Mohr, Peter; Pfeiffer, Christiane; Pföhler, Claudia; Hillen, Uwe; Horn, Susanne; Schadendorf, Dirk; Griewank, Klaus; Rösch, Alexander
    Targeted next generation sequencing of mucosal melanomas identifies frequent NF1 and RAS mutations
    In: OncoTarget Jg. 8 (2017) Nr. 25, S. 40683 - 40692
    ISSN: 1949-2553
    Online Volltext: dx.doi.org/ (Open Access)
  • Young, Arabella; Ngiow, Shin Foong; Madore, Jason; Reinhardt, Julia; Landsberg, Jennifer; Chitsazan, Arash; Rautela, Jai; Bald, Tobias; Barkauskas, Deborah S.; Ahern, Elizabeth; Huntington, Nicholas D.; Schadendorf, Dirk; Long, Georgina V.; Boyle, Glen M.; Hölzel, Michael; Scolyer, Richard A.; Smyth, Mark J.
    Targeting adenosine in BRAF-mutant melanoma reduces tumor growth and metastasis
    In: Cancer Research Jg. 77 (2017) Nr. 17, S. 4684 - 4696
    ISSN: 1538-7445; 0008-5472
    Online Volltext: dx.doi.org/
  • Schadendorf, Dirk; Long, Georgina V.; Stroiakovski, Daniil; Karaszewska, Boguslawa; Hauschild, Axel; Levchenko, Evgeny; Chiarion-Sileni, Vanna; Schachter, Jacob; Garbe, Claus; Dutriaux, Caroline; Gogas, Helen; Mandalà, Mario; Haanen, John B. A. G.; Lebbé, Céleste; Mackiewicz, Andrzej; Rutkowski, Piotr; Grob, Jean-Jacques; Nathan, Paul; Ribas, Antoni; Davies, Michael A.; Zhang, Ying; Kaper, Mathilde; Mookerjee, Bijoyesh; Legos, Jeffrey J.; Flaherty, Keith T.; Robert, Caroline
    Three-year pooled analysis of factors associated with clinical outcomes across dabrafenib and trametinib combination therapy phase 3 randomised trials
    In: European Journal of Cancer Jg. 82 (2017) S. 45 - 55
    ISSN: 1879-2995; 0959-8049; 0014-2964; 1879-0852
    Online Volltext: dx.doi.org/
  • Dréno, Brigitte; Kunstfeld, Rainer; Hauschild, Axel; Fosko, Scott; Zloty, David; Labeille, Bruno; Grob, Jean-Jacques; Puig, Susana; Gilberg, Frank; Bergström, Daniel; Page, Damian R; Rogers, Gary; Schadendorf, Dirk
    Two intermittent vismodegib dosing regimens in patients with multiple basal-cell carcinomas (MIKIE) : a randomised, regimen-controlled, double-blind, phase 2 trial
    In: The Lancet Oncology Jg. 18 (2017) Nr. 3, S. 404 - 412
    ISSN: 1470-2045
    Online Volltext: dx.doi.org/
  • Hoge, Jennifer C.; Schadendorf, Dirk
    Update der S3-Leitlinie zum malignen Melanom : aktuelle Empfehlungen für das fortgeschrittene Melanom
    In: Best Practice Onkologie Jg. 12 (2017) Nr. 2, S. 110 - 118
    ISSN: 1862-8559; 0946-4565
    Online Volltext: dx.doi.org/
  • Cosgarea, Ioana; Ritter, Cathrin; Becker, Jürgen; Schadendorf, Dirk; Ugurel, Selma
    Update on the clinical use of kinase inhibitors in melanoma
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Jg. 15 (2017) Nr. 9, S. 887 - 893
    ISSN: 1610-0387; 1563-2571; 1610-0379; 0301-0481
    Online Volltext: dx.doi.org/
  • McArthur, Grant A.; Maio, Michele; Arance, Ana Maria; Nathan, Paul D.; Blank, Christian U.; Avril, Marie Françoise; Garbe, Claus; Hauschild, Axel; Schadendorf, Dirk; Hamid, Omid A.; Fluck, Michael; Thebeau, Melissa S.; Schachter, Jacob M.; Kefford, Rick F.; Chamberlain, Marc Charles; Makrutzki, Martina; Robson, Susan; Gonzalez, René C.; Margolin, Kim A.
    Vemurafenib in metastatic melanoma patients with brain metastases : An open-label, single-arm, phase 2, multicentre study
    In: Annals of Oncology Jg. 28 (2017) Nr. 3, S. 634 - 641
    ISSN: 1569-8041; 0923-7534
    Online Volltext: dx.doi.org/
  • Campigotto, F.; Schadendorf, Dirk; Nägeli, M.; Micaletto, S.; Schmid, H.; Goldinger, S.M.; Kriemler-Krahn, U.; Dummer, R.; Michielin, O.A.; Pedroncelli, A.
    A phase I, open-label study of pasireotide in patients with BRAF- and NRAS-wild type, unresectable and or metastatic melanoma
    In: Annals of Oncology Jg. 27 (2016) Nr. Suppl. 6,
    ISSN: 1569-8041; 0923-7534
    Online Volltext: dx.doi.org/
  • Eigentler, T K; Gutzmer, R; Hauschild, A; Heinzerling, L; Schadendorf, Dirk; Nashan, D; Hölzle, E; Kiecker, F; Becker, Jürgen; Sunderkötter, C; Moll, I; Richtig, E; Pönitzsch, I; Pehamberger, H; Kaufmann, R; Pföhler, C; Vogt, T; Berking, C; Praxmarer, M; Garbe, C
    Adjuvant treatment with pegylated interferon ?-2a versus low-dose interferon ?-2a in patients with high-risk melanoma : a randomized phase III DeCOG trial
    In: Annals of Oncology Jg. 27 (2016) Nr. 8, S. 1625 - 1632
    ISSN: 0923-7534; 1569-8041
    Online Volltext: dx.doi.org/ (Open Access)
  • Gebhardt, C.; Sucker, A.; Schadendorf, Dirk; Haselmann, V.H.; Neumaier, M.; Duda, A.; Brechtel, I.; Utikal, J.
    Analysis of BRAF V600E mutation status – concordance of results from circulating tumor DNA and tissue-based testing and impact on prediction of the clinical course in patients undergoing BRAFi therapy
    In: Annals of Oncology Jg. 27 (2016) Nr. Suppl. 6, S. 1145P
    ISSN: 1569-8041; 0923-7534
    Online Volltext: dx.doi.org/
  • Robert, C.; Schadendorf, Dirk; Long, G.V.; Stroyakovskiy, D.; Levchenko, E.; Chiarion-Sileni, V.; Flaherty, K.; Nathan, P.; Ribas, A.; Davies, M.; Zhang, J.; Chen, L.; Mookerjee, B.; Redhu, S.; Grob, J.J.
    Analysis of patient-reported outcomes by disease progression status in patients (pts) with BRAF V600–mutant metastatic melanoma in the COMBI-d and COMBI-v trials
    In: Annals of Oncology Jg. 27 (2016) Nr. Suppl. 6, S. 1140P
    ISSN: 1569-8041
    Online Volltext: dx.doi.org/
  • Weide, Benjamin; Martens, Alexander; Hassel, Jessica C; Berking, Carola; Postow, Michael A; Bisschop, Kees; Simeone, Ester; Mangana, Johanna; Schilling, Bastian; Di Giacomo, Anna Maria; Brenner, Nicole; Kähler, Katharina; Heinzerling, Lucie; Gutzmer, Ralf; Bender, Armin; Gebhardt, Christoffer; Romano, Emanuela; Meier, Friedegund; Martus, Peter; Maio, Michele; Blank, Christian; Schadendorf, Dirk; Dummer, Reinhard; Ascierto, Paolo A; Hospers, Geke; Garbe, Claus; Wolchok, Jedd D
    Baseline Biomarkers for Outcome of Melanoma Patients Treated with Pembrolizumab
    In: Clinical Cancer Research Jg. 22 (2016) Nr. 22, S. 5487 - 5496
    ISSN: 1078-0432
    Online Volltext: dx.doi.org/ (Open Access)
  • Martens, Alexander; Wistuba-Hamprecht, Kilian; Geukes Foppen, Marnix; Yuan, Jianda; Postow, Michael A; Wong, Phillip; Romano, Emanuela; Khammari, Amir; Dreno, Brigitte; Capone, Mariaelena; Ascierto, Paolo A; Di Giacomo, Anna Maria; Maio, Michele; Schilling, Bastian; Sucker, Antje; Schadendorf, Dirk; Hassel, Jessica C; Eigentler, Thomas K; Martus, Peter; Wolchok, Jedd D; Blank, Christian; Pawelec, Graham; Garbe, Claus; Weide, Benjamin
    Baseline Peripheral Blood Biomarkers Associated with Clinical Outcome of Advanced Melanoma Patients Treated with Ipilimumab
    In: Clinical Cancer Research Jg. 22 (2016) Nr. 12, S. 2908 - 2918
    ISSN: 1078-0432
    Online Volltext: dx.doi.org/ (Open Access)
  • Hauschild, Axel; Schadendorf, Dirk
    Checkpoint inhibitors : a new standard of care for advanced Merkel cell carcinoma?
    In: The Lancet Oncology Jg. 17 (2016) Nr. 10, S. 1337 - 1339
    ISSN: 1470-2045; 1474-5488
    Online Volltext: dx.doi.org/
  • Herz, Saskia; Höfer, Thomas; Papapanagiotou, Matina; Leyh, Julia Christina; Meyenburg, Sarah; Schadendorf, Dirk; Ugurel, Selma; Rösch, Alexander; Livingstone, Elisabeth; Schilling, Bastian; Franklin, Cindy
    Checkpoint inhibitors in chronic kidney failure and an organ transplant recipient
    In: European Journal of Cancer Jg. 67 (2016) S. 66 - 72
    ISSN: 0959-8049
    Online Volltext: dx.doi.org/
  • McGranahan, Nicholas; Furness, Andrew J S; Rosenthal, Rachel; Ramskov, Sofie; Lyngaa, Rikke; Saini, Sunil Kumar; Jamal-Hanjani, Mariam; Wilson, Gareth A; Birkbak, Nicolai J; Hiley, Crispin T; Watkins, Thomas B K; Shafi, Seema; Murugaesu, Nirupa; Mitter, Richard; Akarca, Ayse U; Linares, Joseph; Marafioti, Teresa; Henry, Jake Y; Van Allen, Eliezer M; Miao, Diana; Schilling, Bastian; Schadendorf, Dirk; Garraway, Levi A; Makarov, Vladimir; Rizvi, Naiyer A; Snyder, Alexandra; Hellmann, Matthew D; Merghoub, Taha; Wolchok, Jedd D; Shukla, Sachet A; Wu, Catherine J; Peggs, Karl S; Chan, Timothy A; Hadrup, Sine R; Quezada, Sergio A; Swanton, Charles
    Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade
    In: Science Jg. 351 (2016) Nr. 6280, S. 1463 - 1469
    ISSN: 0036-8075; 1095-9203
    Online Volltext: dx.doi.org/
  • Santiago-Walker, Ademi; Gagnon, Robert; Mazumdar, Jolly; Casey, Michelle; Long, Georgina V.; Schadendorf, Dirk; Flaherty, Keith; Kefford, Richard; Hauschild, Axel; Hwu, Patrick; Haney, Patricia; O'Hagan, Anne; Carver, Jennifer; Goodman, Vicki; Legos, Jeffrey; Martin, Anne Marie
    Correlation of BRAF Mutation Status in Circulating-Free DNA and Tumor and Association with Clinical Outcome across Four BRAFi and MEKi Clinical Trials
    In: Clinical Cancer Research Jg. 22 (2016) Nr. 3, S. 567 - 574
    ISSN: 1078-0432
    Online Volltext: dx.doi.org/ (Open Access)
  • Hofmann, Lars; Heinzerling, Lucie M.; Dummer, Reinhard; Schuler, Gerold; Schadendorf, Dirk; Krackhardt, Angela M.; Gesierich, Anja; Berking, Carola; Eigentler, Thomas; Kirchberger, Michael C.; Garbe, Claus; Dietrich, Ursula; Wahl, Renate; Leverkus, Martin; Weishaupt, Carsten; Thomas, Ioannis; Tietze, Julia K.; Meier, Friedegund; Hassel, Jessica C.; Göppner, Daniela; Utikal, Jochen S.; Gutzmer, Ralf; Schmidgen, Maria I.; Ugurel, Selma; Zimmer, Lisa; Goldinger, Simone M.; Loquai, Carmen; Forschner, Andrea
    Cutaneous, gastrointestinal, hepatic, endocrine, and renal side-effects of anti-PD-1 therapy
    In: European Journal of Cancer Jg. 60 (2016) S. 190 - 209
    ISSN: 1879-0852; 1879-2995
    Online Volltext: dx.doi.org/
  • van de Nes, Johannes; Wrede, Karsten; Ringelstein, Adrian; Stiller, Mathias; Horn, Susanne; Sucker, Antje; Möller, Inga; Scholz, Simone L; Murali, Rajmohan; Gessi, Marco; Schadendorf, Dirk; Griewank, Klaus
    Diagnosing a Primary Leptomeningeal Melanoma by Gene Mutation Signature
    In: The Journal of Investigative Dermatology Jg. 136 (2016) Nr. 7, S. 1526 - 1528
    ISSN: 0022-202X; 1523-1747
    Online Volltext: dx.doi.org/
  • Schadendorf, Dirk
    Eine Übersicht über Therapiefortschritte in den letzten 50 Jahren beim Metastasierten Melanom
    In: Drug Research Jg. 66 (2016) Nr. S 01, S. 31 - S34
    ISSN: 2194-9379
    Online Volltext: dx.doi.org/
  • Schadendorf, Dirk
    Entscheidungsfindung für die klinische Praxis : Aktuelle Konzepte und Behandlungsalgorithmen mit Immun-Checkpoint-Inhibitoren beim Melanom
    In: Oncology Research and Treatment Jg. 39 (2016) Nr. Suppl. 4, S. 8 - 12
    ISSN: 2296-5262
    Online Volltext: dx.doi.org/
  • Schadendorf, Dirk; Hauschild, A.; Fosko, S.; Zloty, D.; Labeille, B.; Grob, J.J.; Puig, S.; Makrutzki, M.; Templeton, I.; Rogers, G.; Dreno, B.; Kunstfeld, R.
    Evaluation of the pharmacokinetic (PK) profile of vismodegib (VISMO) in patients (pts) with multiple basal cell carcinomas (BCCs) across two intermittent treatment regimens in the MIKIE study
    In: Annals of Oncology Jg. 27 (2016) Nr. Suppl. 6, S. 1152P
    ISSN: 1569-8041
    Online Volltext: dx.doi.org/
  • Ebstein, Frédéric; Keller, Martin; Paschen, Annette; Walden, Peter; Seeger, Michael; Bürger, Elke; Krüger, Elke; Schadendorf, Dirk; Kloetzel, Peter-M; Seifert, Ulrike
    Exposure to Melan-A/MART-126-35 tumor epitope specific CD8(+)T cells reveals immune escape by affecting the ubiquitin-proteasome system (UPS)
    In: Scientific Reports Jg. 6 (2016) S. 25208
    ISSN: 2045-2322
    Online Volltext: dx.doi.org/ (Open Access)
  • Long, Georgina V; Grob, Jean-Jacques; Nathan, Paul; Ribas, Antoni; Robert, Caroline; Schadendorf, Dirk; Lane, Stephen R; Mak, Carmen; Legenne, Philippe; Flaherty, Keith T; Davies, Michael A
    Factors predictive of response, disease progression, and overall survival after dabrafenib and trametinib combination treatment : a pooled analysis of individual patient data from randomised trials
    In: The Lancet Oncology Jg. 17 (2016) Nr. 12, S. 1743 - 1754
    ISSN: 1470-2045; 1474-5488
    Online Volltext: dx.doi.org/
  • Hamid, O.; Puzanov, I.; Dummer, R.; Schachter, J.; Daud, A.; Schadendorf, Dirk; Blank, C.; Cranmer, L.D.; Robert, C.; Pavlick, A.C.; Gonzalez, R.; Hodi, F.S.; Ascierto, P.A.; Salama, A.; Margolin, K.A.; Gangadhar, T.C.; Wei, Z.; Ebbinghaus, S.W.; Ibrahim, N.; Ribas, A.
    Final overall survival for KEYNOTE-002 : pembrolizumab (pembro) versus investigator-choice chemotherapy (chemo) for ipilimumab (ipi)-refractory melanoma
    In: Annals of Oncology Jg. 27 (2016) Nr. Suppl. 6, S. 1107O
    ISSN: 1569-8041
    Online Volltext: dx.doi.org/
  • Schadendorf, Dirk; Dummer, Reinhard; Hauschild, Axel; Robert, Caroline; Hamid, Omid; Daud, Adil; van den Eertwegh, Alfons; Cranmer, Lee; O'Day, Steven; Puzanov, Igor; Schachter, Jacob; Blank, Christian; Salama, April; Loquai, Carmen; Mehnert, Janice M; Hille, Darcy; Ebbinghaus, Scot; Kang, S Peter; Zhou, Wei; Ribas, Antoni
    Health-related quality of life in the randomised KEYNOTE-002 study of pembrolizumab versus chemotherapy in patients with ipilimumab-refractory melanoma
    In: European Journal of Cancer Jg. 67 (2016) S. 46 - 54
    ISSN: 0959-8049
    Online Volltext: dx.doi.org/ (Open Access)
  • Nathan, P.; Levchenko, E.; Davies, M.; Chiarion-Sileni, V.; Grob, J.J.; Long, G.V.; Schadendorf, Dirk; Robert, C.; Chen, L.; Mookerjee, B.; Redhu, S.; Zhang, J.; Ribas, A.; Stroyakovskiy, D.; Flaherty, K.
    Health-related quality-of-life (HRQOL) impact of dabrafenib (D) and trametinib (T) vs BRAF inhibitor (BRAFi) monotherapy by lactate dehydrogenase (LDH) in patients (pts) with BRAF V600–mutant melanoma
    In: Annals of Oncology Jg. 27 (2016) Nr. Suppl. 6, S. 1137P
    ISSN: 1569-8041; 0923-7534
    Online Volltext: dx.doi.org/
  • Ekedahl, Henrik; Lauss, Martin; Olsson, Håkan; Griewank, Klaus; Schadendorf, Dirk; Ingvar, Christian; Jönsson, Göran
    High TERT promoter mutation frequency in non-acral cutaneous metastatic melanoma
    In: Pigment Cell and Melanoma Research Jg. 29 (2016) Nr. 5, S. 598 - 600
    ISSN: 1755-1471; 1755-148X
    Online Volltext: dx.doi.org/
  • Martens, Alexander; Wistuba-Hamprecht, Kilian; Yuan, Jianda; Postow, Michael A; Wong, Phillip; Capone, Mariaelena; Madonna, Gabriele; Khammari, Amir; Schilling, Bastian; Sucker, Antje; Schadendorf, Dirk; Martus, Peter; Dreno, Brigitte; Ascierto, Paolo A; Wolchok, Jedd D; Pawelec, Graham; Garbe, Claus; Weide, Benjamin
    Increases in Absolute Lymphocytes and Circulating CD4+ and CD8+ T Cells Are Associated with Positive Clinical Outcome of Melanoma Patients Treated with Ipilimumab
    In: Clinical Cancer Research Jg. 22 (2016) Nr. 19, S. 4848 - 4858
    ISSN: 1078-0432
    Online Volltext: dx.doi.org/
  • Potrony, Miriam; Carreras, Esther; Aranda, Fernando; Zimmer, Lisa; Puig-Butille, Joan-Anton; Tell-Martí, Gemma; Armiger, Noelia; Sucker, Antje; Giménez-Xavier, Pol; Martínez-Florensa, Mario; Carrera, Cristina; Malvehy, Josep; Schadendorf, Dirk; Puig, Susana; Lozano, Francisco
    Inherited functional variants of the lymphocyte receptor CD5 influence melanoma survival
    In: International Journal of Cancer Jg. 139 (2016) Nr. 6, S. 1297 - 1302
    ISSN: 0020-7136; 1097-0215
    Online Volltext: dx.doi.org/ (Open Access)
  • Sondermann, Wiebke; Zimmer, Lisa; Schadendorf, Dirk; Rösch, Alexander; Klode, Joachim; Dissemond, Joachim
    Initial misdiagnosis of melanoma located on the foot is associated with poorer prognosis
    In: Medicine Jg. 95 (2016) Nr. 29, S. e4332
    ISSN: 0025-7974; 1536-5964
    Online Volltext: dx.doi.org/ (Open Access)
  • Weber, Jeffrey S; Postow, Michael; Lao, Christopher D; Schadendorf, Dirk
    Management of Adverse Events Following Treatment With Anti-Programmed Death-1 Agents
    In: The Oncologist Jg. 21 (2016) Nr. 10, S. 1230 - 1240
    ISSN: 1083-7159; 2159-8401; 1549-490X
    Online Volltext: dx.doi.org/ Online Volltext (Open Access)
  • Xie, Huaping; Sivaramakrishna, Rachakonda; Heidenreich, Barbara; Nagore, Eduardo; Sucker, Antje; Hemminki, Kari; Schadendorf, Dirk; Kumar, Rajiv
    Mapping of deletion breakpoints at the CDKN2A locus in melanoma : Detection of MTAP-ANRIL fusion transcripts
    In: OncoTarget Jg. 7 (2016) Nr. 13, S. 16490 - 16504
    ISSN: 1949-2553
    Online Volltext: dx.doi.org/
  • Livingstone, Elisabeth; Rösch, Alexander; Schadendorf, Dirk; Zimmer, Lisa; Schilling, Bastian
    Medikamentöse Therapie des metastasierten malignen Melanoms
    In: Arzneimitteltherapie Jg. 34 (2016) Nr. 1-2, S. 14 - 22
    ISSN: 0723-6913
  • Zhao, Fang; Sucker, Antje; Horn, Susanne; Heeke, Christina; Bielefeld, Nicola; Schrörs, Barbara; Bicker, Anne; Lindemann, Monika; Rösch, Alexander; Gaudernack, Gustav; Stiller, Mathias; Becker, Jürgen; Lennerz, Volker; Wölfel, Thomas; Schadendorf, Dirk; Griewank, Klaus; Paschen, Annette
    Melanoma Lesions Independently Acquire T-cell Resistance during Metastatic Latency
    In: Cancer Research Jg. 76 (2016) Nr. 15, S. 4347 - 4358
    ISSN: 1538-7445; 0008-5472
    Online Volltext: dx.doi.org/
  • Schadendorf, Dirk; Schilling, Bastian
    Molecular features of response to anti-PD-1 therapy
    In: Chinese Clinical Oncology Jg. 5 (2016) Nr. 6, S. 74
    ISSN: 2304-3865
    Online Volltext: dx.doi.org/ (Open Access)
  • Zimmer, Lisa; Heinzerling, Lucie M.; Dummer, Reinhard; Schuler, Gerold; Schadendorf, Dirk; Krackhardt, Angela M.; Gesierich, Anja; Berking, Carola; Eigentler, Thomas; Kirchberger, Michael C.; Garbe, Claus; Dietrich, Ursula; Wahl, Renate; Leverkus, Martin; Weishaupt, Carsten; Forschner, Andrea; Tietze, Julia K.; Meier, Friedegund; Hassel, Jessica C.; Göppner, Marian-Daniela; Utikal, Jochen S.; Gutzmer, Ralf; Schmidgen, Maria I.; Thomas, Ioannis; Ugurel, Selma; Loquai, Carmen; Hofmann, Lars; Goldinger, Simone M.
    Neurological, respiratory, musculoskeletal, cardiac and ocular side-effects of anti-PD-1 therapy
    In: European Journal of Cancer Jg. 60 (2016) S. 210 - 225
    ISSN: 1879-0852
    Online Volltext: dx.doi.org/
  • Hillen, Uwe; Grabellus, Florian; Franklin, Cindy; Sucker, Antje; Schadendorf, Dirk; Schilling, Bastian
    Oncogene Status of an Interdigitating Dendritic Cell Sarcoma : Recurrent Mutations in NF1, TP53, and ARID2 Shared With Melanoma
    In: The American Journal of Surgical Pathology Jg. 40 (2016) Nr. 12, S. 1721 - 1723
    ISSN: 0147-5185
    Online Volltext: dx.doi.org/
  • Griewank, Klaus; Schilling, Bastian; Scholz, Simone L; Metz, Claudia H; Livingstone, Elisabeth; Sucker, Antje; Möller, Inga; Reis, Henning; Franklin, Cindy; Cosgarea, Ioana; Hillen, Uwe; Steuhl, Klaus-Peter; Schadendorf, Dirk; Westekemper, Henrike; Zimmer, Lisa
    Oncogene status as a diagnostic tool in ocular and cutaneous melanoma
    In: European Journal of Cancer Jg. 57 (2016) S. 112 - 117
    ISSN: 0959-8049
    Online Volltext: dx.doi.org/
  • Wolchok, J.; Wagstaff, J.; Long, G.V.; Hodi, F.S.; Hassel, J.; Hoeller, C.; Larkin, J.; Ascierto, P.A.; Lebbe, C.; Haanen, J.B.A.G.; Schadendorf, Dirk; Hogg, D.; Horak, C.; Robert, C.; Dummer, R.; Sileni, V.; Pavlick, A.C.; Rutkowski, P.; Corrie, P.
    PD-L1 expression as a biomarker for nivolumab (NIVO) plus ipilimumab (IPI) and NIVO alone in advanced melanoma (MEL) : A pooled analysis
    In: Annals of Oncology Jg. 27 (2016) Nr. Suppl. 6, S. 1112PD
    ISSN: 1569-8041; 0923-7534
    Online Volltext: dx.doi.org/
  • Wistuba-Hamprecht, Kilian; Di Benedetto, Svetlana; Schilling, Bastian; Sucker, Antje; Schadendorf, Dirk; Garbe, Claus; Weide, Benjamin; Pawelec, Graham
    Phenotypic characterization and prognostic impact of circulating γδ and αβ T-cells in metastatic malignant melanoma
    In: International Journal of Cancer Jg. 138 (2016) Nr. 3, S. 698 - 704
    ISSN: 0020-7136; 1097-0215
    Online Volltext: dx.doi.org/ (Open Access)
  • Rösch, Alexander; Paschen, Annette; Landsberg, Jenny; Helfrich, Iris; Becker, Jürgen; Schadendorf, Dirk
    Phenotypic tumour cell plasticity as a resistance mechanism and therapeutic target in melanoma
    In: European Journal of Cancer Jg. 59 (2016) S. 109 - 112
    ISSN: 0959-8049
    Online Volltext: dx.doi.org/
  • Petri, M.; Klode, Joachim; Schadendorf, Dirk; Dissemond, Joachim; Schulz, Andrea; Ley, Julia; Stoffels, Ingo; Jose, Jithin
    Photoacoustic imaging of real-time oxygen changes in chronic leg ulcers after topical application of a haemoglobin spray : a pilot study
    In: Journal of Wound Care Jg. 25 (2016) Nr. 2, S. 87 - 91
    ISSN: 0969-0700; 2052-2916
    Online Volltext: dx.doi.org/
  • Grob, J.J.; Schadendorf, Dirk; Mookerjee, B.; Flaherty, K.; Ribas, A.; Nathan, P.; Lane, S.; Robert, C.; Long, G.V.; Davies, M.; Legos, J.J.
    Pooled analysis of factors to predict durable clinical outcomes with combination dabrafenib (D) and trametinib (T) across registration trials
    In: Annals of Oncology Jg. 27 (2016) Nr. Suppl. 6, S. 1134P
    ISSN: 1569-8041; 0923-7534
    Online Volltext: dx.doi.org/
  • Kaehler, Katharina C; Blome, Christine; Forschner, Andrea; Gutzmer, Ralf; Haalck, Thomas; Heinzerling, Lucie; Kornek, Thomas; Livingstone, Elisabeth; Loquai, Carmen; Maul, Lara Valeska; Lang, Berenice M; Schadendorf, Dirk; Stade, Barbara; Terheyden, Patrick; Utikal, Jochen; Wagner, Tobias; Hauschild, Axel; Garbe, Claus; Augustin, Matthias
    Preferences of German melanoma patients for interferon (IFN) α-2b toxicities (the DeCOG "GERMELATOX survey") versus melanoma recurrence to quantify patients' relative values for adjuvant therapy
    In: Medicine Jg. 95 (2016) Nr. 46, S. e5375
    ISSN: 0025-7974; 1536-5964
    Online Volltext: dx.doi.org/ (Open Access)
  • Wistuba-Hamprecht, Kilian; Martens, Alexander; Haehnel, Karin; Geukes Foppen, Marnix; Yuan, Jianda; Postow, Michael A; Wong, Phillip; Romano, Emanuela; Khammari, Amir; Dreno, Brigitte; Capone, Mariaelena; Ascierto, Paolo A; Demuth, Ilja; Steinhagen-Thiessen, Elisabeth; Larbi, Anis; Schilling, Bastian; Schadendorf, Dirk; Wolchok, Jedd D; Blank, Christian U; Pawelec, Graham; Garbe, Claus; Weide, Benjamin
    Proportions of blood-borne Vδ1+ and Vδ2+ T-cells are associated with overall survival of melanoma patients treated with ipilimumab
    In: European Journal of Cancer Jg. 64 (2016) S. 116 - 126
    ISSN: 0959-8049
    Online Volltext: dx.doi.org/ Online Volltext (Open Access)
  • Ebstein, Frédéric; Textoris-Taube, Kathrin; Keller, Christin; Golnik, Richard; Vigneron, N.; Van den Eynde, Benoît J.; Schuler-Thurner, Beatrice; Schadendorf, Dirk; Lorenz, Felix K.M.; Uckert, Wolfgang A.; Urban, Sabrina; Lehmann, Andrea; Albrecht-Koepke, N.; Janek, Katharina; Henklein, Petra; Niewienda, Agathe; Kloetzel, Peter Michael; Mishto, Michele
    Proteasomes generate spliced epitopes by two different mechanisms and as efficiently as non-spliced epitopes
    In: Scientific Reports Jg. 6 (2016) S. 24032
    ISSN: 2045-2322
    Online Volltext: dx.doi.org/ (Open Access)
  • Willmes, Christoph; Ugurel, Selma; Sucker, Antje; Schadendorf, Dirk; Hesbacher, Sonja; Poppe, Lidia; Fried, Isabella; Becker, Jürgen; Kumar, Rajiv
    SERPINB1 expression is predictive for sensitivity and outcome of cisplatin-based chemotherapy in melanoma
    In: OncoTarget Jg. 7 (2016) Nr. 9, S. 10117 - 10132
    ISSN: 1949-2553
    Online Volltext: dx.doi.org/ (Open Access)
  • Gutzmer, R; Rivoltini, L; Levchenko, E; Testori, A; Utikal, J; Ascierto, P A; Demidov, L; Grob, J J; Ridolfi, R; Schadendorf, Dirk; Queirolo, P; Santoro, A; Loquai, C; Dreno, B; Hauschild, A; Schultz, E; Lesimple, T P; Vanhoutte, N; Salaun, B; Gillet, M; Jarnjak, S; De Sousa Alves, P M; Louahed, J; Brichard, V G; Lehmann, F F
    Safety and immunogenicity of the PRAME cancer immunotherapeutic in metastatic melanoma : results of a phase I dose escalation study
    In: ESMO Open Jg. 1 (2016) Nr. 4, S. e000068
    ISSN: 2059-7029
    Online Volltext: dx.doi.org/ (Open Access)
  • Stiller, Mathias; Sucker, Antje; Griewank, Klaus; Aust, Daniela; Baretton, Gustavo Bruno; Schadendorf, Dirk; Horn, Susanne
    Single-strand DNA library preparation improves sequencing of formalin-fixed and paraffin-embedded (FFPE) cancer DNA
    In: OncoTarget Jg. 7 (2016) Nr. 37, S. 59115 - 59128
    ISSN: 1949-2553
    Online Volltext: dx.doi.org/ (Open Access)
  • Ugurel, Selma; Röhmel, Joachim; Ascierto, Paolo A.; Flaherty, Keith T.; Grob, Jean Jacques; Hauschild, Axel; Larkin, James; Long, Georgina V.; Lorigan, Paul; McArthur, Grant A.; Ribas, Antoni; Robert, Caroline; Schadendorf, Dirk; Garbe, Claus
    Survival of patients with advanced metastatic melanoma: The impact of novel therapies
    In: European Journal of Cancer Jg. 53 (2016) S. 125 - 134
    ISSN: 1879-2995; 0959-8049
    Online Volltext: dx.doi.org/
  • van de Nes, Johannes; Gessi, Marco; Sucker, Antje; Möller, Inga; Stiller, Mathias; Horn, Susanne; Scholz, Simone L.; Pischler, Carina; Stadtler, Nadine; Schilling, Bastian; Zimmer, Lisa; Hillen, Uwe; Scolyer, Richard A.; Buckland, Michael E.; Lauriola, Libero; Pietsch, Torsten; Waha, Andreas; Schadendorf, Dirk; Murali, Rajmohan; Griewank, Klaus
    Targeted next generation sequencing reveals unique mutation profile of primary melanocytic tumors of the central nervous system
    In: Journal of Neuro-Oncology Jg. 127 (2016) Nr. 3, S. 435 - 444
    ISSN: 1573-7373; 0167-594X
    Online Volltext: dx.doi.org/ Online Volltext (Open Access)
  • Kandilarova, Snezhina Mihailova; Paschen, Annette; Mihaylova, Anastassia; Ivanova, Milena; Schadendorf, Dirk; Naumova, Elissaveta
    The Influence of HLA and KIR Genes on Malignant Melanoma Development and Progression
    In: Archivum Immunologiae et Therapiae Experimentalis Jg. 64 (2016) Nr. Suppl. 1, S. 73 - 81
    ISSN: 0004-069X; 1661-4917
    Online Volltext: dx.doi.org/
  • van Kempen, Léon C L; Redpath, Margaret; Elchebly, Mounib; Klein, Kathleen Oros; Papadakis, Andreas I; Wilmott, James S; Scolyer, Richard A; Edqvist, Per-Henrik; Pontén, Fredrik; Schadendorf, Dirk; van Rijk, Anke F; Michiels, Stefan; Dumay, Anne; Helbling-Leclerc, Anne; Dessen, Philippe; Wouters, Jasper; Stass, Marguerite; Greenwood, Celia M T; Ghanem, Ghanem E; van den Oord, Joost; Feunteun, Jean; Spatz, Alan
    The protein phosphatase 2A regulatory subunit PR70 is a gonosomal melanoma tumor suppressor gene
    In: Science Translational Medicine Jg. 8 (2016) Nr. 369, S. 369ra177
    ISSN: 1946-6234; 1946-6242
    Online Volltext: dx.doi.org/
  • Robert, C.; Karaszewska, B.; Schachter, J.; Rutkowski, P.; Mackiewicz, A.; Stroyakovskiy, D.; Dummer, R.; Grange, F.; Mortier, L.; Chiarion-Sileni, V.; Drucis, K.; Krajsová, I.; Hauschild, A.; Mookerjee, B.; Legos, J.J.; Zhang, Y.; Lane, S.; Schadendorf, Dirk
    Three-year estimate of overall survival in COMBI-v, a randomized phase 3 study evaluating first-line dabrafenib (D) + trametinib (T) in patients (pts) with unresectable or metastatic BRAF V600E/K–mutant cutaneous melanoma
    In: Annals of Oncology Jg. 27 (2016) Nr. Suppl. 6, S. LBA40
    ISSN: 1569-8041
    Online Volltext: dx.doi.org/
  • Harries, Mark; Malvehy, Josep; Lebbe, Céleste; Heron, Louise; Amelio, Justyna; Szabo, Zsolt; Schadendorf, Dirk
    Treatment patterns of advanced malignant melanoma (stage III–IV) – A review of current standards in Europe
    In: European Journal of Cancer Jg. 60 (2016) S. 179 - 189
    ISSN: 0959-8049
    Online Volltext: dx.doi.org/
  • Kaur, Amanpreet; Schadendorf, Dirk; Schilling, Bastian; Lehrmann, Elin; Yin, Xiangfan; Tang, Hsin-Yao; Meeth, Katrina; Kossenkov, Andrew V.; Ferrucci, Luigi; McDonnell, Nazli B.; Morissette, Rachel; Valiga, Alexander A.; Cheng, Phil; O’Connell, Michael P.; Appleton, Jessica; Dang, Vanessa M.; Kugel, Curtis H.; Ndoye, Abibatou; Behera, Reeti; Marchbank, Katie; Webster, Marie R.
    sFRP2 in the aged microenvironment drives melanoma metastasis and therapy resistance
    In: Nature Jg. 532 (2016) Nr. 7598, S. 250 - 254
    ISSN: 0028-0836; 1476-4687
    Online Volltext: dx.doi.org/ Online Volltext (Open Access)
  • Ugurel, Selma; Loquai, Carmen; Kähler, Katharina; Hassel, Jessica; Berking, Carola; Zimmer, Lisa; Haubitz, Imme; Satzger, Imke; Müller-Brenne, Tina; Mikhaimer, Nadia C.; Becker, Jürgen; Kilian, Katharina J.; Schadendorf, Dirk; Heinzerling, Lucie; Kaatz, Martin; Utikal, Jochen; Göppner, Daniela; Pföhler, Claudia; Pflugfelder, Annette; Mößner, Rotraut; Gutzmer, Ralf
    A multicenter DeCOG study on predictors of vemurafenib therapy outcome in melanoma : pretreatment impacts survival
    In: Annals of Oncology Jg. 26 (2015) Nr. 3, S. 573 - 582
    ISSN: 0923-7534; 1569-8041
    Online Volltext: dx.doi.org/ (Open Access)
  • Johnson, Douglas B.; Schadendorf, Dirk; Egberts, Friederike; Berking, Carola; Becker, Jürgen; Gutzmer, Ralf; Gogask, Helen; Scolyer, Richard A.; Sucker, Antje; Rizos, Helen; Zhao, Shilin; Eroglu, Zeynep; Zimmer, Lisa; Menzies, Alexander M.
    Acquired BRAF inhibitor resistance : A multicenter meta-analysis of the spectrum and frequencies, clinical behaviour, and phenotypic associations of resistance mechanisms
    In: European Journal of Cancer Jg. 51 (2015) Nr. 18, S. 2792 - 2799
    ISSN: 1879-0852; 0959-8049
    Online Volltext: dx.doi.org/ Online Volltext (Open Access)
  • Livingstone, Elisabeth; Eigentler, Thomas Kurt; Windemuth-Kieselbach, Christine; Hauschild, Axel; Rompel, Rainer; Trefzer, Uwe; Nashan, Dorothée; Kilian, Katharina J.; Debus, Dirk; Kähler, Katharina Charlotte; Mauerer, Andreas; Möllenhof, Katrin; Dippel, Edgar; Schadendorf, Dirk
    Actual practice of melanoma follow-up and treatment in Germany : results of a prospective, longitudinal cohort study
    In: British Journal of Dermatology: BJD Jg. 172 (2015) Nr. 6, S. 1646 - 1650
    ISSN: 1365-2133; 0007-0963; 0366-2845
    Online Volltext: dx.doi.org/
  • Scholz, Simone L.; Horn, Susanne; Murali, Rajmohan; Möller, Inga; Sucker, Antje; Sondermann, Wiebke; Stiller, Mathias; Schilling, Bastian; Livingstone, Elisabeth; Zimmer, Lisa; Reis, Henning; Metz, Claudia H; Zeschnigk, Michael; Paschen, Annette; Steuhl, Klaus-Peter; Schadendorf, Dirk; Westekemper, Henrike; Griewank, Klaus
    Analysis of SDHD promoter mutations in various types of melanoma
    In: OncoTarget Jg. 6 (2015) Nr. 28, S. 25868 - 25882
    ISSN: 1949-2553
    Online Volltext: dx.doi.org/ (Open Access)
  • Scholz, S.; Horn, S.; Murali, R.; Moeller, I.; Sucker, A.; Sondermann, W.; Stiller, Mathias; Schilling, Bastian; Livingstone, Elisabeth; Zimmer, Lisa; Reis, Henning; Metz, C.; Zeschnigk, Michael; Paschen, Annette; Steuhl, Klaus-Peter; Schadendorf, Dirk; Westekemper, Henrike; Griewank, Klaus
    Analysis of SDHD promoter mutations in various types of melanoma
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Jg. 13 (2015) Nr. Suppl. 2, S. 11
    ISSN: 1610-0387; 1563-2571; 1610-0379; 0301-0481
    Online Volltext: dx.doi.org/
  • Sun, Vera; Zhou, Wen B.; Nosrati, Mehdi; Majid, Shahana; Thummala, Suresh; De Semir, David; Bezrookove, Vladimir; De Feraudy, Sébastien; Chun, Liane; Schadendorf, Dirk; Debs, Robert; Kashani-Sabet, Mohammed; Dar, Altaf A.
    Antitumor activity of miR-1280 in melanoma by regulation of Src
    In: Molecular Therapy Jg. 23 (2015) Nr. 1, S. 71 - 78
    ISSN: 1525-0016
    Online Volltext: dx.doi.org/ (Open Access)
  • Ahmad-Nejad, Parviz; Duda, Angelika; Sucker, Antje; Werner, Martin; Bronsert, Peter; Stickeler, Elmar; Reifenberger, Guido; Malzkorn, Bastian; Oberländer, Martina; Habermann, Jens K.; Bruch, Hans-Peter; Linnebacher, Michael; Schadendorf, Dirk; Neumaier, Michael
    Assessing quality and functionality of DNA isolated from FFPE tissues through external quality assessment in tissue banks
    In: Clinical Chemistry and Laboratory Medicine Jg. 53 (2015) Nr. 12, S. 1927 - 1934
    ISSN: 1437-4331; 1434-6621; 1437-8523
    Online Volltext: dx.doi.org/
  • Ullrich, Nico; Heinemann, Anja; Nilewski, Elena; Scheffrahn, Inka; Klode, Joachim; Scherag, Andre; Schadendorf, Dirk; Singer, Bernhard B.; Helfrich, Iris
    CEACAM1-3S drives melanoma cells into NK cell-mediated cytolysis and enhances patient survival
    In: Cancer Research Jg. 75 (2015) Nr. 9, S. 1897 - 1907
    ISSN: 1538-7445; 0008-5472
    Online Volltext: dx.doi.org/ (Open Access)
  • Löffek, Stefanie; Ullrich, Nico; Görgens, André; Murke, Florian; Eilebrecht, Mara; Menne, Christopher; Giebel, Bernd; Schadendorf, Dirk; Singer, Bernhard B.; Helfrich, Iris
    CEACAM1-4L promotes anchorage-independent growth in melanoma
    In: Frontiers in Oncology Jg. 5 (2015) S. 234
    ISSN: 2234-943X
    Online Volltext: dx.doi.org/ (Open Access)
  • Stoffels, Ingo; Morscher, S.; Helfrich, Iris; Hillen, Uwe; Lehy, J.; Burton, N.; Pöppel, Thorsten; Gunzer, Matthias; Schadendorf, Dirk; Klode, Joachim
    Clinical application of noninvasive and nonradioactive determination of microscopic lymph node tumor status by multispectral optoacoustic imaging
    In: Journal of Nuclear Medicine Jg. 56 (2015) Nr. Suppl. 3, S. 40
    ISSN: 0161-5505
    Online Volltext
  • Larkin, James; Chiarion-Sileni, Vanna; Gonzalez, Rene; Grob, Jean Jacques; Cowey, C Lance; Lao, Christopher D; Schadendorf, Dirk; Dummer, Reinhard; Smylie, Michael; Rutkowski, Piotr; Ferrucci, Pier F; Hill, Andrew; Wagstaff, John; Carlino, Matteo S; Haanen, John B; Maio, Michele; Marquez-Rodas, Ivan; McArthur, Grant A; Ascierto, Paolo A; Long, Georgina V; Callahan, Margaret K; Postow, Michael A; Grossmann, Kenneth; Sznol, Mario; Dreno, Brigitte; Bastholt, Lars; Yang, Arvin; Rollin, Linda M; Horak, Christine; Hodi, F Stephen; Wolchok, Jedd D
    Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
    In: The New England Journal of Medicine Jg. 373 (2015) Nr. 1, S. 23 - 34
    ISSN: 1533-4406; 0028-4793
    Online Volltext: dx.doi.org/ Online Volltext (Open Access)
  • Livingstone, Elisabeth; Swann, Suzanne; Lilla, Carmen; Schadendorf, Dirk; Rösch, Alexander
    Combining BRAF(V) (600E) inhibition with modulators of the mitochondrial bioenergy metabolism to overcome drug resistance in metastatic melanoma
    In: Experimental Dermatology Jg. 24 (2015) Nr. 9, S. 709 - 710
    ISSN: 1600-0625; 0906-6705
    Online Volltext: dx.doi.org/
  • Grob, Jean Jacques; Amonkar, Mayur M; Karaszewska, Boguslawa; Schachter, Jacob; Dummer, Reinhard; Mackiewicz, Andrzej; Stroyakovskiy, Daniil; Drucis, Kamil; Grange, Florent; Chiarion-Sileni, Vanna; Rutkowski, Piotr; Lichinitser, Mikhail; Levchenko, Evgeny; Wolter, Pascal; Hauschild, Axel; Long, Georgina V; Nathan, Paul; Ribas, Antoni; Flaherty, Keith; Sun, Peng; Legos, Jeffrey J; McDowell, Diane Opatt; Mookerjee, Bijoyesh; Schadendorf, Dirk; Robert, Caroline
    Comparison of dabrafenib and trametinib combination therapy with vemurafenib monotherapy on health-related quality of life in patients with unresectable or metastatic cutaneous BRAF Val600-mutation-positive melanoma (COMBI-v) : results of a phase 3, open-label, randomised trial
    In: The Lancet Oncology Jg. 16 (2015) Nr. 13, S. 1389 - 1398
    ISSN: 1470-2045; 1474-5488
    Online Volltext: dx.doi.org/
  • Sucker, A. Antje; Neumaier, M.; Jones, F.; Haselmann, V.; Schadendorf, Dirk
    Concordance of BRAF V600E mutation status in metastatic melanoma patients by comparison of results from circulating tumor DNA and tissue-based testing
    In: European Journal of Cancer Jg. 51 (2015) Nr. Suppl. 3, S. S685
    ISSN: 0959-8049
    Online Volltext: dx.doi.org/
  • Sondermann, Wiebke; Griewank, Klaus; Schilling, Bastian; Livingstone, Elisabeth; Leyh, Julia C.; Rompoti, Natalia; Cosgarae, Ioana; Schimming, Tobias; Schadendorf, Dirk; Zimmer, Lisa; Hillen, Uwe
    Corticosteroids Augment BRAF Inhibitor Vemurafenib Induced Lymphopenia and Risk of Infection
    In: PLoS ONE Jg. 10 (2015) Nr. 4, S. e0124590
    ISSN: 1932-6203
    Online Volltext: dx.doi.org/ (Open Access)
  • Long, Georgina V.; Stroyakovskiy, Daniil; Gogas, Helen; Levchenko, Evgeny; Braud, Filippo de; Larkin, James; Garbe, Claus; Jouary, Thomas; Hauschild, Axel; Grob, Jean-Jacques; Chiarion-Sileni, Vanna; Lebbe, Celeste; Mandalà, Mario; Millward, Michael; Arance, Ana; Bondarenko, Igor; Haanen, John B. A. G.; Hansson, Johan; Utikal, Jochen; Ferraresi, Virginia; Kovalenko, Nadezhda; Mohr, Peter; Probachai, Volodymr; Schadendorf, Dirk; Nathan, Paul; Robert, Caroline; Ribas, Antoni; DeMarini, Douglas J.; Irani, Jhangir G.; Swann, Suzanne; Legos, Jeffrey J.; Jin, Fan; Mookerjee, Bijoyesh; Flaherty, Keith
    Dabrafenib and trametinib versus dabrafenib and placebo for Val600 BRAF-mutant melanoma : a multicentre, double-blind, phase 3 randomised controlled trial
    In: The Lancet Jg. 386 (2015) Nr. 9992, S. 444 - 451
    ISSN: 0140-6736; 1474-547X
    Online Volltext: dx.doi.org/
  • Stoffels, Ingo; Morscher, S.; Helfrich, Iris; Hillen, Uwe; Lehy, J.; Burton, N. C.; Poppel, T.; Rösch, Alexander; Griewank, Klaus; Schadendorf, Dirk; Gunzer, Matthias; Klode, Joachim
    Die multispektraloptoakustische Tomographie (MSOT) zur nichtinvasiven Diagnostik des Schildwächterlymphknotens bei Patienten mit malignem Melanom
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Jg. 13 (2015) Nr. 12, S. 1323
    ISSN: 1610-0387; 1563-2571; 1610-0379; 0301-0481
    Online Volltext: dx.doi.org/
  • Grob, Jean Jacques; Long, Georgina V; Schadendorf, Dirk; Flaherty, Keith
    Disease kinetics for decision-making in advanced melanoma : a call for scenario-driven strategy trials
    In: The Lancet Oncology Jg. 16 (2015) Nr. 13, S. e522 - e526
    ISSN: 1470-2045; 1474-5488
    Online Volltext: dx.doi.org/
  • Hannani, Dalil; Vétizou, Marie; Enot, David; Rusakiewicz, Sylvie; Chaput, Nathalie; Klatzmann, David; Desbois, Melanie; Jacquelot, Nicolas; Vimond, Nadège; Chouaib, Salem; Mateus, Christine; Allison, James P.; Ribas, Antoni; Wolchok, Jedd D.; Yuan, Jianda; Wong, Philip; Postow, Michael; Mackiewicz, Andrzej; Mackiewicz, Jacek; Schadendorf, Dirk; Jaeger, Dirk; Zörnig, Inka; Hassel, Jessica; Korman, Alan J.; Bahjat, Keith; Maio, Michele; Calabro, Luana; Teng, Michele W.L.; Smyth, Mark J.; Eggermont, Alexander; Robert, Caroline; Kroemer, Guido; Zitvogel, Laurence
    Erratum : Anticancer immunotherapy by CTLA-4 blockade: Obligatory contribution of IL-2 receptors and negative prognostic impact of soluble CD25
    In: Cell Research Jg. 25 (2015) Nr. 3, S. 399 - 400
    ISSN: 1001-0602
    Online Volltext: dx.doi.org/
  • Stoffels, Ingo; Leyh, Julia; Pöppel, Thorsten; Schadendorf, Dirk; Klode, Joachim
    Evaluation of a radioactive and fluorescent hybrid tracer for sentinel lymph node biopsy in head and neck malignancies : prospective randomized clinical trial to compare ICG-99mTc-nanocolloid hybrid tracer versus 99mTc-nanocolloid
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 42 (2015) Nr. 11, S. 1631 - 1638
    ISSN: 1619-7070; 1619-7089
    Online Volltext: dx.doi.org/
  • Lorigan, Paul; Ascierto, Paolo A; Dummer, Reinhard; Eggermont, Alexander M; Flaherty, Keith T; Garbe, Claus; Gogas, Helen; Hauschild, Axel; Kefford, Richard F; Kirkwood, John M; Larkin, James; Long, Georgina V; Maio, Michele; McArthur, Grant A; Ribas, Antoni; Robert, Caroline; Schadendorf, Dirk; Sondak, Vernon K; Wolchok, Jedd D; Hudson, Andrew M
    Expanded access programmes : patient interests versus clinical trial integrity
    In: The Lancet Oncology Jg. 16 (2015) Nr. 1, S. 15 - 17
    ISSN: 1470-2045; 1474-5488
    Online Volltext: dx.doi.org/
  • Vits, Sabine; Dissemond, Joachim; Schadendorf, Dirk; Kriegler, Lisa; Körber, Andreas; Schedlowski, Manfred; Cesko, Elvir
    Expectation-induced placebo responses fail to accelerate wound healing in healthy volunteers : results from a prospective controlled experimental trial
    In: International Wound Journal Jg. 12 (2015) Nr. 6, S. 664 - 668
    ISSN: 1742-4801; 1742-481X
    Online Volltext: dx.doi.org/
  • Scholz, Simone L; Thomasen, Henning; Reis, Henning; Möller, Inga; Darawsha, Raid; Müller, Bettina; Dekowski, Dirk; Sucker, Antje; Schilling, Bastian; Schadendorf, Dirk; Steuhl, Klaus-Peter; Paschen, Annette; Westekemper, Henrike; Meller, Daniel; Griewank, Klaus
    Frequent TERT Promoter Mutations in Ocular Surface Squamous Neoplasia
    In: Investigative Ophthalmology & Visual Science, IOVS Jg. 56 (2015) Nr. 10, S. 5854 - 5861
    ISSN: 1552-5783; 0146-0404
    Online Volltext: dx.doi.org/ (Open Access)
  • Ibarrola-Villava, Maider; Kumar, Rajiv; Nagore, Eduardo; Benfodda, Meriem; Guedj, Mickael; Gazal, Steven; Hu, Hui-Han; Guan, Jian; Rachkonda, P. Sivaramakishna; Descamps, Vincent; Basset-Seguin, Nicole; Bensussan, Armand; Bagot, Martine; Saiag, Philippe; Schadendorf, Dirk; Martin-Gonzalez, Manuel; Mayor, Matias; Grandchamp, Bernard; Ribas, Gloria; Soufir, Nadem
    Genes involved in the WNT and vesicular trafficking pathways are associated with melanoma predisposition
    In: International Journal of Cancer Jg. 136 (2015) Nr. 9, S. 2109 - 2119
    ISSN: 0020-7136; 1097-0215
    Online Volltext: dx.doi.org/
  • Law, Matthew H.; Bishop, D. Timothy; Lee, Jeffrey E.; Brossard, Myriam; Martin, Nicholas G.; Moses, Eric K.; Song, Fengju; Barrett, Jennifer H.; Kumar, Rajiv; Easton, Douglas F.; Pharoah, Paul D. P.; Swerdlow, Anthony J.; Kypreou, Katerina P.; Taylor, John C.; Harland, Mark; Randerson-Moor, Juliette; Akslen, Lars A.; Andresen, Per A.; Avril, Marie-Françoise; Azizi, Esther; Scarrà, Giovanna Bianchi; Brown, Kevin M.; Dębniak, Tadeusz; Duffy, David L.; Elder, David E.; Fang, Shenying; Friedman, Eitan; Galan, Pilar; Ghiorzo, Paola; Gillanders, Elizabeth M.; Goldstein, Alisa M.; Gruis, Nelleke A.; Hansson, Johan; Helsing, Per; Hočevar, Marko; Höiom, Veronica; Ingvar, Christian; Kanetsky, Peter A.; Chen, Wei V.; Landi, Maria Teresa; Lang, Julie; Lathrop, G. Mark; Lubiński, Jan; Mackie, Rona M.; Mann, Graham J.; Molven, Anders; Montgomery, Grant W.; Novaković, Srdjan; Olsson, Håkan; Puig, Susanne; Puig-Butille, Joan Anton; Qureshi, Abrar A.; Radford-Smith, Graham L.; van der Stoep, Nienke; van Doorn, Remco; Whiteman, David C.; Craig, Jamie E.; Schadendorf, Dirk; Simms, Lisa A.; Burdon, Kathryn P.; Nyholt, Dale R.; Pooley, Karen A.; Orr, Nick; Stratigos, Alexander J.; Cust, Anne E.; Ward, Sarah V.; Hayward, Nicholas K.; Han, Jiali; Schulze, Hans-Joachim; Dunning, Alison M.; Newton Bishop, Julia A.; Demenais, Florence; Amos, Christopher I.; MacGregor, Stuart; Iles, Mark M.
    Genome-wide meta-analysis identifies five new susceptibility loci for cutaneous malignant melanoma
    In: Nature Genetics Jg. 47 (2015) Nr. 9, S. 987 - 995
    ISSN: 1061-4036; 1546-1718
    Online Volltext: dx.doi.org/ Online Volltext (Open Access)
  • The Cancer Genome Atlas Network; Schadendorf, Dirk; Klode, Joachim
    Genomic Classification of Cutaneous Melanoma
    In: Cell Jg. 161 (2015) Nr. 7, S. 1681 - 1696
    ISSN: 1097-4172
    Online Volltext: dx.doi.org/ (Open Access)
  • Van Allen, Eliezer M; Miao, Diana; Schilling, Bastian; Shukla, Sachet A; Blank, Christian; Zimmer, Lisa; Sucker, Antje; Hillen, Uwe; Foppen, Marnix H Geukes; Goldinger, Simone M; Utikal, Jochen; Hassel, Jessica C; Weide, Benjamin; Kaehler, Katharina C; Loquai, Carmen; Mohr, Peter; Gutzmer, Ralf; Dummer, Reinhard; Gabriel, Stacey; Wu, Catherine J; Schadendorf, Dirk; Garraway, Levi A
    Genomic correlates of response to CTLA-4 blockade in metastatic melanoma
    In: Science Jg. 350 (2015) Nr. 6257, S. 207 - 211
    ISSN: 0036-8075; 1095-9203
    Online Volltext: dx.doi.org/ Online Volltext (Open Access)
  • Schadendorf, Dirk; Amonkar, Mayur M.; Stroyakovskiy, Daniil; Levchenko, Evgeny; Gogas, Helen; Braud, Filippo de; Grob, Jean-Jacques; Bondarenko, Igor; Garbe, Claus; Lebbe, Celeste; Larkin, James; Chiarion-Sileni, Vanna; Millward, Michael; Arance, Ana; Mandalà, Mario; Flaherty, Keith T.; Nathan, Paul; Ribas, Antoni; Robert, Caroline; Casey, Michelle; DeMarini, Douglas J.; Irani, Jhangir G.; Aktan, Gursel; Long, Georgina
    Health-related quality of life impact in a randomised phase III study of the combination of dabrafenib and trametinib versus dabrafenib monotherapy in patients with BRAF V600 metastatic melanoma
    In: European Journal of Cancer Jg. 51 (2015) Nr. 7, S. 833 - 840
    ISSN: 1879-0852; 1879-2995
    Online Volltext: dx.doi.org/
  • Robert, Caroline; Karaszewska, Boguslawa; Schachter, Jacob; Rutkowski, Piotr; Mackiewicz, Andrzej; Stroiakovski, Daniil; Lichinitser, Michael; Dummer, Reinhard; Grange, Florent; Mortier, Laurent; Chiarion-Sileni, Vanna; Drucis, Kamil; Krajsova, Ivana; Hauschild, Axel; Lorigan, Paul; Wolter, Pascal; Long, Georgina V; Flaherty, Keith; Nathan, Paul; Ribas, Antoni; Martin, Anne-Marie; Sun, Peng; Crist, Wendy; Legos, Jeff; Rubin, Stephen D; Little, Shonda M; Schadendorf, Dirk
    Improved overall survival in melanoma with combined dabrafenib and trametinib
    In: The New England Journal of Medicine Jg. 372 (2015) Nr. 1, S. 30 - 39
    ISSN: 1533-4406; 0028-4793
    Online Volltext: dx.doi.org/ Online Volltext (Open Access)
  • Nsengimana, Jérémie; Laye, Jon; Filia, Anastasia; Walker, Christy; Jewell, Rosalyn; Oord, Joost J. Van den; Wolter, Pascal; Patel, Poulam; Sucker, Antje; Schadendorf, Dirk; Jönsson, Göran B.; Bishop, D. Timothy; Newton- Bishop, Julia
    Independent replication of a melanoma subtype gene signature and evaluation of its prognostic value and biological correlates in a population cohort
    In: OncoTarget Jg. 6 (2015) Nr. 13, S. 11683 - 11693
    ISSN: 1949-2553
    Online Volltext: dx.doi.org/ (Open Access)
  • Dummer, Reinhard; Hauschild, Axel; Lebbé, Célèste; Larkin, James; Ascierto, Paolo A.; Schadendorf, Dirk
    Integrating first-line treatment options into clinical practice : What's new in advanced melanoma?
    In: Melanoma Research Jg. 25 (2015) Nr. 6, S. 461 - 469
    ISSN: 1473-5636; 0960-8931
    Online Volltext: dx.doi.org/
  • Mohr, Peter; Podda, Maurizio; Schadendorf, Dirk; Gogas, Helen; Loquai, Carmen; Weichenthal, Michael; Tilgen, Wolfgang; Enk, Alexander; Hauschild, Axel; Trefzer, Uwe
    Intermittent High-Dose Intravenous Interferon Alfa-2b for Adjuvant Treatment of Stage III Melanoma : Final Analysis of a Randomized Phase III Dermatologic Cooperative Oncology Group Trial
    In: Journal of Clinical Oncology (JCO) Jg. 33 (2015) Nr. 34, S. 4077 - 4084
    ISSN: 0732-183X; 1527-7755
    Online Volltext: dx.doi.org/
  • Stoffels, Ingo; Dissemond, Joachim; Pöppel, Thorsten; Schadendorf, Dirk; Klode, Joachim
    Intraoperative Fluorescence Imaging for Sentinel Lymph Node Detection : Prospective Clinical Trial to Compare the Usefulness of Indocyanine Green vs Technetium Tc 99m for Identification of Sentinel Lymph Nodes
    In: JAMA Surgery Jg. 150 (2015) Nr. 7, S. 617 - 623
    ISSN: 2168-6254; 2168-6262
    Online Volltext: dx.doi.org/ (Open Access)
  • Ullrich, Nico; Löffek, Stefanie; Horn, Susanne; Ennen, Marie; Sánchez‐del‐Campo, Luis; Zhao, Fang; Breitenbücher, Frank; Davidson, Irwin; Singer, Bernhard B.; Schadendorf, Dirk; Goding, Colin R.; Helfrich, Iris
    MITF is a critical regulator of the carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1) in malignant melanoma
    In: Pigment Cell and Melanoma Research Jg. 28 (2015) Nr. 6, S. 736 - 740
    ISSN: 1755-1471; 1755-148X
    Online Volltext: dx.doi.org/
  • Schadendorf, Dirk; Fisher, David E; Garbe, Claus; Gershenwald, Jeffrey E; Grob, Jean-Jacques; Halpern, Allan; Herlyn, Meenhard; Marchetti, Michael A; McArthur, Grant; Ribas, Antoni; Rösch, Alexander; Hauschild, Axel
    Melanoma
    In: Nature Reviews Disease Primers Jg. 1 (2015) S. 15003
    ISSN: 2056-676X
    Online Volltext: dx.doi.org/
  • Stoffels, Ingo; Morscher, Stefan; Helfrich, Iris; Hillen, Uwe; Leyh, Julia; Burton, Neal C.; Sardella, Thomas C.P.; Claussen, Jing; Pöppel, Thorsten; Bachmann, Hagen Sjard; Rösch, Alexander; Griewank, Klaus; Schadendorf, Dirk; Gunzer, Matthias; Klode, Joachim
    Metastatic status of sentinel lymph nodes in melanoma determined noninvasively with multispectral optoacoustic imaging
    In: Immunotherapy Jg. 7 (2015) Nr. 317, S. 317ra199
    ISSN: 1750-743X; 1750-7448
    Online Volltext: dx.doi.org/
  • Cierlitza, Monika; Chauvistré, Heike; Bogeski, Ivan; Zhang, Xin; Hauschild, Axel; Herlyn, Meenhard; Schadendorf, Dirk; Vogt, Thomas; Rösch, Alexander
    Mitochondrial oxidative stress as a novel therapeutic target to overcome intrinsic drug resistance in melanoma cell subpopulations
    In: Experimental Dermatology Jg. 24 (2015) Nr. 2, S. 155 - 157
    ISSN: 1600-0625; 0906-6705
    Online Volltext: dx.doi.org/ Online Volltext (Open Access)
  • Gebhardt, Christoffer; Sevko, Alexandra; Jiang, Huanhuan; Lichtenberger, Ramtin; Reith, Maike; Tarnanidis, Kathrin; Holland-Letz, Tim; Umansky, Ludmila; Beckhove, Philipp; Sucker, Antje; Schadendorf, Dirk; Utikal, Jochen; Umansky, Viktor
    Myeloid Cells and Related Chronic Inflammatory Factors as Novel Predictive Markers in Melanoma Treatment with Ipilimumab
    In: Clinical Cancer Research Jg. 21 (2015) Nr. 24, S. 5453 - 5459
    ISSN: 1078-0432
    Online Volltext: dx.doi.org/ (Open Access)
  • Wasserman, Ernesto; Yamazaki, Naoya; Wolter, Pascal; Demidov, Lev; Ford, James; Arenberger, Petr; Rangoni, Giovanni; Flaherty, Keith; Ascierto, Paolo; Giacomo, Anna Maria Di; Mandalà, Mario; Weill, Marine; Dummer, Reinhard; Long, Georgina; Schadendorf, Dirk
    NEMO : A phase 3 trial of binimetinib (MEK162) versus dacarbazine in patients with advanced NRAS-mutant melanoma who are untreated or have progressed on or after immunotherapy
    In: Cancer Research Jg. 75 (2015) Nr. Suppl. 14, S. B16
    ISSN: 1538-7445; 0008-5472
    Online Volltext: dx.doi.org/
  • Hauschild, Axel; Schadendorf, Dirk
    Nachruf für Prof. Dr. med. Christiane Voit (Berlin)
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Jg. 13 (2015) Nr. 8, S. 851 - 852
    ISSN: 1610-0387; 1563-2571; 1610-0379; 0301-0481
    Online Volltext: dx.doi.org/
  • Robert, Caroline; Long, Georgina V.; Brady, Benjamin; Dutriaux, Caroline; Maio, Michele; Mortier, Laurent; Hassel, Jessica C.; Rutkowski, Piotr; McNeil, Catriona; Kalinka-Warzocha, Ewa; Savage, Kerry J.; Hernberg, Micaela M.; Lebbé, Celeste; Charles, Julie; Mihalcioiu, Catalin; Chiarion-Sileni, Vanna; Mauch, Cornelia; Cognetti, Francesco; Arance, Ana; Schmidt, Henrik; Schadendorf, Dirk; Gogas, Helen; Lundgren-Eriksson, Lotta; Horak, Christine; Sharkey, Brian; Waxman, Ian M.; Atkinson, Victoria; Ascierto, Paolo A.
    Nivolumab in previously untreated melanoma without BRAF mutation
    In: The New England Journal of Medicine Jg. 372 (2015) Nr. 4, S. 311 - 319
    ISSN: 1533-4406; 0028-4793
    Online Volltext: dx.doi.org/ Online Volltext (Open Access)
  • Zimmer, Lisa; Schadendorf, Dirk; Garbe, Claus; Assi, Zeinab; Loquai, Carmen; Rompel, Rainer; Terheyden, Patrick; Fluck, Michael F Z; Hauschild, Axel; Stadler, Rudolf; Dippel, Edgar; Kämpgen, Eckhart; Berking, Carola; Mohr, Peter E.; Utikal, Jochen; Simon, Jan Christoph; Kiecker, Felix; Eigentler, Thomas Kurt
    Open-label, multicenter, single-arm phase II DeCOG-study of ipilimumab in pretreated patients with different subtypes of metastatic melanoma
    In: Journal of Translational Medicine Jg. 13 (2015) Nr. 1, S. 351
    ISSN: 1479-5876
    Online Volltext: dx.doi.org/ (Open Access)
  • Griewank, Klaus; Schadendorf, Dirk
    Panel Sequencing Melanomas
    In: The Journal of Investigative Dermatology Jg. 135 (2015) Nr. 2, S. 335 - 336
    ISSN: 0022-202X; 1523-1747
    Online Volltext: dx.doi.org/ (Open Access)
  • Robert, Caroline; Schachter, Jacob; Long, Georgina V; Arance, Ana; Grob, Jean Jacques; Mortier, Laurent; Daud, Adil; Carlino, Matteo S; McNeil, Catriona; Lotem, Michal; Larkin, James; Lorigan, Paul; Neyns, Bart; Blank, Christian U; Hamid, Omid; Mateus, Christine; Shapira-Frommer, Ronnie; Kosh, Michele; Zhou, Honghong; Ibrahim, Nageatte; Ebbinghaus, Scot; Ribas, Antoni; Carlino, Matteo S; Cebon, Jonathan; Hersey, Peter; Long, Georgina; McNeil, Catriona; Millward, Michael; Walpole, Euan; Höller, Christoph; Kehrer, Helmut; Richtig, Erika; Schmuth, Matthias; Baurain, Jean-François; Neyns, Bart; Wolter, Pascal; Butler, Marcus; McWhirter, Elaine; Miller, Wilson; Petrella, Teresa; Acevedo, Alejandro; Caglevic, Christian; Morales, Luisa; Sanchez, Jesús; Yepes, Andres; Zambrano, Angela Regina; Avril, Marie-Francoise; Dutriaux, Caroline; Grob, Jean Jacques; Guilot, Bernard; Lacour, Jean-Phillippe; Leccia, Marie-Therese; Legoupil, Delphine; Lebbe, Celeste; Machet, Laurent; Mortier, Laurent; Robert, Caroline; Berking, Carola; Loquai, Carmen; Mohr, Peter; Schadendorf, Dirk; Utikal, Jochen; Bar-Sela, Gil; Lotem, Michal; Schachter, Jacob; Blank, Christian; Barrow, Catherine; Fitzharris, Bernie; Kersten, Christian; Nyakas, Marta; Straume, Oddbjørn; Arance, Ana; Berrocal, Alfonso; Cortes, Javier; Espinosa, Enrique; Lopez-Martin, Jose; Martin-Algarra, Salvador; Masucci, Giuseppe; Papworth, Karin; Ullenhag, Gustav; Brown, Ewan; Chao, David; Evans, Thomas; Larkin, James; Lorigan, Paul; Middleton, Mark; Skaria, Sunil; Steven, Neil; Agarwala, Sanjiv; Bhatia, Shailender; Daud, Adil; Gangadhar, Tara; Gonzalez, Rene; Hamid, Omid; Kumar, Pallavi; Kuzel, Timothy; Lutzky, Jose; O'Day, Steven; Perry, David; Pecora, Andrew; Puzanov, Igor; Ribas, Antoni; Slezak, Karen; Sznol, Mario; Tarhini, Ahmad; Weiss, Geoffrey
    Pembrolizumab versus Ipilimumab in Advanced Melanoma
    In: The New England Journal of Medicine Jg. 372 (2015) Nr. 26, S. 2521 - 2532
    ISSN: 1533-4406; 0028-4793
    Online Volltext: dx.doi.org/
  • Ribas, Antoni; Puzanov, Igor; Dummer, Reinhard; Schadendorf, Dirk; Hamid, Omid; Robert, Caroline; Hodi, F. Stephen; Schachter, Jacob; Pavlick, Anna C.; Lewis, Karl D.; Cranmer, Lee D.; Blank, Christian U.; O'Day, Steven J.; Ascierto, Paolo A.; Salama, April K. S.; Margolin, Kim A.; Loquai, Carmen; Eigentler, Thomas K.; Gangadhar, Tara C.; Carlino, Matteo S.; Agarwala, Sanjiv S.; Moschos, Stergios J.; Sosman, Jeffrey A.; Goldinger, Simone M.; Shapira-Frommer, Ronnie; Gonzalez, Rene; Kirkwood, John M.; Wolchok, Jedd D.; Eggermont, Alexander; Li, Xiaoyun Nicole; Zhou, Wei; Zernhelt, Adriane M.; Lis, Joy; Ebbinghaus, Scot; Kang, S. Peter; Daud, Adil
    Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002) : a randomised, controlled, phase 2 trial
    In: The Lancet Oncology Jg. 16 (2015) Nr. 8, S. 908 - 918
    ISSN: 1474-5488; 1470-2045
    Online Volltext: dx.doi.org/
  • Zimmer, Lisa; Vaubel, Julia Marianne; Mohr, Peter; Hauschild, Axel; Utikal, Jochen; Simon, Jan; Garbe, Claus; Herbst, Rudolf; Enk, Alexander; Kämpgen, Eckhart; Livingstone, Elisabeth; Bluhm, Leonie; Rompel, Rainer; Griewank, Klaus; Fluck, Michael; Schilling, Bastian; Schadendorf, Dirk
    Phase II DeCOG-Study of Ipilimumab in Pretreated and Treatment-Naïve Patients with Metastatic Uveal Melanoma
    In: PLoS ONE Jg. 10 (2015) Nr. 3, S. e0118564
    ISSN: 1932-6203
    Online Volltext: dx.doi.org/ (Open Access)
  • Schadendorf, Dirk; Hodi, F Stephen; Robert, Caroline; Weber, Jeffrey S; Margolin, Kim; Hamid, Omid; Patt, Debra; Chen, Tai-Tsang; Berman, David M; Wolchok, Jedd D
    Pooled Analysis of Long-Term Survival Data From Phase II and Phase III Trials of Ipilimumab in Unresectable or Metastatic Melanoma
    In: Journal of Clinical Oncology (JCO) Jg. 33 (2015) Nr. 17, S. 1889 - 1894
    ISSN: 0732-183X; 1527-7755
    Online Volltext: dx.doi.org/ Online Volltext (Open Access)
  • Zörnig, Inka; Halama, Niels; Lorenzo-Bermejo, Justo; Ziegelmeier, Claudia; Dickes, Elke; Migdoll, Alexander; Kaiser, Iris; Waterboer, Tim; Pawlita, Michael; Grabe, Niles; Ugurel, Selma; Schadendorf, Dirk; Falk, Christine; Eichmüller, Stefan B.; Jäger, Dirk
    Prognostic significance of spontaneous antibody responses against tumor-associated antigens in malignant melanoma patients
    In: International Journal of Cancer Jg. 136 (2015) Nr. 1, S. 138 - 151
    ISSN: 0020-7136; 1097-0215
    Online Volltext: dx.doi.org/
  • Esser, Stefan; Geisel, Henrike; Arendt, M.; Schulze, C.; Holzendorf, V.; Warnke, A.; Brockmeyer, N.H.; Hower, M.; Schadendorf, Dirk; Neumann, Till; Eisele, Lewin; Erbel, Raimund; Moebus, Susanne; Jöckel, Karl-Heinz; Reinsch, Nico
    Prolongation of QTc interval in HIV-infected individuals compared to the general population is not caused by antiretroviral therapy
    In: Journal of the International AIDS Society Jg. 18 (2015) Nr. Suppl. 4, S. 20479
    ISSN: 1758-2652
    Online Volltext: dx.doi.org/ (Open Access)
  • Livingstone, Elisabeth; Krajewski, C.; Eigentler, Thomas K.; Windemuth-Kieselbach, Christine; Benson, Sven; Elsenbruch, Sigrid; Hauschild, Axel; Rompel, Rainer; Meiss, Frank; Mauerer, Andreas; Kähler, Katharina C.; Dippel, Edgar; Möllenhoff, Katrin; Kilian, Katharina; Mohr, Mohr, Peter E.; Utikal, Jochen; Schadendorf, Dirk
    Prospective evaluation of follow-up in melanoma patients in Germany : results of a multicentre and longitudinal study
    In: European Journal of Cancer Jg. 51 (2015) Nr. 5, S. 653 - 667
    ISSN: 0959-8049; 1879-0852
    Online Volltext: dx.doi.org/
  • Hecht, Markus; Zimmer, Lisa; Loquai, Carmen; Weishaupt, Carsten; Gutzmer, Ralf; Schuster, B.; Gleisner, S.; Schulze, Björn; Goldinger, S. M.; Berking, Carola; Forschner, Andrea; Clemens, P.; Grabenbauer, Gerhard; Müller-Brenne, Tina; Bauch, Julia; Eich, Hans T.; Grabbe, Stephan; Schadendorf, Dirk; Schuler, Gerold; Keikavoussi, Petra; Semrau, S.; Fietkau, Rainer; Distel, Luitpold V.; Heinzerling, Lucie
    Radiosensitization by BRAF inhibitor therapy-mechanism and frequency of toxicity in melanoma patients
    In: Annals of Oncology Jg. 26 (2015) Nr. 6, S. 1238 - 1244
    ISSN: 0923-7534; 1569-8041
    Online Volltext: dx.doi.org/ (Open Access)
  • Schilling, Bastian; Sondermann, Wiebke; Griewank, Klaus; Livingstone, Elisabeth; Zimmer, Lisa; Hillen, Uwe; Schadendorf, Dirk
    Reply to the letters to the editor ‘Differential influence of vemurafenib and dabrafenib on patients' lymphocytes despite similar clinical efficacy in melanoma’ by Diwakar et al.
    In: Annals of Oncology Jg. 26 (2015) Nr. 1, S. 250 - 251
    ISSN: 0923-7534; 1569-8041
    Online Volltext: dx.doi.org/
  • Griewank, Klaus; Murali, Rajmohan; Scherag, Andre; Schadendorf, Dirk
    Response
    In: Journal of the National Cancer Institute Jg. 107 (2015) Nr. 4, S. djv051
    ISSN: 0027-8874
    Online Volltext: dx.doi.org/
  • Livingstone, Elisabeth; Hillen, Uwe; Hafner, Christian; Piel, Sarah; Groesser, Leopold; Schadendorf, Dirk; Happle, Rudolf
    Segmentally arranged seborrhoeic keratoses with impending atypia and squamous cell carcinoma in an elderly woman
    In: British Journal of Dermatology: BJD Jg. 172 (2015) Nr. 6, S. 1642 - 1645
    ISSN: 1365-2133; 0007-0963; 0366-2845
    Online Volltext: dx.doi.org/
  • Ramanujam, Sangeetha; Long, Georgina V.; Schadendorf, Dirk
    Systemic therapies for melanoma brain metastases : which drug for whom and when?
    In: Chinese Clinical Oncology Jg. 4 (2015) Nr. 2, S. 25 - 29
    ISSN: 2304-3873
    Online Volltext: dx.doi.org/
  • Murali, Rajmohan; Chandramohan, Raghu; Möller, Inga; Scholz, Simone L.; Berger, Michael; Huberman, Kety; Viale, Agnes; Pirun, Mono; Socci, Nicholas D.; Bouvier, Nancy; Bauer, Sebastian; Artl, Monika; Schilling, Bastian; Schimming, Tobias; Sucker, Antje; Schwindenhammer, Benjamin; Grabellus, Florian; Speicher, Michael R.; Schaller, Jörg; Hillen, Uwe; Schadendorf, Dirk; Mentzel, Thomas; Cheng, Donavan T.; Wiesner, Thomas; Griewank, Klaus
    Targeted massively parallel sequencing of angiosarcomas reveals frequent activation of the mitogen activated protein kinase pathway
    In: OncoTarget Jg. 6 (2015) Nr. 34, S. 36041 - 36052
    ISSN: 1949-2553
    Online Volltext: dx.doi.org/ (Open Access)
  • Erfle, Holger; Pashayeva, K.; Harder, N.; Zhang, Lihua; Rohr, K.; Schadendorf, Dirk; Ugurel, Selma; Keese, Michael
    Targeting mitosis-regulating genes in cisplatin-sensitive and -resistant melanoma cells : a live-cell RNAi screen displays differential nucleus-derived phenotypes
    In: Biotechnology Journal Jg. 10 (2015) Nr. 9, S. 1467 - 1477
    ISSN: 1860-7314; 1860-6768
    Online Volltext: dx.doi.org/
  • Wagner, T.; Terheyden, P.; Gutzmer, R.; Forschner, A.; Rudolph, B.; Schadendorf, Dirk; Kaehler, K.C.; Kornek, T.; Heinzerling, L.; Garbe, C.; Stade, B.; Gebhardt, C.; Augustin, M.; Maul, L.V.; Hauschild, A.; Loquai, C.; Blohme, C.; Livingstone, Elisabeth
    The GERMELATOX DeCOG-trial : The attitude of German melanoma patients towards toxicity during adjuvant interferon treatment - Differences between the patient's and the physician's perspective
    In: European Journal of Cancer Jg. 51 (2015) Nr. Suppl. 3, S. S671 - S672
    ISSN: 0959-8049
    Online Volltext: dx.doi.org/
  • Schadendorf, Dirk; Livingstone, Elisabeth; Schilling, Bastian; Rösch, Alexander; Zimmer, Lisa
    Therapie des malignen Melanoms
    In: Der Onkologe Jg. 21 (2015) Nr. 10, S. 965 - 974
    ISSN: 0947-8965
    Online Volltext: dx.doi.org/
  • Espinosa, Enrique; Grob, Jean Jacques R.; Dummer, Reinhard G.; Rutkowski, Piotr; Robert, Caroline; Gogas, Helen J.; Kefford, Richard F.; Eggermont, Alexander Mm. M.; Martín-Algarra, Salvador; Hauschild, Axel; Schadendorf, Dirk
    Treatment algorithms in stage IV melanoma
    In: American Journal of Therapeutics Jg. 22 (2015) Nr. 1, S. 61 - 67
    ISSN: 1536-3686; 1075-2765
    Online Volltext: dx.doi.org/; Online Volltext: dx.doi.org/ (Open Access)
  • Legos, J.; Mortier, L.; Stroyakovskiy, D.; Karaszewska, B.; Grange, F.; Robert, C.; Mackiewicz, A.; Schadendorf, Dirk; Schachter, J.; Rutkowski, P.; Chiarion-Sileni, V.; Dummer, R.; Lichinitser, M.; Drucis, K.; Krajsova, I.; Mookerjee, B.; Hauschild, A.
    Two year estimate of overall survival in COMBI-v, a randomized, open-label, phase III study comparing the combination of dabrafenib (D) and trametinib (T) with vemurafenib (Vem) as first-line therapy in patients (pts) with unresectable or metastatic BRAF V600E/K mutation-positive cutaneous melanoma
    In: European Journal of Cancer Jg. 51 (2015) Nr. Suppl. 3, S. S663
    ISSN: 0959-8049
    Online Volltext: dx.doi.org/
  • Hauschild, Alexander; Kölbl, Oliver; Mackensen, Andreas; Schadendorf, Dirk
    Vorwort
    In: Oncology Research and Treatment Jg. 38 (2015) Nr. Suppl. 3, S. 1
    ISSN: 2296-5262
    Online Volltext: dx.doi.org/
  • Bhattacharya, Animesh; Schmitz, Ulf; Raatz, Yvonne; Schönherr, Madeleine; Kottek, Tina; Schauer, Marianne; Franz, Sandra; Saalbach, Anja; Anderegg, Ulf; Wolkenhauer, Olaf; Schadendorf, Dirk; Simon, Jan Christoph; Magin, Thomas Michael; Vera, Julio; Kunz, Manfred
    miR-638 promotes melanoma metastasis and protects melanoma cells from apoptosis and autophagy
    In: OncoTarget Jg. 6 (2015) Nr. 5, S. 2966 - 2980
    ISSN: 1949-2553
    Online Volltext: dx.doi.org/ (Open Access)
  • Davies, John R; Field, Sinead; Randerson-Moor, Juliette; Harland, Mark; Kumar, Rajiv; Anic, Gabriella M; Nagore, Eduardo; Hansson, Johan; Höiom, Veronica; Jönsson, Göran; Gruis, Nelleke A; Park, Jong Y; Guan, Jian; Sivaramakrishna Rachakonda, P; Wendt, Judith; Pjanova, Dace; Puig, Susana; Schadendorf, Dirk; Okamoto, Ichiro; Olsson, Håkan; Affleck, Paul; García-Casado, Zaida; Puig-Butille, Joan Anton; Stratigos, Alexander J; Kodela, Elizabeth; Donina, Simona; Sucker, Antje; Hosen, Ismail; Egan, Kathleen M; Barrett, Jennifer H; van Doorn, Remco; Bishop, D Timothy; Newton-Bishop, Julia
    An inherited variant in the gene coding for vitamin D-binding protein and survival from cutaneous melanoma : a BioGenoMEL study
    In: Pigment Cell and Melanoma Research Jg. 27 (2014) Nr. 2, S. 234 - 243
    ISSN: 1755-1471; 1755-148X
    Online Volltext: dx.doi.org/ (Open Access)
  • Schimming, Tobias T; Griewank, Klaus; Esser, Stefan; Schadendorf, Dirk; Hillen, Uwe
    Angioplasmacellular hyperplasia - a new histopathologic clue for anogenital herpes simplex recidivans in immunocompromised patients?
    In: American Journal of Dermatopathology Jg. 36 (2014) Nr. 10, S. 822 - 826
    ISSN: 0193-1091; 1533-0311
    Online Volltext: dx.doi.org/
  • Schadendorf, Dirk
    Arbeitsgemeinschaft Dermatologische Onkologie – eine dermatologische Erfolgsgeschichte
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Jg. 12 (2014) Nr. Suppl. 4, S. 40 - 41
    ISSN: 1610-0387; 1563-2571; 1610-0379; 0301-0481
    Online Volltext: dx.doi.org/
  • Schadendorf, Dirk
    Behandlungsalgorithmus bei Patienten mit malignem Melanom
    In: Der Onkologe Jg. 20 (2014) Nr. 6, S. 533 - 534
    ISSN: 0947-8965; 0947-8965
    Online Volltext: dx.doi.org/
  • Matusiewicz, David; Körber, Andreas; Schadendorf, Dirk; Wasem, Jürgen; Neumann, Anja
    Childhood Psoriasis : An Analysis of German Health Insurance Data
    In: Pediatric Dermatology Jg. 31 (2014) Nr. 1, S. 8 - 13
    ISSN: 1525-1470; 0736-8046
    Online Volltext: dx.doi.org/
  • Zelba, Henning; Weide, Benjamin; Martens, Alexander; Derhovanessian, Evelyna; Bailur, Jithendra K.; Kyzirakos, Christina; Pflugfelder, Annette; Eigentler, Thomas K.; Di Giacomo, Anna M.; Maio, Michele; Aarntzen, Eric H. J. G.; Vries, Jolanda de; Sucker, Antje; Schadendorf, Dirk; Büttner, Petra; Garbe, Claus; Pawelec, Graham
    Circulating CD4+ T cells that produce IL4 or IL17 when stimulated by Melan-A but not by NY-ESO-1 have negative impacts on survival of patients with stage IV melanoma
    In: Clinical Cancer Research Jg. 20 (2014) Nr. 16, S. 4390 - 4399
    ISSN: 1557-3265; 1078-0432
    Online Volltext: dx.doi.org/
  • Dreno, Brigitte; Basset-Seguin, Nicole; Caro, Ivor; Yue, Huibin; Schadendorf, Dirk
    Clinical benefit assessment of vismodegib therapy in patients with advanced basal cell carcinoma
    In: The Oncologist Jg. 19 (2014) Nr. 8, S. 790 - 796
    ISSN: 1083-7159; 2159-8401; 1549-490X
    Online Volltext: dx.doi.org/ Online Volltext (Open Access)
  • Malvehy, Josep; Hauschild, Axel; Curiel-Lewandrowski, C.; Mohr, Peter E.; Hofmann-Wellenhof, Rainer; Motley, Richard J.; Berking, Carola; Grossman, Douglas; Paoli, John; Loquai, Carmen; Oláh, Judit; Reinhold, Uwe; Wenger, H.; Dirschka, Thomas P.; Davis, Steven A.; Henderson, Catriona A.; Rabinovitz, Harold S.; Welzel, Julia; Schadendorf, Dirk; Birgersson, Ulrik
    Clinical performance of the Nevisense system in cutaneous melanoma detection : an international, multicentre, prospective and blinded clinical trial on efficacy and safety
    In: British Journal of Dermatology: BJD Jg. 171 (2014) Nr. 5, S. 1099 - 1107
    ISSN: 1365-2133; 0007-0963; 0366-2845
    Online Volltext: dx.doi.org/ (Open Access)
  • Long, Georgina V; Stroyakovskiy, Daniil; Gogas, Helen; Levchenko, Evgeny; de Braud, Filippo; Larkin, James; Garbe, Claus; Jouary, Thomas; Hauschild, Axel; Grob, Jean Jacques; Chiarion Sileni, Vanna; Lebbe, Celeste; Mandalà, Mario; Millward, Michael; Arance, Ana; Bondarenko, Igor; Haanen, John B A G; Hansson, Johan; Utikal, Jochen; Ferraresi, Virginia; Kovalenko, Nadezhda; Mohr, Peter; Probachai, Volodymyr; Schadendorf, Dirk; Nathan, Paul; Robert, Caroline; Ribas, Antoni; DeMarini, Douglas J; Irani, Jhangir G; Casey, Michelle; Ouellet, Daniele; Martin, Anne-Marie; Le, Ngocdiep; Patel, Kiran; Flaherty, Keith
    Combined BRAF and MEK inhibition versus BRAF inhibition alone in melanoma
    In: The New England Journal of Medicine Jg. 371 (2014) Nr. 20, S. 1877 - 1888
    ISSN: 1533-4406; 0028-4793
    Online Volltext: dx.doi.org/ (Open Access)
  • Stoffels, Ingo; Müller, Markus; Geisel, Henrike; Leyh, Julia; Pöppel, Thorsten; Schadendorf, Dirk; Klode, Joachim
    Cost-effectiveness of preoperative SPECT/CT combined with lymphoscintigraphy vs. lymphoscintigraphy for sentinel lymph node excision in patients with cutaneous malignant melanoma
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 41 (2014) Nr. 9, S. 1723 - 1731
    ISSN: 1619-7089
    Online Volltext: dx.doi.org/
  • Stoffels, Ingo; Gunzer, Matthias; Leyh, J.; Hillen, Uwe; Helfrich, Iris; Schadendorf, Dirk; Klode, Joachim
    Die Photooptoakustische Tomographie zur nicht invasiven und nicht radioaktiven Bestimmung des Schildw € achterlymphknotenstatus bei Melanompatienten
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Jg. 12 (2014) Nr. Suppl. 3, S. 5 - 6
    ISSN: 1610-0387; 1563-2571; 1610-0379; 0301-0481
    Online Volltext: dx.doi.org/
  • Schilling, Bastian; Sondermann, W.; Zhao, F.; Griewank, Klaus; Livingstone, Elisabeth; Sucker, A.; Zelba, H.; Weide, B.; Trefzer, U.; Wilhelm, T.; Loquai, C.; Berking, C.; Hassel, J.; Kähler, K. C.; Utikal, J.; Al~ghazal, P.; Gutzmer, R.; Goldinger, S. M.; Zimmer, Lisa; Paschen, Annette; Hillen, Uwe; Schadendorf, Dirk
    Differential influence of vemurafenib and dabrafenib on patients' lymphocytes despite similar clinical efficacy in melanoma
    In: Annals of Oncology Jg. 25 (2014) Nr. 3, S. 747 - 753
    ISSN: 1569-8041
    Online Volltext: dx.doi.org/
  • Paschen, Annette; Baingo, Jolanthe; Schadendorf, Dirk
    Expression of stress ligands of the immunoreceptor NKG2D in melanoma : regulation and clinical significance
    In: European Journal of Cell Biology Jg. 93 (2014) Nr. 1-2, S. 49 - 54
    ISSN: 1618-1298; 0171-9335
    Online Volltext: dx.doi.org/
  • Schadendorf, Dirk; Amonkar, M. M.; Milhem, M.; Grotzinger, K.; Demidov, L. V.; Rutkowski, P.; Garbe, C.; Dummer, R.; Hassel, J. C.; Wolter, P.; Mohr, P.; Trefzer, U.; Lefeuvre-Plesse, C.; Rutten, A.; Steven, N.; Ullenhag, G.; Sherman, L.; Wu, F. S.; Patel, K.; Casey, M.; Robert, C.
    Functional and symptom impact of trametinib versus chemotherapy in BRAF V600E advanced or metastatic melanoma : Quality-of-life analyses of the METRIC study
    In: Annals of Oncology Jg. 25 (2014) Nr. 3, S. 700 - 706
    ISSN: 1569-8041
    Online Volltext: dx.doi.org/
  • Griewank, Klaus; Scolyer, Richard A.; Thompson, John F.; Flaherty, K. T.; Schadendorf, Dirk; Murali, Rajmohan
    Genetic alterations and personalized medicine in melanoma: Progress and future prospects
    In: Journal of the National Cancer Institute Jg. 106 (2014) Nr. 2, S. djt435
    ISSN: 1460-2105
    Online Volltext: dx.doi.org/
  • Griewank, Klaus; van de Nes, Johannes; Schilling, Bastian; Moll, Iris; Sucker, Antje; Kakavand, Hojabr; Haydu, Lauren E; Asher, Marina; Zimmer, Lisa; Hillen, Uwe; Thompson, John F; Scolyer, Richard A; Schadendorf, Dirk; Murali, Rajmohan
    Genetic and clinico-pathologic analysis of metastatic uveal melanoma
    In: Modern Pathology Jg. 27 (2014) Nr. 2, S. 175 - 183
    ISSN: 1530-0285; 0893-3952
    Online Volltext: dx.doi.org/
  • Sucker, Antje; Zhao, Fang; Real, Birgit; Heeke, Christina; Bielefeld, Nicola; Maßen, Stefan; Horn, Susanne; Moll, Iris; Maltaner, Raffaela; Horn, Peter; Schilling, Bastian; Sabbatino, Francesco; Lennerz, Volker; Kloor, Matthias; Ferrone, Soldano; Schadendorf, Dirk; Falk, Christine S; Griewank, Klaus; Paschen, Annette
    Genetic evolution of T-cell resistance in the course of melanoma progression
    In: Clinical Cancer Research Jg. 20 (2014) Nr. 24, S. 6593 - 6604
    ISSN: 1078-0432
    Online Volltext: dx.doi.org/
  • Leyvraz, S.; Piperno-Neumann, S.; Suciu, S.; Baurain, J. F.; Zdzienicki, M.; Testori, A.; Marshall, E.; Scheulen, Max Ernst; Jouary, T.; Negrier, S.; Vermorken, J. B.; Kaempgen, E.; Durando, X.; Schadendorf, Dirk; Gurunath, R. K.; Keilholz, U.
    Hepatic intra-arterial versus intravenous fotemustine in patients with liver metastases from uveal melanoma (EORTC 18021) : A multicentric randomized trial
    In: Annals of Oncology Jg. 25 (2014) Nr. 3, S. 742 - 746
    ISSN: 1569-8041
    Online Volltext: dx.doi.org/
  • Schadendorf, Dirk; Jäger, Dirk
    Immunonkologie "Coming of Age" : die nächste Generation der Immun-Checkpoint-Inhibitoren
    In: Oncology Research and Treatment Jg. 37 (2014) Nr. Suppl. 4, S. 6 - 9
    ISSN: 2296-5262
    Online Volltext: dx.doi.org/
  • Schadendorf, Dirk; Jäger, Dirk
    Immunonkologie «Coming of Age» - die nächste Generation der Immun-Checkpoint-Inhibitoren
    In: Oncology Research and Treatment Jg. 37 (2014) Nr. Suppl. 4, S. 6 - 9
    ISSN: 2296-5262
  • Zimmer, Lisa; Haydu, Lauren E; Menzies, Alexander M; Scolyer, Richard A; Kefford, Richard F; Thompson, John F; Schadendorf, Dirk; Long, Georgina V
    Incidence of new primary melanomas after diagnosis of stage III and IV melanoma
    In: Journal of Clinical Oncology (JCO) Jg. 32 (2014) Nr. 8, S. 816 - 823
    ISSN: 0732-183X; 1527-7755
    Online Volltext: dx.doi.org/
  • Davies, J. R.; Jewell, R.; Affleck, P.; Anic, G. M.; Randerson-Moor, J.; Ozola, A.; Egan, K. M.; Elliott, F.; García-Casado, Z.; Hansson, J.; Harland, M.; Höiom, V.; Jian, G.; Jönsson, G.; Kumar, R.; Nagore, E.; Wendt, J.; Park, J. Y.; Patel, P.; Pjanova, D.; Puig, S.; Schadendorf, Dirk; Sivaramakrishna-Rachakonda, P.; Snowden, H.; Stratigos, A. J.; Bafaloukos, D.; Ogbah, Z.; Sucker, A.; Van Den Oord, J.J.; van Doorn, R.; Walker, C.; Okamoto, I.; Wolter, P.; Barrett, J. H.; Timothy Bishop, D.; Newton-Bishop, J.
    Inherited variation in the PARP1 gene and survival from melanoma
    In: International Journal of Cancer Jg. 135 (2014) Nr. 7, S. 1625 - 1633
    ISSN: 0020-7136; 1097-0215
    Online Volltext: dx.doi.org/ (Open Access)
  • Ullrich, N.; Heinemann, A.; Nilewsk, E.; Scherag, Andre; Schadendorf, Dirk; Singer, Bernhard B.; Helfrich, Iris
    Isoform-specific function of CEACAM1 during tumorigenesis : CEACAM1-3S, a novel prognostic biomarker in malignant melanoma
    In: Experimental Dermatology Jg. 23 (2014) Nr. 3, S. E45
    ISSN: 1600-0625; 0906-6705
    Online Volltext: dx.doi.org/
  • Kunstfeld, Rainer; Hauschild, Axel; Zloty, David; Rogers, Gary; Dreno, Brigitte; Mitchell, Lada; Starnawski, Michal; Schadendorf, Dirk
    MIKIE : A randomized, double-blind, regimen-controlled, phase II, multicenter study to assess the efficacy and safety of two different vismodegib regimens in patients with multiple basal cell carcinomas
    In: Journal of Clinical Oncology (JCO) Jg. 32 (2014) Nr. 15, suppl., S. TPS9121
    ISSN: 0732-183X; 1527-7755
    Online Volltext: dx.doi.org/
  • Schadendorf, Dirk; Schlag, P. M.
    Malignes Melanom
    In: Der Onkologe Jg. 20 (2014) Nr. 6, S. 530 - 532
    ISSN: 0947-8965
    Online Volltext: dx.doi.org/
  • Schadendorf, Dirk; Bernhard, H.
    Medikamentöse Systemtherapie des Melanoms
    In: Der Onkologe Jg. 20 (2014) Nr. 6, S. 568 - 576
    ISSN: 1433-0415
    Online Volltext: dx.doi.org/
  • Schadendorf, Dirk; Hauschild, Axel
    Melanoma in 2013 : Melanoma - The run of success continues
    In: Nature Reviews Clinical Oncology Jg. 11 (2014) Nr. 2, S. 75 - 76
    ISSN: 1759-4782; 1759-4774; 1743-4262; 1743-4254
    Online Volltext: dx.doi.org/
  • McCusker, Margaret; Basset-Seguin, Nicole; Dummer, Reinhard; Lewis, Karl; Schadendorf, Dirk; Sekulic, Aleksandar; Hou, Jeannie; Wang, Lisa; Yue, Huibin; Hauschild, Axel
    Metastatic basal cell carcinoma : prognosis dependent on anatomic site and spread of disease
    In: European Journal of Cancer Jg. 50 (2014) Nr. 4, S. 774 - 783
    ISSN: 0959-8049; 1879-0852; 0014-2964; 1879-2995
    Online Volltext: dx.doi.org/ (Open Access)
  • Weide, Benjamin; Martens, Alexander; Zelba, Henning; Stutz, Christina; Derhovanessian, Evelyna; Di Giacomo, Anna Maria; Maio, Michele; Sucker, Antje; Schilling, Bastian; Schadendorf, Dirk; Büttner, Petra; Garbe, Claus; Pawelec, Graham
    Myeloid-derived suppressor cells predict survival of patients with advanced melanoma : Comparison with regulatory T cells and NY-ESO-1- or melan-A-specific T cells
    In: Clinical Cancer Research Jg. 20 (2014) Nr. 6, S. 1601 - 1609
    ISSN: 1557-3265
    Online Volltext: dx.doi.org/
  • Ugurel, Selma; Mentzel, Thomas; Utikal, Jochen; Helmbold, Peter; Mohr, Peter; Pföhler, Claudia; Schiller, Meinhard; Hauschild; Hein, Rüdiger; Kämpgen, Eckhardt; Kellner, Ivonne; Leverkus, Martin; Becker, Jürgen; Ströbel, Philip; Schadendorf, Dirk
    Neoadjuvant imatinib in advanced primary or locally recurrent dermatofibrosarcoma protuberans : A multicenter phase II DeCOG Trial with Long-Term Follow-Up
    In: Clinical Cancer Research Jg. 20 (2014) Nr. 2, S. 499 - 510
    ISSN: 1557-3265; 1078-0432
    Online Volltext: dx.doi.org/
  • Zelba, Henning; Derhovanessian, Evelyna; Weide, Benjamin; Vries, Jolanda de; Schadendorf, Dirk; Maio, Michele; Giacomo, Anna Maria Di; Martens, Alexander; Pawelec, Graham P.; Garbe, Claus
    Peripheral immune signatures and survival in stage IV melanoma
    In: Cancer Research Jg. 74 (2014) Nr. 19 Suppl., S. 2547
    ISSN: 1538-7445; 0008-5472
    Online Volltext: dx.doi.org/
  • Helfrich, Iris; Ullrich, Nico; Zigrino, Paola; Schadendorf, Dirk
    Primary tumor versus metastasis : new experimental models for studies on cancer cell homing and metastasis in melanoma
    In: Pigment Cell and Melanoma Research Jg. 27 (2014) Nr. 2, S. 309 - 316
    ISSN: 1755-1471; 1755-148X
    Online Volltext: dx.doi.org/
  • Follmann, Markus; Schadendorf, Dirk; Kochs, Corinna; Buchberger, Barbara; Winter, Anna; Wesselmann, Simone
    Quality assurance for care of melanoma patients based on guideline-derived quality indicators and certification
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Jg. 12 (2014) Nr. 2, S. 139 - 147
    ISSN: 1610-0387; 1563-2571; 1610-0379; 0301-0481
    Online Volltext: dx.doi.org/
  • Zimmer, Lisa; Haydu, Lauren E; Menzies, Alexander M; Scolyer, Richard A; Kefford, Richard F; Thompson, John F; Schadendorf, Dirk; Long, Georgina V
    Reply to M. Perier-Muzet et al [Safety and Management of New Primary Melanomas During Receipt of BRAF Inhibitors ]
    In: Journal of Clinical Oncology (JCO) Jg. 32 (2014) Nr. 28, S. 3203 - 3204
    ISSN: 0732-183X; 1527-7755
    Online Volltext: dx.doi.org/
  • Vaubel, Julia Marianne; Livingstone, Elisabeth; Schadendorf, Dirk; Zimmer, Lisa
    Retarded low-dose doxycycline for EGFR or MEK inhibitor-induced papulopustular rash
    In: Journal of the European Academy of Dermatology and Venereology Jg. 28 (2014) Nr. 12, S. 1685 - 1689
    ISSN: 1468-3083
    Online Volltext: dx.doi.org/
  • Schrama, David; Ugurel, Selma; Sucker, Antje; Ritter, Cathrin; Zapatka, Marc; Schadendorf, Dirk; Becker, Jürgen
    STAT3 single nucleotide polymorphism rs4796793 SNP does not correlate with response to adjuvant IFNα therapy in stage III melanoma patients
    In: Frontiers in Medicine Jg. 1 (2014) Nr. 47,
    ISSN: 2296-858X
    Online Volltext: dx.doi.org/ (Open Access)
  • McArthur, Grant A; Chapman, Paul B; Robert, Caroline; Larkin, James; Haanen, John B; Dummer, Reinhard; Ribas, Antoni; Hogg, David; Hamid, Omid; Ascierto, Paolo A; Garbe, Claus; Testori, Alessandro; Maio, Michele; Lorigan, Paul; Lebbé, Celeste; Jouary, Thomas; Schadendorf, Dirk; O'Day, Stephen J; Kirkwood, John M; Eggermont, Alexander M; Dréno, Brigitte; Sosman, Jeffrey A; Flaherty, Keith T; Yin, Ming; Caro, Ivor; Cheng, Suzanne; Trunzer, Kerstin; Hauschild, Axel
    Safety and efficacy of vemurafenib in BRAF(V600E) and BRAF(V600K) mutation-positive melanoma (BRIM-3) : extended follow-up of a phase 3, randomised, open-label study
    In: The Lancet Oncology Jg. 15 (2014) Nr. 3, S. 323 - 332
    ISSN: 1470-2045; 1474-5488
    Online Volltext: dx.doi.org/ Online Volltext (Open Access)
  • Kordelas, Lambros; Verheyen, Jens; Beelen, Dietrich; Horn, Peter; Heinold, Andreas; Kaiser, Rolf; Trenschel, Rudolf; Schadendorf, Dirk; Dittmer, Ulf; Esser, Stefan
    Shift of HIV tropism in stem-cell transplantation with CCR5 Delta32 mutation
    In: The New England Journal of Medicine Jg. 371 (2014) Nr. 9, S. 880 - 882
    ISSN: 1533-4406; 0028-4793
    Online Volltext: dx.doi.org/
  • Livingstone, Elisabeth; Hollestein, Loes M; van Herk-Sukel, Myrthe P P; van de Poll-Franse, Lonneke; Joosse, Arjen; Schilling, Bastian; Nijsten, Tamar; Schadendorf, Dirk; de Vries, Esther
    Statin use and its effect on all-cause mortality of melanoma patients : a population-based Dutch cohort study
    In: Cancer Medicine Jg. 3 (2014) Nr. 5, S. 1284 - 1293
    ISSN: 2045-7634
    Online Volltext: dx.doi.org/ (Open Access)
  • Flaherty, Keith T.; Hennig, Michael; Lee, Sandra J.; Ascierto, Paolo A.; Dummer, Reinhard; Eggermont, Alexander M. M.; Hauschild, Axel; Kefford, Richard; Kirkwood, John M.; Long, Georgina V.; Lorigan, Paul; Mackensen, Andreas; McArthur, Grant; O'Day, Steven; Patel, Poulam M.; Robert, Caroline; Schadendorf, Dirk
    Surrogate endpoints for overall survival in metastatic melanoma: A meta-analysis of randomised controlled trials
    In: The Lancet Oncology Jg. 15 (2014) Nr. 3, S. 297 - 304
    ISSN: 1470-2045; 1474-5488
    Online Volltext: dx.doi.org/
  • Griewank, Klaus; Murali, Rajmohan; Puig-Butille, Joan Anton; Schilling, Bastian; Livingstone, Elisabeth; Potrony, Miriam; Carrera, Cristina; Schimming, Tobias; Möller, Inga; Schwamborn, Marion; Sucker, Antje; Hillen, Uwe; Badenas, Celia; Malvehy, Josep; Zimmer, Lisa; Scherag, Andre; Puig, Susanne; Schadendorf, Dirk
    TERT promoter mutation status as an independent prognostic factor in cutaneous melanoma
    In: Journal of the National Cancer Institute Jg. 106 (2014) Nr. 9,
    ISSN: 1460-2105; 0027-8874
    Online Volltext: dx.doi.org/
  • Griewank, Klaus; Schilling, Bastian; Murali, Rajmohan; Bielefeld, Nicola; Schwamborn, Marion; Sucker, Antje; Zimmer, Lisa; Hillen, Uwe; Schaller, Jörg; Brenn, Thomas; Schadendorf, Dirk; Mentzel, Thomas
    TERT promoter mutations are frequent in atypical fibroxanthomas and pleomorphic dermal sarcomas
    In: Modern Pathology Jg. 27 (2014) Nr. 4, S. 502 - 508
    ISSN: 1530-0285; 0893-3952
    Online Volltext: dx.doi.org/ (Open Access)
  • Van Allen, Eliezer M; Wagle, Nikhil; Sucker, Antje; Treacy, Daniel J; Johannessen, Cory M; Goetz, Eva M; Place, Chelsea S; Taylor-Weiner, Amaro; Whittaker, Steven; Kryukov, Gregory V; Hodis, Eran; Rosenberg, Mara; McKenna, Aaron; Cibulskis, Kristian; Farlow, Deborah; Zimmer, Lisa; Hillen, Uwe; Gutzmer, Ralf; Goldinger, Simone M; Ugurel, Selma; Gogas, Helen J; Egberts, Friederike; Berking, Carola; Trefzer, Uwe; Loquai, Carmen; Weide, Benjamin; Hassel, Jessica C; Gabriel, Stacey B; Carter, Scott L; Getz, Gad; Garraway, Levi A; Schadendorf, Dirk; Dermatologic Cooperative Oncology Group of Germany (DeCOG)
    The Genetic Landscape of Clinical Resistance to RAF Inhibition in Metastatic Melanoma
    In: Cancer Discovery Jg. 4 (2014) Nr. 1, S. 94 - 109
    ISSN: 2159-8290; 2159-8274
    Online Volltext: dx.doi.org/
  • Stockmann, Christian; Schadendorf, Dirk; Klose, Ralph; Helfrich, Iris
    The impact of the immune system on tumor : angiogenesis and vascular remodeling
    In: Frontiers in Oncology Jg. 4 (2014) S. 69
    ISSN: 2234-943X
    Online Volltext: dx.doi.org/ (Open Access)
  • Jarry, J.; Schadendorf, Dirk; Greenwood, C.; Spatz, A.; van Kempen, L.C.
    The validity of circulating microRNAs in oncology : Five years of challenges and contradictions
    In: Molecular Oncology Jg. 8 (2014) Nr. 4, S. 819 - 829
    ISSN: 1878-0261; 1574-7891
    Online Volltext: dx.doi.org/ (Open Access)
  • Bald, Tobias; Quast, Thomas; Landsberg, Jennifer; Rogava, Meri; Glodde, Nicole; Lopez-Ramos, Dorys; Kohlmeyer, Judith; Riesenberg, Stefanie; van den Boorn-Konijnenberg, Debby; Hömig-Hölzel, Cornelia; Reuten, Raphael; Schadow, Benjamin; Weighardt, Heike; Wenzel, Daniela; Helfrich, Iris; Schadendorf, Dirk; Bloch, Wilhelm; Bianchi, Marco E; Lugassy, Claire; Barnhill, Raymond L; Koch, Manuel; Fleischmann, Bernd K; Förster, Irmgard; Kastenmüller, Wolfgang; Kolanus, Waldemar; Hölzel, Michael; Gaffal, Evelyn; Tüting, Thomas
    Ultraviolet-radiation-induced inflammation promotes angiotropism and metastasis in melanoma
    In: Nature Jg. 507 (2014) Nr. 7490, S. 109 - 113
    ISSN: 0028-0836; 1476-4687
    Online Volltext: dx.doi.org/
  • Goldinger, Simone M; Zimmer, Lisa; Schulz, Carsten; Ugurel, Selma; Hoeller, Christoph; Kaehler, Katharina C; Schadendorf, Dirk; Hassel, Jessica C; Becker, Jürgen; Hauschild, Axel; Dummer, Reinhard
    Upstream mitogen-activated protein kinase (MAPK) pathway inhibition : MEK inhibitor followed by a BRAF inhibitor in advanced melanoma patients
    In: European Journal of Cancer Jg. 50 (2014) Nr. 2, S. 406 - 410
    ISSN: 0959-8049
    Online Volltext: dx.doi.org/
  • Whittaker, Steven R.; Theurillat, Jean-Philippe; Van Allen, Eliezer; Wagle, Nikhil; Hsiao, Jessica; Cowley, Glenn S.; Schadendorf, Dirk; Root, David E.; Garraway, Levi A.
    A Genome-Scale RNA Interference Screen Implicates NF1 Loss in Resistance to RAF Inhibition
    In: Cancer Discovery Jg. 3 (2013) Nr. 3, S. 351 - 362
    ISSN: 2159-8290; 2159-8274
    Online Volltext: dx.doi.org/
  • Lacouture, Mario E.; Duvic, Madeleine; Hauschild, Axel; Prieto, Victor G.; Robert, Caroline; Schadendorf, Dirk; Kim, Caroline C.; McCormack, Christopher J.; Myskowski, Patricia L.; Spleiss, Olivia; Trunzer, Kerstin; Su, Fei; Nelson, Betty; Nolop, Keith B.; Grippo, Joseph F.; Lee, Richard J.; Klimek, Matthew J.; Troy, James L.; Joe, Andrew K.
    Analysis of dermatologic events in vemurafenib-treated patients with melanoma
    In: The Oncologist Jg. 18 (2013) Nr. 3, S. 314 - 322
    ISSN: 1083-7159; 2159-8401; 1549-490X
    Online Volltext: dx.doi.org/ Online Volltext (Open Access)
  • Hermes, I.; Tsiogka, Maria; Rompoti, N.; Suttorp, W.; Zimmer, Lisa; Schadendorf, Dirk
    Autoimmuno-hypophysitis, Autoimmuno-colitis and Autoimmuno-hepatitis in a Patient with metastatic Melanoma during Therapy with CTLA-4 Antibody Ipilimumab
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Jg. 11 (2013) Nr. 9, S. 932
    ISSN: 1610-0387; 1563-2571; 1610-0379; 0301-0481
  • Esser, Stefan; Eisele, Lewin; Schwarz, B.; Neumann, Till; Schulze, C.; Warnke, A.; Holzendorf, V.; Potthoff, A.; Brockmeyer, N.; Hower, M.; Schadendorf, Dirk; Erbel, Raimund; Moebus, Susanne; Jöckel, Karl-Heinz; Reinsch, Nico
    B-type natriuretic peptide elevation is more frequent in HIV plus patients compared to the general population
    In: Antiviral Therapy Jg. 18 (2013) Nr. Suppl. 3, S. A41 - A42
    ISSN: 2040-2058; 1359-6535
    Online Volltext
  • Vits, Sabine; Cesko, Elvir; Benson, Sven; Rueckert, Annika; Hillen, Uwe; Schadendorf, Dirk; Schedlowski, Manfred
    Cognitive factors mediate placebo responses in patients with house dust mite allergy
    In: PLoS ONE Jg. 8 (2013) Nr. 11, S. e79576
    ISSN: 1932-6203
    Online Volltext: dx.doi.org/ (Open Access)
  • Rompoti, Natalia; Schilling, Bastian; Livingstone, Elisabeth; Griewank, Klaus; Hillen, Uwe; Sauerwein, Wolfgang; Pöttgen, Christoph; Stuschke, Martin; Schadendorf, Dirk; Zimmer, Lisa
    Combination of BRAF inhibitors and brain radiotherapy in patients with metastatic melanoma shows minimal acute toxicity
    In: Journal of Clinical Oncology (JCO) Jg. 31 (2013) Nr. 30, S. 3844 - 3845
    ISSN: 0732-183X; 1527-7755
    Online Volltext: dx.doi.org/
  • Griewank, Klaus; Westekemper, Henrike; Schilling, Bastian; Livingstone, Elisabeth; Schimming, Tobias; Sucker, Antje; Hillen, Uwe; Steuhl, Klaus-Peter; Zimmer, Lisa; Schadendorf, Dirk; Steuhl, Klaus-Peter
    Conjunctival Melanomas Harbor BRAF and NRAS Mutations—Response
    In: Clinical Cancer Research Jg. 19 (2013) Nr. 22, S. 6331 - 6332
    ISSN: 1557-3265; 1078-0432
    Online Volltext: dx.doi.org/
  • Griewank, Klaus; Westekemper, Henrike; Murali, Rajmohan; Mach, Monika; Schilling, Bastian; Wiesner, Thomas; Schimming, Tobias; Livingstone, Elisabeth; Sucker, Antje; Grabellus, Florian; Metz, Claudia; Süsskind, Daniela; Hillen, Uwe; Speicher, Michael R.; Woodman, Scott E.; Steuhl, Klaus-Peter; Schadendorf, Dirk
    Conjunctival melanomas harbor BRAF and NRAS mutations and copy number changes similar to cutaneous and mucosal melanomas
    In: Clinical Cancer Research Jg. 19 (2013) Nr. 12, S. 3143 - 3152
    ISSN: 1557-3265; 1557-3265
    Online Volltext: dx.doi.org/
  • Sevko, Alexandra; Sade-Feldman, Moshe; Kanterman, Julia; Michels, Tillmann; Falk, Christine S; Umansky, Ludmila; Ramacher, Marcel; Kato, Masashi; Schadendorf, Dirk; Baniyash, Michal; Umansky, Viktor
    Cyclophosphamide promotes chronic inflammation-dependent immunosuppression and prevents antitumor response in melanoma.
    In: The Journal of Investigative Dermatology Jg. 133 (2013) Nr. 6, S. 1610 - 1619
    ISSN: 1523-1747; 0022-202X
    Online Volltext: dx.doi.org/ (Open Access)
  • Lacouture, Mario E; Schadendorf, Dirk; Chu, Chia-Yu; Uttenreuther-Fischer, Martina; Stammberger, Uz; O'Brien, Dennis; Hauschild, Axel; O’Brien, Dennis
    Dermatologic adverse events associated with afatinib : An oral ErbB family blocker
    In: Expert Review of Anticancer Therapy Jg. 13 (2013) Nr. 6, S. 721 - 728
    ISSN: 1473-7140; 1744-8328
    Online Volltext: dx.doi.org/
  • Kochs, Dr. C.; Pflugfelder, A.; Garbe, C.; Schadendorf, Dirk
    Die neue S3-Leitlinie "melanom" : Das Wichtigste für die Praxis
    In: Best Practice Onkologie Jg. 8 (2013) Nr. 2, S. 40 - 48
    ISSN: 1862-8559; 0946-4565
    Online Volltext: dx.doi.org/
  • Kochs, Corinna; Pflugfelder, Annette; Garbe, Claus; Schadendorf, Dirk
    Die neue S3-leitlinie "Diagnostik, therapie und nachsorge des malignen melanoms" : Wie soll das staging durchgeführt werden?
    In: Haut: Dermatologie, Allergologie, Kosmetologie Jg. 24 (2013) Nr. 3, S. 124 - 128
    ISSN: 0938-2216
  • Robert, Caroline; Schadendorf, Dirk; Messina, Marianne; Hodi, F. Stephen; O'Day, Steven
    Efficacy and safety of retreatment with ipilimumab in patients with pretreated advanced melanoma who progressed after initially achieving disease control
    In: Clinical Cancer Research Jg. 19 (2013) Nr. 8, S. 2232 - 2239
    ISSN: 1557-3265; 1078-0432
    Online Volltext: dx.doi.org/
  • Reinsch, Nico; Esser, Stefan; Neumann, Till; Bokhof, B.; Eisele, Lewin; Schwarz, B.; Holzendorf, V.; Jöckel, Karl-Heinz; Schadendorf, Dirk; Erbel, Raimund; German Heart Failure Network
    Framingham risk score and cardiovascular risk profiles in HIV+ patients and HIV- controls differ by sex
    In: European Heart Journal Jg. 34 (2013) Nr. Suppl. 1, S. P5164
    ISSN: 0195-668X; 1522-9645
    Online Volltext: dx.doi.org/
  • Schadendorf, Dirk; Livingstone, Elisabeth; Vaubel, Julia; Zimmer, Lisa
    Hautkrebsforschung reloaded : Paradigmenwechsel in der Dermatoonkologie
    In: Unikate: Berichte aus Forschung und Lehre (2013) Nr. 44: Medizin: 50 Jahre Universitätsklinikum Essen, S. 136 - 143
    ISBN: 978-3-934359-44-4 ISSN: 0944-6060; 1869-3881
    Online Volltext: dx.doi.org/ Online Volltext (Open Access)
  • Miller, Dorothea; Zappala, Valeria; El Hindy, Nicolai; Livingstone, Elisabeth; Schadendorf, Dirk; Sure, Ulrich; Sandalcioglu, Ibrahim Erol
    Intracerebral metastases of malignant melanoma and their recurrences : a clinical analysis
    In: Clinical Neurology and Neurosurgery Jg. 115 (2013) Nr. 9, S. 1721 - 1728
    ISSN: 1872-6968; 0303-8467
    Online Volltext: dx.doi.org/
  • Gramsch, Carolin; Göricke, Sophia Luise; Behrens, Felix; Zimmer, Lisa; Schadendorf, Dirk; Krasny, Andrej; Forsting, Michael; Schlamann, Marc
    Isolated cerebral susceptibility artefacts in patients with malignant melanoma : Metastasis or not?
    In: European Radiology Jg. 23 (2013) Nr. 9, S. 2622 - 2627
    ISSN: 0938-7994; 1432-1084
    Online Volltext: dx.doi.org/
  • Rompoti, N.; Schilling, Bastian; Livingstone, Elisabeth; Griewank, Klaus; Hillen, Uwe; Sauerwein, Wolfgang; Pöttgen, Christoph; Stuschke, Martin; Schadendorf, Dirk; Zimmer, Lisa
    Kombination von BRAF-Inhibitoren (BRAFi) und zerebraler Bestrahlung bei Patienten mit metastasiertem Melanom : Eine mögliche Behandlungsoption für neu aufgetretene oder pro-grediente Hirnmetastasen unter Therapie mit BRAF-Inhibitoren
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Jg. 11 (2013) Nr. 9, S. 952 - 952
    ISSN: 1610-0387; 1563-2571; 1610-0379; 0301-0481
  • Schilling, Bastian; Bielefeld, Nicola; Sucker, Antje; Hillen, Uwe; Zimmer, Lisa; Schadendorf, Dirk; Zeschnigk, Michael; Griewank, Klaus
    Lack of SF3B1 R625 mutations in cutaneous melanoma
    In: Diagnostic Pathology Jg. 8 (2013) S. 87
    ISSN: 1746-1596
    Online Volltext: dx.doi.org/ (Open Access)
  • Hassel, Jessica C.; Amann, Philipp M.; Schadendorf, Dirk; Eichmüller, Stefan B.; Nagler, Markus; Bazhin, Alexandr V.
    Lecithin retinol acyltransferase as a potential prognostic marker for malignant melanoma
    In: Experimental Dermatology Jg. 22 (2013) Nr. 11, S. 757 - 759
    ISSN: 1600-0625; 0906-6705
    Online Volltext: dx.doi.org/
  • Ascierto, Paolo A.; Schadendorf, Dirk; Berking, Carola; Agarwala, Sanjiv S.; van Herpen, Carla M.L.; Queirolo, Paola; Blank, Christian U.; Hauschild, Axel; Beck, J Thaddeus; St-Pierre, Annie; Niazi, Faiz; Wandel, Simon; Peters, Malte; Zubel, Angela; Dummer, Reinhard
    MEK162 for patients with advanced melanoma harbouring NRAS or Val600 BRAF mutations: A non-randomised, open-label phase 2 study
    In: The Lancet Oncology Jg. 14 (2013) Nr. 3, S. 249 - 256
    ISSN: 1470-2045; 1474-5488
    Online Volltext: dx.doi.org/
  • Pflugfelder, Annette; Kochs, Corinna; Blum, Andreas; Capellaro, Marcus; Czeschik, Christina; Dettenborn, Therese; Dill, Dorothee; Dippel, Edgar; Eigentler, Thomas; Feyer, Petra; Follmann, Markus; Frerich, Bernhard; Ganten, Maria-Katharina; Gärtner, Jan; Gutzmer, Ralf; Hassel, Jessica; Hauschild, Axel; Hohenberger, Peter; Hübner, Jutta; Kaatz, Martin; Kleeberg, Ulrich R.; Kölbl, Oliver; Kortmann, Rolf-Dieter; Krause-Bergmann, Albrecht; Kurschat, Peter; Leiter, Ulrike; Link, Hartmut; Loquai, Carmen; Löser, Christoph; Mackensen, Andreas; Meier, Friedegund; Mohr, Peter; Möhrle, Matthias; Nashan, Dorothee; Reske, Sven; Rose, Christian; Sander, Christian; Satzger, Imke; Schiller, Meinhard; Schlemmer, Heinz-Peter; Strittmatter, Gerhard; Sunderkötter, Cord; Swoboda, Lothar; Trefzer, Uwe; Voltz, Raymond; Vordermark, Dirk; Weichenthal, Michael; Werner, Andreas; Wesselmann, Simone; Weyergraf, Ansgar J.; Wick, Wolfgang; Garbe, Claus; Schadendorf, Dirk
    Malignes melanom S3-leitlinie "Diagnostik, Therapie und Nachsorge des Melanoms"
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Jg. 11 (2013) Nr. Suppl. 6, S. 1 - 116; 1 - 126
    ISSN: 1610-0387; 1563-2571; 1610-0379; 0301-0481
    Online Volltext: dx.doi.org/ (Open Access)
  • Luo, Chonglin; Merz, Patrick R.; Chen, Yiwei; Dickes, Elke; Pscherer, Armin; Schadendorf, Dirk; Eichmüller, Stefan B.
    MiR-101 inhibits melanoma cell invasion and proliferation by targeting MITF and EZH2
    In: Cancer Letters Jg. 341 (2013) Nr. 2, S. 240 - 247
    ISSN: 1872-7980; 0304-3835
    Online Volltext: dx.doi.org/
  • Luo, Chonglin; Tetteh, Paul W.; Merz, Patrick R.; Dickes, Elke; Abukiwan, Alia; Hotz-Wagenblatt, Agnes; Holland-Cunz, Stefan; Sinnberg, Tobias; Schittek, Birgit; Schadendorf, Dirk; Diederichs, Sven; Eichmüller, Stefan B.
    MiR-137 inhibits the invasion of melanoma cells through downregulation of multiple oncogenic target genes
    In: The Journal of Investigative Dermatology Jg. 133 (2013) Nr. 3, S. 768 - 775
    ISSN: 1523-1747; 0022-202X
    Online Volltext: dx.doi.org/ (Open Access)
  • Eberhardt, Wilfried; Gauler, Thomas; Schadendorf, Dirk
    Neue Entwicklungen in der Behandlung von soliden Tumoren mit zielgerichteten Medikamenten. Lunge, Niere, Melanom
    In: Der Onkologe Jg. 19 (2013) Nr. 10, S. 821 - 834
    ISSN: 1433-0415
    Online Volltext: dx.doi.org/
  • Helfrich, Iris; Hansen, Wiebke; Hutzler, Marina; Sakaguchi, S.; Albert, J.; Stockmann, C.; Buer, Jan; Schadendorf, Dirk
    Neuropilin-1 Deficiency on CD4+Foxp3+Regulatory T Cells Modulates Tumor Angiogenesis and Impaires Tumor Growth in Melanoma
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Jg. 11 (2013) Nr. Suppl. S7, S. 30
    ISSN: 1610-0387; 1563-2571; 1610-0379; 0301-0481
    Online Volltext: dx.doi.org/
  • Hutzler, Marina; Helfrich, Iris; Schadendorf, Dirk; Buer, Jan; Hansen, Wiebke
    Neuropilin-1 is a key mediator of VEGF-dependent Treg migration to tumors
    In: International Journal of Molecular Medicine Jg. 32 (2013) Nr. Suppl. 1, S. S36
    ISSN: 1107-3756; 1791-244X
  • Griewank, Klaus; Ugurel, Selma; Schadendorf, Dirk; Paschen, Annette
    New developments in biomarkers for melanoma
    In: Current Opinion in Oncology Jg. 25 (2013) Nr. 2, S. 145 - 151
    ISSN: 1040-8746; 1531-703X
    Online Volltext: dx.doi.org/
  • Ascierto, Paolo A.; Minor, David; Ribas, Antoni; Lebbe, Celeste; O'Hagan, Anne; Arya, Niki; Guckert, Mary; Schadendorf, Dirk; Kefford, Richard F.; Grob, Jean-Jacques; Hamid, Omid; Amaravadi, Ravi; Simeone, Ester; Wilhelm, Tabea; Kim, Kevin B.; Long, Georgina V.; Martin, Anne-Marie; Mazumdar, Jolly; Goodman, Vicki L.; Trefzer, Uwe
    Phase II trial (BREAK-2) of the BRAF inhibitor dabrafenib (GSK2118436) in patients with metastatic melanoma
    In: Journal of Clinical Oncology (JCO) Jg. 31 (2013) Nr. 26, S. 3205 - 3211
    ISSN: 0732-183X; 1527-7755
    Online Volltext: dx.doi.org/
  • Esser, Stefan; Gelbrich, Götz; Brockmeyer, Norbert; Goehler, Alexander; Schadendorf, Dirk; Erbel, Raimund; Neumann, Till; Reinsch, Nico
    Prevalence of cardiovascular diseases in HIV-infected outpatients: Results from a prospective, multicenter cohort study
    In: Clinical Research in Cardiology Jg. 102 (2013) Nr. 3, S. 203 - 213
    ISSN: 1861-0692; 1861-0684; 0300-5860; 1435-1285
    Online Volltext: dx.doi.org/
  • Schwarz, B.; Eisele, Lewin; Neumann, Till; Reinsch, Nico; Schulze, C.; Warnke, A.; Holzendorf, V.; Potthoff, A.; Brockmeyer, N.; Hower, M.; Schadendorf, Dirk; Erbel, Raimund; Moebus, Susanne; Jöckel, Karl-Heinz; Esser, Stefan
    Psychotropic drugs are prescribed more frequently in HIV-positive patients compared to the general population. Data from two German prospective cohorts : Heinz Nixdorf Recall Study and HIV HEART Study
    In: Antiviral Therapy Jg. 18 (2013) Nr. Suppl. 3, S. A77 - A78
    ISSN: 2040-2058; 1359-6535
    Online Volltext
  • Löhr, J.-Matthias; Dinter, Dietmar; Diehl, Steffen J.; Haas, Stephan L.; Veeser, Mira; Pfützer, Roland; Retter, Jürgen; Schönberg, Stefan O.; Düber, Christoph; Keim, Volker; Schadendorf, Dirk; Witt, Heiko
    Rapid progression of a splenic aneurysm due to segmental arterial mediolysis: : a rare cause of acute pancreatitis
    In: Pancreatology Jg. 13 (2013) Nr. 5, S. 553 - 556
    ISSN: 1424-3903; 1424-3911
    Online Volltext: dx.doi.org/
  • Pechlivanis, Sonali; Mühleisen, Thomas W.; Möhlenkamp, Stefan; Schadendorf, Dirk; Erbel, Raimund; Jöckel, Karl-Heinz; Hoffmann, Per; Nöthen, Markus M.; Scherag, Andre; Moebus, Susanne
    Risk loci for coronary artery calcification replicated at 9p21 and 6q24 in the Heinz Nixdorf Recall Study
    In: BMC Medical Genetics Jg. 14 (2013) Nr. 1, S. 23
    ISSN: 1471-2350
    Online Volltext: dx.doi.org/ (Open Access)
  • Pflugfelder, Annette; Kochs, Corinna; Blum, Andreas; Capellaro, Marcus; Czeschik, Christina; Dettenborn, Therese; Dill, Dorothee; Dippel, Edgar; Eigentler, Thomas; Feyer, Petra; Follmann, Markus; Frerich, Bernhard; Ganten, Maria-Katharina; Gärtner, Jan; Gutzmer, Ralf; Hassel, Jessica; Hauschild, Axel; Hohenberger, Peter; Hübner, Jutta; Kaatz, Martin; Kleeberg, Ulrich R.; Kölbl, Oliver; Kortmann, Rolf-Dieter; Krause-Bergmann, Albrecht; Kurschat, Peter; Leiter, Ulrike; Link, Hartmut; Loquai, Carmen; Löser, Christoph; MacKensen, Andreas; Meier, Friedegund; Mohr, Peter; Möhrle, Matthias; Nashan, Dorothee; Reske, Sven; Rose, Christian; Sander, Christian; Satzger, Imke; Schiller, Meinhard; Schlemmer, Heinz-Peter; Strittmatter, Gerhard; Sunderkötter, Cord; Swoboda, Lothar; Trefzer, Uwe; Voltz, Raymond; Vordermark, Dirk; Weichenthal, Michael; Werner, Andreas; Wesselmann, Simone; Weyergraf, Ansgar J.; Wick, Wolfgang; Garbe, Claus; Schadendorf, Dirk
    S3-Guideline "diagnosis, therapy and follow-up of melanoma" - short version
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Jg. 11 (2013) Nr. 6, S. 593 - 602
    ISSN: 1610-0387; 1563-2571; 1610-0379; 0301-0481
    Online Volltext: dx.doi.org/
  • Robert, Caroline; Dummer, Reinhard; Gutzmer, Ralf; Lorigan, Paul; Kim, Kevin B.; Nyakas, Marta; Arance, Ana; Liszkay, Gabriella; Schadendorf, Dirk; Cantarini, Mireille; Spencer, Stuart; Middleton, Mark R.
    Selumetinib plus dacarbazine versus placebo plus dacarbazine as first-line treatment for BRAF-mutant metastatic melanoma : A phase 2 double-blind randomised study
    In: The Lancet Oncology Jg. 14 (2013) Nr. 8, S. 733 - 740
    ISSN: 1470-2045; 1474-5488
    Online Volltext: dx.doi.org/
  • Griewank, Klaus; Murali, Rajmohan; Schilling, Bastian; Schimming, Tobias; Möller, Inga; Moll, Iris; Schwamborn, Marion; Sucker, Antje; Zimmer, Lisa; Schadendorf, Dirk; Hillen, Uwe
    TERT promoter mutations are frequent in cutaneous basal cell carcinoma and squamous cell carcinoma
    In: PLoS ONE Jg. 8 (2013) Nr. 11, S. e80354
    ISSN: 1932-6203
    Online Volltext: dx.doi.org/ (Open Access)
  • Rachakonda, P. Sivaramakrishna; Hosen, Ismail; De Verdier, Petra J.; Fallah, Mahdi; Heidenreich, Barbara; Ryk, Charlotta; Wiklund, N. Peter; Steineck, Gunnar; Schadendorf, Dirk; Hemminki, Kari; Kumar, Rajiv
    TERT promoter mutations in bladder cancer affect patient survival and disease recurrence through modification by a common polymorphism
    In: Proceedings of the National Academy of Sciences of the United States of America (PNAS) Jg. 110 (2013) Nr. 43, S. 17426 - 17431
    ISSN: 1091-6490; 0027-8424
    Online Volltext: dx.doi.org/
  • Horn, Susanne; Figl, Adina; Rachakonda, P. Sivaramakrishna; Fischer, Christine; Sucker, Antje; Gast, Andreas; Kadel, Stephanie; Moll, Iris; Nagore, Eduardo; Hemminki, Kari; Schadendorf, Dirk; Kumar, Rajiv
    TERT promoter mutations in familial and sporadic melanoma
    In: Science Jg. 339 (2013) Nr. 6122, S. 959 - 961
    ISSN: 1095-9203; 0036-8075
    Online Volltext: dx.doi.org/
  • Griewank, Klaus; Murali, R.; Schilling, Bastian; Scholz, S.; Sucker, A.; Song, M.; Süsskind, D.; Grabellus, Florian; Zimmer, Lisa; Hillen, Uwe; Steuhl, Klaus-Peter; Schadendorf, Dirk; Westekemper, Henrike; Zeschnigk, Michael
    TERT promoter mutations in ocular melanoma distinguish between conjunctival and uveal tumours
    In: British Journal of Cancer (BJC) Jg. 109 (2013) Nr. 2, S. 497 - 501
    ISSN: 1532-1827; 0007-0920
    Online Volltext: dx.doi.org/ (Open Access)
  • Aarntzen, Erik H. J. G.; De Vries, I. Jolanda M.; Lesterhuis, W. Joost; Schuurhuis, Danita; Jacobs, Joannes F. M.; Bol, Kalijn; Schreibelt, Gerty; Mus, Roel; De Wilt, Johannes H. W.; Haanen, John B. A. G.; Schadendorf, Dirk; Croockewit, Alexandra; Blokx, Willeke A. M.; Van Rossum, Michelle M.; Kwok, William W.; Adema, Gosse J.; Punt, Cornelis J. A.; Figdor, Carl G.
    Targeting CD4+ T-helper cells improves the induction of antitumor responses in dendritic cell -based vaccination
    In: Cancer Research Jg. 73 (2013) Nr. 1, S. 19 - 29
    ISSN: 1538-7445; 0008-5472
    Online Volltext: dx.doi.org/
  • Niessner, Heike; Forschner, Andrea; Klumpp, Bernhard; Honegger, Jürgen B; Witte, Maria; Bornemann, Antje; Dummer, Reinhard; Adam, Annemarie; Bauer, Jürgen; Tabatabai, Ghazaleh; Flaherty, Keith; Sinnberg, Tobias; Beck, Daniela; Leiter, Ulrike; Mauch, Cornelia; Rösch, Alexander; Weide, Benjamin; Eigentler, Thomas; Schadendorf, Dirk; Garbe, Claus; Kulms, Dagmar; Quintanilla-Martinez, Leticia; Meier, Friedegund
    Targeting hyperactivation of the AKT survival pathway to overcome therapy resistance of melanoma brain metastases.
    In: Cancer Medicine Jg. 2 (2013) Nr. 1, S. 76 - 85
    ISSN: 2045-7634
    Online Volltext: dx.doi.org/ (Open Access)
  • Voskens, Caroline J.; Goldinger, Simone M.; Loquai, Carmen; Robert, Caroline; Kaehler, Katharina C.; Berking, Carola; Bergmann, Tanja; Bockmeyer, Clemens L.; Eigentler, Thomas; Fluck, Michael; Garbe, Claus; Gutzmer, Ralf; Grabbe, Stephan; Hauschild, Axel; Hein, Rüdiger; Hundorfean, Gheorghe; Justich, Armin; Keller, Ullrich; Klein, Christina; Mateus, Christine; Mohr, Peter; Paetzold, Sylvie; Satzger, Imke; Schadendorf, Dirk; Schlaeppi, Marc; Schuler, Gerold; Schuler-Thurner, Beatrice; Trefzer, Uwe; Ulrich, Jens; Vaubel, Julia Marianne; Moos, Roger von; Weder, Patrik; Wilhelm, Tabea; Göppner, Daniela; Dummer, Reinhard; Heinzerling, Lucie M.
    The price of tumor control : an analysis of rare side effects of Anti-CTLA-4 therapy in metastatic melanoma from the ipilimumab network
    In: PLoS ONE Jg. 8 (2013) Nr. 1, S. e53745
    ISSN: 1932-6203
    Online Volltext: dx.doi.org/ (Open Access)
  • Hillen, Uwe; Griewank, Klaus; Sommerwerck, Urte; Baba, Hideo Andreas; Schadendorf, Dirk
    Tumor regression and sirolimus-based therapy in lung transplantation
    In: The Journal of Heart and Lung Transplantation Jg. 32 (2013) Nr. 9, S. 938 - 939
    ISSN: 1053-2498; 1557-3117
    Online Volltext: dx.doi.org/
  • Reinsch, Nico; Esser, Stefan; Gelbrich, Götz; Brockmeyer, Norbert; Potthoff, Anja; Schadendorf, Dirk; Erbel, Raimund; Neumann, Till
    Valvular manifestations of human immunodeficiency virus infection - Results from the prospective, multicenter HIV-HEART study
    In: Journal of Cardiovascular Medicine Jg. 14 (2013) Nr. 10, S. 733 - 739
    ISSN: 1558-2027; 1558-2035
    Online Volltext: dx.doi.org/
  • Beck, Daniela; Niessner, Heike; Smalley, Keiran S.M.; Flaherty, Keith; Paraiso, Kim H.T.; Busch, Christian; Sinnberg, Tobias; Vasseur, Sophie; Iovanna, Juan Lucio; Drießen, Stefan; Stork, Björn; Wesselborg, Sebastian; Schaller, Martin; Biedermann, Tilo; Bauer, Jürgen; Lasithiotakis, Konstantinos; Weide, Benjamin; Eberle, Jürgen; Schittek, Birgit; Schadendorf, Dirk; Garbe, Claus; Kulms, Dagmar; Meier, Friedegund
    Vemurafenib potently induces endoplasmic reticulum stress-mediated apoptosis in BRAFV600E melanoma cells
    In: Science Signaling Jg. 6 (2013) Nr. 260,
    ISSN: 1945-0877; 1937-9145; 1525-8882
    Online Volltext: dx.doi.org/
  • Weide, Benjamin; Schilling, Bastian; Paschen, Annette; Görgens, Andre; Sucker, Antje; Zhao, Fang; Giebel, Bernd; Griewank, Klaus; Schadendorf, Dirk
    Vemurafenib reverses immunosuppression by myeloid derived suppressor cells
    In: Cancer Research Jg. 73 (2013) Nr. 8 Suppl., S. 4714
    ISSN: 1538-7445; 0008-5472
    Online Volltext: dx.doi.org/
  • Schilling, Bastian; Sucker, Antje; Griewank, Klaus; Zhao, Fang; Weide, Benjamin; Görgens, André; Giebel, Bernd; Schadendorf, Dirk; Paschen, Annette
    Vemurafenib reverses immunosuppression by myeloid derived suppressor cells
    In: International Journal of Cancer Jg. 133 (2013) Nr. 7, S. 1653 - 1663
    ISSN: 0020-7136; 1097-0215
    Online Volltext: dx.doi.org/
  • Hauschild, Axel; Kölbl, Oliver; Mackensen, Andreas; Schadendorf, Dirk
    Vorwort
    In: Onkologie Jg. 36 (2013) Nr. Suppl. 4, S. 1
    ISSN: 0378-584X; 1423-0240; 2296-5262; 2296-5270
    Online Volltext: dx.doi.org/
  • Livingstone, Elisabeth; Hollestein, L. M.; Herk-Sukel, M. P. P. van; Poll-Franse, L. van de; Nijsten, T.; Schadendorf, Dirk; Vries, E. de
    β-Blocker use and all-cause mortality of melanoma patients : results from a population-based Dutch cohort study
    In: European Journal of Cancer Jg. 49 (2013) Nr. 18, S. 3863 - 3871
    ISSN: 0959-8049; 1879-0852; 1879-2995; 0014-2964
    Online Volltext: dx.doi.org/
  • Hodis, Eran; Watson, Ian R.; Kryukov, Gregory V.; Arold, Stefan T.; Imielinski, Marcin; Theurillat, Jean-Philippe; Nickerson, Elizabeth; Auclair, Daniel; Li, Liren; Place, Chelsea; Dicara, Daniel; Ramos, Alex H.; Lawrence, Michael S.; Cibulskis, Kristian; Sivachenko, Andrey; Voet, Douglas; Saksena, Gordon; Stransky, Nicolas; Onofrio, Robert C.; Winckler, Wendy; Ardlie, Kristin; Wagle, Nikhil; Wargo, Jennifer; Chong, Kelly; Morton, Donald L.; Stemke-Hale, Katherine; Chen, Guo; Noble, Michael; Meyerson, Matthew; Ladbury, John E.; Davies, Michael A.; Gershenwald, Jeffrey E.; Wagner, Stephan N.; Hoon, Dave S.B.; Schadendorf, Dirk; Lander, Eric S.; Gabriel, Stacey B.; Getz, Gad; Garraway, Levi A.; Chin, Lynda
    A Landscape of Driver Mutations in Melanoma
    In: Cell Jg. 150 (2012) Nr. 2, S. 251 - 263
    ISSN: 0092-8674; 1097-4172
    Online Volltext: dx.doi.org/
  • Schadendorf, Dirk; Vaubel, Julia Marianne; Livingstone, Elisabeth; Zimmer, Lisa
    Advances and perspectives in immunotherapy of melanoma
    In: Annals of Oncology Jg. 23 (2012) Nr. Suppl. 10, S. x104 - x108
    ISSN: 0923-7534; 1569-8041
    Online Volltext: dx.doi.org/ Online Volltext
  • Stoffels, Ingo; Dissemond, Joachim; Pöppel, Thorsten; Klötgen, K.; Hillen, Uwe; Körber, Andreas; Schadendorf, Dirk; Klode, Joachim
    Advantages of preoperative ultrasound in conjunction with lymphoscintigraphy in detecting malignant melanoma metastases in sentinel lymph nodes : a retrospective analysis in 221 patients with malignant melanoma AJCC Stages i and II
    In: Journal of the European Academy of Dermatology and Venereology Jg. 26 (2012) Nr. 1, S. 79 - 85
    ISSN: 0926-9959; 1468-3083
    Online Volltext: dx.doi.org/
  • Stoffels, Ingo; Boy, Christian; Pöppel, Thorsten; Kuhn, Jasna; Klötgen, Kerstin; Dissemond, Joachim; Schadendorf, Dirk; Klode, Joachim
    Association Between Sentinel Lymph Node Excision With or Without Preoperative SPECT/CT and Metastatic Node Detection and Disease-Free Survival in Melanoma
    In: JAMA: Journal of the American Medical Association Jg. 308 (2012) Nr. 10, S. 1007 - 1014
    ISSN: 1538-3598; 0098-7484
    Online Volltext: dx.doi.org/
  • Zimmer, Lisa; Hillen, Uwe; Livingstone, Elisabeth; Lacouture, Mario E.; Busam, Klaus; Carvajal, Richard D.; Egberts, Friederike; Hauschild, Axel; Kashani-Sabet, Mohammed; Goldinger, Simone M.; Dummer, Reinhard; Long, Georgina V.; McArthur, Grant; Scherag, Andre; Sucker, Antje; Schadendorf, Dirk
    Atypical Melanocytic Proliferations and New Primary Melanomas in Patients With Advanced Melanoma Undergoing Selective BRAF Inhibition
    In: Journal of Clinical Oncology (JCO) Jg. 30 (2012) Nr. 19, S. 2375 - 2383
    ISSN: 0732-183X; 1527-7755
    Online Volltext: dx.doi.org/
  • Preusser, Matthias; Berghoff, Anna S.; Schadendorf, Dirk; Lin, Nancy U.; Stupp, Roger
    Brain metastasis : Opportunity for drug development?
    In: Current Opinion in Neurology Jg. 25 (2012) Nr. 6, S. 786 - 794
    ISSN: 1473-6551
    Online Volltext: dx.doi.org/
  • Reinsch, N.; Kloetgen, H. W.; Jablonka, Robert; Storim, J.; Warnke, A.; Gelbrich, G.; Erbel, Raimund; Neumann, Till; Schadendorf, Dirk; Esser, Stefan; German Competence Network
    Brain natriuretic peptide (BNP) : A general mortality predictor in HIV-infected patients? - Results from the 5 year follow-up of the HIV-HEART trial
    In: European Heart Journal Jg. 33 (2012) Nr. Suppl. 1, S. 337
    ISSN: 0195-668X; 1522-9645
  • Livingstone, Elisabeth; Zimmer, Lisa; Vaubel, Julia Marianne; Schadendorf, Dirk
    Current advances and perspectives in the treatment of advanced melanoma
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Jg. 10 (2012) Nr. 5, S. 319 - 325
    ISSN: 1610-0387; 1563-2571; 1610-0379; 0301-0481
    Online Volltext: dx.doi.org/
  • Long, Georgina V.; Trefzer, Uwe; Davies, Michael A.; Kefford, Richard F.; Ascierto, Paolo A.; Chapman, Paul B.; Puzanov, Igor; Hauschild, Axel; Robert, Caroline; Algazi, Alain; Mortier, Laurent; Tawbi, Hussein; Wilhelm, Tabea; Zimmer, Lisa; Switzky, Julie; Swann, Suzanne; Martin, Anne-Marie; Guckert, Mary; Goodman, Vicki; Streit, Michael; Kirkwood, John M.; Schadendorf, Dirk
    Dabrafenib in patients with Val600Glu or Val600Lys BRAF-mutant melanoma metastatic to the brain (BREAK-MB) : A multicentre, open-label, phase 2 trial
    In: The Lancet Oncology Jg. 13 (2012) Nr. 11, S. 1087 - 1095
    ISSN: 1470-2045; 1474-5488
    Online Volltext: dx.doi.org/
  • Esser, Stefan; Jablonka, Robert; Heinemann, Falko M.; Reuter, Stefan; Jaeger, Hans; von Krosigk, Ariane; Schenk-Westkamp, Pia; Schadendorf, Dirk; Horn, Peter; Lindemann, Monika
    Detection of abacavir hypersensitivity by ELISpot method
    In: Inflammation & Allergy: Drug Targets Jg. 11 (2012) Nr. 3, S. 227 - 234
    ISSN: 2212-4055; 1871-5281
    Online Volltext: dx.doi.org/
  • Testori, Alessandro; Suciu, Stefan; Akkooi, Alexander C. J. van; Cook, Martin; Ghanem, Ghanem; Karra Gurunath, R.; Keilholz, Ulrich; Kempen, Leon van; Leyvraz, Serge; Mihm, Martin; Newton-Bishop, Julia; Patel, Poulam; Robert, Caroline; Schadendorf, Dirk; Schaetzen, Gaetan de; Spatz, Alan; Vries, Esther de; Eggermont, Alexander M. M.
    EORTC Melanoma Group achievements
    In: European Journal of Cancer / EJC Supplements Jg. 10 (2012) Nr. 1, S. 112 - 119
    ISSN: 1359-6349; 1878-1217
    Online Volltext: dx.doi.org/
  • Stoffels, Ingo; Von Der Stück, Hannah; Boy, Christian; Pöppel, Thorsten; Körber, Nina; Weindorf, Maren; Dissemond, Joachim; Schadendorf, Dirk; Klode, Joachim
    Fluoreszenz-Markierung mittels Indocyanin-Grün bei der Sentinel-Lymphknoten-Exstirpation in der Dermatoonkologie
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Jg. 10 (2012) Nr. 1, S. 51 - 58
    ISSN: 1610-0387; 1563-2571; 1610-0379; 0301-0481
    Online Volltext: dx.doi.org/; Online Volltext: dx.doi.org/
  • Weide, Benjamin; Zelba, Henning; Derhovanessian, Evelyna; Pflugfelder, Annette; Eigentler, Thomas K.; Di Giacomo, Anna Maria; Maio, Michele; Aarntzen, Erik H.J.G.; De Vries, I. Jolanda M.; Sucker, Antje; Schadendorf, Dirk; Büttner, Petra; Garbe, Claus; Pawelec, Graham
    Functional T cells targeting NY-ESO-1 or Melan-A are predictive for survival of patients with distant melanoma metastasis
    In: Journal of Clinical Oncology (JCO) Jg. 30 (2012) Nr. 15, S. 1835 - 1841
    ISSN: 0732-183X; 1527-7755
    Online Volltext: dx.doi.org/
  • Paschen, Annette; Schadendorf, Dirk; Schilling, Bastian
    Gegen den Hautkrebs : Forschung zur Überwindung immuntherapeutischer Hürden beim malignen Melanom
    In: Unikate: Berichte aus Forschung und Lehre (2012) Nr. 42: Translationale Krebsforschung: Auf dem Weg zu neuen Therapien, S. 32 - 41
    ISBN: 978-3-934359-42-0 ISSN: 0944-6060; 1869-3881
    Online Volltext: dx.doi.org/ Online Volltext (Open Access)
  • Kamphausen, Thomas; Schadendorf, Dirk; Von Wurmb-Schwark, Nicole; Bajanowski, Thomas; Poetsch, Micaela
    Good shedder or bad shedder : the influence of skin diseases on forensic DNA analysis from epithelial abrasions
    In: International Journal of Legal Medicine Jg. 126 (2012) Nr. 1, S. 179 - 183
    ISSN: 0937-9827; 1437-1596
    Online Volltext: dx.doi.org/
  • Zimmer, Lisa; Vaubel, Julia Marianne; Schadendorf, Dirk
    Immuntherapie des Melanoms
    In: Der Onkologe Jg. 18 (2012) Nr. 9, S. 801 - 807
    ISSN: 0947-8965; 1433-0415
    Online Volltext: dx.doi.org/
  • Zimmer, Lisa; Vaubel, Julia Marianne; Schadendorf, Dirk
    Immuntherapie des Melanoms
    In: Der Hautarzt Jg. 63 (2012) Nr. 12, S. 952 - 960
    ISSN: 1432-1173
    Online Volltext: dx.doi.org/
  • Flaherty, Keith T.; Robert, Caroline; Hersey, Peter; Nathan, Paul; Garbe, Claus; Milhem, Mohammed; Demidov, Lev V.; Hassel, Jessica C.; Rutkowski, Piotr; Mohr, Peter; Dummer, Reinhard; Trefzer, Uwe; Larkin, James M.G.; Utikal, Jochen; Dreno, Brigitte; Nyakas, Marta; Middleton, Mark R.; Becker, Jürgen; Casey, Michelle; Sherman, Laurie J.; Wu, Frank S.; Ouellet, Daniele; Martin, Anne-Marie; Patel, Kiran; Schadendorf, Dirk
    Improved survival with MEK inhibition in BRAF-mutated melanoma
    In: The New England Journal of Medicine Jg. 367 (2012) Nr. 2, S. 107 - 114
    ISSN: 1533-4406; 0028-4793
    Online Volltext: dx.doi.org/
  • Lenci, Romina Elizabeth; Bevier, Melanie; Brandt, Andreas; Bermejo, Justo Lorenzo; Sucker, Antje; Moll, Iris; Planelles, Dolores; Requena, Celia; Nagore, Eduardo; Hemminki, Kari; Schadendorf, Dirk; Kumar, Rajiv
    Influence of Genetic Variants in Type I Interferon Genes on Melanoma Survival and Therapy
    In: PLoS ONE Jg. 7 (2012) Nr. 11, S. 0050692
    ISSN: 1932-6203
    Online Volltext: dx.doi.org/ (Open Access)
  • Davies, John R.; Randerson-Moor, Juliette; Kukalizch, Kairen; Harland, Mark; Kumar, Rajiv; Madhusudan, Srinivasan; Nagore, Eduardo; Hansson, Johan; Höiom, Veronica; Ghiorzo, Paola; Gruis, Nelleke A.; Kanetsky, Peter A.; Wendt, Judith; Pjanova, Dace; Puig, Susana; Saiag, Philippe; Schadendorf, Dirk; Soufir, Nadem; Okamoto, Ichiro; Affleck, Paul; García-Casado, Zaida; Ogbah, Zighereda; Ozola, Aija; Queirolo, Paola; Sucker, Antje; Barrett, Jennifer H.; van Doorn, Remco; Bishop, D. Timothy; Newton-Bishop, Julia
    Inherited variants in the MC1R gene and survival from cutaneous melanoma : A BioGenoMEL study
    In: Pigment Cell and Melanoma Research Jg. 25 (2012) Nr. 3, S. 384 - 394
    ISSN: 1755-1471; 1755-148X
    Online Volltext: dx.doi.org/
  • Lenci, Romina E.; Rachakonda, P. Sivaramakrishna; Kubarenko, Andriy V.; Weber, Alexander; Brandt, Andreas; Gast, Andreas; Sucker, Antje; Hemminki, Kari; Schadendorf, Dirk; Kumar, Rajiv
    Integrin genes and susceptibility to human melanoma
    In: Mutagenesis Jg. 27 (2012) Nr. 3, S. 367 - 373
    ISSN: 0267-8357; 1464-3804
    Online Volltext: dx.doi.org/
  • Ren, Guangxu; Esser, Stefan; Jochum, Christoph; Schlaak, Jörg Friedrich; Gerken, Guido; Schadendorf, Dirk; Dittmer, Ulf; Wu, Gang; Yuan, Zhenghong; Timm, Jörg
    Interleukin 21 augments the hepatitis B virus-specific CD8+ T-cell response in vitro in patients coinfected with HIV-1
    In: AIDS Jg. 26 (2012) Nr. 17, S. 2145 - 2153
    ISSN: 0269-9370; 1473-5571
    Online Volltext: dx.doi.org/
  • Eggermont, Alexander M. M.; Suciu, Stefan; Testori, Alessandro; Santinami, Mario; Kruit, Wim H. J.; Marsden, Jeremy; Punt, Cornelis J.A.; Salès, François; Dummer, Reinhard; Robert, Caroline; Schadendorf, Dirk; Patel, Poulam M.; De Schaetzen, Gaetan; Spatz, Alan; Keilholz, Ulrich
    Long-Term Results of the Randomized Phase III Trial EORTC 18991 of Adjuvant Therapy With Pegylated Interferon Alfa-2b Versus Observation in Resected Stage III Melanoma
    In: Journal of Clinical Oncology (JCO) Jg. 30 (2012) Nr. 31, S. 3810 - 3818
    ISSN: 0732-183X; 1527-7755
    Online Volltext: dx.doi.org/
  • Flaherty, Keith T.; Robert, Caroline; Schadendorf, Dirk
    MEK inhibition in BRAF-mutated melanoma
    In: The New England Journal of Medicine Jg. 367 (2012) Nr. 14, S. 1365
    ISSN: 1533-4406; 0028-4793
    Online Volltext: dx.doi.org/
  • Berger, Michael F.; Hodis, Eran; Heffernan, Timothy P.; Deribe, Yonathan Lissanu; Lawrence, Michael S.; Protopopov, Alexei; Ivanova, Elena; Watson, Ian R.; Nickerson, Elizabeth; Ghosh, Papia; Zhang, Hailei; Zeid, Rhamy; Ren, Xiaojia; Cibulskis, Kristian; Sivachenko, Andrey Y.; Wagle, Nikhil; Sucker, Antje; Sougnez, Carrie; Onofrio, Robert; Ambrogio, Lauren; Auclair, Daniel; Fennell, Timothy; Carter, Scott L.; Drier, Yotam; Stojanov, Petar; Singer, Meredith A.; Voet, Douglas; Jing, Rui; Saksena, Gordon; Barretina, Jordi; Ramos, Alex H.; Pugh, Trevor J.; Stransky, Nicolas; Parkin, Melissa; Winckler, Wendy; Mahan, Scott; Ardlie, Kristin; Baldwin, Jennifer; Wargo, Jennifer; Schadendorf, Dirk; Meyerson, Matthew; Gabriel, Stacey B.; Golub, Todd R.; Wagner, Stephan N.; Lander, Eric S.; Getz, Gad; Chin, Lynda; Garraway, Levi A.
    Melanoma genome sequencing reveals frequent PREX2 mutations
    In: Nature Jg. 485 (2012) Nr. 7399, S. 502 - 506
    ISSN: 0028-0836; 1476-4687
    Online Volltext: dx.doi.org/
  • Hansen, Wiebke; Hutzler, Marina; Abel, Simone; Alter, Christina; Stockmann, Christian; Kliche, Stefanie; Albert, Juliane; Sparwasser, Tim; Sakaguchi, Shimon; Westendorf, Astrid; Schadendorf, Dirk; Buer, Jan; Helfrich, Iris
    Neuropilin 1 deficiency on CD4⁺Foxp3⁺ regulatory T cells impairs mouse melanoma growth
    In: Journal of Experimental Medicine (JEM) Jg. 209 (2012) Nr. 11, S. 2001 - 2016
    ISSN: 1540-9538; 0022-1007
    Online Volltext: dx.doi.org/ (Open Access)
  • Schimming, Tobias T.; Grabellus, Florian; Roßner, Mathias; Pechlivanis, Sonali; Sucker, Antje; Bielefeld, Nicola; Moll, Iris; Schadendorf, Dirk; Hillen, Uwe
    PHH3 immunostaining improves interobserver agreement of mitotic index in thin melanomas
    In: American Journal of Dermatopathology Jg. 34 (2012) Nr. 3, S. 266 - 269
    ISSN: 1533-0311; 0193-1091
    Online Volltext: dx.doi.org/
  • Zimmer, Lisa; Livingstone, Elisabeth; Hillen, Uwe; Dom̈kes, Stephanie; Becker, Arne; Schadendorf, Dirk
    Panniculitis With Arthralgia in Patients With Melanoma Treated With Selective BRAF Inhibitors and Its Management
    In: Archives of Dermatology Jg. 148 (2012) Nr. 3, S. 357 - 361
    ISSN: 1538-3652
    Online Volltext: dx.doi.org/
  • Matusiewicz, David; Körber, Andreas; Schadendorf, Dirk; Wasem, Jürgen; Neumann, Anja
    Psoriasis im Kindes- und Jugendalter : Eine bundesweite Ärztebefragung zur Versorgungssituation in Deutschland
    In: Der Hautarzt Jg. 63 (2012) Nr. 10, S. 801 - 807
    ISSN: 1432-1173; 0017-8470
    Online Volltext: dx.doi.org/
  • Oberholzer, Patrick A.; Kee, Damien; Dziunycz, Piotr; Sucker, Antje; Kamsukom, Nyam; Jones, Robert; Roden, Christine; Chalk, Clinton J.; Ardlie, Kristin; Palescandolo, Emanuele; Piris, Adriano; MacConaill, Laura E.; Robert, Caroline; Hofbauer, Günther F. L.; McArthur, Grant A.; Schadendorf, Dirk; Garraway, Levi A.
    RAS Mutations Are Associated With the Development of Cutaneous Squamous Cell Tumors in Patients Treated With RAF Inhibitors
    In: Journal of Clinical Oncology (JCO) Jg. 30 (2012) Nr. 3, S. 316 - 321
    ISSN: 0732-183X; 1527-7755
    Online Volltext: dx.doi.org/
  • Stoffels, Ingo; Pöppel, Thorsten; Boy, Christian; Müller, Stefan; Wichmann, F.; Dissemond, Joachim; Schadendorf, Dirk; Rosenbaum-Krumme, Sandra; Klode, Joachim
    Radio-guided surgery : Advantages of a new portable γ-camera (Sentinella®) for intraoperative real time imaging and detection of sentinel lymph nodes in cutaneous malignancies
    In: Journal of the European Academy of Dermatology and Venereology Jg. 26 (2012) Nr. 3, S. 308 - 313
    ISSN: 0926-9959; 1468-3083
    Online Volltext: dx.doi.org/
  • Leyvraz, S.; Suciu, S.; Piperno-Neumann, S.; Baurain, J. F.; Zdzienicki, M.; Testori, A.; Marshall, E.; Scheulen, Max Ernst; Jouary, T.; Negrier, S.; Vermorken, J. B.; Kaempgen, E.; Durando, X.; Schadendorf, Dirk; Gurunath, R. K.; Polders, L.; De Schaetzen, G.; Vanderschaeghe, S.; Gauthier, M. P.; Keilholz, U.
    Randomized phase III trial of intravenous (IV) versus hepatic intra-arterial (HIA) fotemustine in patients with liver metastases from uveal melanoma : Final results of the EORTC 18021 study
    In: Journal of Clinical Oncology Jg. 30 (2012) Nr. Suppl. 15, S. 8532
    ISSN: 0732-183X; 1527-7755
  • Stoffels, Ingo; Dissemond, Joachim; Schulz, Andrea; Hillen, Uwe; Schadendorf, Dirk; Klode, Joachim
    Reliability and cost-effectiveness of complete lymph node dissection under tumescent local anaesthesia vs. general anaesthesia : A retrospective analysis in patients with malignant melanoma AJCC stage III
    In: Journal of the European Academy of Dermatology and Venereology Jg. 26 (2012) Nr. 2, S. 200 - 206
    ISSN: 0926-9959; 1468-3083
    Online Volltext: dx.doi.org/
  • Zimmer, Lisa; Vaubel, Julia Marianne; Livingstone, Elisabeth; Schadendorf, Dirk
    Side effects of systemic oncological therapies in dermatology
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Jg. 10 (2012) Nr. 7, S. 475 - 486
    ISSN: 1610-0387; 1563-2571; 1610-0379; 0301-0481
    Online Volltext: dx.doi.org/
  • Kasparian, N. A.; Bränström, R.; Chang, Y. M.; Affleck, P.; Aspinwall, L. G.; Tibben, A.; Azizi, E.; Baron-Epel, O.; Battistuzzi, L.; Bruno, W.; Chan, M.; Cuellar, F.; Debniak, T.; Pjanova, D.; Ertmanski, S.; Figl, A.; Gonzalez, M.; Hayward, N. K.; Hocevar, M.; Kanetsky, P. A.; Leachman, S.; Bergman, W.; Heisele, O.; Palmer, J.; Peric, B.; Puig, S.; Schadendorf, Dirk; Gruis, N. A.; Newton-Bishop, J.; Brandberg, Y.; Melanoma Genetics Consortium (GenoMEL)
    Skin Examination Behavior : The Role of Melanoma History, Skin Type, Psychosocial Factors, and Region of Residence in Determining Clinical and Self-conducted Skin Examination
    In: Archives of Dermatology Jg. 148 (2012) Nr. 10, S. 1142 - 1151
    ISSN: 0003-987X; 1538-3652
    Online Volltext: dx.doi.org/
  • Dirks, Henrike; Esser, Stefan; Borgmann, R.; Wolter, M.; Fischer, E.; Potthoff, Anja Verena; Jablonka, Robert; Schadendorf, Dirk; Brockmeyer, Norbert Hermann; Scherbaum, Norbert
    Substance use and sexual risk behaviour among HIV-positive men who have sex with men in specialized out-patient clinics
    In: HIV Medicine Jg. 13 (2012) Nr. 9, S. 533 - 540
    ISSN: 1464-2662; 1468-1293
    Online Volltext: dx.doi.org/
  • Abschuetz, Oliver; Osen, Wolfram; Frank, Kathrin; Kato, Masashi; Schadendorf, Dirk; Umansky, Viktor
    T-cell mediated immune responses induced in ret transgenic mouse model of malignant melanoma
    In: Cancers Jg. 4 (2012) Nr. 2, S. 490 - 503
    ISSN: 2072-6694
    Online Volltext: dx.doi.org/
  • Urban, Sabrina; Textoris-Taube, Kathrin; Reimann, Barbara; Janek, Katharina; Dannenberg, Tanja; Ebstein, Frédéric; Seifert, Christin; Zhao, Fang; Kessler, Jan H.; Halenius, Anne; Henklein, Petra; Paschke, Julia; Cadel, Sandrine; Bernhard, Helga; Ossendorp, Ferry; Foulon, Thierry; Schadendorf, Dirk; Paschen, Annette; Seifert, Ulrike
    The efficiency of human cytomegalovirus pp65₄₉₅₋₅₀₃ CD8 ⁺T cell epitope generation is determined by the balanced activities of cytosolic and endoplasmic reticulum-resident peptidases
    In: The Journal of Immunology (JI) Jg. 189 (2012) Nr. 2, S. 529 - 538
    ISSN: 1550-6606; 0022-1767; 1047-7381; 1048-3233
    Online Volltext: dx.doi.org/
  • Brokalaki, E.I.; Voshege, Nadine; Witzke, Oliver; Kribben, Andreas; Schadendorf, Dirk; Hillen, Uwe
    Treatment of Severe Psoriasis With Etanercept in a Pancreas-Kidney Transplant Recipient
    In: Transplantation Proceedings Jg. 44 (2012) Nr. 9, S. 2776 - 2777
    ISSN: 0041-1345; 1873-2623
    Online Volltext: dx.doi.org/
  • Preusser, Matthias; Winkler, Frank; Collette, Laurence; Haller, Sven; Marreaud, Sandrine; Soffietti, Riccardo; Klein, Martin; Reijneveld, Jaap C.; Tonn, Jörg-Christian; Baumert, Brigitta G.; Mulvenna, Paula; Schadendorf, Dirk; Duchnowska, Renata; Berghoff, Anna Sophie; Lin, Nancy; Cameron, David A.; Belkacemi, Yazid; Jassem, Jacek; Weber, Damien C.
    Trial design on prophylaxis and treatment of brain metastases : Lessons learned from the EORTC Brain Metastases Strategic Meeting 2012
    In: European Journal of Cancer Jg. 48 (2012) Nr. 18, S. 3439 - 3447
    ISSN: 0959-8049; 1879-0852
    Online Volltext: dx.doi.org/
  • Heinemann, Anja; Zhao, Fang; Pechlivanis, Sonali; Eberle, Jürgen; Steinle, Alexander; Diederichs, Sven; Schadendorf, Dirk; Paschen, Annette
    Tumor Suppressive MicroRNAs miR-34a/c Control Cancer Cell Expression of ULBP2, a Stress-Induced Ligand of the Natural Killer Cell Receptor NKG2D
    In: Cancer Research Jg. 72 (2012) Nr. 2, S. 460 - 471
    ISSN: 1538-7445; 0008-5472
    Online Volltext: dx.doi.org/
  • Eggermont, Alexander M.M.; Suciu, Stefan; Testori, Alessandro; Kruit, Wim H.; Marsden, Jeremy; Punt, Cornelis J.; Santinami, Mario; Sals, Franois; Schadendorf, Dirk; Patel, Poulam; Dummer, Reinhard; Robert, Caroline; Keilholz, Ulrich; Yver, Antoine; Spatz, Alan
    Ulceration and stage are predictive of interferon efficacy in melanoma : results of the phase III adjuvant trials EORTC 18952 and EORTC 18991
    In: European Journal of Cancer Jg. 48 (2012) Nr. 2, S. 218 - 225
    ISSN: 0959-8049; 1879-0852
    Online Volltext: dx.doi.org/
  • Amann, Philipp M.; Luo, Chonglin; Owen, Robert W.; Hofmann, Claudia; Freudenberger, Muriel; Schadendorf, Dirk; Eichmüller, Stefan B.; Bazhin, Alexandr V.
    Vitamin A metabolism in benign and malignant melanocytic skin cells : Importance of lecithin/retinol acyltransferase and RPE65
    In: Journal of Cellular Physiology Jg. 227 (2012) Nr. 2, S. 718 - 728
    ISSN: 0021-9541; 1097-4652
    Online Volltext: dx.doi.org/
  • Livingstone, Elisabeth; Windemuth-Kieselbach, Christine; Eigentler, Thomas K.; Rompel, Rainer; Trefzer, Uwe; Nashan, Dorothee; Rotterdam, Sebastian; Ugurel, Selma; Schadendorf, Dirk
    A first prospective population-based analysis investigating the actual practice of melanoma diagnosis, treatment and follow-up
    In: European Journal of Cancer Jg. 47 (2011) Nr. 13, S. 1977 - 1989
    ISSN: 0964-1947; 1879-0852
    Online Volltext: dx.doi.org/
  • O'Day, S.; Pavlick, A.; Loquai, C.; Lawson, D.; Gutzmer, R.; Richards, J.; Schadendorf, Dirk; Thompson, J.A.; Gonzalez, R.; Trefzer, U.; Mohr, P.; Chao, D.; Zhong, B.; De Boer, C.J.; Uhlar, C.; Marshall, D.; Gore, M.E.; Lang, Z.; Hait, W.; Ho, P.; Ottensmeier, C
    A randomised, phase II study of intetumumab, an anti-α v-integrin mAb, alone and with dacarbazine in stage IV melanoma
    In: British Journal of Cancer (BJC) Jg. 105 (2011) Nr. 3, S. 346 - 352
    ISSN: 1532-1827; 0007-0920
    Online Volltext: dx.doi.org/ (Open Access)
  • Klode, Joachim; Pöppel, Thorsten; Boy, Christian; Müller, Stefan; Schadendorf, Dirk; Körber, Andreas; Stoffels, Ingo; Dissemond, Joachim
    Advantages of preoperative hybrid SPECT/CT in detection of sentinel lymph nodes in cutaneous head and neck malignancies
    In: Journal of the European Academy of Dermatology and Venereology Jg. 25 (2011) Nr. 10, S. 1213 - 1221
    ISSN: 1468-3083
    Online Volltext: dx.doi.org/
  • Schadendorf, Dirk
    Arbeitsgemeinschaft Dermatologische Onkologie (ADO) : Gezielte Blockade des mutierten BRAF führt zu Überlebensvorteil bei Patienten mit metastasiertem Melanom
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Jg. 9 (2011) Nr. 4, S. 340
    ISSN: 1610-0387; 1563-2571; 1610-0379; 0301-0481
    Online Volltext: dx.doi.org/
  • Gast, Andreas; Bermejo, Justo Lorenzo; Claus, Rainer; Brandt, Andreas; Weires, Marianne; Weber, Alexander; Plass, Christoph; Sucker, Antje; Hemminki, Kari; Schadendorf, Dirk; Kumar, Rajiv
    Association of Inherited Variation in Toll-Like Receptor Genes with Malignant Melanoma Susceptibility and Survival
    In: PLoS ONE Jg. 6 (2011) Nr. 9,
    ISSN: 1932-6203
    Online Volltext: dx.doi.org/ (Open Access)
  • Vits, Sabine; Cesko, Elvir; Enck, Paul; Hillen, Uwe; Schadendorf, Dirk; Schedlowski, Manfred
    Behavioural conditioning as the mediator of placebo responses in the immune system
    In: Philosophical Transactions of the Royal Society B: Biological Sciences Jg. 366 (2011) Nr. 1572, S. 1799 - 1807
    ISSN: 1471-2970
    Online Volltext: dx.doi.org/
  • Helfrich, Iris; Schadendorf, Dirk
    Blood vessel maturation, vascular phenotype and angiogenic potential in malignant melanoma : One step forward for overcoming anti-angiogenic drug resistance?
    In: Molecular Oncology Jg. 5 (2011) Nr. 2, S. 137 - 149
    ISSN: 1878-0261; 1574-7891
    Online Volltext: dx.doi.org/
  • Meyera, Christiane; Sevko, Alexandra; Ramacher, Marcel; Bazhin, Alexandr V.; Falk, Christine S.; Osena, Wolfram; Borrello, Ivan; Kato, Masashi; Schadendorf, Dirk; Baniyash, Michal; Umanskya, Viktor
    Chronic inflammation promotes myeloid-derived suppressor cell activation blocking antitumor immunity in transgenic mouse melanoma model
    In: Proceedings of the National Academy of Sciences of the United States of America (PNAS) Jg. 108 (2011) Nr. 41, S. 17111 - 17116
    ISSN: 1091-6490; 0027-8424
    Online Volltext: dx.doi.org/
  • Leong, Stanley P.L.; Gershenwald, Jeffrey E.; Soong, Seng-Jaw; Schadendorf, Dirk; Tarhini, Ahmad A.; Agarwala, Sanjiv; Hauschild, Axel; Soon, Christopher W.M.; Daud, Adil; Kashani-Sabet, Mohammed
    Cutaneous melanoma : A model to study cancer metastasis
    In: Journal of Surgical Oncology Jg. 103 (2011) Nr. 6, S. 538 - 549
    ISSN: 1096-9098; 0022-4790
    Online Volltext: dx.doi.org/
  • Kirkwood, J. M.; Dreno, B.; Hauschild, A.; Schadendorf, Dirk; Testori, A.; Hersey, P.; Jamoul, C.; Peeters, O.; Therasse, P.
    DERMA phase III trial of MAGE-A3 antigen-specific cancer immunotherapeutic (ASCI) as adjuvant therapy in patients with MAGE-A3-positive resected stage III melanoma
    In: Journal of Clinical Oncology (JCO) Jg. 29 (2011) Nr. 15_suppl, S. TPS232
    ISSN: 0732-183X; 1527-7755
    Online Volltext: dx.doi.org/
  • Klode, Joachim; Klotgen, K.; Korber, A.; Schadendorf, Dirk; Dissemond, Joachim
    Die Sklerotherapie mit Polidocanolschaum ist eine neue und effektive Behandlung von postoperativen Lymphozelen und Lymphorrhoe
    In: Vasomed: Die Fachzeitschrift für Gefäßerkrankungen Jg. 23 (2011) Nr. 5, S. 252
    ISSN: 0942-1181
  • Livingstone, Elisabeth; Trarbach, Tanja; Zimmer, Lisa; Schuler, Martin; Schadendorf, Dirk
    EGFR-Inhibitoren und Multityrosinkinaseinhibitoren : Interdisziplinäre Behandlung der kutanen Nebenwirkungen
    In: Deutsche Medizinische Wochenschrift - DMW Jg. 136 (2011) Nr. 1-2, S. 39 - 44
    ISSN: 1439-4413; 0012-0472; 1437-5982
    Online Volltext: dx.doi.org/
  • Schrama, David; Scherer, Dominique; Schneider, Michael; Zapatka, Marc; Bröcker, Eva-Bettina; Schadendorf, Dirk; Ugurel, Selma; Kumar, Rajiv; Becker, Jürgen
    ERCC5 p.Asp1104His and ERCC2 p.Lys751Gln polymorphisms are independent prognostic factors for the clinical course of melanoma
    In: The Journal of Investigative Dermatology Jg. 131 (2011) Nr. 6, S. 1280 - 1290
    ISSN: 1523-1747; 0022-202X
    Online Volltext: dx.doi.org/ (Open Access)
  • Boehncke, Sandra; Hardt, Katja; Schadendorf, Dirk; Henschler, Reinhard; Boehncke, Wolf-Henning; Duthey, Beatrice
    Endogenous μ-opioid peptides modulate immune response towards malignant melanoma
    In: Experimental Dermatology Jg. 20 (2011) Nr. 1, S. 24 - 28
    ISSN: 1600-0625; 0906-6705
    Online Volltext: dx.doi.org/
  • Arab, Khelifa; Smith, Laura T.; Gast, Andreas; Weichenhan, Dieter; Huang, Joseph Po-Hsien; Claus, Rainer; Hielscher, Thomas; Espinosa, Allan V.; Ringel, Matthew D.; Morrison, Carl D.; Schadendorf, Dirk; Kumar, Rajiv; Plass, Christoph
    Epigenetic deregulation of TCF21 inhibits metastasis suppressor KISS1 in metastatic melanoma
    In: Carcinogenesis Jg. 32 (2011) Nr. 10, S. 1467 - 1473
    ISSN: 1460-2180; 0143-3334
    Online Volltext: dx.doi.org/
  • Körber, Andreas; Klode, Joachim; Al-Benna, Samy; Wax, Caroline; Schadendorf, Dirk; Steinstraesser, Lars; Dissemond, Joachim
    Etiology of chronic leg ulcers in 31,619 patients in Germany analyzed by an expert survey
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Jg. 9 (2011) Nr. 2, S. 116 - 121
    ISSN: 1610-0387; 1563-2571; 1610-0379; 0301-0481
    Online Volltext: dx.doi.org/
  • Cesko, Elvir; Vits, S.; Körber, Andreas; Schadendorf, Dirk; Schedlowski, Manfred; Dissemond, Joachim
    Expectation-induced Placebo effects in Wound healing processes : First results from a prospective clinical Study
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Jg. 9 (2011) Nr. 11, S. 984 - 984
    ISSN: 1610-0387; 1563-2571; 1610-0379; 0301-0481
  • Patel, Poulam M.; Suciu, Stefan; Mortier, Laurent; Kruit, Wim H.; Robert, Caroline; Schadendorf, Dirk; Trefzer, Uwe; Punt, Cornelis J.A.; Dummer, Reinhard; Davidson, Neville; Becker, Jürgen; Conry, Robert; Thompson, John A.; Hwu, Wen-Jen; Engelen, Kristel; Agarwala, Sanjiv S.; Keilholz, Ulrich; Eggermont, Alexander M.M.; Spatz, Alain
    Extended schedule, escalated dose temozolomide versus dacarbazine in stage IV melanoma : Final results of a randomised phase III study (EORTC 18032)
    In: European Journal of Cancer Jg. 47 (2011) Nr. 10, S. 1476 - 1483
    ISSN: 0964-1947; 1879-0852
    Online Volltext: dx.doi.org/
  • Schneider, Thomas; Kimpfler, Silvia; Warth, Arne; Schnabel, Philipp A.; Dienemann, Hendrik; Schadendorf, Dirk; Hoffmann, Hans; Umansky, Viktor
    Foxp3+ Regulatory T Cells and Natural Killer Cells Distinctly Infiltrate Primary Tumors and Draining Lymph Nodes in Pulmonary Adenocarcinoma
    In: Journal of Thoracic Oncology Jg. 6 (2011) Nr. 3, S. 432 - 438
    ISSN: 1556-1380; 1556-0864
    Online Volltext: dx.doi.org/ (Open Access)
  • Chapman, Paul B.; Hauschild, Axel; Robert, Caroline; Haanen, John B.; Ascierto, Paolo; Larkin, James; Dummer, Reinhard; Garbe, Claus; Testori, Alessandro; Maio, Michele; Hogg, David; Lorigan, Paul; Lebbe, Celeste; Jouary, Thomas; Schadendorf, Dirk; Ribas, Antoni; O'Day, Steven J.; Sosman, Jeffrey A.; Kirkwood, John M.; Eggermont, Alexander M. M.; Dreno, Brigitte; Nolop, Keith; Li, Jiang; Nelson, Betty; Hou, Jeannie; Lee, Richard J.; Flaherty, Keith T.; McArthur, Grant A.
    Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
    In: The New England Journal of Medicine Jg. 364 (2011) Nr. 26, S. 2507 - 2516
    ISSN: 1533-4406; 0028-4793
    Online Volltext: dx.doi.org/
  • Meier, F. E.; Beck, D.; Niessner, H.; Flaherty, K. T.; Iovanna, J.; Kulms, D.; Schadendorf, Dirk; Garbe, C.
    Induction of apoptosis by the BRAFV600E kinase inhibitor PLX4032 in BRAFV600E melanoma cells through regulation of endoplasmic reticulum stress-related genes
    In: Journal of Clinical Oncology (JCO) Jg. 29 (2011) Nr. 15_suppl, S. 8518
    ISSN: 0732-183X; 1527-7755
    Online Volltext: dx.doi.org/
  • Klode, Joachim; Schöttler, Larissa; Stoffels, Ingo; Körber, Andreas; Schadendorf, Dirk; Dissemond, Joachim
    Investigation of adhesion of modern wound dressings : a comparative analysis of 56 different wound dressings
    In: Journal of the European Academy of Dermatology and Venereology Jg. 25 (2011) Nr. 8, S. 933 - 939
    ISSN: 1468-3083
    Online Volltext: dx.doi.org/
  • Vaubel, Julia Marianne; Schadendorf, Dirk
    Moderne Pharmakotherapie des malignen Melanoms
    In: Der Internist Jg. 52 (2011) Nr. 6, S. 756 - 764
    ISSN: 0020-9554
    Online Volltext: dx.doi.org/
  • Papaspyrou, Giorgios; Garbe, Claus; Schadendorf, Dirk; Werner, Jochen A.; Hauschild, Axel; Egberts, Friederike
    Mucosal melanomas of the head and neck : New aspects of the clinical outcome, molecular pathology, and treatment with c-kit inhibitors
    In: Melanoma Research Jg. 21 (2011) Nr. 6, S. 475 - 482
    ISSN: 0960-8931; 1473-5636
    Online Volltext: dx.doi.org/
  • Czeschik, Johanna Christina; Huptas, Lisa; Schadendorf, Dirk; Hillen, Uwe
    Nodular scabies: Hypersensitivity reaction or infection?
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Jg. 9 (2011) Nr. 10, S. 840 - 841
    ISSN: 1610-0387; 1563-2571; 1610-0379; 0301-0481
    Online Volltext: dx.doi.org/
  • Eigentler, Thomas K.; Figl, Adina; Krex, Dietmar; Mohr, Peter; Mauch, Cornelia; Rass, Knut; Bostroem, Azize; Heese, Oliver; Koelbl, Oliver; Garbe, Claus; Schadendorf, Dirk
    Number of metastases, serum lactate dehydrogenase level, and type of treatment are prognostic factors in patients with brain metastases of malignant melanoma
    In: Cancer Jg. 117 (2011) Nr. 8, S. 1697 - 1703
    ISSN: 1097-0142; 0008-543X
    Online Volltext: dx.doi.org/
  • Cesko, Elvir; Vits, S.; Körber, Andreas; Schadendorf, Dirk; Schedlowski, Manfred; Dissemond, Joachim
    P4 Vorschlag für Posterpreis Medizin : Beeinflussung der Wundheilung durch Placeboeffekte: Erste Resultate einer prospektiven klinischen Untersuchung
    In: Zeitschrift für Wundheilung Jg. 16 (2011) Nr. Suppl. B, S. 92
    ISSN: 1439-670X
  • Lacouture, M. E.; Chapman, P. B.; Ribas, A.; Sosman, J. A.; McArthur, G. A.; Flaherty, K. T.; Kim, K. B.; Puzanov, I.; Nolop, K. B.; Joe, A. K.; Spleiss, O.; Koehler, A.; Wu, W.; Robert, C.; Hauschild, A.; Schadendorf, Dirk; Troy, J. L.; Duvic, M.; Trunzer, K.
    Presence of frequent underlying RAS mutations in cutaneous squamous cell carcinomas and keratoacanthomas (cuSCC/KA) that develop in patients during vemurafenib therapy
    In: Journal of Clinical Oncology (JCO) Jg. 29 (2011) Nr. 15_suppl, S. 8520
    ISSN: 0732-183X; 1527-7755
    Online Volltext: dx.doi.org/
  • Hofmann, Maja A.; Hauschild, Axel; Mohr, Peter; Garbe, Claus; Weichenthal, Michael; Trefzer, Uwe; Drecoll, Ulrike; Tilgen, Wolfgang; Schadendorf, Dirk; Kaatz, Martin; Ulrich, Jens
    Prospective evaluation of supportive care with or without CVD chemotherapy as a second-line treatment in advanced melanoma by patient's choice : A multicentre Dermatologic Cooperative Oncology Group trial
    In: Melanoma Research Jg. 21 (2011) Nr. 6, S. 516 - 523
    ISSN: 0960-8931; 1473-5636
    Online Volltext: dx.doi.org/
  • Voshege, Nadine; Brokalaki, E.; Witzke, Oliver; Kribben, Andreas; Schadendorf, Dirk; Hillen, Uwe
    Psoriasis therapy with Rtanercept in a Kidney and Pancreas transplant Patients
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Jg. 9 (2011) Nr. Suppl. 1, S. 213
    ISSN: 1610-0387; 1563-2571; 1610-0379; 0301-0481
    Online Volltext: dx.doi.org/
  • Stoffels, Ingo; Dissemond, Joachim; Körber, Andreas; Hillen, Uwe; Pöppel, Thorsten; Schadendorf, Dirk; Klode, Joachim
    Reliability and cost-effectiveness of sentinel lymph node excision under local anaesthesia versus general anaesthesia for malignant melanoma : A retrospective analysis in 300 patients with malignant melanoma AJCC Stages i and II
    In: Journal of the European Academy of Dermatology and Venereology Jg. 25 (2011) Nr. 3, S. 306 - 310
    ISSN: 0926-9959; 1468-3083
    Online Volltext: dx.doi.org/
  • Amann, Philipp M.; Schadendorf, Dirk; Owen, Robert W.; Korn, Bernhard; Eichmüller, Stefan B.; Bazhin, Alexandr V.
    Retinal and retinol are potential regulators of gene expression in the keratinocyte cell line HaCaT
    In: Experimental Dermatology Jg. 20 (2011) Nr. 4, S. 373 - 375
    ISSN: 1600-0625; 0906-6705
    Online Volltext: dx.doi.org/ (Open Access)
  • Jansen, Thomas; Steuhl, Klaus-Peter; Schadendorf, Dirk
    Rosacea in Children - A Case Report
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Jg. 9 (2011) Nr. Suppl. 1, S. 240 - 240
    ISSN: 1610-0387; 1563-2571; 1610-0379; 0301-0481
  • Huptas, L.; Rompoti, N.; Herbig, S.; Körber, Andreas; Klode, Joachim; Schadendorf, Dirk; Dissemond, Joachim
    Schmerzreduktion bei Patienten mit chronischem Ulcus cruris durch ein neu entwickeltes Morphingel : Erste Resultate einer klinischen Untersuchung
    In: Der Hautarzt Jg. 62 (2011) Nr. 4, S. 280 - 286
    ISSN: 1432-1173
    Online Volltext: dx.doi.org/
  • Egberts, F.; Gutzmer, R.; Ugurel, Selma; Becker, J.C.; Trefzer, U.; Degen, A.; Schenck, F.; Frey, L.; Wilhelm, T.; Hassel, J.C.; Schadendorf, Dirk; Livingstone, Elisabeth; Mauch, C.; Garbe, C.; Berking, C.; Rass, K.; Mohr, P.; Kaehler, K.C.; Weichenthal, M.; Hauschild, A.
    Sorafenib and pegylated interferon-α2b in advanced metastatic melanoma : A multicenter phase II DeCOG trial
    In: Annals of Oncology Jg. 22 (2011) Nr. 7, S. 1667 - 1674
    ISSN: 0923-7534; 1569-8041
    Online Volltext: dx.doi.org/
  • Niessner, Heike; Beck, Daniela; Sinnberg, Tobias; Lasithiotakis, Konstantinos; MacZey, Evelyn; Gogel, Jeannette; Venturelli, Sascha; Berger, Alexander; Mauthe, Mario; Toulany, Mahmoud; Flaherty, Keith; Schaller, Martin; Schadendorf, Dirk; Proikas-Cezanne, Tassula; Schittek, Birgit; Garbe, Claus; Kulms, Dagmar; Meier, Friedegund
    The Farnesyl Transferase Inhibitor Lonafarnib Inhibits mTOR Signaling and Enforces Sorafenib-Induced Apoptosis in Melanoma Cells
    In: The Journal of Investigative Dermatology Jg. 131 (2011) Nr. 2, S. 468 - 479
    ISSN: 1523-1747; 0022-202X
    Online Volltext: dx.doi.org/ (Open Access)
  • Liang, Ruixia; Wallace, Andrea R; Schadendorf, Dirk; Rubin, Brian P
    The phosphatidyl inositol 3-kinase pathway is central to the pathogenesis of Kit-activated melanoma
    In: Pigment Cell and Melanoma Research Jg. 24 (2011) Nr. 4, S. 714 - 723
    ISSN: 1755-1471; 1755-148X
    Online Volltext: dx.doi.org/
  • Schilling, Bastian; Vaubel, Julia Marianne; Schadendorf, Dirk
    Adjuvant pegylated interferon α-2b therapy for melanoma
    In: Oncology Letters Jg. 1 (2010) Nr. 2, S. 237 - 241
    ISSN: 1792-1082; 1792-1074
    Online Volltext: dx.doi.org/
  • Scherer, D.; Rachakonda, P. S.; Angelini, S.; Mehnert, F.; Sucker, A.; Egberts, F.; Hauschild, A.; Hemminki, K.; Schadendorf, Dirk; Kumar, R.
    Association between the germline MC1R variants and somatic BRAF/NRAS mutations in melanoma tumors
    In: The Journal of Investigative Dermatology Jg. 130 (2010) Nr. 12, S. 2844 - 2848
    ISSN: 0022-202X; 1523-1747
    Online Volltext: dx.doi.org/
  • Körber, Andreas; Schmid, E. N.; Buer, Jan; Klode, Joachim; Schadendorf, Dirk; Dissemond, Joachim
    Bacterial colonization of chronic leg ulcers : current results compared with data 5 years ago in a specialized dermatology department
    In: Journal of the European Academy of Dermatology and Venereology Jg. 24 (2010) Nr. 9, S. 1017 - 1025
    ISSN: 0926-9959; 1468-3083
    Online Volltext: dx.doi.org/
  • Dangoor, A.; Lorigan, P.; Keilholz, U.; Schadendorf, Dirk; Harris, A.; Ottensmeier, C.; Smyth, J.; Hoffmann, K.; Anderson, R.; Cripps, M.; Schneider, J.; Hawkins, R.
    Clinical and immunological responses in metastatic melanoma patients vaccinated with a high-dose poly-epitope vaccine
    In: Cancer Immunology, Immunotherapy Jg. 59 (2010) Nr. 6, S. 863 - 873
    ISSN: 0340-7004; 1432-0851
    Online Volltext: dx.doi.org/
  • Czeschik, J. C.; Hillen, Uwe; Schadendorf, Dirk
    Diagnostik des malignen Melanoms
    In: Der Onkologe Jg. 16 (2010) Nr. 12, S. 1121 - 1130
    ISSN: 0947-8965
    Online Volltext: dx.doi.org/
  • Bazhin, A. V.; Kahnert, S.; Kimpfler, S.; Schadendorf, Dirk; Umansky, V.
    Distinct metabolism of cyclic adenosine monophosphate in regulatory and helper CD4+ T cells
    In: Molecular Immunology Jg. 47 (2010) Nr. 4, S. 678 - 684
    ISSN: 0161-5890
    Online Volltext: dx.doi.org/
  • Meier, F. E.; Beck, D.; Niessner, H.; Flaherty, K. T.; Sinnberg, T.; Schadendorf, Dirk; Kulms, D.; Garbe, C.
    Effect of mTOR inhibitors on sorafenib-induced endoplasmic reticulum stress and apoptosis in melanoma cells
    In: Journal of Clinical Oncology (JCO) Jg. 28 (2010) Nr. Suppl. 15, S. e19027
    ISSN: 0732-183X; 1527-7755
    Online Volltext: dx.doi.org/
  • Hauschild, A.; Weichenthal, M.; Rass, K.; Linse, R.; Berking, C.; Böttjer, J.; Vogt, T.; Spieth, K.; Eigentler, T.; Brockmeyer, N. H.; Stein, A.; Näher, H.; Schadendorf, Dirk; Mohr, P.; Kaatz, M.; Tronnier, M.; Hein, R.; Schuler, G.; Egberts, F.; Garbe, C.
    Efficacy of Low-Dose Interferon α2a 18 Versus 60 Months of Treatment in Patients With Primary Melanoma of ≥ 1.5 mm Tumor Thickness : Results of a Randomized Phase III DeCOG Trial
    In: Journal of Clinical Oncology (JCO) Jg. 28 (2010) Nr. 5, S. 841 - 846
    ISSN: 0732-183X; 1527-7755
    Online Volltext: dx.doi.org/
  • Peccerella, T.; Lukan, N.; Hofheinz, R.; Schadendorf, Dirk; Kostrezewa, M.; Neumaier, M.; Findeisen, P.
    Endoprotease Profiling with Double-Tagged Peptide Substrates : A New Diagnostic Approach in Oncology
    In: Clinical Chemistry Jg. 56 (2010) Nr. 2, S. 272 - 280
    ISSN: 0009-9147; 1530-8561
    Online Volltext: dx.doi.org/
  • Jansen, Thomas; Denisjuk, Natalja; Romiti, Ricardo; Schadendorf, Dirk
    Facial variant of eruptive vellus hair cysts : A case report and brief review of the literature
    In: Kosmetische Medizin Jg. 31 (2010) Nr. 4, S. 200 - 203
    ISSN: 1430-4031
  • Godet, Y.; Desfrançois, J.; Vignard, V.; Schadendorf, Dirk; Khammari, A.; Dreno, B.; Jotereau, F.; Labarrière, N.
    Frequent occurrence of high affinity T cells against MELOE-1 makes this antigen an attractive target for melanoma immunotherapy
    In: European Journal of Immunology Jg. 40 (2010) Nr. 6, S. 1786 - 1794
    ISSN: 0014-2980
    Online Volltext: dx.doi.org/
  • Broekaert, S. M.; Roy, R.; Okamoto, I.; van den Oord, J.; Bauer, J.; Garbe, C.; Barnhill, R. L.; Busam, K. J.; Cochran, A. J.; Cook, M. G.; Elder, D. E.; McCarthy, S. W.; Mihm, M. C.; Schadendorf, Dirk; Scolyer, R. A.; Spatz, A.; Bastian, B. C.
    Genetic and morphologic features for melanoma classification
    In: Pigment Cell and Melanoma Research Jg. 23 (2010) Nr. 6, S. 763 - 770
    ISSN: 1755-1471; 1755-148X
    Online Volltext: dx.doi.org/
  • Hodi, F. S.; O'Day, S. J.; McDermott, D. F.; Weber, R. W.; Sosman, J. A.; Haanen, J. B.; Gonzalez, R.; Robert, C.; Schadendorf, Dirk; Hassel, J. C.; Akerley, W.; van den Eertwegh, A. J.; Lutzky, J.; Lorigan, P.; Vaubel, Julia Marianne; Linette, G. P.; Hogg, D.; Ottensmeier, C. H.; Lebbé, C.; Peschel, C.; Quirt, I.; Clark, J. I.; Wolchok, J. D.; Weber, J. S.; Tian, J.; Yellin, M. J.; Nichol, G. M.; Hoos, A.; Urba, W. J.
    Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
    In: The New England Journal of Medicine Jg. 363 (2010) Nr. 8, S. 711 - 723
    ISSN: 1533-4406; 0028-4793
    Online Volltext: dx.doi.org/
  • Wolchok, Jedd D.; Weber, Jeffrey S.; Hamid, Omid; Lebbé, Celeste; Maio, Michele; Schadendorf, Dirk; Pril, Veerle de; Heller, Kevin; Chen, Tai-Tsang; Ibrahim, Ramy; Hoos, Axel; O'Day, Steven J.
    Ipilimumab efficacy and safety in patients with advanced melanoma : a retrospective analysis of HLA subtype from four trials
    In: Cancer Immunology: a Journal of the Academy of Cancer Immunology Jg. 10 (2010) Nr. 1, S. 9
    ISSN: 1424-9634
    (Open Access)
  • Wolchok, J. D.; Neyns, B.; Linette, G.; Negrier, S.; Lutzky, J.; Thomas, L.; Waterfield, W.; Schadendorf, Dirk; Smylie, M.; Guthrie, T.; Grob, J. J.; Chesney, J.; Chin, K.; Chen, K.; Hoos, A.; O'Day, S. J.; Lebbé, C.
    Ipilimumab monotherapy in patients with pretreated advanced melanoma : a randomised, double-blind, multicentre, phase 2, dose-ranging study
    In: The Lancet Oncology Jg. 11 (2010) Nr. 2, S. 155 - 164
    ISSN: 1470-2045; 1474-5488
    Online Volltext: dx.doi.org/
  • Weindorf, Maren; Körber, Andreas; Schadendorf, Dirk; Dissemond, Joachim
    Klippel-Trénaunay-Syndrom : eine seltene Ursache eines chronischen Ulcus cruris
    In: Medizinische Klinik Jg. 105 (2010) Nr. 11, S. 841 - 844
    ISSN: 0723-5003; 1615-6722
    Online Volltext: dx.doi.org/
  • Hassel, J. C.; Sucker, A.; Edler, L.; Kurzen, H.; Moll, I.; Stresemann, C.; Spieth, K.; Mauch, C.; Rass, K.; Dummer, R.; Schadendorf, Dirk
    MGMT gene promoter methylation correlates with tolerance of temozolomide treatment in melanoma but not with clinical outcome
    In: British Journal of Cancer (BJC) Jg. 103 (2010) Nr. 6, S. 820 - 826
    ISSN: 1532-1827; 0007-0920
    Online Volltext: dx.doi.org/ (Open Access)
  • Bränström, R.; Chang, Y. M.; Kasparian, N.; Affleck, P.; Tibben, A.; Aspinwall, L. G.; Azizi, E.; Baron-Epel, O.; Battistuzzi, L.; Bruno, W.; Chan, M.; Cuellar, F.; Debniak, T.; Pjanova, D.; Ertma?ski, S.; Figl, A.; Gonzalez, M.; Hayward, N. K.; Hocevar, M.; Kanetsky, P. A.; Leaf, S. L.; van Nieuwpoort, F. A.; Heisele, O.; Palmer, J.; Peric, B.; Puig, S.; Ruffin, A. D.; Schadendorf, Dirk; Gruis, N. A.; Brandberg, Y.; Newton-Bishop, J.
    Melanoma risk factors, perceived threat and intentional tanning : an international online survey
    In: European Journal of Cancer Prevention Jg. 19 (2010) Nr. 3, S. 216 - 226
    ISSN: 0959-8278; 1473-5709
    Online Volltext: dx.doi.org/
  • Browne, William J.; Dryden, Ian L.; Handley, Kelly; Mian, Shahid; Schadendorf, Dirk
    Mixed effect modelling of proteomic mass spectrometry data by using Gaussian mixtures
    In: Journal of the Royal Statistical Society / Series C (Applied Statistics) Jg. 59 (2010) S. 617 - 633
    ISSN: 0035-9254; 1467-9876
    Online Volltext: dx.doi.org/
  • Eberle, J.; Spangler, B.; Becker, J. C.; Heinemann, S. H.; Klein, C. A.; Kunz, M.; Kuphal, S.; Langer, P.; Mauch, C.; Meierjohann, S.; Paschen, Annette; Schadendorf, Dirk; Schartl, M.; Schittek, B.; Schönherr, R.; Tüting, T.; Zigrino, P.; Bosserhoff, A. K.
    Multicentre study on standardisation of melanoma cell culture : An initiative of the German Melanoma Research Network
    In: Pigment Cell and Melanoma Research Jg. 23 (2010) Nr. 2, S. 296 - 298
    ISSN: 1755-1471; 1755-148X
    Online Volltext: dx.doi.org/
  • Muthuswamy, R.; Mueller-Berghaus, J.; Haberkorn, U.; Reinhart, T. A.; Schadendorf, Dirk; Kalinski, P.
    PGE(2) transiently enhances DC expression of CCR7 but inhibits the ability of DCs to produce CCL19 and attract naive T cells
    In: Blood Jg. 116 (2010) Nr. 9, S. 1454 - 1459
    ISSN: 1528-0020; 0006-4971
    Online Volltext: dx.doi.org/
  • Muthuswamy, Ravikumar; Kalinski, Pawel; Reinhart, Todd; Schadendorf, Dirk
    PGE2 Transiently Enhances DC Expression of CCR7 but Inhibits the Ability of DCs to Produce CCL19 and Attract Naïve T cells
    In: Clinical Immunology Jg. 135 (2010) S. S100
    ISSN: 1521-6616
    Online Volltext: dx.doi.org/
  • Livingstone, Elisabeth; Zimmer, Lisa; Piel, S.; Schadendorf, Dirk
    PLX4032 : does it keep its promise for metastatic melanoma treatment?
    In: Expert Opinion on Investigational Drugs Jg. 19 (2010) Nr. 11, S. 1439 - 1449
    ISSN: 1354-3784; 1744-7658
    Online Volltext: dx.doi.org/
  • Kaehler, K. C.; Sondak, V. K.; Schadendorf, Dirk; Hauschild, A.
    Pegylated interferons : Prospects for the use in the adjuvant and palliative therapy of metastatic melanoma
    In: European Journal of Cancer Jg. 46 (2010) Nr. 1, S. 41 - 46
    ISSN: 0959-8049
    Online Volltext: dx.doi.org/
  • Riehemann, A. C.; Körber, Andreas; Voshege, Nadine; Schadendorf, Dirk; Dissemond, Joachim
    Perianale Ulzerationen durch Kaliumpermanganatbäder
    In: Der Hautarzt Jg. 61 (2010) Nr. 5, S. 435 - 438
    ISSN: 0017-8470
    Online Volltext: dx.doi.org/
  • Hillen, Uwe; Meyer, Sabine; Schadendorf, Dirk; Kremens, Bernhard
    Photopheresis in pediatric patients with low-body weight using the UVAR XTS system
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Jg. 8 (2010) Nr. 1, S. 32 - 37
    ISSN: 1610-0387; 1563-2571; 1610-0379; 0301-0481
    Online Volltext: dx.doi.org/
  • Klode, Joachim; Klötgen, K.; Körber, Andreas; Schadendorf, Dirk; Dissemond, Joachim
    Polidocanol foam sclerotherapy is a new and effective treatment for post-operative lymphorrhea and lymphocele
    In: Journal of the European Academy of Dermatology and Venereology Jg. 24 (2010) Nr. 8, S. 904 - 909
    ISSN: 0926-9959; 1468-3083
    Online Volltext: dx.doi.org/
  • Bouwhuis, M. G.; Gast, A.; Figl, A.; Eggermont, A. M. M.; Hemminki, K.; Schadendorf, Dirk; Kumar, R.
    Polymorphisms in the CD28/CTLA4/ICOS genes : role in malignant melanoma susceptibility and prognosis?
    In: Cancer Immunology, Immunotherapy Jg. 59 (2010) Nr. 2, S. 303
    ISSN: 0340-7004; 1432-0851
    Online Volltext: dx.doi.org/
  • Bränström, R.; Kasparian, N. A.; Chang, Y. M.; Affleck, P.; Tibben, A.; Aspinwall, L. G.; Azizi, E.; Baron-Epel, O.; Battistuzzi, L.; Bergman, W.; Bruno, W.; Chan, M.; Cuellar, F.; Debniak, T.; Pjanova, D.; Ertmanski, S.; Figl, A.; Gonzalez, M.; Hayward, N. K.; Hocevar, M.; Kanetsky, P. A.; Leachman, S. A.; Heisele, O.; Palmer, J.; Peric, B.; Puig, S.; Schadendorf, Dirk; Gruis, N. A.; Newton-Bishop, J.; Brandberg, Y.
    Predictors of Sun Protection Behaviors and Severe Sunburn in an International Online Study
    In: Cancer Epidemiology, Biomarkers & Prevention Jg. 19 (2010) Nr. 9, S. 2199 - 2210
    ISSN: 1538-7755; 1055-9965
    Online Volltext: dx.doi.org/
  • Helfrich, Iris; Scheffrahn, Inka; Bartling, Soenke; Weis, Joachim; von Felbert, Verena; Middleton, Mark; Kato, Masahi; Ergün, Süleyman; Schadendorf, Dirk
    Resistance to antiangiogenic therapy is directed by vascular phenotype, vessel stabilization, and maturation in malignant melanoma
    In: Journal of Experimental Medicine (JEM) Jg. 207 (2010) Nr. 3, S. 491 - 503
    ISSN: 1540-9538; 0022-1007
    Online Volltext: dx.doi.org/ (Open Access)
  • Osen, W.; Soltek, S.; Song, M.; Leuchs, B.; Steitz, J.; Tüting, T.; Eichmüller, S. B.; Nguyen, X. D.; Schadendorf, Dirk; Paschen, Annette
    Screening of Human Tumor Antigens for CD4+ T Cell Epitopes by Combination of HLA-Transgenic Mice, Recombinant Adenovirus and Antigen Peptide Libraries
    In: PLoS ONE Jg. 5 (2010) Nr. 11, S. e14137
    ISSN: 1932-6203
    Online Volltext: dx.doi.org/ (Open Access)
  • Figl, A.; Scherer, D.; Nagore, E.; Bermejo, J. L.; Botella-Estrada, R.; Gast, A.; Thirumaran, R. K.; Planelles, D.; Hemminki, K.; Schadendorf, Dirk; Kumar, R.
    Single-nucleotide polymorphisms in DNA-repair genes and cutaneous melanoma
    In: Mutation Research / Genetic Toxicology and Environmental Mutagenesis Jg. 702 (2010) Nr. 1, S. 8 - 16
    ISSN: 1383-5718; 1879-3592; 1388-2120
    Online Volltext: dx.doi.org/
  • Gast, Andreas; Scherer, Dominique; Chen, Bowang; Bloethner, Sandra; Melchert, Stephanie; Sucker, Antje; Hemminki, Kari; Schadendorf, Dirk; Kumar, Rajiv
    Somatic alterations in the melanoma genome : a high-resolution array-based comparative genomic hybridization study
    In: Genes, Chromosomes and Cancer Jg. 49 (2010) Nr. 8, S. 733 - 745
    ISSN: 1098-2264; 1045-2257
    Online Volltext: dx.doi.org/
  • Hauschild, A.; Gutzmer, R.; Ugurel, Selma; Trefzer, U.; Egberts, F.; Hassel, J.; Schadendorf, Dirk; Mauch, C.; Garbe, C.; Weichenthal, M.
    Sorafenib and pegylated interferon-alpha-2b in advanced metastatic melanoma : A multicenter phase II DeCOG trial
    In: Journal of Clinical Oncology (JCO) Jg. 28 (2010) Nr. Suppl. 15, S. 8526
    ISSN: 0732-183X; 1527-7755
    Online Volltext: dx.doi.org/
  • Jansen, Thomas; Melnik, B. C.; Schadendorf, Dirk
    Steroid-induced Periorificial Dermatitis in Children—Clinical Features and Response to Azelaic Acid
    In: Pediatric Dermatology Jg. 27 (2010) Nr. 2, S. 137 - 142
    ISSN: 0736-8046; 1525-1470
    Online Volltext: dx.doi.org/
  • Waltermann, K.; Geier, J.; Diessenbacher, P.; Schadendorf, Dirk; Hillen, Uwe
    Systemic allergic contact dermatitis from intravenous piritramide
    In: Allergy Jg. 65 (2010) Nr. 9, S. 1203 - 1204
    ISSN: 1398-9995; 0105-4538; 1398-9995
    Online Volltext: dx.doi.org/
  • Kaehler, K. C.; Piel, S.; Livingstone, Elisabeth; Schilling, Bastian; Hauschild, A.; Schadendorf, Dirk
    Update on Immunologic Therapy With Anti–CTLA-4 Antibodies in Melanoma : Identification of Clinical and Biological Response Patterns, Immune-Related Adverse Events, and Their Management
    In: Seminars in Oncology Jg. 37 (2010) Nr. 5, S. 485 - 498
    ISSN: 0093-7754; 1532-8708
    Online Volltext: dx.doi.org/
  • Bazhin, A. V.; Tambor, V.; Dikov, B.; Philippov, P. P.; Schadendorf, Dirk; Eichmüller, S. B.
    cGMP-phosphodiesterase 6, transducin and Wnt5a/Frizzled-2-signaling control cGMP and Ca2+ homeostasis in melanoma cells
    In: Cellular and Molecular Life Sciences - CMLS Jg. 67 (2010) Nr. 5, S. 817 - 828
    ISSN: 1420-682X; 1420-9071
    Online Volltext: dx.doi.org/

    • Vorworte / Nachworte

  • Hahn, Andrew W.; Menk, Ashley V.; Rivadeneira, Dayana B.; Augustin, Ryan C.; Xu, Mingchu; Li, Jun; Wu, Xiaogang; Mishra, Aditya K.; Gide, Tuba N.; Quek, Camelia; Zang, Yan; Spencer, Christine N.; Menzies, Alexander M.; Daniel, Carrie R.; Hudgens, Courtney W.; Nowicki, Theodore; Haydu, Lauren E.; Khan, M A Wadud; Gopalakrishnan, Vancheswaran; Burton, Elizabeth M.; Malke, Jared; Simon, Julie M.; Bernatchez, Chantale; Putluri, Nagireddy; Woodman, Scott E.; Vashisht Gopal, Y.N.; Guerrieri, Renato; Fischer, Grant M.; Wang, Jian; Wani, Khalida M.; Thompson, John F.; Lee, Jeffrey E.; Hwu, Patrick; Ajami, Nadim; Gershenwald, Jeffrey E.; Long, Georgina V.; Scolyer, Richard A.; Tetzlaff, Michael T.; Lazar, Alexander J.; Schadendorf, Dirk; Wargo, Jennifer A.; Kirkwood, John M.; DeBerardinis, Ralph J.; Liang, Han; Futreal, Andrew; Zhang, Jianhua; Wilmott, James S.; Peng, Weiyi; Davies, Michael A.; Delgoffe, Greg M.; Najjar, Yana G.; McQuade, Jennifer L.
    Obesity Is Associated with Altered Tumor Metabolism in Metastatic Melanoma
    In: Clinical Cancer Research Jg. 29 (2023) Nr. 1, S. 154 - 164
    ISSN: 1557-3265; 1078-0432
    Online Volltext: dx.doi.org/
  • Brochez, Lieve; Kruse, Vibeke; Schadendorf, Dirk; Muller, Alexander J.; Prendergast, George C.
    Editorial : Targeting Indoleamine 2,3-dioxygenases and Tryptophan Dioxygenase for Cancer Immunotherapy
    In: Frontiers in Immunology Jg. 12 (2021)
    ISSN: 1664-3224
    Online Volltext: dx.doi.org/ (Open Access)
  • Hauschild, Axel; Schadendorf, Dirk
    Vorwort
    In: Oncology Research and Treatment Jg. 39 (2016) Nr. Suppl. 4, S. 1
    ISSN: 2296-5262
    Online Volltext: dx.doi.org/
  • Hauschild, Axel; Kölbl, Oliver; Mackensen, Andreas; Schadendorf, Dirk
    Vorwort
    In: Oncology Research and Treatment Jg. 37 (2014) S. 1
    ISSN: 2296-5270
    Online Volltext: dx.doi.org/ (Open Access)
  • Hauschild, Axel; Kölbl, Oliver; Mackensen, Andreas; Schadendorf, Dirk; Hauschilda, Axel; Kölblb, Oliver; Mackensenc, Andreas; Schadendorfd, Dirk
    Vorwort
    In: Onkologie Jg. 35 (2012) Nr. Suppl. 2, S. 1
    ISSN: 0378-584X; 1423-0240
    Online Volltext: dx.doi.org/ (Open Access)
  • Hauschild, Axel; Kölbl, Oliver; Mackensen, Andreas; Schadendorf, Dirk
    Vorwort
    In: Onkologie Jg. 34 (2011) Nr. SUPPL. 2, S. 1
    ISSN: 1423-0240; 0378-584X
    Online Volltext: dx.doi.org/ (Open Access)

    • Abstracts

  • Schadendorf, Dirk; Hauschild, Axel; Mandalà, Mario; Kirkwood, John M.; Robert, Caroline; Grob, Jean-Jacques; Nathan, Paul D.; Davies, Michael A.; Banerjee, Hiya; Shah, Rohan; Lau, Mike R.; Dummer, Reinhard; Long, Georgina V.
    Adjuvant dabrafenib plus trametinib (D + T) versus placebo in patients with resected stage III BRAFV600-mutant melanoma : Updated 5-year distant metastases-free survival (DMFS) analysis of COMBI-AD
    In: Journal of Clinical Oncology (JCO) Jg. 40 (2022) Nr. 16_Suppl., S. 9563
    ISSN: 0732-183X; 1527-7755
    Online Volltext: dx.doi.org/
  • Dummer, Reinhard; Farberg, Aaron S.; Gutzmer, Ralf; Spencer, James; Kiecker, Felix; Guminski, Alexander; Gebauer, Kurt; Loquai, Carmen; Robert, Caroline; Schadendorf, Dirk; Squittieri, Nicholas; Arntz, Ramon; Martelli, Serena; Migden, Michael;
    Analysis of efficacy outcomes using ERIVANCE-like methodology in patients with locally advanced basal cell carcinoma
    Australasian College of Dermatologists 54th Annual Scientific Meeting, Discover Connect Collaborate; 30 April to 3 May 2022; online,
    In: Australasian Journal of Dermatology Jg. 63 (2022) Nr. 1, SI, S. 112
    ISSN: 0004-8380; 1440-0960
    Online Volltext: dx.doi.org/ (Open Access)
  • Koch, F.; Salva, K.; Wirtz, M.; Hadaschik, Eva; Varaljai, R.; Schadendorf, Dirk; Kehrmann, Jan; Rösch, Alexander
    Cold atmospheric plasma versus diclofenac 3% gel in patients with actinic keratoses
    In: Experimental Dermatology Jg. 31 (2022) Nr. 2, S. e24 - e24
    ISSN: 1600-0625; 0906-6705
  • Placke, Jan-Malte; Bottek, J.; Váraljai, R.; Shannan, B.; Krisp, C.; Spangenberg, P.; Soun, C.; Hoffmann, F.; Zhao, F.; Paschen, Annette; Schlüter, H.; von Eggeling, F.; Helfrich, Iris; Rambow, F.; Schadendorf, Dirk; Engel, Daniel Robert; Rösch, Alexander;
    Compartment-based proteomics of CD8high vs. CD8low melanoma regions reveals differential regulation of TOR signaling
    32. Deutscher Hautkrebskongress (ADO-Jahrestagung), 14.–17. September 2022, Hannover, Germany,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Jg. 20 (2022) Nr. S3, S. 12
    ISSN: 1610-0387; 1563-2571; 1610-0379; 0301-0481
    Online Volltext: dx.doi.org/
  • Albrecht, L. J.; Varaljai, R.; Hoewner, A.; Lueong, S. S.; von Neuhof, N.; Sucker, A.; Sondermann, Wiebke; Schadendorf, Dirk; Rösch, Alexander
    Context Sensitive Links 9 of 29 Circulating tumor derived cell-free RNA (cfRNA) as a potential biomarker in melanoma
    In: Experimental Dermatology Jg. 31 (2022) Nr. 2, S. e26 - e27
    ISSN: 1600-0625; 0906-6705
  • Beckmann, C. L.; Lodde, Georg; Livingstone, Elisabeth; Schadendorf, Dirk; Böckmann, B.;
    Context-Sensitive Modeling of a Standard Operating Procedure for Melanoma Patient Treatment
    32. Deutscher Hautkrebskongress (ADO-Jahrestagung), 14.–17. September 2022, Hannover, Germany,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Jg. 20 (2022) Nr. S3, S. 67
    ISSN: 1610-0387; 1563-2571; 1610-0379; 0301-0481
    Online Volltext: dx.doi.org/
  • Franklin, Cindy; Mohr, P.; Meier, F.; Lodde, Georg; Placke, Jan-Malte; Zimmer, Lisa; Livingstone, Elisabeth; Horn, S.; Schadendorf, Dirk; Ugurel, Selma; et al.;
    Development of brain metastases and survival outcomes upon first-line systemic therapy in BRAF mutant and BRAF wildtype melanoma patients : a multicenter DeCOG study on 1704 patients from the prospective skin cancer registry ADOREG
    32. Deutscher Hautkrebskongress (ADO-Jahrestagung), 14.–17. September 2022, Hannover, Germany,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Jg. 20 (2022) Nr. S3, S. 13 - 14
    ISSN: 1610-0387; 1563-2571; 1610-0379; 0301-0481
    Online Volltext: dx.doi.org/
  • Long, G. V.; Luke, J.; Khattak, M. A.; Schadendorf, Dirk; Ascierto, P. A.; et al.;
    Distant metastasis-free survival with pembrolizumab versus placebo as adjuvant therapy in stage IIB or IIC melanoma: the phase 3 KEYNOTE-716 study
    32. Deutscher Hautkrebskongress (ADO-Jahrestagung), 14.–17. September 2022, Hannover, Germany,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Jg. 20 (2022) Nr. S3, S. 95
    ISSN: 1610-0387; 1563-2571; 1610-0379; 0301-0481
    Online Volltext: dx.doi.org/
  • Weichenthal, Michael; Svane, Inge Marie; Kandolf Sekulovic, Lidija; Mangana, Joanna; Mohr, Peter; Marquez-Rodas, Ivan; Schmidt, Henrik; Ziogas, Dimitrios C.; Bender, Marc; Ellebaek, Eva; Urch, Kristina; Shalamanova-Deleva, Gergana; Gavrilova, Iva; Espinosa, Enrique; Dummer, Reinhard; Rutkowski, Piotr; Ascierto, Paolo Antonio; Gogas, Helen; Schadendorf, Dirk; Bastholt, Lars
    EMRseq : Registry-based outcome analysis on 1,000 patients with BRAF V600–mutated metastatic melanoma in Europe treated with either immune checkpoint or BRAF-/MEK inhibition
    In: Journal of Clinical Oncology (JCO) Jg. 40 (2022) Nr. 16_Suppl., S. 9540
    ISSN: 0732-183X; 1527-7755
    Online Volltext: dx.doi.org/
  • Gutzmer, R.; Weichenthal, M.; Eigentler, T.; Grimmelmann, I.; Sickmann, T.; Zimmer, Lisa; Livingstone, Elisabeth; Ugurel, Selma; Utikal, J. S.; Müller, V.; Göppner, D.; Herbst, R.; Kreuter, A.; Pföhler, C.; Hollburg, W.; Loquai, C.; Kähler, K.; Mohr, P.; Schadendorf, Dirk;
    Early safety signals from nivolumab in the adjuvant treatment of real-world melanoma patients derived from the German prospective non-interventional study NICO
    32. Deutscher Hautkrebskongress (ADO-Jahrestagung), 14.–17. September 2022, Hannover, Germany,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Jg. 20 (2022) Nr. S3, S. 18 - 19
    ISSN: 1610-0387; 1563-2571; 1610-0379; 0301-0481
    Online Volltext: dx.doi.org/
  • Schadendorf, Dirk; Gogas, Helen; Kandolf Sekulovic, Lidija; Meier, Friedegund Elke; Eigentler, Thomas; Simon, Jan-Christoph; Terheyden, Patrick Andres Maximilian; Gesierich, Anja Heike; Herbst, Rudolf Alexander; Kähler, Katharina C.; Ziogas, Dimitrios C.; Mijuskovic, Zeljko; Garzarolli, Marlene; Garbe, Claus; Rösch, Alexander; Ugurel, Selma; Gutzmer, Ralf; Grob, Jean-Jacques; Zimmer, Lisa; Livingstone, Elisabeth
    Efficacy and safety of sequencing with vemurafenib (V) plus cobimetinib (C) followed by atezolizumab (Atezo) in patients (pts) with advanced BRAFV600-positive melanoma : Interim analysis of the ImmunoCobiVem study
    In: Journal of Clinical Oncology (JCO) Jg. 40 (2022) Nr. 16_Suppl., S. 9548
    ISSN: 0732-183X; 1527-7755
    Online Volltext: dx.doi.org/
  • Richtig, E.; Loquai, C.; Forschner, A.; Gutzmer, R.; Hassel, J. C.; Utikal, J. S.; Haferkamp, S.; Meier, F.; Debus, D.; Dummer, R.; von Moos, R. A. F.; Thompson, J.; Gengenbacher, L.; Michielin, O.; Höller, C.; Schadendorf, Dirk;
    Encorafenib plus Binimetinib bei Patienten mit lokal fortgeschrittenem, nicht-resezierbarem oder metastasiertem BRAFV600-mutiertem Melanom : Aktualisierte Daten der multizentrischen, multinationalen, prospektiven, nicht-interventionellen Längsschnittstudie BERING MELANOMA
    32. Deutscher Hautkrebskongress (ADO-Jahrestagung), 14.–17. September 2022, Hannover, Germany,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Jg. 20 (2022) Nr. S3, S. 96 - 97
    ISSN: 1610-0387; 1563-2571; 1610-0379; 0301-0481
    Online Volltext: dx.doi.org/
  • Richtig, Erika; Loquai, Carmen; Forschner, Andrea; Gutzmer, Ralf; Hassel, Jessica Cecile; Utikal, Jochen; Haferkamp, Sebastian; Meier, Friedegund Elke; Debus, Dirk; Dummer, Reinhard; Von Moos, Roger Anton Fredy; Thompson, Jan; Gengenbacher, Laura; Michielin, Olivier; Hoeller, Christoph; Schadendorf, Dirk
    Encorafenib plus binimetinib in patients with locally advanced, unresectable, or metastatic BRAFV600-mutant melanoma : Updated data from the multicenter, multinational, prospective, non-interventional longitudinal study BERINGMELANOMA
    In: Journal of Clinical Oncology (JCO) Jg. 40 (2022) Nr. 16_Suppl., S. 9526
    ISSN: 0732-183X; 1527-7755
    Online Volltext: dx.doi.org/
  • Egetemaier, S.; Chauvistré, H.; Shannan, B.; Váraljai, R.; Lueong, S. S.; Ullrich, V.; Srinivas, N.; Becker, Jürgen C.; Schadendorf, Dirk; Rösch, Alexander
    Epigenetisch-metabolische Vulnerabilität von medikamententoleranten Persisterzellen im Melanom
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Jg. 20 (2022) Nr. S3, S. 24
    ISSN: 1610-0387; 1563-2571; 1610-0379; 0301-0481
    Online Volltext: dx.doi.org/
  • Jansen, P.; Otero Baguer, D.; Duschner, N.; Schaller, Jörg; Schadendorf, Dirk; Hadaschik, Eva; Griewank, Klaus; Maass, P.;
    Etablierung eines Deep-Learning-Algorithmus zur Differenzierung von Morbus Bowen und seborrhoischen Keratosen
    32. Deutscher Hautkrebskongress (ADO-Jahrestagung), 14.–17. September 2022, Hannover, Germany,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Jg. 20 (2022) Nr. S3, S. 15
    ISSN: 1610-0387; 1563-2571; 1610-0379; 0301-0481
    Online Volltext: dx.doi.org/
  • Borys, K.; Livingstone, Elisabeth; Lodde, Georg; Seifert, Christin; Krämer, Nicole; Umutlu, Lale; Schadendorf, Dirk; Friedrich, C. M.; Nensa, Felix;
    Explainable Radiomics by the example of malignant melanoma
    32. Deutscher Hautkrebskongress (ADO-Jahrestagung), 14.–17. September 2022, Hannover, Germany,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Jg. 20 (2022) Nr. S3, S. 65 - 66
    ISSN: 1610-0387; 1563-2571; 1610-0379; 0301-0481
    Online Volltext: dx.doi.org/
  • Zaremba, Anne; Jansen, Philipp; Murali, R.; Mayakonda, A.; Riedel, A.; Krahl, D.; Burkhardt, H.; John, S.; Géraud, C.; Philip, M.; Kretz, J.; Möller, I.; Stadtler, N.; Sucker, A.; Paschen, Annette; Ugurel, Selma; Zimmer, Lisa; Livingstone, Elisabeth; Horn, S.; Plass, C.; Schadendorf, Dirk; Hadaschik, Eva; Lutsik, P.; Griewank, Klaus;
    Genetic and methylation analysis of CTNNB1 mutations in benign and malignant melanocytic lesions
    32. Deutscher Hautkrebskongress (ADO-Jahrestagung), 14.–17. September 2022, Hannover, Germany,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Jg. 20 (2022) Nr. S3, S. 84
    ISSN: 1610-0387; 1563-2571; 1610-0379; 0301-0481
    Online Volltext: dx.doi.org/
  • Albrecht, L. J.; Höwner, A.; Griewank, Klaus; Lueong, S. S.; von Neuhoff, N.; Horn, Peter A.; Sucker, A.; Paschen, Annette; Livingstone, Elisabeth; Ugurel, Selma; Zimmer, Lisa; Horn, S.; Siveke, Jens T.; Schadendorf, Dirk; Váraljai, R.; Rösch, Alexander;
    Im Plasma zirkulierende zellfreie mRNA ermöglicht die minimal-invasive und Genotyp-unabhängige Therapieüberwachung bei Patienten mit Melanom
    32. Deutscher Hautkrebskongress (ADO-Jahrestagung), 14.–17. September 2022, Hannover, Germany,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Jg. 20 (2022) Nr. S3, S. 12 - 13
    ISSN: 1610-0387; 1563-2571; 1610-0379; 0301-0481
    Online Volltext: dx.doi.org/
  • Franklin, Cindy; Mohr, P.; Bluhm, L.; Rösch, Alexander; Zimmer, Lisa; Livingstone, Elisabeth; Schadendorf, Dirk; Horn, S.; Ugurel, Selma; et al.;
    Impact of radiotherapy and sequencing of systemic therapy on survival outcomes in melanoma patients with previously untreated brain metastasis : a multicenter DeCOG study on 450 patients from the prospective skin cancer registry ADOREG
    32. Deutscher Hautkrebskongress (ADO-Jahrestagung), 14.–17. September 2022, Hannover, Germany,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Jg. 20 (2022) Nr. S3, S. 29 - 30
    ISSN: 1610-0387; 1563-2571; 1610-0379; 0301-0481
    Online Volltext: dx.doi.org/
  • Placke, Jan-Malte; Dick, J.; Soun, C.; Spangenberg, P.; Shannan, B.; Varaljai, R.; Krisp, C.; Schlueter, H.; Urbanek, A.; von Eggeling, F.; Schadendorf, Dirk; Engel, Daniel Robert; Rösch, Alexander
    Inhibition of the mTOR inhibitory protein sirtuin 1 leads to faster tumor growth under PD1-based immune checkpoint blockade
    In: Experimental Dermatology Jg. 31 (2022) Nr. 2, S. e92
    ISSN: 1600-0625; 0906-6705
  • Shannan, B.; Matschke, Johann; Larafa, S.; Schadendorf, Dirk; Jendrossek, Verena; Rösch, Alexander;
    KDM5B's role in creating radiation synthetic vulnerabilities and its effects on sequential therapy combinations
    48th Annual Meeting of the Arbeitsgemeinschaft Dermatologische Forschung (ADF): Virtual, Innsbruck, 23-26 February 2022,
    In: Experimental Dermatology Jg. 31 (2022) Nr. 2, S. e9 - e10
    ISSN: 1600-0625; 0906-6705
    Online Volltext: dx.doi.org/
  • Zaremba, Anne; Meier, F.; Schlein, C.; Jansen, Philipp; Lodde, Georg; Song, M.; Kretz, J.; Möller, I.; Stadtler, N.; Livingstone, Elisabeth; Zimmer, Lisa; Hadaschik, Eva; Sucker, A.; Schadendorf, Dirk; Griewank, Klaus;
    Klinische und pathologische Merkmale des familiären Melanoms bei Keimbahn-TERT-Promotorvarianten
    32. Deutscher Hautkrebskongress (ADO-Jahrestagung), 14.–17. September 2022, Hannover, Germany,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Jg. 20 (2022) Nr. S3, S. 6
    ISSN: 1610-0387; 1563-2571; 1610-0379; 0301-0481
    Online Volltext: dx.doi.org/
  • Sauter, D.; Lodde, Georg; Nensa, Felix; Schadendorf, Dirk; Livingstone, Elisabeth; Kukuk, M.;
    Konzept-basierte Erklärung neuronaler Netze für die Dermatohistopathologie
    32. Deutscher Hautkrebskongress (ADO-Jahrestagung), 14.–17. September 2022, Hannover, Germany,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Jg. 20 (2022) Nr. S3, S. 68
    ISSN: 1610-0387; 1563-2571; 1610-0379; 0301-0481
    Online Volltext: dx.doi.org/
  • Kreft, S.; Glutsch, V.; Zaremba, Anne; Schadendorf, Dirk; Ugurel, Selma; Schilling, Bastian; et al.;
    MAPKinase Inhibition nach Versagen einer PD-1 basierten Immuncheckpoint Blockade in Patienten:innen mit fortgeschrittenem Melanom : eine Auswertung des multizentrischen prospektiven Hautkrebsregisters ADOREG
    32. Deutscher Hautkrebskongress (ADO-Jahrestagung), 14.–17. September 2022, Hannover, Germany,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Jg. 20 (2022) Nr. S3, S. 28
    ISSN: 1610-0387; 1563-2571; 1610-0379; 0301-0481
    Online Volltext: dx.doi.org/
  • Küper, Alisa; Lodde, Georg; Livingstone, Elisabeth; Schadendorf, Dirk; Krämer, Nicole;
    Mitigating Cognitive Bias with Decision Support Systems
    32. Deutscher Hautkrebskongress (ADO-Jahrestagung), 14.–17. September 2022, Hannover, Germany,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Jg. 20 (2022) Nr. S3, S. 64
    ISSN: 1610-0387; 1563-2571; 1610-0379; 0301-0481
    Online Volltext: dx.doi.org/
  • Jansen, P.; Zaremba, Anne; Philip, M.; Lodde, Georg; Livingstone, Elisabeth; Zimmer, Lisa; Ugurel, Selma; Paschen, Annette; Sucker, A.; Möller, I.; Landsberg, J.; Rose, C.; Emberger, M.; Schaller, J.; Plass, C.; Hadaschik, Eva; Schadendorf, Dirk; Mentzel, T.; Lutsik, P.; Griewank, Klaus;
    Molekularpathologie und Methylierungsprofile als diagnostische Unterstützung zur Differenzierung von Klarzellsarkomen und melanozytären Tumoren
    32. Deutscher Hautkrebskongress (ADO-Jahrestagung), 14.–17. September 2022, Hannover, Germany,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Jg. 20 (2022) Nr. S3, S. 88
    ISSN: 1610-0387; 1563-2571; 1610-0379; 0301-0481
    Online Volltext: dx.doi.org/
  • Livingstone, Elisabeth; Forschner, Andrea; Hassel, Jessica Cecile; Wulfken, Lena M.; Meier, Friedegund Elke; Mohr, Peter; Kähler, Katharina C.; Schilling, Bastian; Loquai, Carmen; Berking, Carola; Hüning, Svea; Eckardt, Julia; Gutzmer, Ralf; Reinhardt, Lydia; Kowall, Bernd; Galetzka, Wolfgang; Hauschild, Axel; Zimmer, Lisa; Schadendorf, Dirk; Lodde, Georg
    Multicenter real-world data of adjuvant treatment and disease outcome of patients with melanoma with high-risk of recurrence
    In: Journal of Clinical Oncology (JCO) Jg. 40 (2022) Nr. 16_Suppl., S. 9570
    ISSN: 0732-183X; 1527-7755
    Online Volltext: dx.doi.org/
  • Placke, Jan-Malte; Mertens, D.; Tasdogan, A.; Chorti, E.; Schadendorf, Dirk; Ugurel, Selma; Rösch, Alexander; Stoffels, Ingo; Klode, Joachim;
    Multispectral optoacoustic tomography to differentiate between lymph node metastases and coronavirus-19 vaccine-associated lymphadenopathy
    32. Deutscher Hautkrebskongress (ADO-Jahrestagung), 14.–17. September 2022, Hannover, Germany,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Jg. 20 (2022) Nr. S3, S. 105
    ISSN: 1610-0387; 1563-2571; 1610-0379; 0301-0481
    Online Volltext: dx.doi.org/
  • Wong, Michael K.K.; Burgess, Melissa Amber; Chandra, Sunandana; Schadendorf, Dirk; Silk, Ann W.; Olszanski, Anthony J.; Grob, Jean-Jacques; Jang, Sekwon; Grewal, Jaspreet Singh; Lewis, Karl D.; Fecher, Leslie Anne; Rabinowits, Guilherme; Lebbe, Celeste; Shen, Annalise; Chan, Tiffanie; McGreivy, Jesse S.; Rothbaum, Wayne P.; Hanna, Glenn J.; Kelly, Ciara Marie
    Navtemadlin (KRT-232) activity after failure of anti-PD-1/L1 therapy in patients (pts) with TP53WT Merkel cell carcinoma (MCC)
    In: Journal of Clinical Oncology (JCO) Jg. 40 (2022) Nr. 16_Suppl., S. 9506
    ISSN: 0732-183X; 1527-7755
    Online Volltext: dx.doi.org/
  • Kreft, S.; Richter, L.; Peller, V.; Rieß, V.; Albrecht, L. J.; Müseler, A. C.; Rösch, Alexander; Ugurel, Selma; Schadendorf, Dirk; Zimmer, Lisa; Livingstone, Elisabeth;
    Partielle Remission auf Cemiplimab eines beidseitig Orbitae-infiltrierenden Basalzellkarzinoms des Mittelgesichts
    32. Deutscher Hautkrebskongress (ADO-Jahrestagung), 14.–17. September 2022, Hannover, Germany,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Jg. 20 (2022) Nr. S3, S. 44 - 45
    ISSN: 1610-0387; 1563-2571; 1610-0379; 0301-0481
    Online Volltext: dx.doi.org/
  • Chauvistre, H.; Shannan, B.; Daignault-Mill, S. M.; Ju, R. J.; Picard, D.; Egetemaier, S.; Váraljai, R.; Gibhardt, C. S.; Keminer, O.; Horn, S.; Remke, M.; Paschen, Annette; Becker, Jürgen C.; Helfrich, Iris; Gul, S.; Herlyn, M.; Bogeski, I.; Rodríguez-López, J. N.; Haass, N. K.; Schadendorf, Dirk; Rösch, Alexander;
    Persister state-directed transitioning and vulnerability in melanoma
    32. Deutscher Hautkrebskongress (ADO-Jahrestagung), 14.–17. September 2022, Hannover, Germany,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Jg. 20 (2022) Nr. S3, S. 35 - 36
    ISSN: 1610-0387; 1563-2571; 1610-0379; 0301-0481
    Online Volltext: dx.doi.org/
  • Placke, Jan-Malte; Mohr, P.; Bluhm, L.; Engel, Daniel Robert; Franklin, Cindy; Zaremba, Anne; Krefting, F.; Lodde, Georg; Zimmer, Lisa; Livingstone, Elisabeth; Becker, Jürgen C.; Tasdogan, Alpaslan; Rösch, Alexander; Schadendorf, Dirk; Ugurel, Selma; et al.;
    Predictors of long-term survival of stage IV melanoma patients : a multicenter DeCOG study on 539 patients from the prospective skin cancer registry ADOREG
    32. Deutscher Hautkrebskongress (ADO-Jahrestagung), 14.–17. September 2022, Hannover, Germany,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Jg. 20 (2022) Nr. S3, S. 16 - 17
    ISSN: 1610-0387; 1563-2571; 1610-0379; 0301-0481
    Online Volltext: dx.doi.org/
  • Glutsch, V.; Kneitz, H.; Gesierich, A.; Goebeler, M.; Posch, C.; Gebhardt, C.; Haferkamp, S.; Zimmer, Lisa; Becker, Jürgen C.; Leiter-Stöppke, U.; Weichenthal, M.; Schadendorf, Dirk; Ugurel, Selma; Schilling, Bastian;
    REINA - Retrospective Multicenter ADOReg Evaluation of Ipilimumab plus Nivolumab in Avelumab-refractory Merkel cell carcinoma
    32. Deutscher Hautkrebskongress (ADO-Jahrestagung), 14.–17. September 2022, Hannover, Germany,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Jg. 20 (2022) Nr. S3, S. 21
    ISSN: 1610-0387; 1563-2571; 1610-0379; 0301-0481
    Online Volltext: dx.doi.org/
  • Mohr, P.; Scherrer, E.; Alar, V.; Schadendorf, Dirk; Ugurel, Selma; Weichenthal, M.;
    Real-world clinical outcomes of pembrolizumab for advanced melanoma in the German ADOREG skin cancer registry
    32. Deutscher Hautkrebskongress (ADO-Jahrestagung), 14.–17. September 2022, Hannover, Germany,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Jg. 20 (2022) Nr. S3, S. 18
    ISSN: 1610-0387; 1563-2571; 1610-0379; 0301-0481
    Online Volltext: dx.doi.org/
  • Lodde, Georg; Forschner, A.; Hassel, J. C.; Wulfken, L. M.; Meier, F.; Mohr, P.; Kähler, K.; Schilling, Bastian; Loquai, C.; Berking, C.; Hüning, S.; Eckardt, J.; Gutzmer, R.; Reinhardt, L.; Glutsch, V.; Nikfarjam, U.; Erdmann, M.; Kowall, Bernd; Galetzka, W.; Rösch, Alexander; Ugurel, Selma; Zimmer, Lisa; Schadendorf, Dirk; Livingstone, Elisabeth;
    Therapiemanagement des ersten Rezidivs nach adjuvanter Therapie im Stadium III : multizentrische real-world Daten
    32. Deutscher Hautkrebskongress (ADO-Jahrestagung), 14.–17. September 2022, Hannover, Germany,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Jg. 20 (2022) Nr. S3, S. 3
    ISSN: 1610-0387; 1563-2571; 1610-0379; 0301-0481
    Online Volltext: dx.doi.org/
  • Schadendorf, Dirk
    5-Year Overall Survival in COLUMBUS : A randomized Phase 3 Study of Encorafenib plus Binimetinib versus Vemurafenib or Encorafenib in Patients with BRAF(V600)-mutated Melanoma
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Jg. 19 (2021) Nr. Suppl. 4, S. 56
    ISSN: 1610-0387; 1563-2571; 1610-0379; 0301-0481
  • Zaremba, Anne; Ferdinandus, J.; Zimmer, Lisa; Umutlu, Lale; Seifert, R.; Barbato, F.; Ugurel, Selma; Chorti, E.; Grünwald, V.; Herrmann, Ken; Schadendorf, Dirk; Fendler, Wolfgang; Livingstone, Elisabeth
    Additional Benefit of FDG-PET when Discontinuing Immune Checkpoint Inhibitor Therapy in Patients with metastatic Melanoma
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Jg. 19 (2021) Nr. Suppl. 4, S. 75 - 76
    ISSN: 1610-0387; 1563-2571; 1610-0379; 0301-0481
  • Schadendorf, Dirk
    Adjuvant therapy with nivolumab (NIVO) combined with ipilimumab (IPI) vs NIVO alone in patients (pts) with resected stage IIIB-D/IV melanoma (CheckMate 915)
    In: Cancer Research Jg. 81 (2021) Nr. 13,
    ISSN: 1538-7445; 0008-5472
  • Schadendorf, Dirk; Ugurel, Selma
    Age-dependent Efficacy and Safety of Nivolumab (NIVO) as Monotherapy or Combination Therapy with Ipilimumab (NIVO plus IPI) in Patients with advanced Melanoma in the non-interventional Study (NIS) NICO
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Jg. 19 (2021) Nr. Suppl. 4, S. 16 - 17
    ISSN: 1610-0387; 1563-2571; 1610-0379; 0301-0481
  • Wolchok, Jedd D.; Chiarion-Sileni, Vanna; Gonzalez, Rene; Grob, Jean-Jacques; Rutkowski, Piotr; Lao, Christopher D.; Cowey, Charles Lance; Schadendorf, Dirk; Wagstaff, John; Dummer, Reinhard; Ferrucci, Pier Francesco; Smylie, Michael; Butler, Marcus O.; Hill, Andrew Graham; Marquez-Rodas, Ivan; Haanen, John B. A. G.; Bas, Tuba; van Dijck, Wim; Larkin, James; Hodi, F. Stephen
    CheckMate 067 : 6.5-year outcomes in patients (pts) with advanced melanoma
    In: Journal of Clinical Oncology Jg. 39 (2021) Nr. 15_Suppl, S. 9506 - 9506
    ISSN: 0732-183X; 1527-7755
    Online Volltext: dx.doi.org/
  • Maischack, Felix; Reinsch, Nico; Albayrak-Rena, Sarah; Kaiser, Franziska; Dolff, Sebastian; Schadendorf, Dirk; Jöckel, Karl-Heinz; Schmidt, Börge; Esser, Stefan
    Comparing 5-year body-mass-index gain of people living with HIV (PLH) with the general population
    In: Infection - A Journal of Infectious Disease Jg. 49 (2021) Nr. Suppl. 1, S. 23
    ISSN: 1439-0973; 0300-8126
    Online Volltext: dx.doi.org/ Online Volltext (Open Access)
  • Mavarani, Laven; Maischack, Felix; Reinsch, Nico; Albayrak-Rena, Sarah; Kaiser, Franziska; Potthoff, Anja; Hower, Martin; Dolff, Sebastian; Brockmeyer, Norbert; Schadendorf, Dirk; Jöckel, Karl-Heinz; Schmidt, Börge; Esser, Stefan
    Comparing 5-year body-mass-index gain of people living with HIV (PLH) with the general population
    In: Infection - A Journal of Infectious Disease Jg. 49 (2021) Nr. Suppl. 1, S. 23
    ISSN: 1439-0973; 0300-8126
    Online Volltext: dx.doi.org/ Online Volltext (Open Access)
  • Gambichler, T.; Rohrmoser, E. M.; Horny, K.; Sucker, A. Antje; Schadendorf, Dirk; Skrygan, M.; Susok, L.; Stücker, M.; Abu Rached, N.; Becker, Jürgen
    Comparison of Mutation Profiles in primary Melanomas and nodal Nevi using next Generation Sequencing
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Jg. 19 (2021) Nr. Suppl. 4, S. 80 - 81
    ISSN: 1610-0387; 1563-2571; 1610-0379; 0301-0481
  • Gutzmer, R.; Eigentler, T.; Mohr, P.; Weichenthal, M.; Dücker, P.; Gebhardt, C.; Göppner, D.; Grimmelmann, I.; Haferkamp, S.; Kähler, K.C.; Meier, F.; Pföhler, C.; Sickmann, T.; Sindrilaru, A.; Terheyden, P.; Ugurel, Selma; Ulrich, J.; Utikal, J.; Weishaupt, C.; Schadendorf, Dirk
    Comparison of effectiveness and safety of nivolumab monotherapy or in combination therapy with ipilimumab in therapy-naïve and pretreated patients with advanced melanoma within the German noninterventional study NICO
    In: Annals of Oncology Jg. 32 (2021) Nr. Suppl. 5, S. 894 - S895
    ISSN: 1569-8041; 0923-7534
    Online Volltext: dx.doi.org/ (Open Access)
  • Vehring, Justus; Sammet, Stefanie; Heintschel von Heinegg, Evelyn; Schadendorf, Dirk; Esser, Stefan
    Efficacy of syphilis treatment in HIV-infected patients
    In: Infection - A Journal of Infectious Disease Jg. 49 (2021) Nr. Suppl. 1, S. 40
    ISSN: 1439-0973; 0300-8126
    Online Volltext: dx.doi.org/ Online Volltext (Open Access)
  • Esser, Stefan; Kreuter, Alexander; Potthoff, Anja; Oette, Mark; Bilbilis, Konstantinos; Lax, Hildegard; Wiehler, Heidi; Yavuz, Aylin; Brockmeyer, Norbert; Jöckel, Karl-Heinz; Schadendorf, Dirk; Wieland, Ulrike
    Efficacy of trichloroacetic acid vs. electrocautery for the treatment of anal intraepithelial neoplasia marker lesions in HIV-positive patients
    In: Infection - A Journal of Infectious Disease Jg. 49 (2021) Nr. Suppl. 1, S. 24 - S25
    ISSN: 1439-0973; 0300-8126
    Online Volltext: dx.doi.org/ (Open Access)
  • Esser, Stefan; Kreuter, Alexander; Potthoff, Anja; Oette, Mark; Bilbilis, Konstantinos; Lax, Hildegard; Wiehler, Heidi; Yavuz, Aylin; Brockmeyer, Norbert H.; Jöckel, Karl-Heinz; Schadendorf, Dirk; Wieland, Ulrike
    Efficacy of trichloroacetic acid vs. electrocautery for the treatment of anal intraepithelial neoplasia marker lesions in HIV-positive patients
    In: Infection - A Journal of Infectious Disease Jg. 49 (2021) Nr. Suppl. 1, S. 24 - S25
    ISSN: 1439-0973; 0300-8126
    Online Volltext: dx.doi.org/ (Open Access)
  • Schadendorf, Dirk
    Encorafenib plus Binimetinib in Patients with locally advanced, non-resectable or metastatic BRAF(V600) mutated Melanoma : First Data from the multicenter, multinational, prospective, non-interventional Longitudinal Study BERING(MELANOMA)
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Jg. 19 (2021) Nr. Suppl. 4, S. 53
    ISSN: 1610-0387; 1563-2571; 1610-0379; 0301-0481
  • Richtig, Erika; Gutzmer, Ralf; Loquai, Carmen; Utikal, Jochen; Hoeller, Christoph; Stadler, Rudolf; Forschner, Andrea; Hassel, Jessica Cecile; Goeppner, Daniela; Fluck, Michael; Haferkamp, Sebastian; Kaatz, Martin; Welslau, Manfred; Dummer, Reinhard; Von Moos, Roger Anton Fredy; Schmidt, Andrea; Milde, Laura; Michielin, Olivier; Schadendorf, Dirk
    Encorafenib plus Binimetinib in patients with locally advanced, unresectable or metastatic BRAFV600-mutant melanoma : First data of the multicenter, multinational, prospective, non-interventional longitudinal study BERINGMELANOMA
    In: Journal of Clinical Oncology Jg. 39 (2021) Nr. 15_Suppl, S. 9555 - 9555
    ISSN: 0732-183X; 1527-7755
    Online Volltext: dx.doi.org/
  • Michielin, O.; Richtig, E.; Grimmelmann, I.; Loquai, C.; Forschner, A.; Hoeller, C.; Utikal, J.; Gutzmer, R.; Haferkamp, S.; Hassel, J. C.; Debus, D.; Fluck, M.; Goeppner, D.; Kehrer, H.; Dummer, R.; von Moos, R.; Thompson, J.; Milde, L.; Schadendorf, Dirk;
    Encorafenib plus binimetinib in patients with locally advanced, unresectable or metastatic BRAF(V600) mutated melanoma : first data from a multi-centric, multi-national, prospective, longitudinal, non-interventional study - BERINGMELANOMA
    Gemeinsame Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 01.-04. Oktober 2021, Hybrid-Kongress,
    In: Oncology Research and Treatment Jg. 44 (2021) Nr. Supplement 2, S. 249 - 250
    ISSN: 2296-5262; 2296-5270; 1423-0240; 0378-584X
    Online Volltext: dx.doi.org/ (Open Access)
  • Egetemaier, S.; Chauvistre, H.; Shannan, B.; Varaljai, R.; Lueong, S.; Ullrich, V.; Schadendorf, Dirk; Rösch, Alexander
    Epigenetic-metabolic Vulnerability of drug-tolerant Persister Cells in Melanoma
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Jg. 19 (2021) Nr. Suppl. 4, S. 36
    ISSN: 1610-0387; 1563-2571; 1610-0379; 0301-0481
  • Esser, Stefan; Kreuter, A.; Potthoff, A.; Bilbilis, K.; Lax, H.; Oette, M.; Wiesel, P.; Sprinzl, M.; Brockmeyer, N. H.; Schadendorf, Dirk; Wieland, U.;
    Evaluation der Detektion von analen intraepitheliale Neoplasien (AIN) bei HIV‐positiven Menschen durch zytologische Abstriche und HPV Typisierungen beim Screening auf anale HPV‐assoziierte Läsionen
    51. Tagung der Deutschen Dermatologischen Gesellschaft ; 14.‐17. April 2021, Virtuell,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Jg. 19 (2021) Nr. Suppl. 2, S. 22
    ISSN: 1610-0387; 1563-2571; 1610-0379; 0301-0481
    Online Volltext: dx.doi.org/ (Open Access)
  • Rischin, D.; Hughes, B.G.M.; Basset-Séguin, N.; Schadendorf, Dirk; Bowyer, S.; Trabelsi, S.; Meier, F.; Eigentler, T.; Casado Echarren, V.; Migden, M.R.; Hauschild, A.; Schmults, C.D.; Yoo, S-Y.; Paccaly, A.; Jankovic, V.; Seebach, F.; Drutman, S.; Booth, J.; Fury, M.G.; Guminski, A.
    Extended-dose cemiplimab in patients with advanced cutaneous squamous cell carcinoma (CSCC) : Primary analysis of phase II results
    In: Annals of Oncology Jg. 32 (2021) Nr. Suppl. 5, S. 886 - S887
    ISSN: 1569-8041; 0923-7534
    Online Volltext: dx.doi.org/ (Open Access)
  • Zaremba, Anne; Griewank, Klaus; Livingstone, Elisabeth; Schadendorf, Dirk; Ugurel, Selma; Zimmer, Lisa
    Immune checkpoint-Inhibition in Patients with NRAS-mutated Melanoma compared to Patients with NRAS Wild-type Melanoma : Results of a Study on 702 Patients from the prospective, multicenter Registry ADOREG
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Jg. 19 (2021) Nr. Suppl. 4, S. 59 - 60
    ISSN: 1610-0387; 1563-2571; 1610-0379; 0301-0481
  • Thier, B.; Such, L.; Peller, V.; Schwamborn, M.; Sucker, A.; Coch, C.; Schadendorf, Dirk; Griewank, Klaus; Trilling, Mirko; Zhao, F.; Paschen, Annette;
    Interferon-independent enhancement of melanoma cell immunogenicity by RIG-I activation
    47th Annual Meeting of the Arbeitsgemeinschaft Dermatologische Forschung (ADF) Virtual, March 04‐06, 2021,
    In: Experimental Dermatology Jg. 30 (2021) Nr. 3, S. E78
    ISSN: 1600-0625; 0906-6705
  • Thier, B.; Zhao, F.; Horn, S.; Coch, C.; Hartmann, G.; Schadendorf, Dirk; Paschen, Annette
    Intratumoral Immunotherapy : RIG-I Agonists induce a dedifferentiated yet T-Cell-sensitive Melanoma Cell Phantotype
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Jg. 19 (2021) Nr. Suppl. 4, S. 34
    ISSN: 1610-0387; 1563-2571; 1610-0379; 0301-0481
  • Mavarani, L.; Reinsch, N.; Albayrak-Rena, S.; Kaiser, F.; Brockmeyer, N.H.; Potthoff, A.; Hower, M.; Schadendorf, Dirk; Erbel, R.; Jöckel, Karl-Heinz; Schmidt, Börge; Esser, Stefan;
    No difference in changes of the body mass index categories over 5 years in people living with HIV and the general population from the German Ruhr-area
    18th European AIDS Conference (EACS 2021), Online & London, United Kingdom, October 27-30, 2021,
    In: HIV Medicine Jg. 22 (2021) Nr. S3, S. 140
    ISSN: 1464-2662; 1468-1293
    Online Volltext: dx.doi.org/
  • Ugurel, Selma; Griewank, Klaus; Horn, S.; Herbst, R.; Terheyden, P.; Utikal, J. S.; Pfoehler, C.; Ulrich, J.; Kreuter, A.; Mohr, P.; Gutzmer, R.; Meier, F.; Dippel, E.; Sucker, A.; Placke, Jan-Malte; Livingstone, Elisabeth; Zimmer, Lisa; Hadaschik, Eva; Becker, Jürgen; Weichenthal, M.; Schadendorf, Dirk
    PD-L1-Expression and Mutation Profile in pre-therapeutic Tumor Tissue as Predictors of the Therapeutic Success of PD-1-based Immune Checkpoint Inhibition Therapy in Patients with metastatic Melanoma : Evaluation of the prospective multicentric ADO-Study TRIM
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Jg. 19 (2021) Nr. Suppl. 4, S. 19
    ISSN: 1610-0387; 1563-2571; 1610-0379; 0301-0481
  • Robert, C.; Schadendorf, Dirk; Long, G.V.; Ascierto, P.; Intagliata, S.; Meier, F.; van der Veldt, A.A.M.; Ribas, A.; Weber, J.S.; Stenson, L.; Solovieff, N.; Louveau, A-L.; Boran, A.D.; Grob, J.J.; Dummer, R.
    PLATForM : Descriptive analysis from a randomised, phase II study of novel spartalizumab combinations in previously treated unresectable/metastatic melanoma
    In: Annals of Oncology Jg. 32 (2021) Nr. Suppl. 5, S. 898
    ISSN: 1569-8041; 0923-7534
    Online Volltext: dx.doi.org/ (Open Access)
  • Albrecht, L. J.; Grunwald, V.; Becker, Jürgen; Gutzmer, R.; Asan, L.; Uslar, E.; Olischewsky, A.; Mueseler, A. C.; Rösch, Alexander; Schadendorf, Dirk; Zimmer, Lisa; Livingstone, Elisabeth
    PTHrP-induced hypercalcemia Psychosyndrome under Immune Checkpoint Blockade in Patients with penile Squamous Cell Carcinoma
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Jg. 19 (2021) Nr. Suppl. 4, S. 23
    ISSN: 1610-0387; 1563-2571; 1610-0379; 0301-0481
  • Lodde, Georg; Ugurel, Selma; Placke, Jan-Malte; Griewank, Klaus; Sucker, A.; Jansen, Philipp; Becker, Jürgen; Livingstone, Elisabeth; Zimmer, Lisa; Hadaschik, Eva; Schadendorf, Dirk
    Predictors of Super-response (CR/PR within 3 Months) under PD-1-based Immune Checkpoint Inhibition in metastatic Melanoma : A Subgroup Analysis of the prospective multicenter Study ADOREG TRIM
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Jg. 19 (2021) Nr. Suppl. 4, S. 6 - 7
    ISSN: 1610-0387; 1563-2571; 1610-0379; 0301-0481
  • Robbrecht, Debbie; Grob, Jean-Jacques; Bechter, Oliver; Santoro, Armando; Doger, Bernard; Borbath, Ivan; Butler, Marcus; Cheng, Tina; Martin, Patricia; Bennouna, Jaafar; Di Nicola, Massimo; Curigliano, Giuseppe; Ryu, Min-Hee; Vida, Alejo Rodriguez; Schadendorf, Dirk; Garralda, Elena; Abbadessa, Giovanni; Demers, Brigitte; Amrate, Amele; Lin, Tun Tun; Brahmachary, Manisha; Lee, Joon Sange; Theilhaber, Joachim; Pomponio, Rob; Wang, Rui;
    Preliminary biomarker and pharmacodynamic (PD) activity of the TGFβ inhibitor SAR439459, alone or in combination with cemiplimab, in a phase 1 clinical study in patients with advanced solid tumors
    SITC 36th Anniversary Annual Meeting (SITC 2021), 10-14 November 2021, Washington & virtually,
    In: Journal for ImmunoTherapy of Cancer Jg. 9 (2021) Nr. Suppl. 2, S. A550 - A550
    ISSN: 2051-1426
    Online Volltext: dx.doi.org/ (Open Access)
  • Zhao, F.; Peller, V.; Schwamborn, M.; Kwapik, S.; Sucker, A.; Ugurel, Selma; Schadendorf, Dirk; Paschen, Annette;
    Profiling of tumor-infiltrating T cells for guidance of melanoma salvage therapy in immune-checkpoint-blockade resistant patients
    47th Annual Meeting of the Arbeitsgemeinschaft Dermatologische Forschung (ADF) Virtual, March 04‐06, 2021,
    In: Experimental Dermatology Jg. 30 (2021) Nr. 3, S. E52
    ISSN: 1600-0625; 0906-6705
    Online Volltext: dx.doi.org/
  • Ascierto, Paolo Antonio; Robert, Caroline; Nathan, Paul D.; Dummer, Reinhard; Tawbi, Hussein Abdul-Hassan; Flaherty, Keith T.; Ribas, Antoni; Schadendorf, Dirk; Green, Steven; Sandalic, Lali; Lau, Mike R.; Romero, Tonatiuh; Long, Georgina V.
    Pyrexia-related outcomes upon application of an adapted pyrexia management algorithm in patients (pts) with BRAF V600 : Mutant unresectable or metastatic melanoma treated with dabrafenib plus trametinib (DabTram) in the COMBI-i trial
    In: Journal of Clinical Oncology Jg. 39 (2021) Nr. 15_Suppl, S. 9560 - 9560
    ISSN: 0732-183X; 1527-7755
    Online Volltext: dx.doi.org/
  • Lipson, Evan J.; Tawbi, Hussein Abdul-Hassan; Schadendorf, Dirk; Ascierto, Paolo Antonio; Matamala, Luis; Gutiérrez, Erika Castillo; Rutkowski, Piotr; Gogas, Helen; Lao, Christopher D.; Janoski de Menezes, Juliana; Dalle, Stéphane; Arance, Ana Maria; Grob, Jean-Jacques; Srivastava, Shivani; Abaskharoun, Mena; Simonsen, Katy L.; Li, Bin; Long, Georgina V.; Hodi, F. Stephen
    Relatlimab (RELA) plus nivolumab (NIVO) versus NIVO in first-line advanced melanoma : Primary phase III results from RELATIVITY-047 (CA224-047)
    In: Journal of Clinical Oncology Jg. 39 (2021) Nr. 15_Suppl, S. 9503 - 9503
    ISSN: 0732-183X; 1527-7755
    Online Volltext: dx.doi.org/
  • Hassel, Jessica Cecile; Berking, Carola; Schlaak, Max; Eigentler, Thomas; Gutzmer, Ralf; Ascierto, Paolo Antonio; Schilling, Bastian; Hamm, Svetlana; Hermann, F.; Reimann, Philip Gero; Schadendorf, Dirk
    Results from the phase Ib of the SENSITIZE trial combining domatinostat with pembrolizumab in advanced melanoma patients refractory to prior checkpoint inhibitor therapy
    In: Journal of Clinical Oncology Jg. 39 (2021) Nr. 15_Suppl, S. 9545 - 9545
    ISSN: 0732-183X; 1527-7755
    Online Volltext: dx.doi.org/
  • Vehring, J.; Sammet, S.; Maischack, F.; Heintschel von Heinegg, Evelyn; Schadendorf, Dirk; Esser, Stefan;
    S7/1 Behandlungsergebnisse der Therapie einer Syphilis-Infektion
    65. Deutschen STI-Kongresses – virtuell – vom 5./6. Februar 2021,
    In: Der Hautarzt Jg. 72 (2021) Nr. Supplement 1, S. S5 - S6
    ISSN: 1432-1173; 0017-8470
    Online Volltext: dx.doi.org/ (Open Access)
  • Thielmann, Carl Maximilian; Matull, J.; Zaremba, Anne; Chorti, E.; Lodde, Georg; Jansen, Philipp; Kretz, J.; Möller, I.; Sucker, A.; Paschen, Annette; Livingstone, Elisabeth; Zimmer, Lisa; Hadaschik, Eva; Ugurel, Selma; Schadendorf, Dirk; Griewank, Klaus
    TERT Promoter Mutations associated with longer progression-free and Overall Survival under BRAF/MEK Therapy
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Jg. 19 (2021) Nr. Suppl. 4, S. 31
    ISSN: 1610-0387; 1563-2571; 1610-0379; 0301-0481
  • Schadendorf, Dirk; Ugurel, Selma; Livingstone, Elisabeth; Zimmer, Lisa
    Termination of targeted Therapy with BRAF-/MEK Inhibitors after an initial complete Response in Patients with metastatic Melanoma and its clinical Implications : A retrospective, multicenter ADOReg Study
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Jg. 19 (2021) Nr. Suppl. 4, S. 15 - 16
    ISSN: 1610-0387; 1563-2571; 1610-0379; 0301-0481
  • Ugurel, Selma; Schadendorf, Dirk
    The Effects of Brain Metastases in Melanoma Patients on anti-PD1 Antibody Therapy with Pembrolizumab
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Jg. 19 (2021) Nr. Suppl. 4, S. 5 - 6
    ISSN: 1610-0387; 1563-2571; 1610-0379; 0301-0481
  • Weichenthal, Michael; Scherrer, Emilie; Chandwani, Sheenu; Mohr, Peter; Leiter, Ulrike; Ugurel, Selma; Kähler, Katharina C.; Gutzmer, Ralf; Pföhler, Claudia; Hassel, Jessica; Terheyden, Patrick; Schell, Beatrice; Utikal, Jochen; Kreuter, Alexander; Haferkamp, Sebastian; Sindrilaru, Anca; Hassel, Jessica; Nashan, Dorothee; Kaune, Kjell M.; Berking, Carola; Debus, Dirk; Ulrich, Jens; Dabrowski, Evelyn; Eigentler, Thomas; Herbst, Rudolf; Welzel, Julia; Loquai, Carmen; Meier, Friedegund; Schadendorf, Dirk;
    The impact of brain involvement in metastatic melanoma patients treated with pembrolizumab
    Immunotherapy Bridge and Melanoma Bridge 2020, 02.-03.12.2020, Virtual Meeting,
    In: Journal of Translational Medicine Jg. 19 (2021) Nr. Suppl. 1, S. 17
    ISSN: 1479-5876
    Online Volltext: dx.doi.org/ (Open Access)
  • Tawbi, Hussein Abdul-Hassan; Long, Georgina V.; Meyer, Nicolas; Breznen, Boris; Vyas, Charmy; Leung, Lisa; Moshyk, Andriy; Pushkarna, Divya; Thakkar, Pratik K.; Fazeli, Mir Sohail; Schadendorf, Dirk
    Treatment outcomes in patients (pts) with melanoma brain metastases (MBM) treated with systemic therapy : A systematic literature review (SLR) and meta-analysis.
    In: Journal of Clinical Oncology Jg. 39 (2021) Nr. 15_Suppl, S. 9561 - 9561
    ISSN: 0732-183X; 1527-7755
    Online Volltext: dx.doi.org/
  • Long, G.V.; Tawbi, H.A.; Meyer, N.; Breznen, B.; Vyas, C.; Leung, L.; Moshyk, A.; Pushkarna, D.; Thakkar, P.; Fazeli, M.S.; Kotapati, S.; Schadendorf, Dirk
    Treatment outcomes in patients (pts) with melanoma brain metastases (MBM) undergoing systemic therapy : A systematic literature review (SLR) and meta-analysis (MA) of real-world evidence (RWE)
    In: Annals of Oncology Jg. 32 (2021) Nr. Suppl. 5, S. 892 - S893
    ISSN: 1569-8041; 0923-7534
    Online Volltext: dx.doi.org/ (Open Access)
  • Zimmer, Lisa; Krackhardt, Angela; Schultz, Erwin S.; Goeppner, Daniela; Assaf, Chalid; Trebing, Dietrich; Livingstone, Elisabeth; Schadendorf, Dirk
    Triplet therapy with pembrolizumab (PEM), encorafenib (ENC) and binimetinib (BIN) in advanced, BRAF V600 mutant melanoma : Final results from the dose-finding phase I part of the IMMU-Target trial
    In: Journal of Clinical Oncology Jg. 39 (2021) Nr. 15_Suppl, S. 9532 - 9532
    ISSN: 0732-183X; 1527-7755
    Online Volltext: dx.doi.org/
  • Ugurel, Selma; Griewank, Klaus; Horn, Susanne; Herbst, Rudolf; Terheyden, Patrick; Utikal, Jochen; Pföhler, Claudia; Ulrich, Jens; Kreuter, Alexander; Mohr, Peter; Gutzmer, Ralf; Meier, Friedegund Elke; Dippel, Edgar; Sucker, Antje; Placke, Jan-Malte; Hadaschik, Eva; Becker, Jürgen; Weichenthal, Michael; Schadendorf, Dirk
    Tumor PD-L1 expression and gene panel mutational profile as outcome predictors of PD-1-based checkpoint inhibition therapy in metastatic melanoma : A prospective multicenter DeCOG study
    In: Journal of Clinical Oncology Jg. 39 (2021) Nr. 15_Suppl, S. 9568 - 9568
    ISSN: 0732-183X; 1527-7755
    Online Volltext: dx.doi.org/
  • Placke, Jan-Malte; Soun, C.; Bottek, J.; Zimmer, Lisa; Livingstone, Elisabeth; Becker, Jürgen; Lodde, Georg; Sucker, A.; Griewank, Klaus; Horn, S.; Hadaschik, Eva; Rösch, Alexander; Schadendorf, Dirk; Engel, Daniel Robert; Ugurel, Selma
    Tumor PD-L1-Positivity in medical and digital Quantification predicts a favorable Patient Outcome for a PD-1-based Immune Checkpoint-Blockade in metastatic Melanoma
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Jg. 19 (2021) Nr. Suppl. 4, S. 58 - 59
    ISSN: 1610-0387; 1563-2571; 1610-0379; 0301-0481
  • Robert, Caroline; Long, G.V.; Larkin, J.; Wolchok, Jedd D.; Hassel, J.C.; Schadendorf, Dirk; Hodi, F. Stephen; Lebbé, C.; Grob, Jean-Jacquez; Grossmann, Kenneth F.; Wagstaff, J.; Chesney, Jason A.; Butler, Marcus; Bechter, O.; Márquez-Rodas, I.; Pavlick, A.C.; Re, S.; van Dijck, W.; Postow, Michael A.; Ascierto, P.A.
    5-year characterization of complete responses in patients with advanced melanoma who received nivolumab plus ipilimumab (NIVO plus IPI) or NIVO alone
    In: Annals of Oncology Jg. 31 (2020) Nr. Suppl. 4, S. S734 - S735
    ISSN: 0923-7534
    Online Volltext: dx.doi.org/ (Open Access)
  • Zaremba, Anne; Martaki, Anna; Salzmann, Martin; Baroudjian, Barouyr; Sachse, Michael M.; Gesierich, A.; Reinhardt, Lydia; Meier, F.; Hassel, Jessica C.; Ugurel, Selma; Rösch, Alexander; Schadendorf, Dirk; Livingstone, Elisabeth; Broeckelmann, Paul; Kramer, R.; Heinzerling, L.; Zimmer, Lisa
    Agranulozytose unter Immuncheckpoint‐Blockade : Eine retrospektive, multizentrische Auswertung
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Jg. 18 (2020) Nr. Suppl. 2: Special Issue: Abstractband anlässlich des 30. Deutschen Hautkrebskongresses (ADO‐Jahrestagung) 09.–12. September 2020, S. FV28
    ISSN: 1610-0387; 1563-2571; 1610-0379; 0301-0481
    Online Volltext: dx.doi.org/
  • Robert, Caroline; Flaherty, K.T.; Gogas, Helen; Fernandez, A.M. Arance; Mandala, Mario; Liszkay, G.; Garbe, C.; Schadendorf, Dirk; Krajsova, I.; Gutzmer, Ralf; de Groot, Jan Willem B.; Dutriaux, Caroline; Loquai, Carmen; Harney, A.; Kiprilov, E.; Pickard, Michael D.; Cantey-Kiser, J.; Dummer, Reinhard; Ascierto, Paolo A.
    Correlation of BRAF mutation status in circulating tumour DNA (ctDNA) with tumour biopsy and clinical outcomes in COLUMBUS
    In: Annals of Oncology Jg. 31 (2020) Nr. Suppl. 4, S. S757 - S758
    ISSN: 0923-7534
    Online Volltext: dx.doi.org/ (Open Access)
  • Placke, Jan-Malte; Ugurel, Selma; Lodde, Georg; Zimmer, Lisa; Livingstone, Elisabeth; Rösch, Alexander; Schadendorf, Dirk; Funke-Lorenz, Carolin
    Die Extracorporale Photopherese verbessert therapierefraktäre autoimmune Nebenwirkungen nach Immuncheckpointblockade
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Jg. 18 (2020) Nr. Suppl. 2: Special Issue: Abstractband anlässlich des 30. Deutschen Hautkrebskongresses (ADO‐Jahrestagung) 09.–12. September 2020, S. FV06
    ISSN: 1610-0387; 1563-2571; 1610-0379; 0301-0481
    Online Volltext: dx.doi.org/
  • Franklin, Cindy; Wetter, Axel; Baba, Hideo Andreas; Cosgarea, Ioana; Mauch, Cornelia; Livingstone, Elisabeth; Zimmer, Lisa; Schadendorf, Dirk; Ugurel, Selma
    Die diagnostische Bedeutung der CT-gesteuerten Punktion bei Hauttumorpatienten
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Jg. 18 (2020) Nr. Suppl. 2: Special Issue: Abstractband anlässlich des 30. Deutschen Hautkrebskongresses (ADO‐Jahrestagung) 09.–12. September 2020, S. FV49
    ISSN: 1610-0387; 1563-2571; 1610-0379; 0301-0481
    Online Volltext: dx.doi.org/
  • Placke, Jan-Malte; Soun, Camille; Bottek, Jenny; Herbst, Rudolf; Terheyden, Patrick; Utikal, Jochen; Pfoehler, Claudia; Ulrich, Jens; Kreuter, Alexander; Pfeiffer, Constance M.; Mohr, Peter; Gutzmer, Ralf; Meier, F.; Dippel, Edgar; Zimmer, Lisa; Livingstone, Elisabeth; Becker, Jürgen; Lodde, Georg; Sucker, Antje; Griewank, Klaus; Horn, Susanne; Hadaschik, Eva; Rösch, Alexander; Engel, Daniel Robert; Schadendorf, Dirk; Ugurel, Selma
    Die digitale Analyse der Tumor PD‐L1 Expression ist ein guter Prädiktor des Therapieerfolgs einer anti‐PD1‐basierten Immuntherapie : Eine Subgruppenanalyse der multizentrischen translationalen Studie ADOREG/TRIM
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Jg. 18 (2020) Nr. Suppl. 2: Special Issue: Abstractband anlässlich des 30. Deutschen Hautkrebskongresses (ADO‐Jahrestagung) 09.–12. September 2020, S. FV36
    ISSN: 1610-0387; 1563-2571; 1610-0379; 0301-0481
    Online Volltext: dx.doi.org/
  • Zhao, F.; Harbers, Franziska; Thier, Beatrice; Stupia, Simone; Zhu, S.; Schwamborn, Marion; Peller, Vladimir; Chauvistre, Heike; Rösch, Alexander; Sucker, Antje; Schadendorf, Dirk; Paschen, Annette
    Distinct melanoma differentiation trajectories driven by MAPKi associate with activation of CD8+tumor-infiltrating lymphocytes
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Jg. 18 (2020) Nr. Suppl. 2: Special Issue: Abstractband anlässlich des 30. Deutschen Hautkrebskongresses (ADO‐Jahrestagung) 09.–12. September 2020, S. FV17
    ISSN: 1610-0387; 1563-2571; 1610-0379; 0301-0481
    Online Volltext: dx.doi.org/
  • Dummer, Reinhard; Biette, Kelly; Gusenleitner, Daniel; Ramesh, Radha; Lebbe, Celeste; Atkinson, Victoria; Mandalà, Mario; Nathan, Paul D.; Arance, Ana; Richtig, Erika; Yamazaki, Naoya; Robert, Caroline; Schadendorf, Dirk; Tawbi, Hussein Abdul-Hassan; Ascierto, Paolo Antonio; Ribas, Antoni; Flaherty, Keith; Gasal, Eduard; Brase, Jan C.; Long, Georgina V.
    Effect of first-line spartalizumab + dabrafenib + trametinib on immunosuppressive features detected in peripheral blood and clinical outcome in patients (pts) with advanced BRAF V600–mutant melanoma
    In: Journal of Clinical Oncology Jg. 38 (2020) Nr. 15_Suppl., S. 10034
    ISSN: 0732-183X; 1527-7755
    Online Volltext: dx.doi.org/
  • Berking, Carola; Schadendorf, Dirk; Weichenthal, Michael; Eigentler, Thomas K.; Schober, Karola; Mohr, Peter; Kiecker, Felix; Loquai, Carmen; Debus, Dirk; Gutzmer, Ralf; Leiter-Stoeppke, Ulrike
    Effektivität von Dabrafenib plus Trametinib bei der Behandlung von Melanompatienten mit BRAFV600‐mutierten Hirnmetastasen
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Jg. 18 (2020) Nr. Suppl. 2: Special Issue: Abstractband anlässlich des 30. Deutschen Hautkrebskongresses (ADO‐Jahrestagung) 09.–12. September 2020, S. P128
    ISSN: 1610-0387; 1563-2571; 1610-0379; 0301-0481
    Online Volltext: dx.doi.org/
  • Lodde, Georg; Ruebben, Albert; Zimmer, Lisa; Livingstone, Elisabeth; Becker, Jürgen; Placke, Jan-Malte; Griewank, Klaus; Hadaschik, Eva; Schadendorf, Dirk; Ugurel, Selma
    Eindrucksvolles und schnelles Therapieansprechen eines metastasierten Adnexkarzinoms unter Cemiplimab
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Jg. 18 (2020) Nr. Suppl. 2: Special Issue: Abstractband anlässlich des 30. Deutschen Hautkrebskongresses (ADO‐Jahrestagung) 09.–12. September 2020, S. FV08
    ISSN: 1610-0387; 1563-2571; 1610-0379; 0301-0481
    Online Volltext: dx.doi.org/
  • Gilde, Christian; Ugurel, Selma; Mohr, Peter; Weichenthal, Michael; Terheyden, Patrick; Meier, F.; Pfoehler, Claudia; Leiter-Stoeppke, Ulrike; Kaatz, Miriam; Haferkamp, Sebastian; Ulrich, Jens; Kochanek, Chris; Schadendorf, Dirk; Gutzmer, Ralf
    Einfluss des BRAF‐V600 Mutationsstatus auf die Effizienz einer Immun‐Checkpoint‐Blockade : Eine Auswertung des ADOREG
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Jg. 18 (2020) Nr. Suppl. 2: Special Issue: Abstractband anlässlich des 30. Deutschen Hautkrebskongresses (ADO‐Jahrestagung) 09.–12. September 2020, S. FV33
    ISSN: 1610-0387; 1563-2571; 1610-0379; 0301-0481
    Online Volltext: dx.doi.org/
  • Richtig, Erika; Debus, Dirk; Stadler, Rudolf; Holler, Christoph; Utikal, Jochen; Dummer, Reinhard; Haferkamp, Sebastian; von Moos, Rover; Michielin, Olivier; Schadendorf, Dirk
    Encorafenib plus Binimetinib bei Patienten mit lokal fortgeschrittenem, inoperablem oder metastasiertem BRAFV600‐mutierten Melanom : Erste Daten der multizentrischen, multinationalen, prospektiven, nicht‐interventionellen Längsschnittstudie BERINGMELANOM
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Jg. 18 (2020) Nr. Suppl. 2: Special Issue: Abstractband anlässlich des 30. Deutschen Hautkrebskongresses (ADO‐Jahrestagung) 09.–12. September 2020, S. P130
    ISSN: 1610-0387; 1563-2571; 1610-0379; 0301-0481
    Online Volltext: dx.doi.org/
  • Weichenthal, Michael; Stadler, Rudolf; Schley, Gaston; Duecker, Pia; Mohr, Peter; Terheyden, Patrick; Debus, Dirk; Utikal, Jochen S.; Schlaak, M.; Gutzmer, Ralf; Susok, Laura; Klemke, Claus-Detlev; Ulrich, Jens; Lang, C.; Schadendorf, Dirk
    E‐Health trifft auf „Real‐World“ : App‐basierte Unterstützung in der adjuvanten Therapie von Melanompatienten im Stadium III mit Dabrafenib und Trametinib (Combi‐EU)
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Jg. 18 (2020) Nr. Suppl. 2: Special Issue: Abstractband anlässlich des 30. Deutschen Hautkrebskongresses (ADO‐Jahrestagung) 09.–12. September 2020, S. FV45
    ISSN: 1610-0387; 1563-2571; 1610-0379; 0301-0481
    Online Volltext: dx.doi.org/
  • Spassova, Ivelina; Ugurel, Selma; Zimmer, Lisa; Schadendorf, Dirk; Terheyden, Patrick; Andtback, H. B.; Villabona, Luis; Leiter-Stoeppke, Ulrike; Eigentler, Thomas K.; Loquai, Carmen; Hassel, Jessica C.; Gambichler, Thilo; Haferkamp, Sebastian; Mohr, Peter; Pfoehler, Claudia; Heinzerling, L.; Horny, Kai; Habermann, Dirk; Hoffmann, D.; Becker, Jürgen
    Immun‐Checkpoint‐Blockade beim Merkelzellkarzinom : Klinische und molekulare Biomarker‐Analyse
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Jg. 18 (2020) Nr. Suppl. 2: Special Issue: Abstractband anlässlich des 30. Deutschen Hautkrebskongresses (ADO‐Jahrestagung) 09.–12. September 2020, S. FV22
    ISSN: 1610-0387; 1563-2571; 1610-0379; 0301-0481
    Online Volltext: dx.doi.org/
  • Weber, Jeffrey; Ascierto, Paolo; Middleton, Mark; Hennicken, Delphine; Zoffoli, Roberto; Pieters, Anne; Amadi, Adenike; Kupas, Katrin; Kotapati, Srividya; Moshyk, Andriy; Schadendorf, Dirk
    Indirect treatment comparison of nivolumab versus placebo as adjuvant treatment for melanoma
    In: Journal for ImmunoTherapy of Cancer Jg. 8 (2020) Nr. Suppl. 3, S. A308
    ISSN: 2051-1426
    Online Volltext: dx.doi.org/ (Open Access)
  • Hauschild, Axel; Dummer, Reinhard; Santinami, Mario; Atkinson, Victoria; Mandalà, Mario; Kirkwood, John M.; Chiarion Sileni, Vanna; Larkin, James M. G.; Nyakas, Marta; Dutriaux, Caroline; Haydon, Andrew Mark; Robert, Caroline; Mortier, Laurent; Schachter, Jacob; Dasgupta, Kohinoor; Gasal, Eduard; Tan, Monique; Long, Georgina V.; Schadendorf, Dirk
    Long-term benefit of adjuvant dabrafenib + trametinib (D+T) in patients (pts) with resected stage III BRAF V600–mutant melanoma : Five-year analysis of COMBI-AD
    In: Journal of Clinical Oncology Jg. 38 (2020) Nr. 15_Suppl., S. 10001
    ISSN: 0732-183X; 1527-7755
    Online Volltext: dx.doi.org/
  • Olischewsky, Alexandra; Schneider, M.; Koch, Fiona; Lodde, Georg; Alt, Clemens; Rösch, Alexander; Ugurel, Selma; Schadendorf, Dirk; Zimmer, Lisa; Livingstone, Elisabeth
    Neoadjuvante Immun‐ und zielgerichtete Therapie bei Melanompatienten im Stadium III B
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Jg. 18 (2020) Nr. Suppl. 2: Special Issue: Abstractband anlässlich des 30. Deutschen Hautkrebskongresses (ADO‐Jahrestagung) 09.–12. September 2020, S. FV44
    ISSN: 1610-0387; 1563-2571; 1610-0379; 0301-0481
    Online Volltext: dx.doi.org/
  • Gutzmer, Ralf; Eigentler, T.; Mohr, P.; Weichenthal, M.; Dücker, P.; Gebhardt, Christoffer; Göppner, D.; Haferkamp, S.; Kähler, Katharina C.; Meier, Friedegund; Pföhler, Claudia; Satzger, Imke; Sickmann, T.; Sindrilaru, Anca; Terheyden, P.; Ugurel, Selma; Ulrich, J.; Utikal, Jens; Weishaupt, C.; Schadendorf, Dirk
    Nivolumab (NIVO) monotherapy or combination therapy with ipilimumab (NIVO+IPI) in advanced melanoma patients with brain metastases : Real-world evidence from the German non-interventional study NICO
    In: Annals of Oncology Jg. 31 (2020) Nr. Suppl. 4, S. 746 - S747
    ISSN: 0923-7534
    Online Volltext: dx.doi.org/ (Open Access)
  • Rischin, Danny; Khushalani, Nikhil I.; Schmults, Chrysalyne D.; Guminski, Alexander David; Chang, Anne Lynn S.; Lewis, Karl D.; Lim, Annette May Ling; Hernandez-Aya, Leonel Fernando; Hughes, Brett Gordon Maxwell; Schadendorf, Dirk; Hauschild, Axel; Stankevich, Elizabeth; Booth, Jocelyn; Li, Siyu; Chen, Zhen; Okoye, Emmanuel; Lowy, Israel; Fury, Matthew G.; Migden, Michael Robert
    Phase II study of cemiplimab in patients (pts) with advanced cutaneous squamous cell carcinoma (CSCC) : Longer follow-up
    In: Journal of Clinical Oncology Jg. 38 (2020) Nr. 15_Suppl.,
    ISSN: 0732-183X; 1527-7755
    Online Volltext: dx.doi.org/
  • Michel, Lars; Hendgen-Cotta, Ulrike B.; Mincu, R.I; Helfrich, Iris; Korste, S; Mrotzek, Simone; Rischpler, C; Herrmann, Ken; Ugurel, Selma; Zimmer, Lisa; Coman, C; Ahrends, R; Schadendorf, Dirk; Rassaf, Tienush; Totzeck, Matthias;
    Preclinical and clinical assessment of immune checkpoint inhibitor-associated left ventricular dysfunction
    ESC Congress 2020 – The Digital Experience 29 August – 1 September 2020,
    In: European Heart Journal Jg. 41 (2020) Nr. Supplement_2, S. 3260
    ISSN: 0195-668X; 1522-9645
    Online Volltext: dx.doi.org/
  • Thier, B.; Such, L.; Schwamborn, M.; Sucker, A.; Coch, C.; Schadendorf, Dirk; Griewank, Klaus; Trilling, Mirko; Zhao, F.; Paschen, Annette
    RIG-I activation enhances melanoma immunogenicity and improves anti-tumor T cell responses in combination with anti-PD-1 immune checkpoint blocking antibodies
    In: Journal for ImmunoTherapy of Cancer Jg. 8 (2020) Nr. Suppl. 2, S. A3
    ISSN: 2051-1426
    Online Volltext: dx.doi.org/ (Open Access)
  • Ugurel, Selma; Satzger, Imke; Eigentler, Thomas K.; Mohr, Peter; Goeppner, Daniela; Herber, Matthew P.; Herbst, Rudolf; Meier, F.; Meiss, Frank; Pfohler, C.; Sachse, Michael Max; Schneider, Stefan W.; Terheyden, Patrick; Ulrich, Jens; Utikal, Jochen; Welzel, Julia; Schadendorf, Dirk; Gutzmer, Ralf
    Real World‐ Daten zur Anwendung von Nivolumab (Nivo) als Monotherapie oder in Kombination mit Ipilimumab (Nivo+Ipi) in der Behandlung des fortgeschrittenen Melanoms : Zwischenergebnisse der nicht‐interventionellen Studie NICO
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Jg. 18 (2020) Nr. Suppl. 2: Special Issue: Abstractband anlässlich des 30. Deutschen Hautkrebskongresses (ADO‐Jahrestagung) 09.–12. September 2020, S. P101
    ISSN: 1610-0387; 1563-2571; 1610-0379; 0301-0481
    Online Volltext: dx.doi.org/
  • Kirkwood, J.M.; Dummer, Reinhard; Hauschild, Axel; Santinami, M.; Atkinson, Victoria; Sileni, Vanna Chiarion; Larkin, J.; Nyakas, M.S.; Haydon, Andrew M.; Dutriaux, Caroline; Schachter, Jacob; Robert, Caroline; Mortier, Laurent; Banerjee, Haimanti; Haas, T.; Tan, M.; Lau, M.; Schadendorf, Dirk; Long, G.V.; Mandala, Mario
    Restricted mean survival time (RMST) and cure-rate modeling in estimating survival benefit with adjuvant dabrafenib (D) plus trametinib (T) treatment in melanoma
    In: Annals of Oncology Jg. 31 (2020) Nr. Suppl. 4, S. 743 - S744
    ISSN: 0923-7534
    Online Volltext: dx.doi.org/ (Open Access)
  • Nathan, Paul D.; Dummer, Reinhard; Long, G.V.; Ascierto, Paolo A.; Tawbi, Hussein A.; Robert, Caroline; Rutkowski, P.; Leonov, O.; Dutriaux, C.; Mandala, Mario; Lorigan, P.; Ferrucci, Pier Francesco; Flaherty, K.T.; Brase, Jan C.; Green, S.; Haas, T.; Masood, A.; Gasal, Eduard; Ribas, A.; Schadendorf, Dirk
    Spartalizumab plus dabrafenib and trametinib (Sparta-DabTram) in patients (pts) with previously untreated BRAF V600–mutant unresectable or metastatic melanoma : Results from the randomized part 3 of the phase III COMBI-i trial
    In: Annals of Oncology Jg. 31 (2020) Nr. Suppl. 4, S. S1172
    ISSN: 0923-7534
    Online Volltext: dx.doi.org/ (Open Access)
  • Long, Georgina V.; Lebbe, Celeste; Atkinson, Victoria; Mandalà, Mario; Nathan, Paul D.; Arance, Ana; Richtig, Erika; Yamazaki, Naoya; Robert, Caroline; Schadendorf, Dirk; Tawbi, Hussein Abdul-Hassan; Ascierto, Paolo Antonio; Ribas, Antoni; Flaherty, Keith; Pakhle, Neha; Masood, Aisha; Gasal, Eduard; Dummer, Reinhard
    The anti–PD-1 antibody spartalizumab in combination with dabrafenib and trametinib in advanced BRAF V600–mutant melanoma : Efficacy and safety findings from parts 1 and 2 of the Phase III COMBI-i trial
    In: Journal of Clinical Oncology Jg. 38 (2020) Nr. 15_Suppl., S. 10028
    ISSN: 0732-183X; 1527-7755
    Online Volltext: dx.doi.org/
  • Lodde, Georg; Forschner, Andrea; Wulfken, Lena M.; Meier, F.; Mohr, Peter; Kaehler, Katharina C.; Schilling, Bastian; Loquai, Carmen; Berking, Carola; Gebhardt, C.; Huening, Svea; Schatton, Kerstin; Eckardt, Josephine; Gutzmer, Ralf; Reinhardt, Lydia; Glutsch, Valerie; Nikfarjam, Ulrike; Erdmann, Michael; Stang, Alexander; Ugurel, Selma; Zimmer, Lisa; Schadendorf, Dirk; Livingstone, Elisabeth
    Therapieentscheidung bei Indikation zur adjuvanten Therapie des Melanoms : Multizentrische Real World Data
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Jg. 18 (2020) Nr. Suppl. 2: Special Issue: Abstractband anlässlich des 30. Deutschen Hautkrebskongresses (ADO‐Jahrestagung) 09.–12. September 2020, S. FV43
    ISSN: 1610-0387; 1563-2571; 1610-0379; 0301-0481
    Online Volltext: dx.doi.org/
  • Michel, Lars; Hendgen-Cotta, Ulrike B.; Mincu, R.I; Helfrich, Iris; Korste, S; Mrotzek, Simone; Schadendorf, Dirk; Rassaf, Tienush; Totzeck, Matthias;
    Tumor necrosis factor alpha blockade prevents immune checkpoint inhibitor therapy-related cardiotoxicity
    ESC Congress 2020 – The Digital Experience 29 August – 1 September 2020,
    In: European Heart Journal Jg. 41 (2020) Nr. Supplement_2, S. 3250
    ISSN: 0195-668X; 1522-9645
    Online Volltext: dx.doi.org/
  • Thier, Beatrice; Such, Lina; Sucker, Antje; Coch, Carla; Hartmann, G.; Schadendorf, Dirk; Griewank, Klaus; Trilling, Mirko; Zhao, F.; Paschen, Annette
    Tumorzell‐intrinsiche Aktivierung des Immunrezeptors RIG‐I in Kombination mit Immun‐Checkpoint‐Blockade verbessert anti‐Tumor T‐Zellantworten
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Jg. 18 (2020) Nr. Suppl. 2: Special Issue: Abstractband anlässlich des 30. Deutschen Hautkrebskongresses (ADO‐Jahrestagung) 09.–12. September 2020, S. FV18
    ISSN: 1610-0387; 1563-2571; 1610-0379; 0301-0481
    Online Volltext: dx.doi.org/
  • Schadendorf, Dirk; Garbe, Carolina; Gutzmer, Ralf; Loquai, Carmen; Fluck, Michael; Kiecker, Felix; Mohr, Peter; Terheyden, Patrick; Gogas, Helen; Ascierto, Paolo A.; Flaherty, Keith T.; Arance, Antonio; Mandala, Marco; Liszkay, Gabriella; Krajsova, Ivana; de Groot, Jan Willem B.; Dutriaux, Caroline; Gollerkeri, Ashwin; Pickard, Michael D.; Robert, Chrissy; Dummer, Reinhard
    Update zum Gesamtüberleben in der COLUMBUS‐Studie : Eine randomisierte Phase 3‐Studie mit Encorafenib (ENCO) plus Binimetinib (BINI) vs Vemurafenib (VEM) oder ENCO bei Patienten mit BRAF V600–mutiertem Melanom
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Jg. 18 (2020) Nr. Suppl. 2: Special Issue: Abstractband anlässlich des 30. Deutschen Hautkrebskongresses (ADO‐Jahrestagung) 09.–12. September 2020, S. P127
    ISSN: 1610-0387; 1563-2571; 1610-0379; 0301-0481
    Online Volltext: dx.doi.org/
  • Robert, Caroline; Dummer, Reinhard; Arance, Ana; Ribas, Antoni; Weber, Jeffrey; Long, Georgina V.; Haanen, John; Nathan, Paul; Ascierto, Paolo A.; Gasal, Eduard; D'Amelio, Anthony; Bettinger, Severine; Boran, Aislyn D.; Schadendorf, Dirk
    A randomized, open-label, open-platform, Phase II study evaluating the efficacy and safety of novel spartalizumab (PDR001) combinations in previously treated unresectable or metastatic melanoma (PLATforM)
    In: Cancer Research Jg. 79 (2019) Nr. Suppl. 13,
    ISSN: 1538-7445; 0008-5472
    Online Volltext: dx.doi.org/
  • Schadendorf, Dirk; Dummer, Reinhard; Hauschild, Axel; Santinami, Mario; Atkinson, Victoria; Mandalà, Mario; Chiarion-Sileni, Vanna; Larkin, James M.G.; Nyakas, Marta; Dutriaux, Caroline; Haydon, Andrew Mark; Mortier, Laurent; Robert, Caroline; Schachter, Jacob; Ortmann, Christine-Elke; De Jong, Egbert; Gasal, Eduard; Kefford, Richard; Kirkwood, John M.; Long, Georgina V.
    Association between baseline disease characteristics and relapse-free survival (RFS) in patients (pts) with BRAF V600-mutant resected stage III melanoma treated with adjuvant dabrafenib (D) + trametinib (T) or placebo (PBO)
    In: Journal of Clinical Oncology Jg. 37 (2019) Nr. 15, S. 9582 - 9582
    ISSN: 0732-183X; 1527-7755
    Online Volltext: dx.doi.org/
  • Jansen, Philipp; Petri, Maximilian; Merz, S.; Brinker, T. J.; Schadendorf, Dirk; Stang, Andreas; Stoffels, Ingo; Klode, Joachim
    Der Stellenwert der Schildwächterlymphknotenentnahme auf das metastasenfreie Überleben von Patienten mit Hoch- risiko-Plattenepithelkarzinomen
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Jg. 17 (2019) Nr. Suppl. 5, S. 23 - 23
    ISSN: 1610-0387; 1563-2571; 1610-0379; 0301-0481
    Online Volltext: dx.doi.org/
  • Izar, Benjamin; Jerby-Arnon, Livnat; Tirosh, Itay; Shah, Parin; Cuoco, Michael C.; Rodman, Christopher; Su, Mei-Ju; Melms, Johannes C.; Leeson, Rachel; Kanodia, Abhay; Lin, Jia-Ren; Boland, Genevieve M.; Zhang, Gao; Hodi, F. Stephen; Sorger, Peter K.; Wucherpfennig, Kai W.; Allen, Eli M. Van; Schadendorf, Dirk; Rozenblatt-Rosen, Orit; Garraway, Levi A.; Rotem, Asaf; Yoon, Charles H.; Regev, Aviv
    Development of therapeutic strategies by resolving the tumor ecosystem
    In: Cancer Research Jg. 79 (2019) Nr. Suppl. 13,
    ISSN: 1538-7445; 0008-5472
    Online Volltext: dx.doi.org/
  • Nathan, Paul D.; Robert, Caroline; Grob, Jean Jacques; Stroyakovskiy, Daniil; Karaszewska, Boguslawa; Hauschild, Axel; Levchenko, Eugeny; Chiarion Sileni, Vanna; Schachter, Jacob; Garbe, Claus; Bondarenko, Igor; Davies, Michael A.; Ribas, Antoni; Flaherty, Keith; Burgess, Paul; Tan, Monique; Gasal, Eduard; Schadendorf, Dirk; Long, Georgina V.
    Five-year analysis on the long-term effects of dabrafenib plus trametinib (D + T) in patients with BRAF V600–mutant unresectable or metastatic melanoma
    In: Journal of Clinical Oncology Jg. 37 (2019) Nr. 15, S. 9507 - 9507
    ISSN: 0732-183X; 1527-7755
    Online Volltext: dx.doi.org/
  • Hodi, F. Stephen; Wolchok, Jedd D.; Schadendorf, Dirk; Larkin, James; Qian, Max; Saci, Abdel; Young, Tina C.; Srinivasan, Sujaya; Chang, Han; Wind-Rotolo, Megan; Rizzo, Jasmine I.; Jackson, Donald G.; Ascierto, Paolo A.
    Genomic analyses and immunotherapy in advanced melanoma
    In: Cancer Research Jg. 79 (2019) Nr. Suppl. 13,
    ISSN: 1538-7445; 0008-5472
    Online Volltext: dx.doi.org/
  • Schadendorf, Dirk; Larkin, James M.G.; Wolchok, Jedd D.; Chiarion-Sileni, Vanna; Taylor, Fiona; Lawrance, Rachael; Moreno-Koehler, Alejandro; Lord-Bessen, Jennifer; Rizzo, Jasmine I.; Moshyk, Andriy; Kotapati, Serividya; Hodi, F. Stephen
    Patient-reported quality of life (QoL) of advanced melanoma patients in a Phase 3 study of nivolumab (NIVO) with or without ipilimumab (IPI) versus IPI : CheckMate 067 4-year data
    In: Journal of Clinical Oncology Jg. 37 (2019) Nr. 15, S. 9551 - 9551
    ISSN: 0732-183X; 1527-7755
    Online Volltext: dx.doi.org/
  • Migden, Michael Robert; Khushalani, Nikhil I.; Chang, Anne Lynn S.; Rischin, Danny; Schmults, Chrysalyne D.; Hernandez-Aya, Leonel Fernando; Meier, Friedegund Elke; Schadendorf, Dirk; Guminski, Alexander David; Hauschild, Axel; Wong, Deborah J.L.; Daniels, Gregory A.; Berking, Carola; Jankovic, Vladimir; Stankevich, Elizabeth; Booth, Jocelyn; Li, Siyu; Lowy, Israel; Fury, Matthew G.; Lewis, Karl D.
    Primary analysis of phase 2 results of cemiplimab, a human monoclonal anti-PD-1, in patients (pts) with locally advanced cutaneous squamous cell carcinoma (laCSCC)
    In: Journal of Clinical Oncology Jg. 37 (2019) Nr. 15, S. 6015 - 6015
    ISSN: 0732-183X; 1527-7755
    Online Volltext: dx.doi.org/
  • Jerby, Livnat; Shah, Parin; Cuoco, Michael S.; Rodman, Christopher; Su, Mei-Ju; Melms, Johannes M.; Leeson, Rachel; Kanodia, Abhay; Mei, Shaolin; Lin, Jia-Ren; Wang, Shu; Rabasha, Bokang; Liu, David; Zhang, Gao; Margolais, Claire; Ashenberg, Orr; Ott, Patrick A.; Buchbinder, Elizabeth I.; Haq, Riz; Hodi, Stephen; Boland, Genevieve M.; Sullivan, Ryan J.; Frederick, Dennie; Miao, Benchun; Moll, Tabea; Flaherty, Keith; Herlyn, Meenhard; Jenkins, Russell S.; Thummalapalli, Rohit; Kowalczyk, Monika S.; Canadas, Israel; Schilling, Bastian; Cartwright, Adam N.R; Luoma, Adrienne M.; Malu, Shruti; Hwu, Patrick; Bernatchez, Chantale; Forget, Marie-Andree; Barbie, David A.; Shalek, Alex K.; Tirosh, Itay; Sorger, Peter K.; Wucherpfennig, Kai W.; Allen, Eliezer M. Van; Schadendorf, Dirk; Johnson, Bruce E.; Rotem, Asaf; Rosenblatt-Rozen, Orit; Garraway, Levi A.; Yoon, Charles H.; Izar, Benjamin; Regev, Aviv;
    Single-cell RNA-sequencing of metastatic melanoma identifies a cancer cell-intrinsic program associated with immune checkpoint inhibitor resistance
    4th CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference: Translating Science into Survival, September 30 - October 3, 2018, New York, NY,
    In: Cancer Immunology Research Jg. 7 (2019) Nr. 2, Supplement, S. A082
    ISSN: 2326-6074; 2326-6066
    Online Volltext: dx.doi.org/
  • Long, Georgina V.; Lebbe, Celeste; Atkinson, Victoria; Mandalà, Mario; Nathan, Paul D.; Arance Fernandez, Ana Maria; Richtig, Erika; Yamazaki, Naoya; Robert, Caroline; Schadendorf, Dirk; Tawbi, Hussein Abdul-Hassan; Ascierto, Paolo Antonio; Ribas, Antoni; Flaherty, Keith; Lee, Dung-Yang; Masood, Aisha; Gasal, Eduard; Dummer, Reinhard
    The anti–PD-1 antibody spartalizumab (S) in combination with dabrafenib (D) and trametinib (T) in previously untreated patients (pts) with advanced BRAF V600–mutant melanoma : Updated efficacy and safety from parts 1 and 2 of COMBI-i
    In: Journal of Clinical Oncology Jg. 37 (2019) Nr. 15, S. 9531 - 9531
    ISSN: 0732-183X; 1527-7755
    Online Volltext: dx.doi.org/
  • Dummer, Reinhard; Gusenleitner, Daniel; Campbell, Catarina D.; Lebbe, Celeste; Atkinson, Victoria; Mandalà, Mario; Nathan, Paul D.; Arance, Ana; Richtig, Erika; Yamazaki, Naoya; Robert, Caroline; Schadendorf, Dirk; Tawbi, Hussein Abdul-Hassan; Ascierto, Paolo Antonio; Ribas, Antoni; Flaherty, Keith; Gasal, Eduard; Brase, Jan C.; Long, Georgina V.
    Tumor microenvironment (TME), longitudinal biomarker changes, and clinical outcome in patients (pts) with advanced BRAF V600–mutant melanoma treated with first-line spartalizumab (S) + dabrafenib (D) + trametinib (T)
    In: Journal of Clinical Oncology Jg. 37 (2019) Nr. 15, S. 9515 - 9515
    ISSN: 0732-183X; 1527-7755
    Online Volltext: dx.doi.org/
  • Liszkay, Gabriella; Gogas, Helen; Mandalà, Mario; Arance Fernandez, Ana Maria; Garbe, Claus; Schadendorf, Dirk; Dummer, Reinhard; Ascierto, Paolo Antonio; Robert, Caroline; Pickard, Michael D.; Sandor, Victor; Gollerkeri, Ashwin; Flaherty, Keith
    Update on overall survival in COLUMBUS : A randomized phase III trial of encorafenib (ENCO) plus binimetinib (BINI) versus vemurafenib (VEM) or ENCO in patients with BRAF V600–mutant melanoma
    In: Journal of Clinical Oncology Jg. 37 (2019) Nr. 15, S. 9512 - 9512
    ISSN: 0732-183X; 1527-7755
    Online Volltext: dx.doi.org/
  • Puig-Butille, J. A.; Potrony, M.; Gimenez-Xavier, P.; Tell-Marti, G.; Rebollo-Morell, A.; Zimmer, Lisa; Carreras, E.; Aranda, F.; Sucker, A.; Schadendorf, Dirk
    Variants in CD5 and IRF4 impact into melanoma survival
    In: European Journal of Human Genetics Jg. 26 (2019) Nr. Suppl., S. 688 - 689
    ISSN: 1018-4813
    Online Volltext: dx.doi.org/ (Open Access)
  • Gogas, H.; Samoylenko, I.; Schadendorf, Dirk; Gutzmer, Ralf; Grob, J.J.; Sacco, Joseph J.; Gorski, Kevin S.; Anderson, Abraham A.; Liu, C.; Malvehy, Rovira, J.
    1246PD - Talimogene laherparepvec (T-VEC) treatment increases intratumoral effector T-cell and natural killer (NK) cell density in noninjected tumors in patients (pts) with stage IIIB–IVM1c melanoma: : Evidence for systemic effects in a phase II, single-arm study
    In: Annals of Oncology Jg. 29 (2018) Nr. 8, S. viii443
    ISSN: 1569-8041; 0923-7534
    Online Volltext: dx.doi.org/ (Open Access)
  • Lipson, Evan J.; Long, Georgina V.; Tawbi, Hussein; Schadendorf, Dirk; Atkinson, Victoria G.; Maurer, M.; Simonsen, Katy L.; Harbison, Christopher T.; Hodi, Frank S.
    A randomized, double-blind, phase II/III study of relatlimab (anti-LAG-3) in combination with nivolumab (anti-PD-1) versus nivolumab alone in previously untreated metastatic or unresectable melanoma
    In: Annals of Oncology Jg. 29 (2018) Nr. Suppl. 8, S. viii464 - viii465
    ISSN: 0923-7534; 1569-8041
    Online Volltext: dx.doi.org/ (Open Access)
  • Weber, Jeffrey S.; Long, Georgina V.; Haanen, John B.; Arance, Ana M.; Dummer, Reinhard G.; Nathan, Paul; Ribas, Antoni; Ascierto, Paolo A.; Robert, Caroline; Gasal, Eduard; D'Amelio, A.; Bettinger, Severine; Boran, A. D.; Schadendorf, Dirk
    A randomized, open-label, phase II open platform study evaluating the efficacy and safety of novel spartalizumab (PDR001) combinations in previously treated unresectable or metastatic melanoma (PLATForM)
    In: Annals of Oncology Jg. 29 (2018) Nr. Suppl. 8, S. viii465 - viii466
    ISSN: 0923-7534
    Online Volltext: dx.doi.org/ (Open Access)
  • Becker, Jürgen; Hassel, Jessica Cecile; Menzer, Christian; Kahler, Katharina C.; Eigentler, Thomas K.; Meier, Friedegund Elke; Berking, Carola; Gutzmer, Ralf; Mohr, Peter; Kiecker, Felix; Kaatz, Martin; Windemuth-Kieselbach, Christiane; Lorenz-Schlüter, Claudia; Zimmer, Lisa; Ugurel, Selma; Schadendorf, Dirk
    Adjuvant ipilimumab compared with observation in completely resected Merkel cell carcinoma (ADMEC) : A randomized, multicenter DeCOG/ADO study
    In: Journal of Clinical Oncology (JCO) Jg. 36 (2018) Nr. Suppl. 15, S. 9527
    ISSN: 0732-183X; 1527-7755
    Online Volltext: dx.doi.org/ (Open Access)
  • Becker, Jürgen; Hassel, J.; Menzer, C.; Hauschild, A.; Eigentler, T.; Meier, F.; Berking, C.; Gutzmer, R.; Mohr, P.; Kiecker, F.; Kaatz, M.; Windemuth‐Kieselbach, C.; Lorenz‐Schlüter, C.; Zimmer, Lisa; Ugurel, Selma; Schadendorf, Dirk; German Dermatooncology Group (DeCOG/ADO);
    Adjuvante Therapie des Merkelzellkarzinoms mit Ipilimumab im Vergleich zur Beobachtung (ADMEC) : eine randomisierte, multizentrische ADO‐Studie
    28. Deutschen Hautkrebskongresses (ADO‐Jahrestagung); 13.–15. September 2018; Stuttgart,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Jg. 16 (2018) Nr. S6, S. 6
    ISSN: 1610-0387; 1563-2571; 1610-0379; 0301-0481
    Online Volltext: dx.doi.org/ (Open Access)
  • Albrecht, M.; Hadaschik, Eva; Zimmer, L.; Livingstone, Elisabeth; Hamacher, R.; Bauer, Sebastian; Schadendorf, Dirk; Ugurel, Selma;
    Angiosarkom im Bereich des Capillitium mit der Symptomatik eines Quincke‐Ödems
    28. Deutschen Hautkrebskongresses (ADO‐Jahrestagung); 13.–15. September 2018; Stuttgart,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Jg. 16 (2018) Nr. Suppl. 6, S. 34
    ISSN: 1610-0387; 1563-2571; 1610-0379; 0301-0481
    Online Volltext: dx.doi.org/ (Open Access)
  • Varaljai, R.; Neuhoff, N.; Sucker, A.; Newton-Bishop, J.; Schadendorf, Dirk; Rösch, Alexander;
    Application of circulating cell-free tumor DNA (ctDNA) profiles for monitoring metastatic melanoma progression under therapy
    45th Annual Meeting of the Arbeitsgemeinschaft Dermatologische Forschung (ADF) ; March 7‐10, 2018, Zürich,
    In: Experimental Dermatology Jg. 27 (2018) Nr. 3, S. e22 - e23
    ISSN: 1600-0625; 0906-6705
    Online Volltext: dx.doi.org/
  • Kanaki, T.; Knispel, Sarah; Chorti, E.; Albrecht, M.; Martaki, A.; Zaremba, Anne; Sucker, A.; Hadaschik, Eva; Rösch, Alexander; Ugurel, Selma; Schadendorf, Dirk; Zimmer, Lisa; Livingstone, Elisabeth;
    Auswirkungen der überarbeiteten AJCC‐Klassifikation (8. Edition) auf das Essener Melanomkollektiv
    28. Deutschen Hautkrebskongresses (ADO‐Jahrestagung); 13.–15. September 2018; Stuttgart,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Jg. 16 (2018) Nr. S6, S. 61 - 62
    ISSN: 1610-0387; 1563-2571; 1610-0379; 0301-0481
    Online Volltext: dx.doi.org/ (Open Access)
  • Placke, Jan-Malte; Knispel, Sarah; Chorti, E.; Albrecht, M.; Kanaki, T.; Jockenhöfer, Finja; Martaki, A.; Zaremba, Anne; Rösch, Alexander; Ugurel, Selma; Schadendorf, Dirk; Livingstone, Elisabeth; Zimmer, Lisa;
    Autoimmunbedingte Gastritis nach Immuncheckpoint‐Blockade : eine Fallserie
    28. Deutschen Hautkrebskongresses (ADO‐Jahrestagung); 13.–15. September 2018; Stuttgart,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Jg. 16 (2018) Nr. S6, S. 26 - 27
    ISSN: 1610-0387; 1563-2571; 1610-0379; 0301-0481
    Online Volltext: dx.doi.org/ (Open Access)
  • Spassova, Ivelina; Ugurel, Selma; Kubat, L.; Terheyden, P.; Hassel, J.; Schadendorf, Dirk; Becker, Jürgen;
    Biomarkers of response to PD‐1 inhibition in Merkel cell carcinoma
    28. Deutschen Hautkrebskongresses (ADO‐Jahrestagung); 13.–15. September 2018; Stuttgart,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Jg. 16 (2018) Nr. S6, S. 5
    ISSN: 1610-0387; 1563-2571; 1610-0379; 0301-0481
    Online Volltext: dx.doi.org/ (Open Access)
  • Kubat, L.; Schrama, D.; Melior, Anita; Herbst, R.; Terheyden, P.; Utikal, J.; Pföhler, C.; Ulrich, J.; Kreuter, A.; Pfeiffer, C.; Mohr, P.; Gutzmer, R.; Schilling, Bastian; Sucker, A.; Meier, F.; Dippel, E.; Kaatz, M.; Zimmer, Lisa; Livingstone, Elisabeth; Schadendorf, Dirk; Ugurel, Selma; Becker, Jürgen;
    CCR5 Δ32 Polymorphismus als prädiktiver Marker für die Therapie mit Immuncheckpoint‐Inhibitoren beim Melanom
    28. Deutschen Hautkrebskongresses (ADO‐Jahrestagung); 13.–15. September 2018; Stuttgart,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Jg. 16 (2018) Nr. S6, S. 49 - 50
    ISSN: 1610-0387; 1563-2571; 1610-0379; 0301-0481
    Online Volltext: dx.doi.org/ (Open Access)
  • Herrera-Rios, D.; Schmitt, V.; Herz, Josephine; Hinze, D.; Pierscianek, Daniela; Kato, M.; Felsberg, J.; Singer, Bernhard B.; Sure, Ulrich; Reifenberger, Guido; Schadendorf, Dirk; Holzel, M.; Helfrich, Iris;
    Catch me if you can! : Novel immune escape mechanisms in melanoma metastases of the brain
    45th Annual Meeting of the Arbeitsgemeinschaft Dermatologische Forschung (ADF) ; March 7‐10, 2018, Zürich,
    In: Experimental Dermatology Jg. 27 (2018) Nr. 3, S. e15
    ISSN: 1600-0625; 0906-6705
    Online Volltext: dx.doi.org/
  • Zaremba, Anne; Chorti, E.; Jockenhöfer, Finja; Albrecht, M.; Placke, Jan-Malte; Knispel, Sarah; Bauer, Sebastian; Podleska, Lars; Schulz, A.; Schimming, Tobias; Hadaschik, Eva; Griewank, Klaus; Schadendorf, Dirk; Rösch, Alexander; Ugurel, Selma; Zimmer, Lisa; Livingstone, Elisabeth
    Clear Cell Sarcoma - a rare Differential Diagnosis of malignant Melanoma
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Jg. 16 (2018) Nr. Suppl. 6, S. 3
    ISSN: 1610-0387; 1563-2571; 1610-0379; 0301-0481
  • Ugurel, Selma; Horn, S.; Griewank, Klaus; Sucker, A.; Herbst, R.; Terheyden, P.; Utikal, J.; Pföhler, C.; Ulrich, J.; Kreuter, A.; Pfeiffer, C.; Mohr, P.; Gutzmer, R.; Weyandt, G.; Meier, F.; Dippel, E.; Kaatz, M.; Weichenthal, M.; Schilling, Bastian; Becker, Jürgen; Zimmer, Lisa; Livingstone, Elisabeth; Rebmann, Vera; Schadendorf, Dirk
    Die Anzahl mutierter Melanom‐assoziierter Gene und die Expression von PD‐L1 sind unabhängige Prädiktoren der anti‐PD1 Immuntherapie ‐ eine prospektive Registerstudie der ADO (ADOREG/TRIM)
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Jg. 16 (2018) Nr. S6, S. 7 - 8
    ISSN: 1610-0387; 1563-2571; 1610-0379; 0301-0481
    Online Volltext: dx.doi.org/ (Open Access)
  • Weichenthal, Michael; Akkooi, Alexander van; Mohr, Peter; Ellebaek, Eva; Svane, Inge Marie; Ugurel-Becker, Selma; Leiter, Ulrike; Hoejberg, Lise; Haanen, John B. A. G.; Schmidt, Henrik; Oellegaard, T. H.; Wouters, Michel W. J. M.; Schadendorf, Dirk; Bastholt, Lars
    EUMelaReg : A European platform for outcome research on real world treatment data of patients with advanced melanoma
    In: Annals of Oncology Jg. 29 (2018) Nr. Suppl. 8, S. viii459
    ISSN: 0923-7534; 1569-8041
    Online Volltext: dx.doi.org/ (Open Access)
  • Knispel, Sarah; Zimmer, Lisa; Gutzmer, R.; Heinzerling, L.; Weishaupt, C.; Pföhler, C.; Gesierich, A.; Herbst, R.; Kähler, K.; Weide, B.; Schlaak, M.; Loquai, C.; Utikal, J.; Terheyden, P.; Kaatz, M.; Berking, C.; Kreuter, A.; Ulrich, J.; Mohr, P.; Dippel, E.; Weichenthal, M.; Livingstone, Elisabeth; Schadendorf, Dirk; Ugurel, Selma;
    Einfluss einer vorangegangenen Radiatio auf den Erfolg einer immunonkologischen Therapie beim metastasierten Melanom – eine retrospektive multizentrische Studie der ADO
    28. Deutschen Hautkrebskongresses (ADO‐Jahrestagung); 13.–15. September 2018; Stuttgart,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Jg. 16 (2018) Nr. S6, S. 28 - 29
    ISSN: 1610-0387; 1563-2571; 1610-0379; 0301-0481
    Online Volltext: dx.doi.org/ (Open Access)
  • Pieper, N.; Zaremba, Anne; Harbers, F. N.; Schwamborn, M.; Lübcke, S.; Schrörs, B.; Sucker, A.; Lennerz, V.; Wölfel, T.; Schadendorf, Dirk; Paschen, Annette; Zhao, F.;
    Evolution of cross‐resistance to CD8+ T cells in the course of BRAF and MEK inhibitor treatment in BRAFV600E melanoma
    28. Deutschen Hautkrebskongresses (ADO‐Jahrestagung); 13.–15. September 2018; Stuttgart,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Jg. 16 (2018) Nr. 6, S. 53
    ISSN: 1610-0387; 1563-2571; 1610-0379; 0301-0481
    Online Volltext: dx.doi.org/ (Open Access)
  • Schaarschmidt, B. M.; Grueneisen, J.; Stebner, Vanessa; Klode, Joachim; Stoffels, Ingo; Umutlu, Lale; Schadendorf, Dirk; Heusch, P.; Antoch, G.; Pöppel, Thorsten
    F-18-FDG PET/MR including DWI in initial N-Staging in patients with malignant melanoma : Is it a possible replacement for sentinel lymph node biopsy?
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 45 (2018) Nr. Suppl. 1, S. 38
    ISSN: 1619-7089
    Online Volltext: dx.doi.org/
  • Vokes, Natalie; Miao, Diana; Margolis, Claire; Liu, David; Wankowicz, Stephanie; Schilling, Bastian; Sholl, Lynette M.; Getz, Gad; Janne, Pasi A.; Haddad, Robert I.; Choueiri, Toni K.; Barbie, David Allen; Haq, Rizwan; Awad, Mark M.; Schadendorf, Dirk; Hodi, F. Stephen; Bellmunt, Joaquim; Wong, Kwok-Kin; Hammerman, Peter S.; Van Allen, Eliezer Mendel
    Genomic correlates of response to immune checkpoint blockade in microsatellite stable solid tumors
    In: Journal of Clinical Oncology (JCO) Jg. 36 (2018) Nr. Suppl. 15, S. 3036
    ISSN: 0732-183X; 1527-7755
    Online Volltext: dx.doi.org/
  • Dummer, R.; Ascierto, P. A.; Gogas, H. J.; Arance, A.; Mandala, M.; Liszkay, G.; Garbe, C.; Schadendorf, Dirk; Krajsova, I.; Gutzmer, R.; Chiarion‐Sileni, V.; Dutriaux, C.; de Groot, J. W.; Yamazaki, N.; Loquai, C.; Moutouh‐de Parseval, L. A.; Pickard, M. D.; Sandor, V.; Robert, C.; Flaherty, K. T.;
    Gesamtüberleben (OS) in COLUMBUS: eine Phase‐III‐Studie mit Encorafenib (ENCO) plus Binimetinib (BINI) vs. Vemurafenib (VEM) oder ENCO beim BRAF‐mutierten Melanom
    28. Deutschen Hautkrebskongresses (ADO‐Jahrestagung); 13.–15. September 2018; Stuttgart,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Jg. 16 (2018) Nr. S6, S. 41
    ISSN: 1610-0387; 1563-2571; 1610-0379; 0301-0481
    Online Volltext: dx.doi.org/ (Open Access)
  • Brinker, T. J.; Klode, Joachim; Esser, Stefan; Schadendorf, Dirk;
    Gesichtsalterungs‐Apps in Warteräumen : Eine neue Möglichkeit für die Hautkrebsprävention?
    28. Deutschen Hautkrebskongresses (ADO‐Jahrestagung); 13.–15. September 2018; Stuttgart,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Jg. 16 (2018) Nr. S6, S. 66 - 67
    ISSN: 1610-0387; 1563-2571; 1610-0379; 0301-0481
    Online Volltext: dx.doi.org/ (Open Access)
  • Brinker, T. J.; Esser, Stefan; Klode, Joachim; Schadendorf, Dirk;
    Gesichtsalterungs‐Apps in Warteräumen von HIV‐positiven Patienten zur Tabakentwöhnung : Führt die öffentliche Selfiebearbeitung zum Aufhörversuch? – eine Interventionsstudie
    28. Deutschen Hautkrebskongresses (ADO‐Jahrestagung); 13.–15. September 2018; Stuttgart,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Jg. 16 (2018) Nr. S6, S. 65 - 66
    ISSN: 1610-0387; 1563-2571; 1610-0379; 0301-0481
    Online Volltext: dx.doi.org/ (Open Access)
  • Brinker, T. J.; Klode, Joachim; Schadendorf, Dirk;
    Gesichtsalterungs‐Apps in der schulischen Melanomprävention: : erste Ergebnisse aus Deutschland und Brasilen – Perspektiven für großflächige Implementation
    Konferenz 28. Deutschen Hautkrebskongresses (ADO‐Jahrestagung); 13.–15. September 2018; Stuttgart,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Jg. 16 (2018) Nr. S6, S. 67
    ISSN: 1610-0387; 1563-2571; 1610-0379; 0301-0481
    Online Volltext: dx.doi.org/ (Open Access)
  • Coens, Corneel; Bottomley, Andrew; Blank, Christian U.; Mandala, Mario; Long, Georgina V.; Atkinson, Victoria G.; Dalle, Stéphane; Haydon, Andrew M. M.; Lichinitser, Mikhail R.; Khattak, Adnan; Carlino, Matteo S.; Sandhu, Shahneen K.; Larkin, James M. G.; Puig Sarda, Susana; Ascierto, Paolo A.; Schadendorf, Dirk; Ibrahim, Nageatte; Suciu, Stefan; Robert, Caroline; Eggermont, Alexander M.M.
    Health-related quality-of-life results for pembrolizumab versus placebo after complete resection of high-risk stage III melanoma from the EORTC 1325-MG/Keynote 054 trial : An international randomized double-blind phase III trial
    In: Annals of Oncology Jg. 29 (2018) Nr. Suppl. 8, S. viii456
    ISSN: 0923-7534; 1569-8041
    Online Volltext: dx.doi.org/ (Open Access)
  • Brunßen, A.; Hübner, J.; Schadendorf, Dirk; Terheyden, P.; Katalinic, Alexander;
    Impact of skin cancer screening on the incidence of advanced melanoma and melanoma mortality : A pilot project for a case-control study in the setting of the German nationwide skin cancer screening (PiKoM)
    33. Deutscher Krebskongress - Perspektiven verändern Krebs - Krebs verändert Perspektiven. Diagnose - Therapie - (Über-)Leben ; 21.-24. Februar 2018, Berlin,
    In: Oncology Research and Treatment Jg. 41 (2018) Nr. Suppl. 1, S. 159
    ISSN: 2296-5262; 2296-5270
    Online Volltext: dx.doi.org/ (Open Access)
  • Wendlinger, S. A.; Wohlfarth, J.; Kerstan, A.; Schwamborn, M.; Sucker, A.; Siedel, C.; Schadendorf, Dirk; Goebeler, Matthias; Schilling, B.;
    Interaction of neutrophils and melanoma in the context of MAP kinase inhibition
    45th Annual Meeting of the Arbeitsgemeinschaft Dermatologische Forschung (ADF) ; March 7‐10, 2018, Zürich,
    In: Experimental Dermatology Jg. 27 (2018) Nr. 3, S. e85 - e86
    ISSN: 1600-0625; 0906-6705
    Online Volltext: dx.doi.org/
  • Zaremba, Anne; Chorti, E.; Jockenhöfer, Finja; Albrecht, M.; Placke, Jan-Malte; Knispel, Sarah; Bauer, Sebastian; Podleska, Lars; Schulz, Andrea; Schimming, T.; Hadaschik, Eva; Griewank, Klaus; Schadendorf, Dirk; Rösch, Alexander; Ugurel, Selma; Zimmer, Lisa; Livingstone, Elisabeth;
    Klarzellsarkom – eine seltene Differentialdiagnose des malignen Melanoms
    28. Deutschen Hautkrebskongresses (ADO‐Jahrestagung); 13.–15. September 2018; Stuttgart,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Jg. 16 (2018) Nr. S6, S. 3
    ISSN: 1610-0387; 1563-2571; 1610-0379; 0301-0481
    Online Volltext: dx.doi.org/ (Open Access)
  • Brinker, T. J.; Enk, A.; Schadendorf, Dirk; Berking, C.; von Kalle, C.;
    Künstliche Intelligenz in der dermatologischen Diagnostik : Das Skin‐Classification‐Projekt
    28. Deutschen Hautkrebskongresses (ADO‐Jahrestagung); 13.–15. September 2018; Stuttgart,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Jg. 16 (2018) Nr. S6, S. 7
    ISSN: 1610-0387; 1563-2571; 1610-0379; 0301-0481
    Online Volltext: dx.doi.org/ (Open Access)
  • Kirchberger, M. C.; Ugurel, Selma; Mangana, J.; Heppt, M.; Eigentler, T.; Berking, C.; Schadendorf, Dirk; Schuler, G.; Dummer, R.; Heinzerling, L.;
    MEK‐Inhibitoren könnten das Überleben von NRAS‐mutierten Melanompatienten unter Checkpoint‐Inhibitoren verbessern : Ergebnisse einer retrospektiven, multizentrischen Analyse von 364 Patienten
    28. Deutschen Hautkrebskongresses (ADO‐Jahrestagung); 13.–15. September 2018; Stuttgart,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Jg. 16 (2018) Nr. S6, S. 4
    ISSN: 1610-0387; 1563-2571; 1610-0379; 0301-0481
    Online Volltext: dx.doi.org/ (Open Access)
  • Chorti, E.; Keyvani, Kathy; Umutlu, Lale; Kanaki, T.; Zaremba, Anne; Jockenhöfer, Finja; Knispel, Sarah; Placke, Jan-Malte; Albrecht, M.; Martaki, A.; Rösch, Alexander; Ugurel, Selma; Schadendorf, Dirk; Livingstone, Elisabeth; Glas, M.; Zimmer, Lisa;
    Meningeosis melanomatosa : Schlechte Prognose trotz neuer Systemtherapeutika
    28. Deutschen Hautkrebskongresses (ADO‐Jahrestagung); 13.–15. September 2018; Stuttgart,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Jg. 16 (2018) Nr. S6, S. 11 - 12
    ISSN: 1610-0387; 1563-2571; 1610-0379; 0301-0481
    Online Volltext: dx.doi.org/ (Open Access)
  • Gutzmer, R.; Eigentler, T.; Mohr, P.; Becker, S.; Haferkamp, S.; Meiß, F.; Pföhler, C.; Satzger, I.; Schneider, S. W.; Terheyden, P.; Ulrich, J.; Utikal, J.; Weichenthal, M.; Weishaupt, C.; Zimmer, Lisa; Schadendorf, Dirk;
    NICO ‐ eine nationale, prospektive, nicht‐interventionelle Studie (NIS) mit Nivolumab als Monotherapie oder in Kombination mit Ipilimumab bei Patienten mit fortgeschrittenem (inoperablem oder metastasiertem) Melanom zur Erhebung von real‐world data
    Konferenz 28. Deutschen Hautkrebskongresses (ADO‐Jahrestagung); 13.–15. September 2018; Stuttgart,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Jg. 16 (2018) Nr. S6, S. 79
    ISSN: 1610-0387; 1563-2571; 1610-0379; 0301-0481
    Online Volltext: dx.doi.org/ (Open Access)
  • Dummer, Reinhard; Ascierto, Paolo Antonio; Gogas, Helen; Arance, Ana M.; Mandalà, Mario; Liszkay, Gabriella; Garbe, Claus; Schadendorf, Dirk; Krajsova, Ivana; Gutzmer, Ralf; Chiarion-Sileni, Vanna; Dutriaux, Caroline; de Groot, Jan Willem; Yamazaki, Naoya; Loquai, Carmen; De Parseval, Laure A.; Pickard, Michael D.; Sandor, Victor; Robert, Caroline; Flaherty, Keith
    Overall survival in COLUMBUS : A phase 3 trial of encorafenib (ENCO) plus binimetinib (BINI) vs vemurafenib (VEM) or enco in BRAF-mutant melanoma
    In: Journal of Clinical Oncology (JCO) Jg. 36 (2018) Nr. Suppl. 15, S. 9504 - 9504
    ISSN: 0732-183X; 1527-7755
    Online Volltext: dx.doi.org/
  • Brütting, J.; Bergmann, M.; Schadendorf, Dirk; Berking, C.; Tilgen, W.; Weber, C.; Meier, F.;
    PAKOME‐RCT: Projektskizze für die Evaluation des Einsatzes einer evidenzbasierten Patienteninformation (EBPI) zum Melanom in der Praxis
    28. Deutschen Hautkrebskongresses (ADO‐Jahrestagung); 13.–15. September 2018; Stuttgart,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Jg. 16 (2018) Nr. S6, S. 60
    ISSN: 1610-0387; 1563-2571; 1610-0379; 0301-0481
    Online Volltext: dx.doi.org/ (Open Access)
  • Zaremba, Anne; Chorti, E.; Jockenhöfer, Finja; Albrecht, M.; Placke, Jan-Malte; Knispel, Sarah; Schadendorf, Dirk; Hadaschik, Eva; Rösch, Alexander; Ugurel, Selma; Zimmer, Lisa; Livingstone, Elisabeth;
    Partielle Remission eines fortgeschrittenen Melanoms durch eine Kombinationstherapie mit Nivolumab und Trametinib nach Therapieversagen unter Ipilimumab + Nivolumab
    28. Deutschen Hautkrebskongresses (ADO‐Jahrestagung); 13.–15. September 2018; Stuttgart,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Jg. 16 (2018) Nr. S6, S. 38
    ISSN: 1610-0387; 1563-2571; 1610-0379; 0301-0481
    Online Volltext: dx.doi.org/ (Open Access)
  • Eggermont, Alexander M.; Blank, Christian U.; Mandala, Mario; Long, Georgina V.; Atkinson, Victoria; Dalle, Stéphane; Haydon, Andrew; Lichinitser, Mikhail; Khattak, Adnan; Carlino, Matteo S.; Sandhu, Shahneen; Larkin, James; Puig, Susana; Ascierto, Paolo A.; Rutkowski, Piotr; Schadendorf, Dirk; Koornstra, Rutger; Hernandez-Aya, Leonel; Maio, Michele; Eertwegh, Alfonsus J. van den; Grob, Jean-Jacques; Gutzmer, Ralf; Jamal, Rahima; Rivas, Veronica; Ibrahim, Nageatte; Marreaud, Sandrine; Janssen, Sven; Akkooi, Alexander van; Suciu, Stefan; Robert, Caroline
    Pembrolizumab versus placebo after complete resection of high-risk stage III melanoma : Efficacy and safety results from the EORTC 1325-MG/Keynote 054 double-blinded phase III trial
    In: Cancer Research Jg. 78 (2018) Nr. Suppl. 13,
    ISSN: 1538-7445; 0008-5472
    Online Volltext: dx.doi.org/
  • Khattak, A.; Robert, C.; Blank, C. U.; Mandala, M.; Long, G. V.; Atkinson, V.; Dalle, S.; Haydon, A.; Lichinitser, M.; Carlino, M. S.; Sandhu, S.; Larkin, J.; Puig, S.; Ascierto, P. A.; Rutkowski, P.; Schadendorf, Dirk; Lorigan, P.; Ibrahim, N.; Suciu, S.; Eggermont, A. M. M.;
    Phase 3 Randomized Eortc 1325‐Mg/Keynote‐054 Study Results: Pembrolizumab Versus Placebo after Complete Resection in Patients with High‐Risk Stage III Melanoma
    Medical Oncology Group of Australia Incorporated Annual Scientific Meeting, New Directions in Personalised Cancer Therapy; 1–3 August 2018; Adelaide, Australia,
    In: Asia-Pacific Journal of Clinical Oncology Jg. 14 (2018) Nr. Supplement 3, S. 48
    ISSN: 1743-7563; 1743-7555
    Online Volltext: dx.doi.org/
  • Löffek, S.; Horn, S.; Dujardin, P.; Hölzel, M.; Schadendorf, Dirk; Helfrich, Iris;
    Potential role of TGF-beta signaling in immune-checkpoint-therapy-induced resistance in malignant melanoma
    45th Annual Meeting of the Arbeitsgemeinschaft Dermatologische Forschung (ADF) ; March 7‐10, 2018, Zürich,
    In: Experimental Dermatology Jg. 27 (2018) Nr. 3, S. e63 - e64
    ISSN: 1600-0625; 0906-6705
    Online Volltext: dx.doi.org/
  • Rischin, Danny; Migden, Michael Robert; Chang, Anne; Chung, Christine H.; Dunn, Lara; Guminski, Alexander; Hauschild, Axel; Hernandez-Aya, Leonel; Hughes, Brett Gordon Maxwell; Lewis, Karl D.; Lim, Annette May Ling; Modi, Badri; Schadendorf, Dirk; Schmults, Chrysalyne; Booth, Jocelyn; Li, Siyu; Mohan, Kosalai Kal; Stankevich, Elizabeth; Lowy, Israel; Fury, Matthew G.
    Primary analysis of phase 2 results for cemiplimab, a human monoclonal anti-PD-1, in patients with metastatic cutaneous squamous cell carcinoma (mCSCC)
    In: Journal of Clinical Oncology (JCO) Jg. 36 (2018) Nr. Suppl. 15, S. 9519 - 9519
    ISSN: 0732-183X; 1527-7755
    Online Volltext: dx.doi.org/ (Open Access)
  • Schadendorf, Dirk; Lewis, Karl; Maio, Michele; Demidov, Lev; Mandalà, Mario; Bondarenko, Igor; Ascierto, Paolo A.; Herbert, Christopher; Mackiewicz, Andrzej; Rutkowski, Piotr; Guminski, Alexander; Goodman, Grant; Simmons, Brian; Ye, Chenglin; Hooper, Gregory; Wongchenk, Matthew J.; Yan, Yibing;
    Prognostic impact of baseline tumor immune infiltrate on disease-free survival (DFS) in patients with completely resected, BRAF(V600) mutation-positive (BRAF(V600+)) melanoma receiving adjuvant vemurafenib
    Immunotherapy Bridge 2017 and Melanoma Bridge 2017 ; 29 November–2 December 2017. Naples, Italy,
    In: Journal of Translational Medicine Jg. 16 (2018) Nr. Suppl. 1, S. O20
    ISSN: 1479-5876
    Online Volltext: dx.doi.org/ (Open Access)
  • Jansen, Philipp; Petri, Maximilian; Schedlowski, Manfred; Schadendorf, Dirk; Stoffels, Ingo; Engler, Harald; Klode, Joachim;
    Prospektive Studie zur Evaluation der perioperativen Angst und des Speichelkortisollevels bei Melanompatienten mit Schildwächterlymphknotenexstirpationen in Tumeszenz‐ vs. Vollnarkose
    28. Deutschen Hautkrebskongresses (ADO‐Jahrestagung); 13.–15. September 2018; Stuttgart,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Jg. 16 (2018) Nr. S6, S. 62
    ISSN: 1610-0387; 1563-2571; 1610-0379; 0301-0481
    Online Volltext: dx.doi.org/ (Open Access)
  • Eigentler, T.; Gutzmer, R.; Mohr, P.; Kaatz, M.; Pföhler, C.; Terheyden, P.; Ulrich, J.; Utikal, J.; Zimmer, Lisa; Schadendorf, Dirk;
    Real-world evidence in melanoma : A national, prospective, non-interventional study (NIS) of nivolumab monotherapy or in combination with ipilimumab in patients with advanced (unresected or metastatic) melanoma (NICO)
    33. Deutscher Krebskongress - Perspektiven verändern Krebs - Krebs verändert Perspektiven. Diagnose - Therapie - (Über-)Leben ; 21.-24. Februar 2018, Berlin,
    In: Oncology Research and Treatment Jg. 41 (2018) Nr. Suppl. 1, S. 159
    ISSN: 2296-5262; 2296-5270
    Online Volltext: dx.doi.org/ (Open Access)
  • Izar, Benjamin; Jerby-Arnon, Livnat; Rotem, Asaf; Shah, Parin; Liu, David; Zhang, Gao; Schilling, Bastian; Rozenblatt-Rosen, Orit; Boland, Genevieve Marie; Hodi, F. Stephen; Flaherty, Keith; Van Allen, Eliezer Mendel; Johnson, Bruce E.; Schadendorf, Dirk; Yoon, Charles; Garraway, Levi A.; Regev, Aviv
    Single-cell RNA-sequencing and -imaging of melanoma ecosystems reveals sources of resistance to immune checkpoint blockade
    In: Journal of Clinical Oncology (JCO) Jg. 36 (2018) Nr. Suppl. 15, S. 3074 - 3074
    ISSN: 0732-183X; 1527-7755
    Online Volltext: dx.doi.org/
  • Dummer, Reinhard; Schadendorf, Dirk; Nathan, Paul; Tawbi, Hussein; Robert, Caroline; Ascierto, Paolo A.; Ribas, Antoni; Lebbé, Celeste; Mandala, Mario; Yamazaki, Naoya; Richtig, Erika; Miller, Wilson H.; Gasal, Eduard; Kaper, Mathilde; Brase, Jan C.; Mookerjee, Bijoyesh; Long, Georgina V.
    The anti-PD-1 antibody spartalizumab (PDR001) in combination with dabrafenib and trametinib in previously untreated patients with advancedBRAFV600-mutant melanoma : First efficacy, safety, and biomarker findings from the part 2 biomarker cohort of COMBi-i
    In: Cancer Research Jg. 78 (2018) Nr. Suppl. 13,
    ISSN: 1538-7445; 0008-5472
    Online Volltext: dx.doi.org/
  • Bischof, L.; Zimmer, Lisa; Livingstone, Elisabeth; Rösch, Alexander; Hadaschik, Eva; Becker, Jürgen; Schadendorf, Dirk; Ugurel, Selma;
    Therapieversagen der Immuncheckpoint‐Blockade mit PD1‐Antikörpern bei Patienten mit metastasierten Hauttumorerkrankungen und gleichzeitiger Immunsuppression durch eine Chronisch Lymphatische Leukämie
    28. Deutschen Hautkrebskongresses (ADO‐Jahrestagung); 13.–15. September 2018; Stuttgart,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Jg. 16 (2018) Nr. S6, S. 28
    ISSN: 1610-0387; 1563-2571; 1610-0379; 0301-0481
    Online Volltext: dx.doi.org/ (Open Access)
  • Gutzmer, R.; Gogas, H. J.; Dummer, R.; Ascierto, P. A.; Arance, A.; Mandala, M.; Liszkay, G.; Garbe, C.; Schadendorf, Dirk; Krajsova, I.; Chiarion‐Sileni, V.; Dutriaux, C.; de Groot, J. W. B.; Yamazaki, N.; Loquai, C.; Moutouh‐de Parseval, L. A.; Pickard, M. D.; Gollerkeri, A.; Robert, C.; Flaherty, K. T.;
    Unerwünschte Ereignisse von besonderem Interesse in der Phase‐3‐COLUMBUS‐Studie
    28. Deutschen Hautkrebskongresses (ADO‐Jahrestagung); 13.–15. September 2018; Stuttgart,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Jg. 16 (2018) Nr. S6, S. 42
    ISSN: 1610-0387; 1563-2571; 1610-0379; 0301-0481
    Online Volltext: dx.doi.org/ (Open Access)
  • Chorti, E.; Tiedje, Vera; Zaremba, Anne; Jockenhöfer, Finja; Hoge, J.; Rösch, Alexander; Ugurel, Selma; Schadendorf, Dirk; Führer, Dagmar; Livingstone, Elisabeth; Zimmer, Lisa
    Diagnostik und Therapie der immunvermittelten Thyreoiditis unter Therapie mit Ipilimumab und Nivolumab
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Jg. 15 (2017) Nr. Suppl. 3, S. 26 - 27
    ISSN: 1610-0387; 1563-2571; 1610-0379; 0301-0481
    Online Volltext: dx.doi.org/
  • Dreesen, J.; Schilling, Bastian; Koldehoff, Michael; Schadendorf, Dirk; Singer, Bernhard B.
    Mechanistic analysis of CD3-driven T cell functions reveals a CD32a polymorphism associated with melanoma emergence
    In: Experimental Dermatology Jg. 24 (2015) Nr. 3, 42nd Annual Meeting of the Arbeitsgemeinschaft Dermatologische Forschung (ADF), March 05-07, 2015, Ulm, Germany, S. E18 - E18
    ISSN: 1600-0625; 0906-6705
    Online Volltext: dx.doi.org/
  • Shannan, B.; Matschke, Johann; Hoewner, A.; Jendrossek, Verena; Schadendorf, Dirk; Rösch, Alexander
    Senescence-like responses in irradiated melanoma cells
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Jg. 13 (2015) Nr. Suppl.2, S. 34
    ISSN: 1610-0387; 1563-2571; 1610-0379; 0301-0481
    Online Volltext: dx.doi.org/
  • Eigentler, Thomas K.; Gutzmer, Ralf; Hauschild, Axel; Kämpgen, Eckhart; Schadendorf, Dirk; Nashan, Dorothee; Hölzle, Erhard; Trefzer, Uwe; Becker, Jürgen C.; Sunderkötter, Cord; Moll, Ingrid; Richtig, Erika; Pönitzsch, Iris; Pehamberger, Hubert; Kaufmann, Roland; Pfoehler, Claudia; Vogt, Thomas; Berking, Carola; Praxmarer, Michael; Garbe, Claus
    Adjuvant therapy with pegylated interferon alfa-2a (PEG-IFN) versus low-dose interferon alfa-2a (IFN) in patients with malignant melanoma in stages IIa(T3a): IIIb (AJCC 2002) : Decog-trial
    In: Journal of Clinical Oncology (JCO) Jg. 32 (2014) Nr. 15, suppl., S. 9071
    ISSN: 0732-183X; 1527-7755
    Online Volltext: dx.doi.org/
  • Lewis, Karl D.; Maio, Michele; Mandalà, Mario; Nelson, Betty J.; Goodman, Grant R.; Schadendorf, Dirk
    BRIM8 : A phase III, randomized, double-blind, placebo-controlled study of vemurafenib adjuvant therapy in patients with surgically resected, cutaneous BRAF-mutant melanoma at high risk for recurrence (NCT01667419)
    In: Journal of Clinical Oncology (JCO) Jg. 32 (2014) Nr. 15, Suppl., S. TPS9118
    ISSN: 0732-183X; 1527-7755
    Online Volltext: dx.doi.org/
  • Reinsch, Nico; Eisele, Lewin; Schwarz, B.; Neumann, Till; Schulze, C.; Holzendorf, V.; Brockmeyer, N.; Schadendorf, Dirk; Erbel, Raimund; Esser, Stefan; HIV-HEART Study Grp;
    Brain natriuretic peptide (BNP) as a prognostic parameter for cardiovascular events and death in HV-infected patients
    ESC Congress 2014, Barcelona, Spain, 30 August – 3 September 2014,
    In: European Heart Journal Jg. 35 (2014) Nr. Suppl. 1, S. 231
    ISSN: 0195-668X; 1522-9645
    Online Volltext: dx.doi.org/
  • Meier, Friedegund Elke; Garbe, Claus; Smalley, Keiran; Flaherty, Keith; Schadendorf, Dirk; Beissert, Stefan; Kulms, Dagmar; Niessner, Heike
    Effect of the BRAF inhibitor LGX818 on endoplasmic reticulum stress and sensitivity of NRAS-mutant melanoma cells to the MEK inhibitor binimetinib
    In: Journal of Clinical Oncology (JCO) Jg. 32 (2014) Nr. 15, Suppl., S. 9062
    ISSN: 0732-183X; 1527-7755
    Online Volltext: dx.doi.org/
  • Reinsch, Nico; Eisele, Lewin; Schwarz, B.; Neumann, Till; Lunschken, F.; Holzendorf, V.; Brockmeyer, N.; Schadendorf, Dirk; Erbel, Raimund; Esser, Stefan;
    Left ventricular ejection fraction as a prognostic marker for all-cause mortality in HIV-infected patients
    ESC Congress 2016, 27 - 31 August, Rome, Italy,
    In: European Heart Journal Jg. 35 (2014) Nr. Suppl. 1, S. 3
    ISSN: 0195-668X; 1522-9645
    Online Volltext: dx.doi.org/
  • Sekulic, Aleksandar; Migden, Michael Robert; Basset-Seguin, Nicole; Garbe, Claus; Gesierich, Anja; Lao, Christopher; Miller, Chris; Mortier, Laurent; Murrell, Dedee F.; Hamid, Omid; Quevedo, Fernando; Hou, Jeannie; Tripathi, Mukta; Schadendorf, Dirk
    Long-term safety and efficacy of vismodegib in patients with advanced basal cell carcinoma : Final update (30-month) of the pivotal ERIVANCE BCC study
    In: Journal of Clinical Oncology (JCO) Jg. 32 (2014) Nr. 15, Suppl., S. 9013
    ISSN: 0732-183X; 1527-7755
    Online Volltext: dx.doi.org/
  • Ascierto, Paolo Antonio; Minor, David R.; Ribas, Antoni; Lebbe, Celeste; O'Hagan, Anne; Swann, R. Suzanne; Scheuber, Anita; Schadendorf, Dirk; Kefford, Richard; Grob, Jean Jacques; Hamid, Omid; Schuchter, Lynn Mara; Simeone, Ester; Wilhelm, Tabea; Kim, Kevin; Aktan, Gursel; Trefzer, Uwe
    Long-term safety and overall survival update for BREAK-2, a phase 2, single-arm, open-label study of dabrafenib in previously treated metastatic melanoma (NCT01153763)
    In: Journal of Clinical Oncology (JCO) Jg. 32 (2014) Nr. 15, suppl., S. 9034
    ISSN: 0732-183X; 1527-7755
    Online Volltext: dx.doi.org/
  • Flaherty, Keith; Arenberger, Petr; Ascierto, Paolo Antonio; De Groot, Jan Willem; Hallmeyer, Sigrun; Long, Georgina V.; Lotem, Michal; Marples, Maria; Schadendorf, Dirk; Starodub, Alexander; Taylor, Matthew Hiram; Wolter, Pascal; Yamazaki, Naoya; Wasserman, Ernesto; Ford, James; Weill, Marine; Dummer, Reinhard
    NEMO : A phase 3 trial of binimetinib (MEK162) versus dacarbazine in patients with untreated or progressed after first-line immunotherapy unresectable or metastatic NRAS-mutant cutaneous melanoma
    In: Journal of Clinical Oncology (JCO) Jg. 32 (2014) Nr. 15, suppl., S. TPS9102 - TPS9102
    ISSN: 0732-183X; 1527-7755
    Online Volltext: dx.doi.org/
  • Zimmer, Lisa; Eigentler, Thomas K.; Vaubel, Julia Marianne; Mohr, Peter; Jradi, Zeinab; Kiecker, Felix; Utikal, Jochen; Berking, Carola; Kämpgen, Eckhart; Hauschild, Axel; Dippel, Edgar; Rompel, Rainer; Fluck, Michael; Stadler, Rudolf; Herbst, Rudolf; Terheyden, Patrick; Garbe, Claus; Loquai, Carmen; Schadendorf, Dirk
    Open-label, multicenter, single-arm phase II study (DeCOG-Trial) to further evaluate the efficacy and safety of ipilimumab in patients with cutaneous melanoma and rare subgroups
    In: Journal of Clinical Oncology (JCO) Jg. 32 (2014) Nr. 15, Suppl., S. 9031
    ISSN: 0732-183X; 1527-7755
    Online Volltext: dx.doi.org/
  • Storim, J.; Verheyen, Jens; Wolff, E.; Wohlschläger, Jeremias; Jablonka, Robert; Heintschel von Heinegg, Evelyn; Schadendorf, Dirk; Esser, Stefan;
    Proktitiden mit N. gonorrhoeae/C. trachomatis führen zur Rekrutierung von HIV-Zielzellen aber nicht zu einer gesteigerten HIV-Sekretion
    Leopoldina-Symposium und STI-Kongress, 18. und 19.–21. Juni 2014, Berlin,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Jg. 12 (2014) Nr. 10, S. 952 - 953
    ISSN: 1610-0387; 1563-2571; 1610-0379; 0301-0481
    Online Volltext: dx.doi.org/
  • Kordelas, L.; Verheyen, Jens; Beelen, Dietrich; Horn, Peter; Heinold, Andreas; Kaiser, R.; Trenschel, Rudolf; Schadendorf, Dirk; Dittmer, Ulf; Esser, Stefan;
    Shift of HIV-Tropism in a HIV-patient with large cell anaplastic T-cell-lymphoma undergoing allogeneic stem cell transplantation from a donor with homozygosity for the CCR5 delta32 mutation
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 10.-14. Oktober 2014, Hamburg,
    In: Oncology Research and Treatment Jg. 37 (2014) Nr. Suppl. 5, S. 38
    ISSN: 2296-5262
    Online Volltext: dx.doi.org/
  • Kähler, Katharina C.; Kornek, Thomas; Blome, Christine; Wagner, Tobias; Utikal, Jochen; Gebhardt, Christoffer; Gutzmer, Ralf; Schenck, Florian; Livingstone, Elisabeth; Schadendorf, Dirk; Loquai, Carmen; Rudolph, Berenice M.; Mohr, Peter; Forschner, Andrea; Garbe, Claus; Terheyden, Patrick; Angün, Ozan; Stade, Barbara; Augustin, Matthias; Hauschild, Axel
    The GERMELATOX DeCOG-trial : German melanoma patients and their attitude toward toxicity during adjuvant interferon treatment
    In: Journal of Clinical Oncology (JCO) Jg. 32 (2014) Nr. 15, suppl., S. TPS9113
    ISSN: 0732-183X; 1527-7755
    Online Volltext: dx.doi.org/
  • Gogas, Helen; Schadendorf, Dirk; Dummer, Reinhard; Garbe, Claus; Lebbe, Celeste; Nathan, Paul D.; Larkin, James M. G.; Haydon, Andrew Mark; Bafaloukos, Dimitris; Robert, Caroline
    Vemurafenib treatment in patients with BRAF-mutated melanoma failing MEK inhibition with trametinib
    In: Journal of Clinical Oncology (JCO) Jg. 32 (2014) Nr. 15, suppl., S. 9061
    ISSN: 0732-183X; 1527-7755
    Online Volltext: dx.doi.org/
  • Buer, Jan; Hutzler, Marina; Helfrich, Iris; Schadendorf, Dirk; Hansen, Wiebke
    Neuropilin-1 mediates infiltration of regulatory T cells into tumors favoring immune escape
    In: Eur J Immunol Jg. 190 (2013) S. P2063
    ISSN: 0014-2980; 1521-4141
  • Griewank, Klaus; Westekemper, Henrike; Schilling, Bastian; Mach, M.; Murali, R.; Wiesner, T.; Schimming, T.; Grabellus, Florian; Metz, C.; Sucker, A.; Hillen, Uwe; Speicher, M.; Woodman, S.; Steuhl, Klaus-Peter; Schadendorf, Dirk
    Oncogene and copy number analysis of a larger cohort of conjunctival melanoma
    In: Experimental Dermatology Jg. 22 (2013) Nr. 3, S. E43
    ISSN: 1600-0625; 0906-6705
  • Warnke, A; Esser, Stefan; Neumann, Till; Schadendorf, Dirk; Potthoff, A; Brockmeyer, N; Reinsch, Nico; Becker-Boost, I; Erbel, Raimund; Hower, M
    A five-year observance of changes in the cardiovascular risk profile in 505 HIV-positive individuals
    In: Journal of the International AIDS Society Jg. 15 (2012) Nr. S4, S. P211
    ISSN: 1758-2652
    Online Volltext: dx.doi.org/ (Open Access)
  • Hodis, Eran; Watson, Ian; Theurillat, Jean-Philippe; Zou, Lihua; Place, Chelsea; Nickerson, Elizabeth; Auclair, Daniel; Cibulskis, Kristian; Sivachenko, Andrey; Kryukov, Gregory; Stransky, Nicolas; Ramos, Alex H.; Voet, Douglas; Lawrence, Michael S.; Stojanov, Petar; Saksena, Gordon; McKenna, Aaron; Carter, Scott L.; Pugh, Trevor; Noble, Michael; Lin, Pei; Lichtenstein, Lee; Zupko, Robert; Sougnez, Carrie; Guiducci, Candace; Onofrio, Robert C.; Ambrogio, Lauren; Fennell, Timothy; Chong, Kelly; Winckler, Wendy; Ardlie, Kristin; Lander, Eric S.; Golub, Todd; Meyerson, Matthew; Gabriel, Stacey B.; Getz, Gad; Wagner, Stefan; Schadendorf, Dirk; Hoon, Dave S. B.; Chin, Lynda; Garraway, Levi A.
    A glimpse into the somatic mutation landscape of melanoma through exome sequencing of 121 tumor-normal pairs
    In: Cancer Research Jg. 72 (2012) Nr. 8, Suppl., S. 5056
    ISSN: 1538-7445; 0008-5472
    Online Volltext: dx.doi.org/
  • Storim, J; Jochum, Christoph; Timm, Jörg; Schadendorf, Dirk; Esser, Stefan
    HIV-infection during treatment of a chronic hepatitis B virus infection : implications for PrEP?
    In: Journal of the International AIDS Society Jg. 15 (2012) Nr. S4, S. P234
    ISSN: 1758-2652
    Online Volltext: dx.doi.org/
  • Robert, Caroline; Flaherty, Keith T.; Hersey, Peter; Nathan, Paul D.; Garbe, Claus; Milhem, Mohammed M.; Demidov, Lev V.; Hassel, Jessica C.; Rutkowski, Piotr; Mohr, Peter; Dummer, Reinhard; Trefzer, Uwe; Larkin, James M. G.; Utikal, Jochen; Casey, Michelle; Sherman, Laurie Jill; Crist, Wendy A.; Wu, Frank S.; Patel, Kiran; Schadendorf, Dirk
    METRIC phase III study : Efficacy of trametinib (T), a potent and selective MEK inhibitor (MEKi), in progression-free survival (PFS) and overall survival (OS), compared with chemotherapy (C) in patients (pts) with BRAFV600E/K mutant advanced or metastatic melanoma (MM)
    In: Journal of Clinical Oncology (JCO) Jg. 30 (2012) Nr. 18, Suppl., S. LBA8509
    ISSN: 0732-183X; 1527-7755
    Online Volltext: dx.doi.org/
  • Voshege, Nadine; Moebus, Susanne; Mohlenkamp, S.; Erbel, Raimund; Jöckel, Karl-Heinz; Körber, Andreas; Schadendorf, Dirk;
    Cardiovascular Risk factors of Psoriasis : Results from the Heinz Nixdorf Recall Study
    46. Tagung der Deutschen Dermatologischen Gesellschaft Vereinigung Deutschsprachiger Dermatologen e. V., 30. März bis 2. April 2011, Dresden,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Jg. 9 (2011) Nr. S1, Abstraktband anläßlich der 46. Tagung der Deutschen Dermatologischen Gesellschaft Vereinigung Deutschsprachiger Dermatologen e. V. in Dresden vom 30. März bis 2. April 2011, S. 147 - 148
    ISSN: 1610-0387; 1563-2571; 1610-0379; 0301-0481
    Online Volltext: dx.doi.org/
  • Spatz, Alan; van Kempen, Leon C.; Job, Bastien; Richon, Catherine; Barrois, Michiel; Dessen, Philipe; Lazar, Vladimir; Michiels, Stefan; Helbling-Leclerc, Anne; Dumay, Anne; Petrella, Teresa; Batist, Gerald; Stas, Marguerite; Schadendorf, Dirk; van den Oord, Joost; Feunteun, Jean
    Gonosome-linked expression of PPP2R3B in cutaneous melanoma correlates with distant metastasis free survival
    In: Cancer Research Jg. 71 (2011) Nr. 8, Suppl., S. 4835
    ISSN: 1538-7445; 0008-5472
    Online Volltext: dx.doi.org/

    • Beiträge in Sammelwerken und Tagungsbänden

  • Schadendorf, Dirk; Flaherty, Keith T.; Duncan, Lyn M.; Kashani-Sabet, Mohammed; Ugurel, Selma
    Biomarkers for Melanoma
    In: Cutaneous Melanoma / Balch, Charles M.; Atkins, Michael B.; Garbe, Claus; Gershenwald, Jeffrey E.; Halpern, Allan C.; Kirkwood, John M.; McArthur, Grant A.; Thompson, John F.; Sober, Arthur J. (Hrsg.) 2020, S. 73 - 104
    ISBN: 978-3-030-05068-9; 978-3-030-05069-6; 978-3-030-05070-2
    Online Volltext: dx.doi.org/
  • Paschen, Annette; Schadendorf, Dirk
    The era of checkpoint inhibition : Lessons learned from melanoma
    In: Current Immunotherapeutic Strategies in Cancer / Theobald, Matthias (Hrsg.) 2020, S. 169 - 187
    ISBN: 978-3-030-23764-6; 978-3-030-23765-3
    Online Volltext: dx.doi.org/
  • Eggermont, Alexander M.M.; Schadendorf, Dirk; Robert, Caroline
    Immune checkpoint inhibitors in melanoma define a new era in immunotherapy aiming for cure
    In: Melanoma Development: Molecular Biology, Genetics and Clinical Application / Bosserhoff, Anja K. (Hrsg.) 2017, S. 427 - 436
    ISBN: 978-3-319-41319-8; 978-3-319-41317-4
    Online Volltext: dx.doi.org/
  • Fink, Wolfram; Schadendorf, Dirk
    The common and the unusual presentation of skin metastases in cancer patients
    In: Handbook of Skin Care in Cancer Patients / Awada, Ahmad; Vereecken, Pierre (Hrsg.) 2012, S. 95 - 115
    ISBN: 9781616684198

    • Forschungsberichte

  • Merz, Simon F.; Jansen, Philipp; Ulankiewicz, Ricarda; Bornemann, Lea; Schimming, Tobias; Griewank, Klaus; Cibir, Zülal; Kraus, Andreas; Stoffels, Ingo; Aspelmeier, Timo; Brandau, Sven; Schadendorf, Dirk; Hadaschik, Eva; Ebel, Gernot; Gunzer, Matthias; Klode, Joachim
    High-resolution 3-D imaging for precise staging in malignant melanoma
    New York (2020) 37 Seiten
    Online Volltext: dx.doi.org/ Online Volltext (Open Access)
  • Chauvistré, Heike; Daignault, Sheena M.; Shannan, Batool; Ju, Robert J.; Picard, Daniel; Vogel, Felix C. E.; Egetemaier, Stefanie; Krepler, Clemens; Rebecca, Vito W.; Sechi, Antonio; Kaschani, Farnusch; Keminer, Oliver; Stehbens, Samantha J.; Váraljai, Renáta; Ninck, Sabrina; Liu, Qin; Yin, Xiangfan; Jeyakumar, Kirujan; Xiao, Min; Löffek, Stefanie; Kubat, Linda; Spassova, Ivelina; Gul, Sheraz; Rahmann, Sven; Horn, Susanne; Ehrmann, Michael; Paschen, Annette; Becker, Jürgen; Helfrich, Iris; Rauh, Daniel; Kaiser, Markus; Remke, Marc; Herlyn, Meenhard; Haass, Nikolas K.; Schadendorf, Dirk; Rösch, Alexander
    The Janus-faced role of KDM5B heterogeneity in melanoma : Differentiation as a situational driver of both growth arrest and drug-resistance
    (2020) 50 Seiten
    Online Volltext: dx.doi.org/ (Open Access)

    • Forschungsdaten

  • Merz, Simon; Jansen, Philipp; Ulankiewicz, Ricarda; Bornemann, Lea; Schimming, Tobias; Griewank, Klaus; Cibir, Zülal; Kraus, Andreas; Stoffels, Ingo; Aspelmeier, Timo; Brandau, Sven; Schadendorf, Dirk; Hadaschik, Eva; Ebel, Gernot; Gunzer, Matthias; Klode, Joachim
    3D data related to : Identification and quantification of hidden melanoma metastases in human sentinel lymph nodes using light sheet fluorescence microscopy
    (2020)
    Online Volltext: dx.doi.org/ Online Volltext; Online Volltext (Open Access)